GO.ID,Term,Annotated,Significant,Expected,classicFisher,bonferroni,bh,foldEnrichment,Ontology
GO:0044237,cellular metabolic process,9392,1032,678.45, 1e-30,4.812e-27,1.1190697674418607e-28,1.52,BP
GO:0008152,metabolic process,10362,1084,748.52, 1e-30,4.812e-27,1.1190697674418607e-28,1.45,BP
GO:0006807,nitrogen compound metabolic process,8802,960,635.83, 1e-30,4.812e-27,1.1190697674418607e-28,1.51,BP
GO:0044238,primary metabolic process,9317,984,673.04, 1e-30,4.812e-27,1.1190697674418607e-28,1.46,BP
GO:1901564,organonitrogen compound metabolic proces...,6107,736,441.15, 1e-30,4.812e-27,1.1190697674418607e-28,1.67,BP
GO:0071704,organic substance metabolic process,9887,1022,714.21, 1e-30,4.812e-27,1.1190697674418607e-28,1.43,BP
GO:0034641,cellular nitrogen compound metabolic pro...,5536,660,399.91, 1e-30,4.812e-27,1.1190697674418607e-28,1.65,BP
GO:0009987,cellular process,15679,1357,1132.61, 1e-30,4.812e-27,1.1190697674418607e-28,1.2,BP
GO:0006518,peptide metabolic process,749,179,54.11, 1e-30,4.812e-27,1.1190697674418607e-28,3.31,BP
GO:0044267,cellular protein metabolic process,4573,565,330.34, 1e-30,4.812e-27,1.1190697674418607e-28,1.71,BP
GO:0071840,cellular component organization or bioge...,6181,698,446.5, 1e-30,4.812e-27,1.1190697674418607e-28,1.56,BP
GO:0034613,cellular protein localization,1709,286,123.45, 1e-30,4.812e-27,1.1190697674418607e-28,2.32,BP
GO:0051641,cellular localization,2629,380,189.91, 1e-30,4.812e-27,1.1190697674418607e-28,2,BP
GO:0006412,translation,572,147,41.32, 1e-30,4.812e-27,1.1190697674418607e-28,3.56,BP
GO:0070727,cellular macromolecule localization,1719,286,124.18, 1e-30,4.812e-27,1.1190697674418607e-28,2.3,BP
GO:0043043,peptide biosynthetic process,595,147,42.98, 1e-30,4.812e-27,1.1190697674418607e-28,3.42,BP
GO:0043603,cellular amide metabolic process,970,196,70.07, 1e-30,4.812e-27,1.1190697674418607e-28,2.8,BP
GO:0016043,cellular component organization,6004,671,433.71, 1e-30,4.812e-27,1.1190697674418607e-28,1.55,BP
GO:0044260,cellular macromolecule metabolic process,7120,757,514.33, 1e-30,4.812e-27,1.1190697674418607e-28,1.47,BP
GO:0043170,macromolecule metabolic process,8366,850,604.34, 1e-30,4.812e-27,1.1190697674418607e-28,1.41,BP
GO:0043604,amide biosynthetic process,701,158,50.64, 1e-30,4.812e-27,1.1190697674418607e-28,3.12,BP
GO:0019538,protein metabolic process,5210,597,376.36, 1e-30,4.812e-27,1.1190697674418607e-28,1.59,BP
GO:0034622,cellular protein-containing complex asse...,1000,193,72.24, 1e-30,4.812e-27,1.1190697674418607e-28,2.67,BP
GO:0065003,protein-containing complex assembly,1740,275,125.69, 1e-30,4.812e-27,1.1190697674418607e-28,2.19,BP
GO:0008104,protein localization,2633,362,190.2, 1e-30,4.812e-27,1.1190697674418607e-28,1.9,BP
GO:0043933,protein-containing complex subunit organ...,1969,296,142.24, 1e-30,4.812e-27,1.1190697674418607e-28,2.08,BP
GO:0044085,cellular component biogenesis,3057,398,220.83, 1e-30,4.812e-27,1.1190697674418607e-28,1.8,BP
GO:0046907,intracellular transport,1523,245,110.02, 1e-30,4.812e-27,1.1190697674418607e-28,2.23,BP
GO:0006996,organelle organization,3599,444,259.98, 1e-30,4.812e-27,1.1190697674418607e-28,1.71,BP
GO:0033036,macromolecule localization,2958,385,213.68, 1e-30,4.812e-27,1.1190697674418607e-28,1.8,BP
GO:0006091,generation of precursor metabolites and ...,385,104,27.81, 1e-30,4.812e-27,1.1190697674418607e-28,3.74,BP
GO:0051649,establishment of localization in cell,1933,284,139.63, 1e-30,4.812e-27,1.1190697674418607e-28,2.03,BP
GO:0045333,cellular respiration,168,67,12.14, 1e-30,4.812e-27,1.1190697674418607e-28,5.52,BP
GO:1901566,organonitrogen compound biosynthetic pro...,1564,245,112.98, 1e-30,4.812e-27,1.1190697674418607e-28,2.17,BP
GO:0009161,ribonucleoside monophosphate metabolic p...,275,86,19.87, 1e-30,4.812e-27,1.1190697674418607e-28,4.33,BP
GO:0046034,ATP metabolic process,246,81,17.77, 1e-30,4.812e-27,1.1190697674418607e-28,4.56,BP
GO:0022900,electron transport chain,87,48,6.28, 1e-30,4.812e-27,1.1190697674418607e-28,7.64,BP
GO:0022607,cellular component assembly,2829,367,204.36, 1e-30,4.812e-27,1.1190697674418607e-28,1.8,BP
GO:0009167,purine ribonucleoside monophosphate meta...,271,84,19.58, 1e-30,4.812e-27,1.1190697674418607e-28,4.29,BP
GO:0009123,nucleoside monophosphate metabolic proce...,284,86,20.52, 1e-30,4.812e-27,1.1190697674418607e-28,4.19,BP
GO:0009126,purine nucleoside monophosphate metaboli...,272,84,19.65, 1e-30,4.812e-27,1.1190697674418607e-28,4.27,BP
GO:0022904,respiratory electron transport chain,83,46,6, 1e-30,4.812e-27,1.1190697674418607e-28,7.67,BP
GO:0009205,purine ribonucleoside triphosphate metab...,271,83,19.58, 1e-30,4.812e-27,1.1190697674418607e-28,4.24,BP
GO:0009144,purine nucleoside triphosphate metabolic...,279,84,20.15,1.2e-30,5.7743999999999994e-27,1.3123636363636363e-28,4.17,BP
GO:0042775,mitochondrial ATP synthesis coupled elec...,59,39,4.26,1.3e-30,6.2556e-27,1.3901333333333334e-28,9.15,BP
GO:0009199,ribonucleoside triphosphate metabolic pr...,275,83,19.87,2.2e-30,1.05864e-26,2.3013913043478256e-28,4.18,BP
GO:0042773,ATP synthesis coupled electron transport,63,40,4.55,2.5e-30,1.203e-26,2.559574468085106e-28,8.79,BP
GO:0045184,establishment of protein localization,1896,272,136.96,6.6e-30,3.1759200000000005e-26,6.6165000000000005e-28,1.99,BP
GO:0009141,nucleoside triphosphate metabolic proces...,295,85,21.31,1.8e-29,8.661599999999999e-26,1.767673469387755e-27,3.99,BP
GO:0007005,mitochondrion organization,468,110,33.81,3.1e-29,1.49172e-25,2.9834400000000003e-27,3.25,BP
GO:0010467,gene expression,4801,531,346.81,5.0e-29,2.406e-25,4.7176470588235296e-27,1.53,BP
GO:0006886,intracellular protein transport,901,163,65.09,1.3e-28,6.2556e-25,1.203e-26,2.5,BP
GO:0033365,protein localization to organelle,789,149,57,3.3e-28,1.5879600000000002e-24,2.9961509433962266e-26,2.61,BP
GO:0006119,oxidative phosphorylation,101,48,7.3,3.4e-28,1.63608e-24,3.029777777777778e-26,6.58,BP
GO:0015980,energy derivation by oxidation of organi...,262,78,18.93,3.6e-28,1.73232e-24,3.149672727272727e-26,4.12,BP
GO:0044249,cellular biosynthetic process,4923,538,355.62,3.8e-28,1.82856e-24,3.2652857142857144e-26,1.51,BP
GO:0044265,cellular macromolecule catabolic process,1024,176,73.97,4.0e-28,1.9248e-24,3.376842105263158e-26,2.38,BP
GO:0044271,cellular nitrogen compound biosynthetic ...,3970,457,286.78,4.9e-28,2.35788e-24,4.065310344827587e-26,1.59,BP
GO:0009057,macromolecule catabolic process,1235,199,89.21,5.0e-28,2.406e-24,4.077966101694916e-26,2.23,BP
GO:1901576,organic substance biosynthetic process,5019,545,362.56,7.1e-28,3.41652e-24,5.6942e-26,1.5,BP
GO:0044248,cellular catabolic process,2013,278,145.41,7.7e-28,3.70524e-24,6.074163934426231e-26,1.91,BP
GO:0044257,cellular protein catabolic process,740,142,53.46,1.2e-27,5.7744e-24,9.313548387096774e-26,2.66,BP
GO:0009056,catabolic process,2279,303,164.63,1.3e-27,6.2556e-24,9.92952380952381e-26,1.84,BP
GO:0030163,protein catabolic process,902,161,65.16,1.4e-27,6.7368e-24,1.052625e-25,2.47,BP
GO:0009058,biosynthetic process,5115,551,369.49,2.4e-27,1.15488e-23,1.7767384615384617e-25,1.49,BP
GO:0051234,establishment of localization,4469,494,322.83,1.8e-26,8.661600000000001e-23,1.3123636363636365e-24,1.53,BP
GO:0051128,regulation of cellular component organiz...,2590,328,187.09,3.3e-26,1.58796e-22,2.3700895522388056e-24,1.75,BP
GO:0051179,localization,5896,608,425.91,1.1e-25,5.293200000000001e-22,7.784117647058824e-24,1.43,BP
GO:0006139,nucleobase-containing compound metabolic...,4840,522,349.63,1.2e-25,5.7744e-22,8.368695652173913e-24,1.49,BP
GO:0009259,ribonucleotide metabolic process,431,99,31.13,1.4e-25,6.7368e-22,9.624e-24,3.18,BP
GO:1901575,organic substance catabolic process,1874,258,135.37,1.6e-25,7.699200000000001e-22,1.084394366197183e-23,1.91,BP
GO:0015031,protein transport,1784,249,128.87,1.8e-25,8.6616e-22,1.203e-23,1.93,BP
GO:0009150,purine ribonucleotide metabolic process,421,97,30.41,3.4e-25,1.63608e-21,2.241205479452055e-23,3.19,BP
GO:0017144,drug metabolic process,727,135,52.52,7.1e-25,3.41652e-21,4.616918918918919e-23,2.57,BP
GO:0019693,ribose phosphate metabolic process,448,100,32.36,8.3e-25,3.99396e-21,5.32528e-23,3.09,BP
GO:1901565,organonitrogen compound catabolic proces...,1158,183,83.65,9.6e-25,4.61952e-21,6.078315789473684e-23,2.19,BP
GO:0051603,proteolysis involved in cellular protein...,696,131,50.28,1.0e-24,4.812e-21,6.169230769230769e-23,2.61,BP
GO:1903827,regulation of cellular protein localizat...,526,110,38,1.0e-24,4.812e-21,6.169230769230769e-23,2.89,BP
GO:0015833,peptide transport,1838,252,132.77,1.2e-24,5.7744e-21,7.217999999999999e-23,1.9,BP
GO:0042886,amide transport,1859,254,134.29,1.2e-24,5.7744e-21,7.217999999999999e-23,1.89,BP
GO:0006725,cellular aromatic compound metabolic pro...,5041,534,364.15,1.8e-24,8.6616e-21,1.0693333333333333e-22,1.47,BP
GO:0046483,heterocycle metabolic process,4969,528,358.95,1.9e-24,9.142800000000001e-21,1.1149756097560977e-22,1.47,BP
GO:0006163,purine nucleotide metabolic process,446,99,32.22,2.3e-24,1.1067600000000001e-20,1.3334457831325301e-22,3.07,BP
GO:0006810,transport,4327,474,312.57,2.8e-24,1.3473600000000001e-20,1.604e-22,1.52,BP
GO:0071705,nitrogen compound transport,2178,283,157.33,4.3e-24,2.0691600000000002e-20,2.434305882352941e-22,1.8,BP
GO:0060341,regulation of cellular localization,971,160,70.14,1.4e-23,6.7368e-20,7.833488372093023e-22,2.28,BP
GO:1901360,organic cyclic compound metabolic proces...,5235,545,378.16,3.0e-23,1.4436e-19,1.6593103448275862e-21,1.44,BP
GO:0009117,nucleotide metabolic process,556,111,40.16,3.4e-23,1.63608e-19,1.859181818181818e-21,2.76,BP
GO:0006457,protein folding,153,53,11.05,5.7e-23,2.74284e-19,3.0818426966292135e-21,4.8,BP
GO:0072521,purine-containing compound metabolic pro...,492,102,35.54,1.1e-22,5.2932e-19,5.816703296703297e-21,2.87,BP
GO:0006753,nucleoside phosphate metabolic process,564,111,40.74,1.1e-22,5.2932e-19,5.816703296703297e-21,2.72,BP
GO:0010257,NADH dehydrogenase complex assembly,45,29,3.25,1.3e-22,6.2556e-19,6.726451612903226e-21,8.92,BP
GO:0032981,mitochondrial respiratory chain complex ...,45,29,3.25,1.3e-22,6.2556e-19,6.726451612903226e-21,8.92,BP
GO:0019941,modification-dependent protein catabolic...,589,113,42.55,4.0e-22,1.9248e-18,2.047659574468085e-20,2.66,BP
GO:0055086,nucleobase-containing small molecule met...,631,118,45.58,4.2e-22,2.02104e-18,2.1274105263157896e-20,2.59,BP
GO:0008219,cell death,2108,270,152.28,5.2e-22,2.50224e-18,2.6065e-20,1.77,BP
GO:0031323,regulation of cellular metabolic process,5454,557,393.98,7.5e-22,3.609e-18,3.720618556701031e-20,1.41,BP
GO:0043632,modification-dependent macromolecule cat...,599,113,43.27,1.6e-21,7.6992e-18,7.856326530612245e-20,2.61,BP
GO:0019222,regulation of metabolic process,6009,598,434.07,4.3e-21,2.06916e-17,2.090060606060606e-19,1.38,BP
GO:0033108,mitochondrial respiratory chain complex ...,78,36,5.63,6.1e-21,2.93532e-17,2.93532e-19,6.39,BP
GO:0051171,regulation of nitrogen compound metaboli...,5150,527,372.02,1.5e-20,7.218000000000001e-17,7.146534653465348e-19,1.42,BP
GO:0006511,ubiquitin-dependent protein catabolic pr...,577,108,41.68,2.5e-20,1.203e-16,1.1794117647058823e-18,2.59,BP
GO:0071702,organic substance transport,2551,305,184.28,2.9e-20,1.39548e-16,1.3548349514563108e-18,1.66,BP
GO:0080090,regulation of primary metabolic process,5295,537,382.5,3.7e-20,1.78044e-16,1.7119615384615383e-18,1.4,BP
GO:0033554,cellular response to stress,1781,233,128.65,4.5e-20,2.1654000000000001e-16,2.0622857142857144e-18,1.81,BP
GO:0034645,cellular macromolecule biosynthetic proc...,4006,430,289.38,6.5e-20,3.1278000000000003e-16,2.9507547169811324e-18,1.49,BP
GO:0009059,macromolecule biosynthetic process,4105,438,296.53,7.8e-20,3.7533600000000003e-16,3.50781308411215e-18,1.48,BP
GO:0055114,oxidation-reduction process,878,141,63.42,8.4e-20,4.04208e-16,3.742666666666667e-18,2.22,BP
GO:0048522,positive regulation of cellular process,5410,543,390.8,2.0e-19,9.624e-16,8.829357798165139e-18,1.39,BP
GO:0051130,positive regulation of cellular componen...,1303,184,94.13,2.6e-19,1.2511200000000001e-15,1.1373818181818181e-17,1.95,BP
GO:1903829,positive regulation of cellular protein ...,302,71,21.82,2.9e-19,1.39548e-15,1.2571891891891892e-17,3.25,BP
GO:0012501,programmed cell death,1947,246,140.65,3.3e-19,1.5879599999999999e-15,1.4178214285714286e-17,1.75,BP
GO:0006915,apoptotic process,1905,242,137.61,3.4e-19,1.6360800000000002e-15,1.4478584070796462e-17,1.76,BP
GO:0048518,positive regulation of biological proces...,6114,596,441.66,8.4e-19,4.04208e-15,3.545684210526316e-17,1.35,BP
GO:0006793,phosphorus metabolic process,2985,337,215.63,1.8e-18,8.6616e-15,7.466896551724139e-17,1.56,BP
GO:0006796,phosphate-containing compound metabolic ...,2963,335,214.04,1.8e-18,8.6616e-15,7.466896551724139e-17,1.57,BP
GO:0009060,aerobic respiration,76,33,5.49,2.7e-18,1.2992399999999999e-14,1.1104615384615384e-16,6.01,BP
GO:0010498,proteasomal protein catabolic process,460,89,33.23,6.9e-18,3.32028e-14,2.813796610169492e-16,2.68,BP
GO:0002181,cytoplasmic translation,83,34,6,7.5e-18,3.609e-14,3.0327731092436977e-16,5.67,BP
GO:0006397,mRNA processing,453,88,32.72,8.1e-18,3.89772e-14,3.2481e-16,2.69,BP
GO:0008380,RNA splicing,366,77,26.44,8.8e-18,4.2345599999999995e-14,3.4996363636363636e-16,2.91,BP
GO:0072657,protein localization to membrane,555,100,40.09,1.0e-17,4.812e-14,3.9442622950819677e-16,2.49,BP
GO:0060255,regulation of macromolecule metabolic pr...,5534,545,399.76,1.1e-17,5.2932e-14,4.3034146341463417e-16,1.36,BP
GO:0019637,organophosphate metabolic process,957,144,69.13,1.3e-17,6.2556e-14,5.044838709677419e-16,2.08,BP
GO:1902600,proton transmembrane transport,90,35,6.5,1.8e-17,8.6616e-14,6.929280000000001e-16,5.38,BP
GO:0022613,ribonucleoprotein complex biogenesis,427,84,30.85,2.1e-17,1.01052e-13,8.019999999999999e-16,2.72,BP
GO:0006396,RNA processing,822,129,59.38,2.4e-17,1.15488e-13,9.093543307086612e-16,2.17,BP
GO:0032880,regulation of protein localization,1057,153,76.35,4.1e-17,1.97292e-13,1.54134375e-15,2,BP
GO:0016192,vesicle-mediated transport,1382,184,99.83,1.2e-16,5.7744e-13,4.476279069767442e-15,1.84,BP
GO:0072594,establishment of protein localization to...,383,77,27.67,1.3e-16,6.2556e-13,4.812e-15,2.78,BP
GO:0016071,mRNA metabolic process,647,108,46.74,1.4e-16,6.7368e-13,5.142595419847328e-15,2.31,BP
GO:0006120,"mitochondrial electron transport, NADH t...",21,17,1.52,1.7e-16,8.1804e-13,6.197272727272727e-15,11.18,BP
GO:0010941,regulation of cell death,1723,216,124.47,1.8e-16,8.661599999999999e-13,6.463880597014925e-15,1.74,BP
GO:0051246,regulation of protein metabolic process,2720,306,196.49,1.8e-16,8.661599999999999e-13,6.463880597014925e-15,1.56,BP
GO:0071826,ribonucleoprotein complex subunit organi...,230,56,16.61,3.4e-16,1.63608e-12,1.2119111111111111e-14,3.37,BP
GO:0022618,ribonucleoprotein complex assembly,217,54,15.68,4.2e-16,2.02104e-12,1.4860588235294117e-14,3.44,BP
GO:0032879,regulation of localization,2869,317,207.25,5.8e-16,2.7909599999999997e-12,2.0371970802919705e-14,1.53,BP
GO:0043161,proteasome-mediated ubiquitin-dependent ...,393,77,28.39,5.9e-16,2.83908e-12,2.0425035971223022e-14,2.71,BP
GO:0033043,regulation of organelle organization,1260,170,91.02,5.9e-16,2.83908e-12,2.0425035971223022e-14,1.87,BP
GO:0009894,regulation of catabolic process,837,127,60.46,6.4e-16,3.07968e-12,2.199771428571429e-14,2.1,BP
GO:0000375,"RNA splicing, via transesterification re...",257,59,18.57,1.0e-15,4.812e-12,3.3650349650349654e-14,3.18,BP
GO:0000377,"RNA splicing, via transesterification re...",257,59,18.57,1.0e-15,4.812e-12,3.3650349650349654e-14,3.18,BP
GO:0000398,"mRNA splicing, via spliceosome",257,59,18.57,1.0e-15,4.812e-12,3.3650349650349654e-14,3.18,BP
GO:0048519,negative regulation of biological proces...,5347,518,386.25,3.4e-15,1.63608e-11,1.1361666666666666e-13,1.34,BP
GO:0032268,regulation of cellular protein metabolic...,2529,284,182.69,3.9e-15,1.87668e-11,1.2942620689655173e-13,1.55,BP
GO:0065009,regulation of molecular function,2513,282,181.53,5.5e-15,2.6466e-11,1.8127397260273975e-13,1.55,BP
GO:0060548,negative regulation of cell death,1067,148,77.08,5.6e-15,2.69472e-11,1.8331428571428574e-13,1.92,BP
GO:0051129,negative regulation of cellular componen...,761,116,54.97,9.0e-15,4.3308e-11,2.926216216216216e-13,2.11,BP
GO:0006508,proteolysis,1661,203,119.99,2.3e-14,1.10676e-10,7.427919463087248e-13,1.69,BP
GO:0043067,regulation of programmed cell death,1573,194,113.63,4.0e-14,1.9248e-10,1.2832e-12,1.71,BP
GO:0031329,regulation of cellular catabolic process,711,109,51.36,4.1e-14,1.9729200000000002e-10,1.3065695364238411e-12,2.12,BP
GO:0090150,establishment of protein localization to...,226,52,16.33,4.6e-14,2.21352e-10,1.4562631578947369e-12,3.18,BP
GO:0065008,regulation of biological quality,4092,411,295.6,5.3e-14,2.55036e-10,1.6669019607843137e-12,1.39,BP
GO:0048523,negative regulation of cellular process,4750,464,343.13,6.1e-14,2.9353200000000004e-10,1.9060519480519483e-12,1.35,BP
GO:0042981,regulation of apoptotic process,1552,191,112.11,7.9e-14,3.80148e-10,2.452567741935484e-12,1.7,BP
GO:0061024,membrane organization,655,102,47.32,1.0e-13,4.812000000000001e-10,3.084615384615385e-12,2.16,BP
GO:0009893,positive regulation of metabolic process,3528,362,254.85,1.7e-13,8.1804e-10,5.210445859872612e-12,1.42,BP
GO:0044093,positive regulation of molecular functio...,1450,180,104.74,2.1e-13,1.01052e-9,6.395696202531645e-12,1.72,BP
GO:0043069,negative regulation of programmed cell d...,955,132,68.99,2.4e-13,1.1548799999999998e-9,7.2633962264150946e-12,1.91,BP
GO:0032386,regulation of intracellular transport,445,77,32.15,5.6e-13,2.69472e-9,1.6842e-11,2.4,BP
GO:0044281,small molecule metabolic process,1760,207,127.14,5.7e-13,2.74284e-9,1.7036273291925464e-11,1.63,BP
GO:0043066,negative regulation of apoptotic process,937,129,67.69,6.1e-13,2.93532e-9,1.8119259259259258e-11,1.91,BP
GO:0016310,phosphorylation,2198,246,158.78,6.2e-13,2.9834399999999998e-9,1.8303312883435583e-11,1.55,BP
GO:0006839,mitochondrial transport,182,44,13.15,6.6e-13,3.17592e-9,1.9365365853658535e-11,3.35,BP
GO:0015985,"energy coupled proton transport, down el...",22,15,1.59,7.5e-13,3.6090000000000003e-9,2.174096385542169e-11,9.43,BP
GO:0015986,ATP synthesis coupled proton transport,22,15,1.59,7.5e-13,3.6090000000000003e-9,2.174096385542169e-11,9.43,BP
GO:0097190,apoptotic signaling pathway,612,95,44.21,9.0e-13,4.3308e-9,2.5932934131736524e-11,2.15,BP
GO:0043254,regulation of protein complex assembly,458,78,33.08,9.2e-13,4.427039999999999e-9,2.635142857142857e-11,2.36,BP
GO:1901135,carbohydrate derivative metabolic proces...,1003,135,72.45,9.3e-13,4.47516e-9,2.6480236686390533e-11,1.86,BP
GO:0006605,protein targeting,260,54,18.78,1.2e-12,5.7743999999999994e-9,3.3967058823529406e-11,2.88,BP
GO:0044087,regulation of cellular component biogene...,957,130,69.13,1.3e-12,6.2556e-9,3.6582456140350876e-11,1.88,BP
GO:0034248,regulation of cellular amide metabolic p...,384,69,27.74,1.5e-12,7.2180000000000005e-9,4.196511627906977e-11,2.49,BP
GO:0006979,response to oxidative stress,402,71,29.04,1.7e-12,8.1804e-9,4.728554913294797e-11,2.44,BP
GO:0097193,intrinsic apoptotic signaling pathway,296,58,21.38,2.4e-12,1.1548799999999999e-8,6.637241379310345e-11,2.71,BP
GO:0010638,positive regulation of organelle organiz...,604,93,43.63,2.5e-12,1.203e-8,6.874285714285714e-11,2.13,BP
GO:1990778,protein localization to cell periphery,355,65,25.64,2.8e-12,1.34736e-8,7.655454545454546e-11,2.54,BP
GO:0051049,regulation of transport,1973,223,142.52,3.6e-12,1.73232e-8,9.787118644067796e-11,1.56,BP
GO:0042176,regulation of protein catabolic process,383,68,27.67,3.9e-12,1.87668e-8,1.0543146067415731e-10,2.46,BP
GO:0051050,positive regulation of transport,1096,142,79.17,4.2e-12,2.02104e-8,1.129072625698324e-10,1.79,BP
GO:0031647,regulation of protein stability,276,55,19.94,4.4e-12,2.11728e-8,1.1762666666666667e-10,2.76,BP
GO:0031325,positive regulation of cellular metaboli...,3240,331,234.05,5.0e-12,2.406e-8,1.329281767955801e-10,1.41,BP
GO:0006413,translational initiation,105,31,7.58,6.5e-12,3.1278000000000004e-8,1.7185714285714286e-10,4.09,BP
GO:0016070,RNA metabolic process,3787,375,273.56,8.4e-12,4.04208e-8,2.2087868852459015e-10,1.37,BP
GO:0090304,nucleic acid metabolic process,4304,416,310.91,1.2e-11,5.7744000000000004e-8,3.1382608695652175e-10,1.34,BP
GO:0070201,regulation of establishment of protein l...,757,107,54.68,1.3e-11,6.255600000000001e-8,3.381405405405405e-10,1.96,BP
GO:0051173,positive regulation of nitrogen compound...,3096,316,223.65,2.0e-11,9.624e-8,5.174193548387097e-10,1.41,BP
GO:0051098,regulation of binding,407,69,29.4,2.4e-11,1.1548800000000001e-7,6.175828877005348e-10,2.35,BP
GO:0048193,Golgi vesicle transport,266,52,19.22,3.6e-11,1.73232e-7,9.214468085106382e-10,2.71,BP
GO:2001242,regulation of intrinsic apoptotic signal...,174,40,12.57,3.9e-11,1.87668e-7,9.929523809523808e-10,3.18,BP
GO:0006417,regulation of translation,334,60,24.13,4.4e-11,2.1172800000000003e-7,1.1027500000000001e-9,2.49,BP
GO:0080135,regulation of cellular response to stres...,674,97,48.69,4.4e-11,2.1172800000000003e-7,1.1027500000000001e-9,1.99,BP
GO:0050684,regulation of mRNA processing,146,36,10.55,4.4e-11,2.1172800000000003e-7,1.1027500000000001e-9,3.41,BP
GO:1903362,regulation of cellular protein catabolic...,244,49,17.63,4.8e-11,2.3097600000000002e-7,1.1967668393782383e-9,2.78,BP
GO:0033157,regulation of intracellular protein tran...,213,45,15.39,5.1e-11,2.45412e-7,1.2650103092783506e-9,2.92,BP
GO:0006464,cellular protein modification process,3496,347,252.54,5.2e-11,2.5022400000000003e-7,1.2766530612244898e-9,1.37,BP
GO:0036211,protein modification process,3496,347,252.54,5.2e-11,2.5022400000000003e-7,1.2766530612244898e-9,1.37,BP
GO:1905475,regulation of protein localization to me...,191,42,13.8,5.9e-11,2.83908e-7,1.4411573604060915e-9,3.04,BP
GO:0042254,ribosome biogenesis,278,53,20.08,6.2e-11,2.98344e-7,1.506787878787879e-9,2.64,BP
GO:0042255,ribosome assembly,61,22,4.41,9.6e-11,4.6195200000000003e-7,2.3213668341708543e-9,4.99,BP
GO:0010604,positive regulation of macromolecule met...,3247,325,234.55,1.0e-10,4.812e-7,2.4059999999999998e-9,1.39,BP
GO:2001233,regulation of apoptotic signaling pathwa...,421,69,30.41,1.1e-10,5.2932e-7,2.6334328358208953e-9,2.27,BP
GO:1903311,regulation of mRNA metabolic process,258,50,18.64,1.2e-10,5.7744e-7,2.858613861386139e-9,2.68,BP
GO:1905477,positive regulation of protein localizat...,105,29,7.58,1.8e-10,8.6616e-7,4.26679802955665e-9,3.83,BP
GO:0072659,protein localization to plasma membrane,287,53,20.73,2.1e-10,1.01052e-6,4.953529411764706e-9,2.56,BP
GO:0070972,protein localization to endoplasmic reti...,58,21,4.19,2.4e-10,1.15488e-6,5.579130434782609e-9,5.01,BP
GO:0048024,"regulation of mRNA splicing, via spliceo...",106,29,7.66,2.4e-10,1.15488e-6,5.579130434782609e-9,3.79,BP
GO:0043484,regulation of RNA splicing,140,34,10.11,2.4e-10,1.15488e-6,5.579130434782609e-9,3.36,BP
GO:0034976,response to endoplasmic reticulum stress,240,47,17.34,2.9e-10,1.3954799999999999e-6,6.70903846153846e-9,2.71,BP
GO:0009889,regulation of biosynthetic process,3570,349,257.89,3.0e-10,1.4436e-6,6.907177033492823e-9,1.35,BP
GO:0009892,negative regulation of metabolic process,2874,291,207.61,3.9e-10,1.87668e-6,8.936571428571429e-9,1.4,BP
GO:0050790,regulation of catalytic activity,1833,202,132.41,4.0e-10,1.9248e-6,9.122274881516587e-9,1.53,BP
GO:0010608,posttranscriptional regulation of gene e...,510,77,36.84,5.1e-10,2.45412e-6,1.1576037735849056e-8,2.09,BP
GO:0010499,proteasomal ubiquitin-independent protei...,23,13,1.66,8.0e-10,3.8496e-6,1.7988785046728972e-8,7.83,BP
GO:0006950,response to stress,3538,344,255.58,8.0e-10,3.8496e-6,1.7988785046728972e-8,1.35,BP
GO:0051186,cofactor metabolic process,506,76,36.55,8.4e-10,4.04208e-6,1.8800372093023255e-8,2.08,BP
GO:0006754,ATP biosynthetic process,133,32,9.61,1.0e-09,4.812000000000001e-6,2.217511520737327e-8,3.33,BP
GO:0010468,regulation of gene expression,3892,372,281.15,1.0e-09,4.812000000000001e-6,2.217511520737327e-8,1.32,BP
GO:0050821,protein stabilization,170,37,12.28,1.1e-09,5.2931999999999996e-6,2.4280733944954127e-8,3.01,BP
GO:0043412,macromolecule modification,3676,354,265.54,1.3e-09,6.2556e-6,2.8564383561643837e-8,1.33,BP
GO:0007006,mitochondrial membrane organization,100,27,7.22,1.4e-09,6.7368e-6,3.062181818181818e-8,3.74,BP
GO:0009156,ribonucleoside monophosphate biosyntheti...,158,35,11.41,1.9e-09,9.1428e-6,4.137013574660634e-8,3.07,BP
GO:1903050,regulation of proteolysis involved in ce...,213,42,15.39,2.1e-09,1.0105200000000001e-5,4.5518918918918925e-8,2.73,BP
GO:0009145,purine nucleoside triphosphate biosynthe...,144,33,10.4,2.2e-09,1.0586399999999999e-5,4.747264573991031e-8,3.17,BP
GO:0006897,endocytosis,615,86,44.43,2.4e-09,1.15488e-5,5.1557142857142857e-8,1.94,BP
GO:1901698,response to nitrogen compound,997,123,72.02,2.7e-09,1.2992400000000001e-5,5.7744000000000004e-8,1.71,BP
GO:0098657,import into cell,749,99,54.11,3.1e-09,1.49172e-5,6.600530973451327e-8,1.83,BP
GO:0031324,negative regulation of cellular metaboli...,2476,253,178.86,3.2e-09,1.53984e-5,6.783436123348017e-8,1.41,BP
GO:0060627,regulation of vesicle-mediated transport,570,81,41.18,3.3e-09,1.58796e-5,6.964736842105264e-8,1.97,BP
GO:0010243,response to organonitrogen compound,898,113,64.87,4.0e-09,1.9248000000000003e-5,8.40524017467249e-8,1.74,BP
GO:0070585,protein localization to mitochondrion,98,26,7.08,4.1e-09,1.97292e-5,8.577913043478262e-8,3.67,BP
GO:0046390,ribose phosphate biosynthetic process,235,44,16.98,4.6e-09,2.2135199999999998e-5,9.54103448275862e-8,2.59,BP
GO:0010556,regulation of macromolecule biosynthetic...,3333,323,240.77,4.6e-09,2.2135199999999998e-5,9.54103448275862e-8,1.34,BP
GO:0051223,regulation of protein transport,725,96,52.37,4.9e-09,2.35788e-5,1.0076410256410257e-7,1.83,BP
GO:0009142,nucleoside triphosphate biosynthetic pro...,156,34,11.27,4.9e-09,2.35788e-5,1.0076410256410257e-7,3.02,BP
GO:0009124,nucleoside monophosphate biosynthetic pr...,164,35,11.85,5.3e-09,2.55036e-5,1.0852595744680851e-7,2.95,BP
GO:0009260,ribonucleotide biosynthetic process,228,43,16.47,5.5e-09,2.6465999999999997e-5,1.1214406779661017e-7,2.61,BP
GO:0070647,protein modification by small protein co...,748,98,54.03,5.9e-09,2.83908e-5,1.1979240506329115e-7,1.81,BP
GO:0009206,purine ribonucleoside triphosphate biosy...,143,32,10.33,7.0e-09,3.3684e-5,1.4152941176470588e-7,3.1,BP
GO:0031326,regulation of cellular biosynthetic proc...,3496,335,252.54,7.5e-09,3.6089999999999995e-5,1.5100418410041838e-7,1.33,BP
GO:0061136,regulation of proteasomal protein catabo...,182,37,13.15,7.8e-09,3.75336e-5,1.5639e-7,2.81,BP
GO:0051247,positive regulation of protein metabolic...,1659,181,119.84,8.0e-09,3.8496000000000005e-5,1.597344398340249e-7,1.51,BP
GO:0006099,tricarboxylic acid cycle,31,14,2.24,8.2e-09,3.94584e-5,1.630512396694215e-7,6.25,BP
GO:0120035,regulation of plasma membrane bounded ce...,784,101,56.63,8.3e-09,3.99396e-5,1.6436049382716048e-7,1.78,BP
GO:2000112,regulation of cellular macromolecule bio...,3241,314,234.12,8.4e-09,4.0420800000000004e-5,1.6565901639344264e-7,1.34,BP
GO:0018130,heterocycle biosynthetic process,3392,326,245.03,9.4e-09,4.52328e-5,1.8462367346938773e-7,1.33,BP
GO:0016999,antibiotic metabolic process,130,30,9.39,9.6e-09,4.61952e-5,1.8778536585365856e-7,3.19,BP
GO:1904951,positive regulation of establishment of ...,467,69,33.73,1.0e-08,4.812e-5,1.9481781376518217e-7,2.05,BP
GO:0009201,ribonucleoside triphosphate biosynthetic...,146,32,10.55,1.2e-08,5.7744e-5,2.3283870967741935e-7,3.03,BP
GO:0009127,purine nucleoside monophosphate biosynth...,154,33,11.12,1.3e-08,6.2556e-5,2.5022400000000003e-7,2.97,BP
GO:0009168,purine ribonucleoside monophosphate bios...,154,33,11.12,1.3e-08,6.2556e-5,2.5022400000000003e-7,2.97,BP
GO:0006101,citrate metabolic process,32,14,2.31,1.4e-08,6.7368e-5,2.662766798418972e-7,6.06,BP
GO:0031330,negative regulation of cellular cataboli...,252,45,18.2,1.4e-08,6.7368e-5,2.662766798418972e-7,2.47,BP
GO:0019438,aromatic compound biosynthetic process,3405,326,245.97,1.4e-08,6.7368e-5,2.662766798418972e-7,1.33,BP
GO:0072350,tricarboxylic acid metabolic process,37,15,2.67,1.5e-08,7.217999999999999e-5,2.808560311284047e-7,5.62,BP
GO:0019219,regulation of nucleobase-containing comp...,3382,324,244.31,1.5e-08,7.217999999999999e-5,2.808560311284047e-7,1.33,BP
GO:0031344,regulation of cell projection organizati...,793,101,57.28,1.5e-08,7.217999999999999e-5,2.808560311284047e-7,1.76,BP
GO:0009152,purine ribonucleotide biosynthetic proce...,219,41,15.82,1.5e-08,7.217999999999999e-5,2.808560311284047e-7,2.59,BP
GO:0072593,reactive oxygen species metabolic proces...,288,49,20.8,1.6e-08,7.699200000000001e-5,2.9841860465116284e-7,2.36,BP
GO:0034654,nucleobase-containing compound biosynthe...,3328,319,240.41,1.9e-08,9.1428e-5,3.53003861003861e-7,1.33,BP
GO:0006164,purine nucleotide biosynthetic process,238,43,17.19,2.1e-08,1.01052e-4,3.8866153846153847e-7,2.5,BP
GO:0072655,establishment of protein localization to...,92,24,6.65,2.3e-08,1.1067600000000001e-4,4.240459770114943e-7,3.61,BP
GO:0090087,regulation of peptide transport,769,98,55.55,2.4e-08,1.15488e-4,4.4079389312977096e-7,1.76,BP
GO:0032270,positive regulation of cellular protein ...,1551,169,112.04,2.9e-08,1.39548e-4,5.306007604562738e-7,1.51,BP
GO:0034599,cellular response to oxidative stress,267,46,19.29,3.0e-08,1.4435999999999998e-4,5.468181818181817e-7,2.38,BP
GO:0031333,negative regulation of protein complex a...,144,31,10.4,3.1e-08,1.49172e-4,5.629132075471697e-7,2.98,BP
GO:0042592,homeostatic process,1899,199,137.18,3.2e-08,1.5398400000000002e-4,5.788872180451129e-7,1.45,BP
GO:1902115,regulation of organelle assembly,208,39,15.03,3.3e-08,1.58796e-4,5.947415730337078e-7,2.59,BP
GO:1901701,cellular response to oxygen-containing c...,1207,138,87.19,3.6e-08,1.73232e-4,6.463880597014925e-7,1.58,BP
GO:0043085,positive regulation of catalytic activit...,1065,125,76.93,3.8e-08,1.82856e-4,6.772444444444446e-7,1.62,BP
GO:0072522,purine-containing compound biosynthetic ...,243,43,17.55,3.8e-08,1.82856e-4,6.772444444444446e-7,2.45,BP
GO:0045727,positive regulation of translation,123,28,8.89,4.1e-08,1.97292e-4,7.280147601476014e-7,3.15,BP
GO:0034250,positive regulation of cellular amide me...,147,31,10.62,5.2e-08,2.50224e-4,9.199411764705883e-7,2.92,BP
GO:0042274,ribosomal small subunit biogenesis,63,19,4.55,5.3e-08,2.55036e-4,9.341978021978023e-7,4.18,BP
GO:1901293,nucleoside phosphate biosynthetic proces...,290,48,20.95,5.6e-08,2.69472e-4,9.79898181818182e-7,2.29,BP
GO:0009895,negative regulation of catabolic process,299,49,21.6,5.6e-08,2.69472e-4,9.79898181818182e-7,2.27,BP
GO:1901362,organic cyclic compound biosynthetic pro...,3529,332,254.93,6.4e-08,3.0796800000000004e-4,1.1117978339350182e-6,1.3,BP
GO:0032269,negative regulation of cellular protein ...,1020,120,73.68,6.4e-08,3.0796800000000004e-4,1.1117978339350182e-6,1.63,BP
GO:0051248,negative regulation of protein metabolic...,1087,126,78.52,6.8e-08,3.27216e-4,1.1770359712230217e-6,1.6,BP
GO:0070887,cellular response to chemical stimulus,3063,294,221.26,7.2e-08,3.46464e-4,1.241806451612903e-6,1.33,BP
GO:0009165,nucleotide biosynthetic process,284,47,20.52,7.7e-08,3.70524e-4,1.3233e-6,2.29,BP
GO:0072599,establishment of protein localization to...,36,14,2.6,8.3e-08,3.99396e-4,1.421338078291815e-6,5.38,BP
GO:0019725,cellular homeostasis,940,112,67.9,9.2e-08,4.4270400000000004e-4,1.5698723404255318e-6,1.65,BP
GO:1905897,regulation of response to endoplasmic re...,78,21,5.63,9.5e-08,4.5714000000000003e-4,1.6153356890459365e-6,3.73,BP
GO:1903076,regulation of protein localization to pl...,113,26,8.16,9.8e-08,4.71576e-4,1.6604788732394365e-6,3.19,BP
GO:0010639,negative regulation of organelle organiz...,407,60,29.4,9.9e-08,4.76388e-4,1.6715368421052634e-6,2.04,BP
GO:0051172,negative regulation of nitrogen compound...,2297,230,165.93,1.0e-07,4.812e-4,1.6825174825174826e-6,1.39,BP
GO:2001243,negative regulation of intrinsic apoptot...,99,24,7.15,1.1e-07,5.2932e-4,1.8315570934256057e-6,3.36,BP
GO:1901700,response to oxygen-containing compound,1593,170,115.07,1.1e-07,5.2932e-4,1.8315570934256057e-6,1.48,BP
GO:0030162,regulation of proteolysis,730,92,52.73,1.1e-07,5.2932e-4,1.8315570934256057e-6,1.74,BP
GO:0032271,regulation of protein polymerization,218,39,15.75,1.2e-07,5.774399999999999e-4,1.991172413793103e-6,2.48,BP
GO:0045047,protein targeting to ER,32,13,2.31,1.3e-07,6.2556e-4,2.1496907216494846e-6,5.63,BP
GO:1990542,mitochondrial transmembrane transport,73,20,5.27,1.4e-07,6.736800000000001e-4,2.307123287671233e-6,3.8,BP
GO:1903078,positive regulation of protein localizat...,61,18,4.41,1.7e-07,8.180399999999999e-4,2.791945392491467e-6,4.08,BP
GO:0070925,organelle assembly,801,98,57.86,1.8e-07,8.661599999999999e-4,2.9262162162162166e-6,1.69,BP
GO:1904375,regulation of protein localization to ce...,139,29,10.04,1.8e-07,8.661599999999999e-4,2.9262162162162166e-6,2.89,BP
GO:0016482,cytosolic transport,147,30,10.62,1.8e-07,8.661599999999999e-4,2.9262162162162166e-6,2.82,BP
GO:0032527,protein exit from endoplasmic reticulum,44,15,3.18,2.2e-07,0.00105864,3.5524832214765105e-6,4.72,BP
GO:0010942,positive regulation of cell death,710,89,51.29,2.2e-07,0.00105864,3.5524832214765105e-6,1.74,BP
GO:1903047,mitotic cell cycle process,658,84,47.53,2.3e-07,0.00110676,3.701538461538461e-6,1.77,BP
GO:0009896,positive regulation of catabolic process,428,61,30.92,2.6e-07,0.00125112,4.156544850498339e-6,1.97,BP
GO:1904377,positive regulation of protein localizat...,69,19,4.98,2.6e-07,0.00125112,4.156544850498339e-6,3.82,BP
GO:0031331,positive regulation of cellular cataboli...,361,54,26.08,2.7e-07,0.0012992400000000001,4.287920792079208e-6,2.07,BP
GO:1901998,toxin transport,39,14,2.82,2.7e-07,0.0012992400000000001,4.287920792079208e-6,4.96,BP
GO:0090316,positive regulation of intracellular pro...,134,28,9.68,2.8e-07,0.0013473600000000001,4.4031372549019606e-6,2.89,BP
GO:0070199,establishment of protein localization to...,24,11,1.73,2.8e-07,0.0013473600000000001,4.4031372549019606e-6,6.36,BP
GO:0010035,response to inorganic substance,498,68,35.97,2.8e-07,0.0013473600000000001,4.4031372549019606e-6,1.89,BP
GO:0032535,regulation of cellular component size,400,58,28.89,2.9e-07,0.00139548,4.530779220779221e-6,2.01,BP
GO:2001234,negative regulation of apoptotic signali...,234,40,16.9,2.9e-07,0.00139548,4.530779220779221e-6,2.37,BP
GO:0051258,protein polymerization,279,45,20.15,3.1e-07,0.00149172,4.827572815533981e-6,2.23,BP
GO:0051656,establishment of organelle localization,481,66,34.75,3.5e-07,0.0016841999999999998,5.432903225806452e-6,1.9,BP
GO:0000380,"alternative mRNA splicing, via spliceoso...",77,20,5.56,3.6e-07,0.0017323199999999999,5.5701607717041806e-6,3.6,BP
GO:2000377,regulation of reactive oxygen species me...,202,36,14.59,4.0e-07,0.0019248,6.149520766773163e-6,2.47,BP
GO:0050794,regulation of cellular process,10724,868,774.67,4.0e-07,0.0019248,6.149520766773163e-6,1.12,BP
GO:0032446,protein modification by small protein co...,627,80,45.29,4.5e-07,0.0021654,6.8961783439490446e-6,1.77,BP
GO:0008637,apoptotic mitochondrial changes,114,25,8.24,4.6e-07,0.00221352,7.004810126582278e-6,3.03,BP
GO:0030100,regulation of endocytosis,292,46,21.09,4.6e-07,0.00221352,7.004810126582278e-6,2.18,BP
GO:0042221,response to chemical,4182,378,302.1,4.7e-07,0.00226164,7.134511041009464e-6,1.25,BP
GO:0006888,ER to Golgi vesicle-mediated transport,122,26,8.81,4.9e-07,0.0023578799999999997,7.391473354231974e-6,2.95,BP
GO:0000381,"regulation of alternative mRNA splicing,...",65,18,4.7,4.9e-07,0.0023578799999999997,7.391473354231974e-6,3.83,BP
GO:0010605,negative regulation of macromolecule met...,2612,252,188.68,5.2e-07,0.00250224,7.8195e-6,1.34,BP
GO:0099173,postsynapse organization,196,35,14.16,5.5e-07,0.0026466000000000003,8.244859813084113e-6,2.47,BP
GO:0036473,cell death in response to oxidative stre...,93,22,6.72,5.6e-07,0.0026947200000000003,8.368695652173914e-6,3.27,BP
GO:0016032,viral process,285,45,20.59,5.7e-07,0.0027428400000000003,8.465555555555555e-6,2.19,BP
GO:0035304,regulation of protein dephosphorylation,86,21,6.21,5.7e-07,0.0027428400000000003,8.465555555555555e-6,3.38,BP
GO:0034504,protein localization to nucleus,276,44,19.94,5.8e-07,0.00279096,8.56122699386503e-6,2.21,BP
GO:0032388,positive regulation of intracellular tra...,205,36,14.81,5.8e-07,0.00279096,8.56122699386503e-6,2.43,BP
GO:0031334,positive regulation of protein complex a...,249,41,17.99,5.9e-07,0.00283908,8.629422492401216e-6,2.28,BP
GO:0007010,cytoskeleton organization,1323,143,95.57,5.9e-07,0.00283908,8.629422492401216e-6,1.5,BP
GO:0006612,protein targeting to membrane,108,24,7.8,5.9e-07,0.00283908,8.629422492401216e-6,3.08,BP
GO:0007049,cell cycle,1659,172,119.84,6.1e-07,0.00293532,8.894909090909092e-6,1.44,BP
GO:0000278,mitotic cell cycle,813,97,58.73,6.5e-07,0.0031278,9.449546827794561e-6,1.65,BP
GO:0022604,regulation of cell morphogenesis,530,70,38.29,6.7e-07,0.00322404,9.710963855421688e-6,1.83,BP
GO:0050789,regulation of biological process,11466,919,828.27,7.1e-07,0.0034165199999999997,1.025981981981982e-5,1.11,BP
GO:0006891,intra-Golgi vesicle-mediated transport,26,11,1.88,7.6e-07,0.0036571200000000002,1.094946107784431e-5,5.85,BP
GO:0098876,vesicle-mediated transport to the plasma...,102,23,7.37,7.7e-07,0.0037052400000000003,1.1060417910447763e-5,3.12,BP
GO:2000378,negative regulation of reactive oxygen s...,67,18,4.84,8.0e-07,0.0038496,1.1457142857142857e-5,3.72,BP
GO:0043393,regulation of protein binding,243,40,17.55,8.1e-07,0.00389772,1.156593471810089e-5,2.28,BP
GO:0031345,negative regulation of cell projection o...,208,36,15.03,8.3e-07,0.00399396,1.1781592920353982e-5,2.4,BP
GO:0051099,positive regulation of binding,208,36,15.03,8.3e-07,0.00399396,1.1781592920353982e-5,2.4,BP
GO:0006626,protein targeting to mitochondrion,74,19,5.35,8.5e-07,0.0040902000000000004,1.203e-5,3.55,BP
GO:0031346,positive regulation of cell projection o...,474,64,34.24,9.3e-07,0.00447516,1.3123636363636363e-5,1.87,BP
GO:0006914,autophagy,395,56,28.53,9.5e-07,0.0045714,1.3327696793002915e-5,1.96,BP
GO:0061919,process utilizing autophagic mechanism,395,56,28.53,9.5e-07,0.0045714,1.3327696793002915e-5,1.96,BP
GO:0008631,intrinsic apoptotic signaling pathway in...,43,14,3.11,1.1e-06,0.0052932000000000005,1.5123428571428574e-5,4.5,BP
GO:1903312,negative regulation of mRNA metabolic pr...,82,20,5.92,1.1e-06,0.0052932000000000005,1.5123428571428574e-5,3.38,BP
GO:0010256,endomembrane system organization,387,55,27.96,1.1e-06,0.0052932000000000005,1.5123428571428574e-5,1.97,BP
GO:0099175,regulation of postsynapse organization,127,26,9.17,1.1e-06,0.0052932000000000005,1.5123428571428574e-5,2.84,BP
GO:0045862,positive regulation of proteolysis,339,50,24.49,1.1e-06,0.0052932000000000005,1.5123428571428574e-5,2.04,BP
GO:0051493,regulation of cytoskeleton organization,548,71,39.59,1.1e-06,0.0052932000000000005,1.5123428571428574e-5,1.79,BP
GO:0000302,response to reactive oxygen species,202,35,14.59,1.1e-06,0.0052932000000000005,1.5123428571428574e-5,2.4,BP
GO:0044089,positive regulation of cellular componen...,538,70,38.86,1.2e-06,0.0057744,1.631186440677966e-5,1.8,BP
GO:0044403,symbiont process,349,51,25.21,1.2e-06,0.0057744,1.631186440677966e-5,2.02,BP
GO:0051252,regulation of RNA metabolic process,3073,287,221.99,1.2e-06,0.0057744,1.631186440677966e-5,1.29,BP
GO:0051336,regulation of hydrolase activity,1001,113,72.31,1.2e-06,0.0057744,1.631186440677966e-5,1.56,BP
GO:0051222,positive regulation of protein transport,448,61,32.36,1.3e-06,0.0062556,1.752268907563025e-5,1.89,BP
GO:0065007,biological regulation,12076,960,872.34,1.3e-06,0.0062556,1.752268907563025e-5,1.1,BP
GO:0032272,negative regulation of protein polymeriz...,76,19,5.49,1.3e-06,0.0062556,1.752268907563025e-5,3.46,BP
GO:1902903,regulation of supramolecular fiber organ...,351,51,25.36,1.4e-06,0.006736799999999999,1.8817877094972067e-5,2.01,BP
GO:0043065,positive regulation of apoptotic process,647,80,46.74,1.6e-06,0.0076992,2.144623955431755e-5,1.71,BP
GO:0045807,positive regulation of endocytosis,171,31,12.35,1.7e-06,0.0081804000000000009,2.2723333333333333e-5,2.51,BP
GO:0030036,actin cytoskeleton organization,670,82,48.4,1.8e-06,0.0086616,2.3795604395604394e-5,1.69,BP
GO:0022411,cellular component disassembly,364,52,26.29,1.8e-06,0.0086616,2.3795604395604394e-5,1.98,BP
GO:0070198,"protein localization to chromosome, telo...",28,11,2.02,1.8e-06,0.0086616,2.3795604395604394e-5,5.45,BP
GO:0031399,regulation of protein modification proce...,1783,180,128.8,1.8e-06,0.0086616,2.3795604395604394e-5,1.4,BP
GO:0032206,positive regulation of telomere maintena...,51,15,3.68,1.9e-06,0.0091428,2.4912261580381472e-5,4.08,BP
GO:0032781,positive regulation of ATPase activity,39,13,2.82,1.9e-06,0.0091428,2.4912261580381472e-5,4.61,BP
GO:0043462,regulation of ATPase activity,64,17,4.62,1.9e-06,0.0091428,2.4912261580381472e-5,3.68,BP
GO:0042177,negative regulation of protein catabolic...,131,26,9.46,2.0e-06,0.009623999999999999,2.6152173913043475e-5,2.75,BP
GO:0006470,protein dephosphorylation,243,39,17.55,2.1e-06,0.010105199999999998,2.7311351351351347e-5,2.22,BP
GO:0043068,positive regulation of programmed cell d...,652,80,47.1,2.1e-06,0.010105199999999998,2.7311351351351347e-5,1.7,BP
GO:1902532,negative regulation of intracellular sig...,537,69,38.79,2.2e-06,0.010586400000000001,2.8458064516129033e-5,1.78,BP
GO:0016236,macroautophagy,199,34,14.38,2.2e-06,0.010586400000000001,2.8458064516129033e-5,2.36,BP
GO:0010033,response to organic substance,3108,288,224.51,2.3e-06,0.0110676,2.9671849865951743e-5,1.28,BP
GO:0060996,dendritic spine development,124,25,8.96,2.4e-06,0.0115488,3.07968e-5,2.79,BP
GO:0010975,regulation of neuron projection developm...,612,76,44.21,2.4e-06,0.0115488,3.07968e-5,1.72,BP
GO:0051881,regulation of mitochondrial membrane pot...,79,19,5.71,2.5e-06,0.01203,3.1994680851063834e-5,3.33,BP
GO:1902904,negative regulation of supramolecular fi...,149,28,10.76,2.6e-06,0.0125112,3.318620689655173e-5,2.6,BP
GO:0007033,vacuole organization,166,30,11.99,2.7e-06,0.0129924,3.437142857142857e-5,2.5,BP
GO:0007007,inner mitochondrial membrane organizatio...,29,11,2.09,2.8e-06,0.013473599999999999,3.5271204188481676e-5,5.26,BP
GO:0033119,negative regulation of RNA splicing,29,11,2.09,2.8e-06,0.013473599999999999,3.5271204188481676e-5,5.26,BP
GO:0042026,protein refolding,29,11,2.09,2.8e-06,0.013473599999999999,3.5271204188481676e-5,5.26,BP
GO:0015672,monovalent inorganic cation transport,459,61,33.16,2.8e-06,0.013473599999999999,3.5271204188481676e-5,1.84,BP
GO:0051640,organelle localization,604,75,43.63,2.9e-06,0.013954800000000002,3.64355091383812e-5,1.72,BP
GO:0000422,autophagy of mitochondrion,66,17,4.77,3.0e-06,0.014436000000000001,3.74961038961039e-5,3.56,BP
GO:0061726,mitochondrion disassembly,66,17,4.77,3.0e-06,0.014436000000000001,3.74961038961039e-5,3.56,BP
GO:0006611,protein export from nucleus,126,25,9.1,3.2e-06,0.0153984,3.9789147286821704e-5,2.75,BP
GO:0023051,regulation of signaling,3409,311,246.26,3.2e-06,0.0153984,3.9789147286821704e-5,1.26,BP
GO:2000058,regulation of ubiquitin-dependent protei...,151,28,10.91,3.4e-06,0.016360800000000002,4.216701030927835e-5,2.57,BP
GO:0006913,nucleocytoplasmic transport,295,44,21.31,3.6e-06,0.0173232,4.4418461538461536e-5,2.06,BP
GO:0051169,nuclear transport,295,44,21.31,3.6e-06,0.0173232,4.4418461538461536e-5,2.06,BP
GO:0051054,positive regulation of DNA metabolic pro...,249,39,17.99,3.9e-06,0.0187668,4.7996930946291565e-5,2.17,BP
GO:0031400,negative regulation of protein modificat...,578,72,41.75,4.0e-06,0.019247999999999998,4.897709923664122e-5,1.72,BP
GO:0050807,regulation of synapse organization,268,41,19.36,4.0e-06,0.019247999999999998,4.897709923664122e-5,2.12,BP
GO:0060284,regulation of cell development,1106,120,79.89,4.2e-06,0.020210399999999996,5.0907808564231736e-5,1.5,BP
GO:1903533,regulation of protein targeting,54,15,3.9,4.2e-06,0.020210399999999996,5.0907808564231736e-5,3.85,BP
GO:0007034,vacuolar transport,136,26,9.82,4.2e-06,0.020210399999999996,5.0907808564231736e-5,2.65,BP
GO:0035966,response to topologically incorrect prot...,136,26,9.82,4.2e-06,0.020210399999999996,5.0907808564231736e-5,2.65,BP
GO:0050803,regulation of synapse structure or activ...,278,42,20.08,4.3e-06,0.0206916,5.198894472361809e-5,2.09,BP
GO:0017038,protein import,214,35,15.46,4.5e-06,0.021654,5.4270676691729324e-5,2.26,BP
GO:0032387,negative regulation of intracellular tra...,68,17,4.91,4.7e-06,0.0226164,5.654099999999999e-5,3.46,BP
GO:0010646,regulation of cell communication,3387,308,244.67,4.8e-06,0.0230976,5.76e-5,1.26,BP
GO:1901653,cellular response to peptide,290,43,20.95,5.4e-06,0.0259848,6.463880597014925e-5,2.05,BP
GO:0019220,regulation of phosphate metabolic proces...,1720,172,124.25,5.6e-06,0.026947199999999998,6.686650124069479e-5,1.38,BP
GO:0051174,regulation of phosphorus metabolic proce...,1721,172,124.32,5.8e-06,0.027909600000000003,6.90831683168317e-5,1.38,BP
GO:0050767,regulation of neurogenesis,967,107,69.85,5.9e-06,0.0283908,7.010074074074074e-5,1.53,BP
GO:0044419,interspecies interaction between organis...,399,54,28.82,6.0e-06,0.028872000000000002,7.111330049261084e-5,1.87,BP
GO:0030029,actin filament-based process,758,88,54.76,6.4e-06,0.0307968,7.566781326781326e-5,1.61,BP
GO:0034249,negative regulation of cellular amide me...,156,28,11.27,6.6e-06,0.0317592,7.784117647058824e-5,2.48,BP
GO:0031175,neuron projection development,1097,118,79.24,7.5e-06,0.036090000000000004,8.8239608801956e-5,1.49,BP
GO:0007399,nervous system development,2347,223,169.54,7.8e-06,0.0375336,9.110097087378641e-5,1.32,BP
GO:0032434,regulation of proteasomal ubiquitin-depe...,124,24,8.96,7.8e-06,0.0375336,9.110097087378641e-5,2.68,BP
GO:0090407,organophosphate biosynthetic process,505,64,36.48,7.8e-06,0.0375336,9.110097087378641e-5,1.75,BP
GO:0034614,cellular response to reactive oxygen spe...,149,27,10.76,7.9e-06,0.0380148,9.204552058111381e-5,2.51,BP
GO:2001252,positive regulation of chromosome organi...,184,31,13.29,8.3e-06,0.0399396,9.624e-5,2.33,BP
GO:0045664,regulation of neuron differentiation,785,90,56.71,8.3e-06,0.0399396,9.624e-5,1.59,BP
GO:0009891,positive regulation of biosynthetic proc...,1960,191,141.59,8.4e-06,0.04042079999999999,9.693237410071941e-5,1.35,BP
GO:0050686,negative regulation of mRNA processing,32,11,2.31,8.4e-06,0.04042079999999999,9.693237410071941e-5,4.76,BP
GO:0060998,regulation of dendritic spine developmen...,93,20,6.72,8.6e-06,0.0413832,9.876658711217185e-5,2.98,BP
GO:0070849,response to epidermal growth factor,44,13,3.18,8.6e-06,0.0413832,9.876658711217185e-5,4.09,BP
GO:0045022,early endosome to late endosome transpor...,38,12,2.75,8.9e-06,0.0428268,1.0196857142857142e-4,4.36,BP
GO:0030970,"retrograde protein transport, ER to cyto...",27,10,1.95,1.0e-05,0.04812,1.1349056603773586e-4,5.13,BP
GO:1903513,endoplasmic reticulum to cytosol transpo...,27,10,1.95,1.0e-05,0.04812,1.1349056603773586e-4,5.13,BP
GO:0061640,cytoskeleton-dependent cytokinesis,94,20,6.79,1.0e-05,0.04812,1.1349056603773586e-4,2.95,BP
GO:0009890,negative regulation of biosynthetic proc...,1524,154,110.09,1.0e-05,0.04812,1.1349056603773586e-4,1.4,BP
GO:0022402,cell cycle process,1128,120,81.48,1.1e-05,0.052932,1.2396252927400467e-4,1.47,BP
GO:0051402,neuron apoptotic process,298,43,21.53,1.1e-05,0.052932,1.2396252927400467e-4,2,BP
GO:0002183,cytoplasmic translational initiation,22,9,1.59,1.1e-05,0.052932,1.2396252927400467e-4,5.66,BP
GO:0034314,Arp2/3 complex-mediated actin nucleation,33,11,2.38,1.2e-05,0.057744000000000004,1.3397679814385153e-4,4.62,BP
GO:0051345,positive regulation of hydrolase activit...,522,65,37.71,1.2e-05,0.057744000000000004,1.3397679814385153e-4,1.72,BP
GO:0016567,protein ubiquitination,575,70,41.54,1.2e-05,0.057744000000000004,1.3397679814385153e-4,1.69,BP
GO:0044088,regulation of vacuole organization,39,12,2.82,1.2e-05,0.057744000000000004,1.3397679814385153e-4,4.26,BP
GO:0008064,regulation of actin polymerization or de...,179,30,12.93,1.3e-05,0.062556,1.4380689655172412e-4,2.32,BP
GO:0006812,cation transport,1110,118,80.18,1.3e-05,0.062556,1.4380689655172412e-4,1.47,BP
GO:1902531,regulation of intracellular signal trans...,1733,171,125.19,1.3e-05,0.062556,1.4380689655172412e-4,1.37,BP
GO:1903051,negative regulation of proteolysis invol...,73,17,5.27,1.3e-05,0.062556,1.4380689655172412e-4,3.23,BP
GO:0051259,protein complex oligomerization,620,74,44.79,1.4e-05,0.067368,1.5172972972972974e-4,1.65,BP
GO:0030833,regulation of actin filament polymerizat...,162,28,11.7,1.4e-05,0.067368,1.5172972972972974e-4,2.39,BP
GO:1901214,regulation of neuron death,370,50,26.73,1.4e-05,0.067368,1.5172972972972974e-4,1.87,BP
GO:0048699,generation of neurons,1687,167,121.86,1.4e-05,0.067368,1.5172972972972974e-4,1.37,BP
GO:0032984,protein-containing complex disassembly,216,34,15.6,1.4e-05,0.067368,1.5172972972972974e-4,2.18,BP
GO:0051051,negative regulation of transport,546,67,39.44,1.4e-05,0.067368,1.5172972972972974e-4,1.7,BP
GO:0000045,autophagosome assembly,96,20,6.93,1.4e-05,0.067368,1.5172972972972974e-4,2.89,BP
GO:0070997,neuron death,411,54,29.69,1.4e-05,0.067368,1.5172972972972974e-4,1.82,BP
GO:0098662,inorganic cation transmembrane transport,621,74,44.86,1.4e-05,0.067368,1.5172972972972974e-4,1.65,BP
GO:0045010,actin nucleation,46,13,3.32,1.5e-05,0.07218000000000001,1.6147651006711409e-4,3.92,BP
GO:1903364,positive regulation of cellular protein ...,137,25,9.9,1.5e-05,0.07218000000000001,1.6147651006711409e-4,2.53,BP
GO:0098655,cation transmembrane transport,698,81,50.42,1.5e-05,0.07218000000000001,1.6147651006711409e-4,1.61,BP
GO:1901215,negative regulation of neuron death,245,37,17.7,1.6e-05,0.07699199999999999,1.6996026490066226e-4,2.09,BP
GO:1903201,regulation of oxidative stress-induced c...,74,17,5.35,1.6e-05,0.07699199999999999,1.6996026490066226e-4,3.18,BP
GO:0098927,vesicle-mediated transport between endos...,40,12,2.89,1.6e-05,0.07699199999999999,1.6996026490066226e-4,4.15,BP
GO:0010629,negative regulation of gene expression,1800,176,130.03,1.6e-05,0.07699199999999999,1.6996026490066226e-4,1.35,BP
GO:2000785,regulation of autophagosome assembly,34,11,2.46,1.6e-05,0.07699199999999999,1.6996026490066226e-4,4.47,BP
GO:0061077,chaperone-mediated protein folding,53,14,3.83,1.6e-05,0.07699199999999999,1.6996026490066226e-4,3.66,BP
GO:0036503,ERAD pathway,97,20,7.01,1.7e-05,0.081804,1.7900218818380745e-4,2.85,BP
GO:0006986,response to unfolded protein,113,22,8.16,1.7e-05,0.081804,1.7900218818380745e-4,2.7,BP
GO:0051960,regulation of nervous system development,1082,115,78.16,1.7e-05,0.081804,1.7900218818380745e-4,1.47,BP
GO:0051961,negative regulation of nervous system de...,363,49,26.22,1.7e-05,0.081804,1.7900218818380745e-4,1.87,BP
GO:0008361,regulation of cell size,209,33,15.1,1.8e-05,0.086616,1.8829565217391304e-4,2.19,BP
GO:0048583,regulation of response to stimulus,3798,336,274.36,1.8e-05,0.086616,1.8829565217391304e-4,1.22,BP
GO:0030832,regulation of actin filament length,182,30,13.15,1.8e-05,0.086616,1.8829565217391304e-4,2.28,BP
GO:0043523,regulation of neuron apoptotic process,266,39,19.22,1.9e-05,0.09142800000000001,1.974686825053996e-4,2.03,BP
GO:1903008,organelle disassembly,90,19,6.5,1.9e-05,0.09142800000000001,1.974686825053996e-4,2.92,BP
GO:0030433,ubiquitin-dependent ERAD pathway,75,17,5.42,1.9e-05,0.09142800000000001,1.974686825053996e-4,3.14,BP
GO:0019058,viral life cycle,201,32,14.52,2.0e-05,0.09624,2.047659574468085e-4,2.2,BP
GO:0010628,positive regulation of gene expression,2000,192,144.47,2.0e-05,0.09624,2.047659574468085e-4,1.33,BP
GO:0051100,negative regulation of binding,174,29,12.57,2.0e-05,0.09624,2.047659574468085e-4,2.31,BP
GO:0030182,neuron differentiation,1507,151,108.86,2.0e-05,0.09624,2.047659574468085e-4,1.39,BP
GO:0050773,regulation of dendrite development,192,31,13.87,2.0e-05,0.09624,2.047659574468085e-4,2.24,BP
GO:1901699,cellular response to nitrogen compound,638,75,46.09,2.0e-05,0.09624,2.047659574468085e-4,1.63,BP
GO:0007017,microtubule-based process,770,87,55.62,2.0e-05,0.09624,2.047659574468085e-4,1.56,BP
GO:0051168,nuclear export,140,25,10.11,2.2e-05,0.105864,2.2476433121019107e-4,2.47,BP
GO:0016241,regulation of macroautophagy,107,21,7.73,2.3e-05,0.110676,2.3398731501057083e-4,2.72,BP
GO:0043467,regulation of generation of precursor me...,132,24,9.54,2.3e-05,0.110676,2.3398731501057083e-4,2.52,BP
GO:0045732,positive regulation of protein catabolic...,212,33,15.31,2.4e-05,0.11548800000000001,2.426218487394958e-4,2.16,BP
GO:0051494,negative regulation of cytoskeleton orga...,158,27,11.41,2.4e-05,0.11548800000000001,2.426218487394958e-4,2.37,BP
GO:0000245,spliceosomal complex assembly,48,13,3.47,2.4e-05,0.11548800000000001,2.426218487394958e-4,3.75,BP
GO:0010557,positive regulation of macromolecule bio...,1813,176,130.97,2.5e-05,0.1203,2.5062500000000003e-4,1.34,BP
GO:0040007,growth,1103,116,79.68,2.5e-05,0.1203,2.5062500000000003e-4,1.46,BP
GO:0000281,mitotic cytokinesis,69,16,4.98,2.5e-05,0.1203,2.5062500000000003e-4,3.21,BP
GO:0048025,"negative regulation of mRNA splicing, vi...",24,9,1.73,2.5e-05,0.1203,2.5062500000000003e-4,5.2,BP
GO:1901799,negative regulation of proteasomal prote...,55,14,3.97,2.6e-05,0.125112,2.5956846473029044e-4,3.53,BP
GO:0006367,transcription initiation from RNA polyme...,62,15,4.48,2.6e-05,0.125112,2.5956846473029044e-4,3.35,BP
GO:0010976,positive regulation of neuron projection...,369,49,26.66,2.7e-05,0.12992399999999998,2.673333333333333e-4,1.84,BP
GO:1905037,autophagosome organization,100,20,7.22,2.7e-05,0.12992399999999998,2.673333333333333e-4,2.77,BP
GO:0050768,negative regulation of neurogenesis,339,46,24.49,2.7e-05,0.12992399999999998,2.673333333333333e-4,1.88,BP
GO:0010770,positive regulation of cell morphogenesi...,186,30,13.44,2.7e-05,0.12992399999999998,2.673333333333333e-4,2.23,BP
GO:0009628,response to abiotic stimulus,1048,111,75.7,2.8e-05,0.134736,2.766652977412731e-4,1.47,BP
GO:0006732,coenzyme metabolic process,330,45,23.84,2.9e-05,0.139548,2.8595901639344267e-4,1.89,BP
GO:0048524,positive regulation of viral process,85,18,6.14,3.0e-05,0.14436000000000002,2.9222672064777326e-4,2.93,BP
GO:1900407,regulation of cellular response to oxida...,85,18,6.14,3.0e-05,0.14436000000000002,2.9222672064777326e-4,2.93,BP
GO:1903363,negative regulation of cellular protein ...,85,18,6.14,3.0e-05,0.14436000000000002,2.9222672064777326e-4,2.93,BP
GO:1903427,negative regulation of reactive oxygen s...,36,11,2.6,3.0e-05,0.14436000000000002,2.9222672064777326e-4,4.23,BP
GO:1904358,positive regulation of telomere maintena...,36,11,2.6,3.0e-05,0.14436000000000002,2.9222672064777326e-4,4.23,BP
GO:2001244,positive regulation of intrinsic apoptot...,70,16,5.06,3.0e-05,0.14436000000000002,2.9222672064777326e-4,3.16,BP
GO:0006898,receptor-mediated endocytosis,224,34,16.18,3.1e-05,0.149172,3.0135757575757577e-4,2.1,BP
GO:0035556,intracellular signal transduction,2646,243,191.14,3.2e-05,0.15398399999999998,3.0858517034068134e-4,1.27,BP
GO:0045454,cell redox homeostasis,63,15,4.55,3.2e-05,0.15398399999999998,3.0858517034068134e-4,3.3,BP
GO:0031328,positive regulation of cellular biosynth...,1919,184,138.62,3.2e-05,0.15398399999999998,3.0858517034068134e-4,1.33,BP
GO:0010720,positive regulation of cell development,669,77,48.33,3.2e-05,0.15398399999999998,3.0858517034068134e-4,1.59,BP
GO:0010952,positive regulation of peptidase activit...,170,28,12.28,3.4e-05,0.163608,3.2591235059760957e-4,2.28,BP
GO:0043524,negative regulation of neuron apoptotic ...,179,29,12.93,3.4e-05,0.163608,3.2591235059760957e-4,2.24,BP
GO:0080134,regulation of response to stress,1357,137,98.03,3.4e-05,0.163608,3.2591235059760957e-4,1.4,BP
GO:1902882,regulation of response to oxidative stre...,94,19,6.79,3.6e-05,0.173232,3.4371428571428574e-4,2.8,BP
GO:1903573,negative regulation of response to endop...,43,12,3.11,3.6e-05,0.173232,3.4371428571428574e-4,3.86,BP
GO:0032469,endoplasmic reticulum calcium ion homeos...,25,9,1.81,3.7e-05,0.17804399999999998,3.518656126482213e-4,4.97,BP
GO:1903649,regulation of cytoplasmic transport,25,9,1.81,3.7e-05,0.17804399999999998,3.518656126482213e-4,4.97,BP
GO:0060999,positive regulation of dendritic spine d...,64,15,4.62,3.9e-05,0.187668,3.701538461538461e-4,3.25,BP
GO:0006458,'de novo' protein folding,37,11,2.67,4.0e-05,0.19248,3.774117647058824e-4,4.12,BP
GO:0071417,cellular response to organonitrogen comp...,575,68,41.54,4.0e-05,0.19248,3.774117647058824e-4,1.64,BP
GO:0022008,neurogenesis,1793,173,129.52,4.0e-05,0.19248,3.774117647058824e-4,1.34,BP
GO:1990182,exosomal secretion,20,8,1.44,4.2e-05,0.20210399999999998,3.9396491228070173e-4,5.56,BP
GO:0071310,cellular response to organic substance,2470,228,178.43,4.2e-05,0.20210399999999998,3.9396491228070173e-4,1.28,BP
GO:0055082,cellular chemical homeostasis,819,90,59.16,4.2e-05,0.20210399999999998,3.9396491228070173e-4,1.52,BP
GO:0098660,inorganic ion transmembrane transport,664,76,47.97,4.4e-05,0.211728,4.119221789883269e-4,1.58,BP
GO:0016358,dendrite development,296,41,21.38,4.5e-05,0.21654,4.204660194174758e-4,1.92,BP
GO:0001558,regulation of cell growth,439,55,31.71,4.6e-05,0.221352,4.28147001934236e-4,1.73,BP
GO:0006890,"retrograde vesicle-mediated transport, G...",44,12,3.18,4.6e-05,0.221352,4.28147001934236e-4,3.77,BP
GO:0048666,neuron development,1238,126,89.43,5.0e-05,0.2406,4.626923076923078e-4,1.41,BP
GO:0051301,cell division,590,69,42.62,5.0e-05,0.2406,4.626923076923078e-4,1.62,BP
GO:0042542,response to hydrogen peroxide,121,22,8.74,5.0e-05,0.2406,4.626923076923078e-4,2.52,BP
GO:0046496,nicotinamide nucleotide metabolic proces...,156,26,11.27,5.2e-05,0.250224,4.7935632183908046e-4,2.31,BP
GO:0051188,cofactor biosynthetic process,249,36,17.99,5.2e-05,0.250224,4.7935632183908046e-4,2,BP
GO:0070861,regulation of protein exit from endoplas...,26,9,1.88,5.3e-05,0.255036,4.867099236641221e-4,4.79,BP
GO:1902175,regulation of oxidative stress-induced i...,26,9,1.88,5.3e-05,0.255036,4.867099236641221e-4,4.79,BP
GO:0040008,regulation of growth,724,81,52.3,5.5e-05,0.26466,5.031558935361216e-4,1.55,BP
GO:0009966,regulation of signal transduction,2819,255,203.64,5.5e-05,0.26466,5.031558935361216e-4,1.25,BP
GO:0032212,positive regulation of telomere maintena...,32,10,2.31,5.6e-05,0.269472,5.113320683111954e-4,4.33,BP
GO:0006733,oxidoreduction coenzyme metabolic proces...,175,28,12.64,5.8e-05,0.279096,5.285909090909091e-4,2.22,BP
GO:0006414,translational elongation,45,12,3.25,5.9e-05,0.283908,5.366880907372401e-4,3.69,BP
GO:1903902,positive regulation of viral life cycle,59,14,4.26,6.0e-05,0.28872000000000003,5.447547169811321e-4,3.29,BP
GO:2000573,positive regulation of DNA biosynthetic ...,74,16,5.35,6.2e-05,0.298344,5.618531073446327e-4,2.99,BP
GO:0051016,barbed-end actin filament capping,21,8,1.52,6.3e-05,0.303156,5.677078651685393e-4,5.26,BP
GO:0097734,extracellular exosome biogenesis,21,8,1.52,6.3e-05,0.303156,5.677078651685393e-4,5.26,BP
GO:1901652,response to peptide,392,50,28.32,6.3e-05,0.303156,5.677078651685393e-4,1.77,BP
GO:0050808,synapse organization,455,56,32.87,6.4e-05,0.30796799999999996,5.75641121495327e-4,1.7,BP
GO:0019362,pyridine nucleotide metabolic process,158,26,11.41,6.5e-05,0.31277999999999995,5.835447761194029e-4,2.28,BP
GO:0010506,regulation of autophagy,252,36,18.2,6.7e-05,0.322404,6.003798882681565e-4,1.98,BP
GO:0010563,negative regulation of phosphorus metabo...,563,66,40.67,6.8e-05,0.327216,6.059555555555556e-4,1.62,BP
GO:0045936,negative regulation of phosphate metabol...,563,66,40.67,6.8e-05,0.327216,6.059555555555556e-4,1.62,BP
GO:0031669,cellular response to nutrient levels,195,30,14.09,6.8e-05,0.327216,6.059555555555556e-4,2.13,BP
GO:0034220,ion transmembrane transport,887,95,64.07,6.9e-05,0.332028,6.137301293900184e-4,1.48,BP
GO:2001235,positive regulation of apoptotic signali...,186,29,13.44,7.0e-05,0.33684,6.214760147601475e-4,2.16,BP
GO:0010821,regulation of mitochondrion organization,141,24,10.19,7.1e-05,0.341652,6.268844036697248e-4,2.36,BP
GO:0090066,regulation of anatomical structure size,564,66,40.74,7.1e-05,0.341652,6.268844036697248e-4,1.62,BP
GO:0006403,RNA localization,177,28,12.79,7.1e-05,0.341652,6.268844036697248e-4,2.19,BP
GO:0016049,cell growth,521,62,37.64,7.2e-05,0.346464,6.345494505494506e-4,1.65,BP
GO:0031668,cellular response to extracellular stimu...,224,33,16.18,7.3e-05,0.351276,6.410145985401459e-4,2.04,BP
GO:0046847,filopodium assembly,60,14,4.33,7.3e-05,0.351276,6.410145985401459e-4,3.23,BP
GO:0098754,detoxification,46,12,3.32,7.5e-05,0.36089999999999994,6.573770491803278e-4,3.61,BP
GO:0042743,hydrogen peroxide metabolic process,53,13,3.83,7.6e-05,0.36571200000000004,6.649309090909092e-4,3.39,BP
GO:0030041,actin filament polymerization,178,28,12.86,7.9e-05,0.380148,6.86187725631769e-4,2.18,BP
GO:0048878,chemical homeostasis,1192,121,86.11,7.9e-05,0.380148,6.86187725631769e-4,1.41,BP
GO:1903828,negative regulation of cellular protein ...,116,21,8.38,7.9e-05,0.380148,6.86187725631769e-4,2.51,BP
GO:0031503,protein-containing complex localization,254,36,18.35,7.9e-05,0.380148,6.86187725631769e-4,1.96,BP
GO:0010038,response to metal ion,274,38,19.79,8.2e-05,0.394584,7.096834532374101e-4,1.92,BP
GO:0071426,ribonucleoprotein complex export from nu...,68,15,4.91,8.2e-05,0.394584,7.096834532374101e-4,3.05,BP
GO:0032273,positive regulation of protein polymeriz...,125,22,9.03,8.4e-05,0.40420799999999996,7.256876122082585e-4,2.44,BP
GO:0032204,regulation of telomere maintenance,84,17,6.07,8.9e-05,0.428268,7.675053763440859e-4,2.8,BP
GO:0022603,regulation of anatomical structure morph...,1091,112,78.81,9.3e-05,0.44751599999999997,7.991357142857143e-4,1.42,BP
GO:0032970,regulation of actin filament-based proce...,398,50,28.75,9.3e-05,0.44751599999999997,7.991357142857143e-4,1.74,BP
GO:0010721,negative regulation of cell development,388,49,28.03,9.6e-05,0.46195200000000003,8.234438502673797e-4,1.75,BP
GO:0071166,ribonucleoprotein complex localization,69,15,4.98,9.8e-05,0.471576,8.391032028469751e-4,3.01,BP
GO:0090313,regulation of protein targeting to membr...,34,10,2.46,9.9e-05,0.476388,8.44659574468085e-4,4.07,BP
GO:1990748,cellular detoxification,34,10,2.46,9.9e-05,0.476388,8.44659574468085e-4,4.07,BP
GO:0071333,cellular response to glucose stimulus,144,24,10.4,1.0e-04,0.4812,8.45694200351494e-4,2.31,BP
GO:0006811,ion transport,1581,153,114.21,0.00010,0.4812,8.45694200351494e-4,1.34,BP
GO:0051270,regulation of cellular component movemen...,1035,107,74.77,0.00010,0.4812,8.45694200351494e-4,1.43,BP
GO:0008088,axo-dendritic transport,77,16,5.56,0.00010,0.4812,8.45694200351494e-4,2.88,BP
GO:0032956,regulation of actin cytoskeleton organiz...,348,45,25.14,0.00010,0.4812,8.45694200351494e-4,1.79,BP
GO:0043624,cellular protein complex disassembly,136,23,9.82,0.00011,0.52932,9.221602787456447e-4,2.34,BP
GO:0072524,pyridine-containing compound metabolic p...,163,26,11.77,0.00011,0.52932,9.221602787456447e-4,2.21,BP
GO:0071364,cellular response to epidermal growth fa...,41,11,2.96,0.00011,0.52932,9.221602787456447e-4,3.72,BP
GO:0006364,rRNA processing,191,29,13.8,0.00011,0.52932,9.221602787456447e-4,2.1,BP
GO:0006892,post-Golgi vesicle-mediated transport,102,19,7.37,0.00011,0.52932,9.221602787456447e-4,2.58,BP
GO:0006468,protein phosphorylation,1842,174,133.06,0.00012,0.5774400000000001,9.990311418685122e-4,1.31,BP
GO:0051495,positive regulation of cytoskeleton orga...,220,32,15.89,0.00012,0.5774400000000001,9.990311418685122e-4,2.01,BP
GO:0071322,cellular response to carbohydrate stimul...,155,25,11.2,0.00012,0.5774400000000001,9.990311418685122e-4,2.23,BP
GO:0009108,coenzyme biosynthetic process,192,29,13.87,0.00012,0.5774400000000001,9.990311418685122e-4,2.09,BP
GO:0040017,positive regulation of locomotion,597,68,43.13,0.00013,0.6255599999999999,0.0010748453608247423,1.58,BP
GO:0035308,negative regulation of protein dephospho...,35,10,2.53,0.00013,0.6255599999999999,0.0010748453608247423,3.95,BP
GO:0097435,supramolecular fiber organization,687,76,49.63,0.00013,0.6255599999999999,0.0010748453608247423,1.53,BP
GO:0140112,extracellular vesicle biogenesis,23,8,1.66,0.00013,0.6255599999999999,0.0010748453608247423,4.82,BP
GO:0045666,positive regulation of neuron differenti...,468,56,33.81,0.00014,0.67368,0.0011418305084745762,1.66,BP
GO:0071331,cellular response to hexose stimulus,147,24,10.62,0.00014,0.67368,0.0011418305084745762,2.26,BP
GO:0006376,mRNA splice site selection,29,9,2.09,0.00014,0.67368,0.0011418305084745762,4.31,BP
GO:1902235,regulation of endoplasmic reticulum stre...,29,9,2.09,0.00014,0.67368,0.0011418305084745762,4.31,BP
GO:1902883,negative regulation of response to oxida...,56,13,4.05,0.00014,0.67368,0.0011418305084745762,3.21,BP
GO:0032092,positive regulation of protein binding,112,20,8.09,0.00014,0.67368,0.0011418305084745762,2.47,BP
GO:0010833,telomere maintenance via telomere length...,79,16,5.71,0.00014,0.67368,0.0011418305084745762,2.8,BP
GO:0042326,negative regulation of phosphorylation,469,56,33.88,0.00014,0.67368,0.0011418305084745762,1.65,BP
GO:0055085,transmembrane transport,1281,127,92.54,0.00015,0.7217999999999999,0.001215151515151515,1.37,BP
GO:0045665,negative regulation of neuron differenti...,262,36,18.93,0.00015,0.7217999999999999,0.001215151515151515,1.9,BP
GO:0071326,cellular response to monosaccharide stim...,148,24,10.69,0.00015,0.7217999999999999,0.001215151515151515,2.25,BP
GO:1904356,regulation of telomere maintenance via t...,64,14,4.62,0.00015,0.7217999999999999,0.001215151515151515,3.03,BP
GO:0045935,positive regulation of nucleobase-contai...,1852,174,133.78,0.00016,0.76992,0.001291812080536913,1.3,BP
GO:0071456,cellular response to hypoxia,96,18,6.93,0.00016,0.76992,0.001291812080536913,2.6,BP
GO:0045787,positive regulation of cell cycle,355,45,25.64,0.00017,0.8180400000000001,0.0013588704318936878,1.76,BP
GO:0051084,'de novo' posttranslational protein fold...,36,10,2.6,0.00017,0.8180400000000001,0.0013588704318936878,3.85,BP
GO:0051973,positive regulation of telomerase activi...,36,10,2.6,0.00017,0.8180400000000001,0.0013588704318936878,3.85,BP
GO:0000910,cytokinesis,158,25,11.41,0.00017,0.8180400000000001,0.0013588704318936878,2.19,BP
GO:0008154,actin polymerization or depolymerization,205,30,14.81,0.00017,0.8180400000000001,0.0013588704318936878,2.03,BP
GO:0035967,cellular response to topologically incor...,105,19,7.58,0.00017,0.8180400000000001,0.0013588704318936878,2.51,BP
GO:0010977,negative regulation of neuron projection...,177,27,12.79,0.00018,0.86616,0.0014293069306930695,2.11,BP
GO:0010769,regulation of cell morphogenesis involve...,346,44,24.99,0.00018,0.86616,0.0014293069306930695,1.76,BP
GO:0006278,RNA-dependent DNA biosynthetic process,65,14,4.7,0.00018,0.86616,0.0014293069306930695,2.98,BP
GO:0007004,telomere maintenance via telomerase,65,14,4.7,0.00018,0.86616,0.0014293069306930695,2.98,BP
GO:0006351,"transcription, DNA-templated",2897,257,209.27,0.00019,0.9142800000000001,0.0014988196721311476,1.23,BP
GO:0019068,virion assembly,24,8,1.73,0.00019,0.9142800000000001,0.0014988196721311476,4.62,BP
GO:0009408,response to heat,106,19,7.66,0.00019,0.9142800000000001,0.0014988196721311476,2.48,BP
GO:0050804,modulation of chemical synaptic transmis...,673,74,48.62,0.00019,0.9142800000000001,0.0014988196721311476,1.52,BP
GO:0052547,regulation of peptidase activity,421,51,30.41,0.00020,0.9624,0.0015623376623376624,1.68,BP
GO:0033044,regulation of chromosome organization,358,45,25.86,0.00020,0.9624,0.0015623376623376624,1.74,BP
GO:0045931,positive regulation of mitotic cell cycl...,169,26,12.21,0.00020,0.9624,0.0015623376623376624,2.13,BP
GO:0097237,cellular response to toxic substance,169,26,12.21,0.00020,0.9624,0.0015623376623376624,2.13,BP
GO:0006790,sulfur compound metabolic process,276,37,19.94,0.00020,0.9624,0.0015623376623376624,1.86,BP
GO:0099177,regulation of trans-synaptic signaling,674,74,48.69,0.00020,0.9624,0.0015623376623376624,1.52,BP
GO:0051693,actin filament capping,37,10,2.67,0.00022,1,0.001693824,3.75,BP
GO:0099003,vesicle-mediated transport in synapse,247,34,17.84,0.00022,1,0.001693824,1.91,BP
GO:0030834,regulation of actin filament depolymeriz...,51,12,3.68,0.00022,1,0.001693824,3.26,BP
GO:2000059,negative regulation of ubiquitin-depende...,51,12,3.68,0.00022,1,0.001693824,3.26,BP
GO:0034605,cellular response to heat,66,14,4.77,0.00022,1,0.001693824,2.94,BP
GO:0042325,regulation of phosphorylation,1559,149,112.62,0.00022,1,0.001693824,1.32,BP
GO:0007051,spindle organization,170,26,12.28,0.00022,1,0.001693824,2.12,BP
GO:0097659,nucleic acid-templated transcription,2905,257,209.85,0.00022,1,0.001693824,1.22,BP
GO:0032774,RNA biosynthetic process,2918,258,210.79,0.00022,1,0.001693824,1.22,BP
GO:0051276,chromosome organization,1105,111,79.82,0.00023,1,0.0017679872204472843,1.39,BP
GO:0051726,regulation of cell cycle,976,100,70.5,0.00024,1,0.0018419138755980862,1.42,BP
GO:0035773,insulin secretion involved in cellular r...,91,17,6.57,0.00025,1,0.0019125596184419713,2.59,BP
GO:0050769,positive regulation of neurogenesis,589,66,42.55,0.00025,1,0.0019125596184419713,1.55,BP
GO:0090559,regulation of membrane permeability,67,14,4.84,0.00026,1,0.0019610031347962378,2.89,BP
GO:0061178,regulation of insulin secretion involved...,83,16,6,0.00026,1,0.0019610031347962378,2.67,BP
GO:0046688,response to copper ion,25,8,1.81,0.00026,1,0.0019610031347962378,4.42,BP
GO:1903747,regulation of establishment of protein l...,25,8,1.81,0.00026,1,0.0019610031347962378,4.42,BP
GO:0010507,negative regulation of autophagy,75,15,5.42,0.00026,1,0.0019610031347962378,2.77,BP
GO:0043281,regulation of cysteine-type endopeptidas...,210,30,15.17,0.00026,1,0.0019610031347962378,1.98,BP
GO:0009267,cellular response to starvation,144,23,10.4,0.00026,1,0.0019610031347962378,2.21,BP
GO:0055076,transition metal ion homeostasis,126,21,9.1,0.00026,1,0.0019610031347962378,2.31,BP
GO:1903202,negative regulation of oxidative stress-...,52,12,3.76,0.00026,1,0.0019610031347962378,3.19,BP
GO:0071496,cellular response to external stimulus,290,38,20.95,0.00027,1,0.0020332394366197183,1.81,BP
GO:0120032,regulation of plasma membrane bounded ce...,182,27,13.15,0.00028,1,0.002101965678627145,2.05,BP
GO:1900006,positive regulation of dendrite developm...,109,19,7.87,0.00028,1,0.002101965678627145,2.41,BP
GO:0032886,regulation of microtubule-based process,241,33,17.41,0.00029,1,0.002173644859813084,1.9,BP
GO:0017148,negative regulation of translation,136,22,9.82,0.00030,1,0.0022277777777777773,2.24,BP
GO:0034620,cellular response to unfolded protein,84,16,6.07,0.00030,1,0.0022277777777777773,2.64,BP
GO:0051338,regulation of transferase activity,843,88,60.9,0.00030,1,0.0022277777777777773,1.44,BP
GO:0044092,negative regulation of molecular functio...,1018,103,73.54,0.00030,1,0.0022277777777777773,1.4,BP
GO:0006893,Golgi to plasma membrane transport,68,14,4.91,0.00030,1,0.0022277777777777773,2.85,BP
GO:0042273,ribosomal large subunit biogenesis,68,14,4.91,0.00030,1,0.0022277777777777773,2.85,BP
GO:0007041,lysosomal transport,101,18,7.3,0.00031,1,0.0022914285714285714,2.47,BP
GO:0051651,maintenance of location in cell,101,18,7.3,0.00031,1,0.0022914285714285714,2.47,BP
GO:0001678,cellular glucose homeostasis,164,25,11.85,0.00031,1,0.0022914285714285714,2.11,BP
GO:0051253,negative regulation of RNA metabolic pro...,1281,125,92.54,0.00032,1,0.002358101071975498,1.35,BP
GO:1900408,negative regulation of cellular response...,53,12,3.83,0.00032,1,0.002358101071975498,3.13,BP
GO:0032200,telomere organization,128,21,9.25,0.00033,1,0.002420670731707317,2.27,BP
GO:0023056,positive regulation of signaling,1893,175,136.75,0.00033,1,0.002420670731707317,1.28,BP
GO:0051272,positive regulation of cellular componen...,584,65,42.19,0.00033,1,0.002420670731707317,1.54,BP
GO:0050792,regulation of viral process,184,27,13.29,0.00034,1,0.002478909090909091,2.03,BP
GO:0060491,regulation of cell projection assembly,184,27,13.29,0.00034,1,0.002478909090909091,2.03,BP
GO:0034502,protein localization to chromosome,85,16,6.14,0.00034,1,0.002478909090909091,2.61,BP
GO:0072595,maintenance of protein localization in o...,39,10,2.82,0.00034,1,0.002478909090909091,3.55,BP
GO:0030837,negative regulation of actin filament po...,61,13,4.41,0.00035,1,0.0025402714932126697,2.95,BP
GO:0034655,nucleobase-containing compound catabolic...,431,51,31.13,0.00035,1,0.0025402714932126697,1.64,BP
GO:0072332,intrinsic apoptotic signaling pathway by...,77,15,5.56,0.00035,1,0.0025402714932126697,2.7,BP
GO:0046677,response to antibiotic,305,39,22.03,0.00037,1,0.002673333333333333,1.77,BP
GO:0009749,response to glucose,185,27,13.36,0.00037,1,0.002673333333333333,2.02,BP
GO:0009266,response to temperature stimulus,166,25,11.99,0.00037,1,0.002673333333333333,2.09,BP
GO:0001701,in utero embryonic development,542,61,39.15,0.00038,1,0.002737365269461078,1.56,BP
GO:1902905,positive regulation of supramolecular fi...,195,28,14.09,0.00038,1,0.002737365269461078,1.99,BP
GO:2000147,positive regulation of cell motility,565,63,40.81,0.00039,1,0.0027968405365126677,1.54,BP
GO:0010647,positive regulation of cell communicatio...,1887,174,136.31,0.00039,1,0.0027968405365126677,1.28,BP
GO:0006402,mRNA catabolic process,215,30,15.53,0.00039,1,0.0027968405365126677,1.93,BP
GO:2000116,regulation of cysteine-type endopeptidas...,235,32,16.98,0.00040,1,0.002860029717682021,1.88,BP
GO:0035303,regulation of dephosphorylation,167,25,12.06,0.00040,1,0.002860029717682021,2.07,BP
GO:0001836,release of cytochrome c from mitochondri...,62,13,4.48,0.00041,1,0.0029185207100591716,2.9,BP
GO:0006405,RNA export from nucleus,78,15,5.63,0.00041,1,0.0029185207100591716,2.66,BP
GO:0120036,plasma membrane bounded cell projection ...,1544,146,111.53,0.00041,1,0.0029185207100591716,1.31,BP
GO:0051489,regulation of filopodium assembly,47,11,3.4,0.00042,1,0.0029808849557522127,3.24,BP
GO:0043902,positive regulation of multi-organism pr...,177,26,12.79,0.00042,1,0.0029808849557522127,2.03,BP
GO:1902108,regulation of mitochondrial membrane per...,40,10,2.89,0.00043,1,0.003047363770250368,3.46,BP
GO:0042594,response to starvation,168,25,12.14,0.00044,1,0.0031136470588235296,2.06,BP
GO:1901879,regulation of protein depolymerization,87,16,6.28,0.00045,1,0.003179735682819383,2.55,BP
GO:0043112,receptor metabolic process,207,29,14.95,0.00046,1,0.0032267055393586006,1.94,BP
GO:0030042,actin filament depolymerization,55,12,3.97,0.00046,1,0.0032267055393586006,3.02,BP
GO:0032210,regulation of telomere maintenance via t...,55,12,3.97,0.00046,1,0.0032267055393586006,3.02,BP
GO:0045773,positive regulation of axon extension,55,12,3.97,0.00046,1,0.0032267055393586006,3.02,BP
GO:0046902,regulation of mitochondrial membrane per...,55,12,3.97,0.00046,1,0.0032267055393586006,3.02,BP
GO:0006352,"DNA-templated transcription, initiation",96,17,6.93,0.00048,1,0.003347478260869565,2.45,BP
GO:0046916,cellular transition metal ion homeostasi...,96,17,6.93,0.00048,1,0.003347478260869565,2.45,BP
GO:0070059,intrinsic apoptotic signaling pathway in...,63,13,4.55,0.00048,1,0.003347478260869565,2.86,BP
GO:0010558,negative regulation of macromolecule bio...,1428,136,103.16,0.00048,1,0.003347478260869565,1.32,BP
GO:0051962,positive regulation of nervous system de...,660,71,47.68,0.00049,1,0.0034024242424242424,1.49,BP
GO:0110053,regulation of actin filament organizatio...,258,34,18.64,0.00049,1,0.0034024242424242424,1.82,BP
GO:0016197,endosomal transport,208,29,15.03,0.00049,1,0.0034024242424242424,1.93,BP
GO:0006090,pyruvate metabolic process,114,19,8.24,0.00051,1,0.003515931232091691,2.31,BP
GO:0032870,cellular response to hormone stimulus,526,59,38,0.00051,1,0.003515931232091691,1.55,BP
GO:0010970,transport along microtubule,160,24,11.56,0.00051,1,0.003515931232091691,2.08,BP
GO:0099111,microtubule-based transport,160,24,11.56,0.00051,1,0.003515931232091691,2.08,BP
GO:0007030,Golgi organization,123,20,8.89,0.00051,1,0.003515931232091691,2.25,BP
GO:0009746,response to hexose,189,27,13.65,0.00052,1,0.003579742489270386,1.98,BP
GO:0030030,cell projection organization,1590,149,114.86,0.00053,1,0.0036433714285714286,1.3,BP
GO:0010950,positive regulation of endopeptidase act...,161,24,11.63,0.00056,1,0.003822297872340425,2.06,BP
GO:0042593,glucose homeostasis,270,35,19.5,0.00056,1,0.003822297872340425,1.79,BP
GO:0032091,negative regulation of protein binding,106,18,7.66,0.00056,1,0.003822297872340425,2.35,BP
GO:0120034,positive regulation of plasma membrane b...,106,18,7.66,0.00056,1,0.003822297872340425,2.35,BP
GO:0034284,response to monosaccharide,190,27,13.73,0.00056,1,0.003822297872340425,1.97,BP
GO:0040012,regulation of locomotion,1025,102,74.04,0.00057,1,0.003885042492917847,1.38,BP
GO:0033500,carbohydrate homeostasis,271,35,19.58,0.00060,1,0.004083734087694483,1.79,BP
GO:0090314,positive regulation of protein targeting...,28,8,2.02,0.00061,1,0.00414593220338983,3.96,BP
GO:0051261,protein depolymerization,116,19,8.38,0.00063,1,0.004275825105782793,2.27,BP
GO:0050657,nucleic acid transport,153,23,11.05,0.00064,1,0.004325393258426967,2.08,BP
GO:0050658,RNA transport,153,23,11.05,0.00064,1,0.004325393258426967,2.08,BP
GO:0007610,behavior,724,76,52.3,0.00064,1,0.004325393258426967,1.45,BP
GO:0019080,viral gene expression,57,12,4.12,0.00065,1,0.00436234309623431,2.91,BP
GO:0010765,positive regulation of sodium ion transp...,42,10,3.03,0.00065,1,0.00436234309623431,3.3,BP
GO:0030835,negative regulation of actin filament de...,42,10,3.03,0.00065,1,0.00436234309623431,3.3,BP
GO:0045740,positive regulation of DNA replication,42,10,3.03,0.00065,1,0.00436234309623431,3.3,BP
GO:2000145,regulation of cell motility,946,95,68.34,0.00065,1,0.00436234309623431,1.39,BP
GO:1902307,positive regulation of sodium ion transm...,22,7,1.59,0.00066,1,0.004417134909596662,4.4,BP
GO:0032435,negative regulation of proteasomal ubiqu...,35,9,2.53,0.00066,1,0.004417134909596662,3.56,BP
GO:0010001,glial cell differentiation,242,32,17.48,0.00067,1,0.004465429362880887,1.83,BP
GO:2000113,negative regulation of cellular macromol...,1391,132,100.48,0.00067,1,0.004465429362880887,1.31,BP
GO:0006355,"regulation of transcription, DNA-templat...",2805,245,202.63,0.00067,1,0.004465429362880887,1.21,BP
GO:0071453,cellular response to oxygen levels,135,21,9.75,0.00068,1,0.004525809128630706,2.15,BP
GO:1901137,carbohydrate derivative biosynthetic pro...,600,65,43.34,0.00069,1,0.004586022099447514,1.5,BP
GO:0051650,establishment of vesicle localization,263,34,19,0.00070,1,0.004639669421487603,1.79,BP
GO:0000723,telomere maintenance,126,20,9.1,0.00070,1,0.004639669421487603,2.2,BP
GO:0044106,cellular amine metabolic process,82,15,5.92,0.00071,1,0.004699477303988996,2.53,BP
GO:0042063,gliogenesis,326,40,23.55,0.00072,1,0.0047460821917808226,1.7,BP
GO:0043270,positive regulation of ion transport,326,40,23.55,0.00072,1,0.0047460821917808226,1.7,BP
GO:0007264,small GTPase mediated signal transductio...,489,55,35.32,0.00072,1,0.0047460821917808226,1.56,BP
GO:0009743,response to carbohydrate,203,28,14.66,0.00073,1,0.004798852459016393,1.91,BP
GO:2001141,regulation of RNA biosynthetic process,2822,246,203.85,0.00073,1,0.004798852459016393,1.21,BP
GO:1901880,negative regulation of protein depolymer...,74,14,5.35,0.00075,1,0.004923601637107776,2.62,BP
GO:0016311,dephosphorylation,370,44,26.73,0.00077,1,0.005048010899182561,1.65,BP
GO:0051701,interaction with host,118,19,8.52,0.00079,1,0.005130202429149798,2.23,BP
GO:0045185,maintenance of protein location,109,18,7.87,0.00079,1,0.005130202429149798,2.29,BP
GO:1900542,regulation of purine nucleotide metaboli...,109,18,7.87,0.00079,1,0.005130202429149798,2.29,BP
GO:1903506,regulation of nucleic acid-templated tra...,2813,245,203.2,0.00079,1,0.005130202429149798,1.21,BP
GO:0006734,NADH metabolic process,29,8,2.09,0.00079,1,0.005130202429149798,3.83,BP
GO:0045292,"mRNA cis splicing, via spliceosome",29,8,2.09,0.00079,1,0.005130202429149798,3.83,BP
GO:0097345,mitochondrial outer membrane permeabiliz...,29,8,2.09,0.00079,1,0.005130202429149798,3.83,BP
GO:0090317,negative regulation of intracellular pro...,43,10,3.11,0.00080,1,0.005188140161725067,3.22,BP
GO:0032436,positive regulation of proteasomal ubiqu...,83,15,6,0.00081,1,0.005245921938088829,2.5,BP
GO:0033238,regulation of cellular amine metabolic p...,36,9,2.6,0.00083,1,0.005361020134228188,3.46,BP
GO:0043900,regulation of multi-organism process,393,46,28.39,0.00083,1,0.005361020134228188,1.62,BP
GO:0051236,establishment of RNA localization,156,23,11.27,0.00084,1,0.0054183378016085795,2.04,BP
GO:0071824,protein-DNA complex subunit organization,215,29,15.53,0.00085,1,0.0054536,1.87,BP
GO:0070507,regulation of microtubule cytoskeleton o...,205,28,14.81,0.00085,1,0.0054536,1.89,BP
GO:0030838,positive regulation of actin filament po...,92,16,6.65,0.00085,1,0.0054536,2.41,BP
GO:0022898,regulation of transmembrane transporter ...,266,34,19.22,0.00085,1,0.0054536,1.77,BP
GO:0098693,regulation of synaptic vesicle cycle,147,22,10.62,0.00088,1,0.005638561917443409,2.07,BP
GO:0071375,cellular response to peptide hormone sti...,246,32,17.77,0.00089,1,0.005672423841059602,1.8,BP
GO:0007015,actin filament organization,405,47,29.26,0.00089,1,0.005672423841059602,1.61,BP
GO:0009991,response to extracellular stimulus,405,47,29.26,0.00089,1,0.005672423841059602,1.61,BP
GO:1902410,mitotic cytokinetic process,23,7,1.66,0.00089,1,0.005672423841059602,4.22,BP
GO:0071806,protein transmembrane transport,59,12,4.26,0.00090,1,0.005728571428571428,2.82,BP
GO:0018193,peptidyl-amino acid modification,1147,111,82.86,0.00091,1,0.0057769393139841686,1.34,BP
GO:0048675,axon extension,138,21,9.97,0.00091,1,0.0057769393139841686,2.11,BP
GO:0048584,positive regulation of response to stimu...,2187,195,157.98,0.00096,1,0.006078315789473685,1.23,BP
GO:0034764,positive regulation of transmembrane tra...,237,31,17.12,0.00096,1,0.006078315789473685,1.81,BP
GO:0009967,positive regulation of signal transducti...,1527,142,110.31,0.00097,1,0.006133561103810776,1.29,BP
GO:0015931,nucleobase-containing compound transport,187,26,13.51,0.00098,1,0.006180550458715597,1.92,BP
GO:0032507,maintenance of protein location in cell,76,14,5.49,0.00098,1,0.006180550458715597,2.55,BP
GO:0030334,regulation of cell migration,899,90,64.94,0.00099,1,0.00623544502617801,1.39,BP
GO:0007059,chromosome segregation,321,39,23.19,0.00100,1,0.006281984334203655,1.68,BP
GO:0000902,cell morphogenesis,1114,108,80.47,0.00100,1,0.006281984334203655,1.34,BP
GO:0034101,erythrocyte homeostasis,139,21,10.04,0.00101,1,0.006311844155844157,2.09,BP
GO:0009719,response to endogenous stimulus,1430,134,103.3,0.00101,1,0.006311844155844157,1.3,BP
GO:0070979,protein K11-linked ubiquitination,30,8,2.17,0.00101,1,0.006311844155844157,3.69,BP
GO:1902253,regulation of intrinsic apoptotic signal...,30,8,2.17,0.00101,1,0.006311844155844157,3.69,BP
GO:0031667,response to nutrient levels,375,44,27.09,0.00102,1,0.0063578238341968915,1.62,BP
GO:0036474,cell death in response to hydrogen perox...,37,9,2.67,0.00102,1,0.0063578238341968915,3.37,BP
GO:0032940,secretion by cell,1091,106,78.81,0.00103,1,0.0064035658914728694,1.35,BP
GO:0001932,regulation of protein phosphorylation,1431,134,103.37,0.00103,1,0.0064035658914728694,1.3,BP
GO:0016072,rRNA metabolic process,228,30,16.47,0.00105,1,0.006519483870967742,1.82,BP
GO:0051668,localization within membrane,188,26,13.58,0.00106,1,0.006573092783505155,1.91,BP
GO:0032989,cellular component morphogenesis,1225,117,88.49,0.00107,1,0.0066180462724935735,1.32,BP
GO:0044070,regulation of anion transport,121,19,8.74,0.00107,1,0.0066180462724935735,2.17,BP
GO:2000060,positive regulation of ubiquitin-depende...,94,16,6.79,0.00108,1,0.006671322207958922,2.36,BP
GO:0006401,RNA catabolic process,249,32,17.99,0.00109,1,0.006707263427109975,1.78,BP
GO:0019079,viral genome replication,112,18,8.09,0.00109,1,0.006707263427109975,2.22,BP
GO:0032990,cell part morphogenesis,726,75,52.44,0.00109,1,0.006707263427109975,1.43,BP
GO:0030335,positive regulation of cell migration,543,59,39.22,0.00111,1,0.0068216091954022996,1.5,BP
GO:0006887,exocytosis,377,44,27.23,0.00113,1,0.006935663265306122,1.62,BP
GO:0045934,negative regulation of nucleobase-contai...,1410,132,101.85,0.00114,1,0.006988127388535032,1.3,BP
GO:0030307,positive regulation of cell growth,199,27,14.38,0.00115,1,0.00703151207115629,1.88,BP
GO:0043903,"regulation of symbiosis, encompassing mu...",199,27,14.38,0.00115,1,0.00703151207115629,1.88,BP
GO:0031327,negative regulation of cellular biosynth...,1485,138,107.27,0.00118,1,0.0071966539923954374,1.29,BP
GO:0051341,regulation of oxidoreductase activity,86,15,6.21,0.00118,1,0.0071966539923954374,2.42,BP
GO:0043436,oxoacid metabolic process,940,93,67.9,0.00119,1,0.007239292035398231,1.37,BP
GO:0016239,positive regulation of macroautophagy,69,13,4.98,0.00119,1,0.007239292035398231,2.61,BP
GO:0071495,cellular response to endogenous stimulus,1241,118,89.65,0.00120,1,0.007281715006305169,1.32,BP
GO:0051052,regulation of DNA metabolic process,444,50,32.07,0.00120,1,0.007281715006305169,1.56,BP
GO:0006140,regulation of nucleotide metabolic proce...,113,18,8.16,0.00121,1,0.0073239245283018865,2.21,BP
GO:0030516,regulation of axon extension,113,18,8.16,0.00121,1,0.0073239245283018865,2.21,BP
GO:0051648,vesicle localization,282,35,20.37,0.00122,1,0.0073474843554443055,1.72,BP
GO:0031113,regulation of microtubule polymerization,53,11,3.83,0.00122,1,0.0073474843554443055,2.87,BP
GO:0006446,regulation of translational initiation,61,12,4.41,0.00122,1,0.0073474843554443055,2.72,BP
GO:0072665,protein localization to vacuole,61,12,4.41,0.00122,1,0.0073474843554443055,2.72,BP
GO:0043269,regulation of ion transport,741,76,53.53,0.00124,1,0.007458599999999999,1.42,BP
GO:0007611,learning or memory,293,36,21.17,0.00125,1,0.007509363295880149,1.7,BP
GO:0051491,positive regulation of filopodium assemb...,31,8,2.24,0.00128,1,0.00766089552238806,3.57,BP
GO:1902745,positive regulation of lamellipodium org...,31,8,2.24,0.00128,1,0.00766089552238806,3.57,BP
GO:0019439,aromatic compound catabolic process,490,54,35.4,0.00128,1,0.00766089552238806,1.53,BP
GO:0052548,regulation of endopeptidase activity,347,41,25.07,0.00130,1,0.007770931677018633,1.64,BP
GO:0043648,dicarboxylic acid metabolic process,87,15,6.28,0.00134,1,0.007980297029702972,2.39,BP
GO:2000117,negative regulation of cysteine-type end...,87,15,6.28,0.00134,1,0.007980297029702972,2.39,BP
GO:0048589,developmental growth,790,80,57.07,0.00134,1,0.007980297029702972,1.4,BP
GO:1903530,regulation of secretion by cell,849,85,61.33,0.00135,1,0.00802991347342398,1.39,BP
GO:0010657,muscle cell apoptotic process,105,17,7.58,0.00136,1,0.008079407407407408,2.24,BP
GO:0044270,cellular nitrogen compound catabolic pro...,469,52,33.88,0.00137,1,0.008128779284833538,1.53,BP
GO:0008037,cell recognition,133,20,9.61,0.00139,1,0.008227158671586715,2.08,BP
GO:1902850,microtubule cytoskeleton organization in...,133,20,9.61,0.00139,1,0.008227158671586715,2.08,BP
GO:0051291,protein heterooligomerization,162,23,11.7,0.00141,1,0.008335282555282555,1.97,BP
GO:0050793,regulation of developmental process,2753,238,198.87,0.00142,1,0.008343150183150185,1.2,BP
GO:0007040,lysosome organization,62,12,4.48,0.00142,1,0.008343150183150185,2.68,BP
GO:0048488,synaptic vesicle endocytosis,62,12,4.48,0.00142,1,0.008343150183150185,2.68,BP
GO:0080171,lytic vacuole organization,62,12,4.48,0.00142,1,0.008343150183150185,2.68,BP
GO:0140238,presynaptic endocytosis,62,12,4.48,0.00142,1,0.008343150183150185,2.68,BP
GO:0030705,cytoskeleton-dependent intracellular tra...,172,24,12.42,0.00143,1,0.008391658536585366,1.93,BP
GO:0043434,response to peptide hormone,328,39,23.69,0.00149,1,0.008733105968331304,1.65,BP
GO:0008360,regulation of cell shape,153,22,11.05,0.00150,1,0.008781021897810218,1.99,BP
GO:0007346,regulation of mitotic cell cycle,505,55,36.48,0.00152,1,0.008887290400972053,1.51,BP
GO:1905710,positive regulation of membrane permeabi...,39,9,2.82,0.00153,1,0.00891326876513317,3.19,BP
GO:2001024,negative regulation of response to drug,39,9,2.82,0.00153,1,0.00891326876513317,3.19,BP
GO:1905809,negative regulation of synapse organizat...,25,7,1.81,0.00153,1,0.00891326876513317,3.87,BP
GO:0002262,myeloid cell homeostasis,173,24,12.5,0.00155,1,0.009018863361547762,1.92,BP
GO:1901796,regulation of signal transduction by p53...,71,13,5.13,0.00156,1,0.00906608695652174,2.53,BP
GO:0019752,carboxylic acid metabolic process,901,89,65.09,0.00157,1,0.00911319662243667,1.37,BP
GO:0036475,neuron death in response to oxidative st...,32,8,2.31,0.00160,1,0.009242737094837935,3.46,BP
GO:0043457,regulation of cellular respiration,32,8,2.31,0.00160,1,0.009242737094837935,3.46,BP
GO:1902110,positive regulation of mitochondrial mem...,32,8,2.31,0.00160,1,0.009242737094837935,3.46,BP
GO:1903203,regulation of oxidative stress-induced n...,32,8,2.31,0.00160,1,0.009242737094837935,3.46,BP
GO:0032409,regulation of transporter activity,276,34,19.94,0.00161,1,0.009289352517985612,1.71,BP
GO:0043154,negative regulation of cysteine-type end...,80,14,5.78,0.00165,1,0.009486021505376344,2.42,BP
GO:1902117,positive regulation of organelle assembl...,80,14,5.78,0.00165,1,0.009486021505376344,2.42,BP
GO:0033120,positive regulation of RNA splicing,47,10,3.4,0.00165,1,0.009486021505376344,2.94,BP
GO:0070646,protein modification by small protein re...,135,20,9.75,0.00167,1,0.009589546539379476,2.05,BP
GO:0035306,positive regulation of dephosphorylation,55,11,3.97,0.00168,1,0.009601140142517815,2.77,BP
GO:0045687,positive regulation of glial cell differ...,55,11,3.97,0.00168,1,0.009601140142517815,2.77,BP
GO:0000209,protein polyubiquitination,194,26,14.01,0.00168,1,0.009601140142517815,1.86,BP
GO:0032869,cellular response to insulin stimulus,194,26,14.01,0.00168,1,0.009601140142517815,1.86,BP
GO:0070301,cellular response to hydrogen peroxide,89,15,6.43,0.00169,1,0.009646832740213523,2.33,BP
GO:0010324,membrane invagination,72,13,5.2,0.00178,1,0.010148530805687202,2.5,BP
GO:0043244,regulation of protein complex disassembl...,117,18,8.45,0.00181,1,0.010307360946745562,2.13,BP
GO:0007339,binding of sperm to zona pellucida,40,9,2.89,0.00185,1,0.010510271546635183,3.11,BP
GO:0035307,positive regulation of protein dephospho...,40,9,2.89,0.00185,1,0.010510271546635183,3.11,BP
GO:0072384,organelle transport along microtubule,81,14,5.85,0.00186,1,0.010554622641509435,2.39,BP
GO:1901361,organic cyclic compound catabolic proces...,521,56,37.64,0.00187,1,0.0105864,1.49,BP
GO:0007052,mitotic spindle organization,108,17,7.8,0.00187,1,0.0105864,2.18,BP
GO:0017157,regulation of exocytosis,247,31,17.84,0.00188,1,0.010630505287896592,1.74,BP
GO:0046700,heterocycle catabolic process,476,52,34.39,0.00189,1,0.010637052631578946,1.51,BP
GO:0010658,striated muscle cell apoptotic process,64,12,4.62,0.00189,1,0.010637052631578946,2.6,BP
GO:1903900,regulation of viral life cycle,146,21,10.55,0.00189,1,0.010637052631578946,1.99,BP
GO:0006366,transcription by RNA polymerase II,2067,183,149.31,0.00189,1,0.010637052631578946,1.23,BP
GO:0009135,purine nucleoside diphosphate metabolic ...,99,16,7.15,0.00190,1,0.010655944055944055,2.24,BP
GO:0009179,purine ribonucleoside diphosphate metabo...,99,16,7.15,0.00190,1,0.010655944055944055,2.24,BP
GO:0044772,mitotic cell cycle phase transition,365,42,26.37,0.00190,1,0.010655944055944055,1.59,BP
GO:1990138,neuron projection extension,196,26,14.16,0.00195,1,0.010923632130384168,1.84,BP
GO:0051123,RNA polymerase II preinitiation complex ...,26,7,1.88,0.00196,1,0.010966883720930232,3.72,BP
GO:0001933,negative regulation of protein phosphory...,421,47,30.41,0.00197,1,0.011010034843205575,1.55,BP
GO:0017004,cytochrome complex assembly,33,8,2.38,0.00198,1,0.01105308584686775,3.36,BP
GO:0072331,signal transduction by p53 class mediato...,137,20,9.9,0.00200,1,0.01113888888888889,2.02,BP
GO:1903052,positive regulation of proteolysis invol...,118,18,8.52,0.00200,1,0.01113888888888889,2.11,BP
GO:0009725,response to hormone,708,72,51.14,0.00204,1,0.011348531791907514,1.41,BP
GO:0051240,positive regulation of multicellular org...,1957,174,141.37,0.00205,1,0.011390993071593535,1.23,BP
GO:0009636,response to toxic substance,345,40,24.92,0.00209,1,0.011586497695852533,1.61,BP
GO:0042493,response to drug,898,88,64.87,0.00209,1,0.011586497695852533,1.36,BP
GO:0001505,regulation of neurotransmitter levels,378,43,27.31,0.00210,1,0.011628538550057537,1.57,BP
GO:0010660,regulation of muscle cell apoptotic proc...,100,16,7.22,0.00211,1,0.011670482758620688,2.22,BP
GO:0046903,secretion,1250,117,90.3,0.00215,1,0.011878071182548794,1.3,BP
GO:0009314,response to radiation,401,45,28.97,0.00220,1,0.012140366972477066,1.55,BP
GO:0035774,positive regulation of insulin secretion...,41,9,2.96,0.00222,1,0.012222700228832952,3.04,BP
GO:0043001,Golgi to plasma membrane protein transpo...,41,9,2.96,0.00222,1,0.012222700228832952,3.04,BP
GO:0008090,retrograde axonal transport,20,6,1.44,0.00226,1,0.012414520547945205,4.17,BP
GO:0071157,negative regulation of cell cycle arrest,20,6,1.44,0.00226,1,0.012414520547945205,4.17,BP
GO:0017156,calcium ion regulated exocytosis,178,24,12.86,0.00229,1,0.01256497149372862,1.87,BP
GO:0036465,synaptic vesicle recycling,74,13,5.35,0.00230,1,0.01257681818181818,2.43,BP
GO:0050435,amyloid-beta metabolic process,49,10,3.54,0.00230,1,0.01257681818181818,2.82,BP
GO:0090199,regulation of release of cytochrome c fr...,49,10,3.54,0.00230,1,0.01257681818181818,2.82,BP
GO:0016050,vesicle organization,261,32,18.85,0.00234,1,0.012781021566401816,1.7,BP
GO:0043242,negative regulation of protein complex d...,83,14,6,0.00236,1,0.012861064552661382,2.33,BP
GO:1901992,positive regulation of mitotic cell cycl...,83,14,6,0.00236,1,0.012861064552661382,2.33,BP
GO:0009308,amine metabolic process,92,15,6.65,0.00237,1,0.012900950226244346,2.26,BP
GO:0006984,ER-nucleus signaling pathway,34,8,2.46,0.00242,1,0.013128568207440811,3.25,BP
GO:0045070,positive regulation of viral genome repl...,34,8,2.46,0.00242,1,0.013128568207440811,3.25,BP
GO:1902686,mitochondrial outer membrane permeabiliz...,34,8,2.46,0.00242,1,0.013128568207440811,3.25,BP
GO:0030968,endoplasmic reticulum unfolded protein r...,66,12,4.77,0.00248,1,0.013408719101123595,2.52,BP
GO:0043549,regulation of kinase activity,737,74,53.24,0.00248,1,0.013408719101123595,1.39,BP
GO:0043086,negative regulation of catalytic activit...,690,70,49.84,0.00248,1,0.013408719101123595,1.4,BP
GO:0042744,hydrogen peroxide catabolic process,27,7,1.95,0.00249,1,0.013432600896860988,3.59,BP
GO:0051560,mitochondrial calcium ion homeostasis,27,7,1.95,0.00249,1,0.013432600896860988,3.59,BP
GO:0044770,cell cycle phase transition,404,45,29.18,0.00254,1,0.013686987681970884,1.54,BP
GO:0050890,cognition,327,38,23.62,0.00256,1,0.013779328859060403,1.61,BP
GO:0035601,protein deacylation,102,16,7.37,0.00259,1,0.01387870824053452,2.17,BP
GO:0050772,positive regulation of axonogenesis,102,16,7.37,0.00259,1,0.01387870824053452,2.17,BP
GO:0098732,macromolecule deacylation,102,16,7.37,0.00259,1,0.01387870824053452,2.17,BP
GO:0106027,neuron projection organization,102,16,7.37,0.00259,1,0.01387870824053452,2.17,BP
GO:0010564,regulation of cell cycle process,598,62,43.2,0.00260,1,0.013916796440489432,1.44,BP
GO:0065002,intracellular protein transmembrane tran...,58,11,4.19,0.00262,1,0.013992719200887902,2.63,BP
GO:0098930,axonal transport,58,11,4.19,0.00262,1,0.013992719200887902,2.63,BP
GO:0099084,postsynaptic specialization organization,42,9,3.03,0.00264,1,0.01408390243902439,2.97,BP
GO:0036294,cellular response to decreased oxygen le...,121,18,8.74,0.00265,1,0.014121594684385381,2.06,BP
GO:0060249,anatomical structure homeostasis,394,44,28.46,0.00268,1,0.01426566371681416,1.55,BP
GO:0051046,regulation of secretion,930,90,67.18,0.00269,1,0.014287284768211922,1.34,BP
GO:0035690,cellular response to drug,383,43,27.67,0.00269,1,0.014287284768211922,1.55,BP
GO:0007265,Ras protein signal transduction,417,46,30.12,0.00276,1,0.014642910694597574,1.53,BP
GO:0006082,organic acid metabolic process,968,93,69.93,0.00285,1,0.01510374449339207,1.33,BP
GO:0009185,ribonucleoside diphosphate metabolic pro...,103,16,7.44,0.00287,1,0.015176307692307692,2.15,BP
GO:1903426,regulation of reactive oxygen species bi...,103,16,7.44,0.00287,1,0.015176307692307692,2.15,BP
GO:1904950,negative regulation of establishment of ...,212,27,15.31,0.00290,1,0.015318111964873765,1.76,BP
GO:0010508,positive regulation of autophagy,122,18,8.81,0.00291,1,0.015320481400437637,2.04,BP
GO:2000278,regulation of DNA biosynthetic process,122,18,8.81,0.00291,1,0.015320481400437637,2.04,BP
GO:0090068,positive regulation of cell cycle proces...,254,31,18.35,0.00291,1,0.015320481400437637,1.69,BP
GO:0010822,positive regulation of mitochondrion org...,76,13,5.49,0.00293,1,0.015392096069868995,2.37,BP
GO:0051865,protein autoubiquitination,76,13,5.49,0.00293,1,0.015392096069868995,2.37,BP
GO:0046031,ADP metabolic process,94,15,6.79,0.00294,1,0.015427786259541984,2.21,BP
GO:0048679,regulation of axon regeneration,35,8,2.53,0.00295,1,0.015446572361262241,3.16,BP
GO:1902116,negative regulation of organelle assembl...,35,8,2.53,0.00295,1,0.015446572361262241,3.16,BP
GO:0000413,protein peptidyl-prolyl isomerization,21,6,1.52,0.00297,1,0.015500694143167027,3.95,BP
GO:0098780,response to mitochondrial depolarisation,21,6,1.52,0.00297,1,0.015500694143167027,3.95,BP
GO:0098969,neurotransmitter receptor transport to p...,21,6,1.52,0.00297,1,0.015500694143167027,3.95,BP
GO:0099536,synaptic signaling,886,86,64,0.00305,1,0.015900975081256773,1.34,BP
GO:0034767,positive regulation of ion transmembrane...,182,24,13.15,0.00307,1,0.015987922077922077,1.83,BP
GO:0008283,cell proliferation,2027,178,146.43,0.00309,1,0.01605732181425486,1.22,BP
GO:0042391,regulation of membrane potential,442,48,31.93,0.00309,1,0.01605732181425486,1.5,BP
GO:0010939,regulation of necrotic cell death,28,7,2.02,0.00311,1,0.016126422413793105,3.47,BP
GO:1904292,regulation of ERAD pathway,28,7,2.02,0.00311,1,0.016126422413793105,3.47,BP
GO:0051353,positive regulation of oxidoreductase ac...,51,10,3.68,0.00313,1,0.01619522580645161,2.72,BP
GO:0051972,regulation of telomerase activity,51,10,3.68,0.00313,1,0.01619522580645161,2.72,BP
GO:0010648,negative regulation of cell communicatio...,1326,122,95.79,0.00314,1,0.01622951664876477,1.27,BP
GO:0099504,synaptic vesicle cycle,224,28,16.18,0.00321,1,0.016573519313304724,1.73,BP
GO:1903578,regulation of ATP metabolic process,95,15,6.86,0.00326,1,0.01681363344051447,2.19,BP
GO:0065004,protein-DNA complex assembly,173,23,12.5,0.00333,1,0.01715627408993576,1.84,BP
GO:0099537,trans-synaptic signaling,877,85,63.35,0.00334,1,0.01718939037433155,1.34,BP
GO:0032502,developmental process,6278,501,453.51,0.00336,1,0.017273846153846157,1.1,BP
GO:0051239,regulation of multicellular organismal p...,3294,276,237.95,0.00340,1,0.017460832443970117,1.16,BP
GO:0010662,regulation of striated muscle cell apopt...,60,11,4.33,0.00345,1,0.017679872204472844,2.54,BP
GO:0042982,amyloid precursor protein metabolic proc...,60,11,4.33,0.00345,1,0.017679872204472844,2.54,BP
GO:0006325,chromatin organization,735,73,53.09,0.00347,1,0.017744569606801274,1.38,BP
GO:0023057,negative regulation of signaling,1330,122,96.08,0.00347,1,0.017744569606801274,1.27,BP
GO:1901800,positive regulation of proteasomal prote...,105,16,7.58,0.00350,1,0.017878980891719746,2.11,BP
GO:0034205,amyloid-beta formation,36,8,2.6,0.00355,1,0.018076825396825397,3.08,BP
GO:0097106,postsynaptic density organization,36,8,2.6,0.00355,1,0.018076825396825397,3.08,BP
GO:1902991,regulation of amyloid precursor protein ...,36,8,2.6,0.00355,1,0.018076825396825397,3.08,BP
GO:1901989,positive regulation of cell cycle phase ...,96,15,6.93,0.00361,1,0.018362917547568712,2.16,BP
GO:0001666,response to hypoxia,205,26,14.81,0.00363,1,0.018386905263157897,1.76,BP
GO:0006406,mRNA export from nucleus,52,10,3.76,0.00363,1,0.018386905263157897,2.66,BP
GO:0071427,mRNA-containing ribonucleoprotein comple...,52,10,3.76,0.00363,1,0.018386905263157897,2.66,BP
GO:0048168,regulation of neuronal synaptic plastici...,69,12,4.98,0.00363,1,0.018386905263157897,2.41,BP
GO:0048872,homeostasis of number of cells,312,36,22.54,0.00366,1,0.0184805036726128,1.6,BP
GO:0007268,chemical synaptic transmission,868,84,62.7,0.00366,1,0.0184805036726128,1.34,BP
GO:0098916,anterograde trans-synaptic signaling,868,84,62.7,0.00366,1,0.0184805036726128,1.34,BP
GO:0032412,regulation of ion transmembrane transpor...,258,31,18.64,0.00368,1,0.018542575916230368,1.66,BP
GO:0045055,regulated exocytosis,258,31,18.64,0.00368,1,0.018542575916230368,1.66,BP
GO:1902743,regulation of lamellipodium organization,44,9,3.18,0.00369,1,0.018573514644351464,2.83,BP
GO:0042069,regulation of catecholamine metabolic pr...,22,6,1.59,0.00384,1,0.019178260869565218,3.77,BP
GO:0071870,cellular response to catecholamine stimu...,22,6,1.59,0.00384,1,0.019178260869565218,3.77,BP
GO:0098877,neurotransmitter receptor transport to p...,22,6,1.59,0.00384,1,0.019178260869565218,3.77,BP
GO:1901626,regulation of postsynaptic membrane orga...,22,6,1.59,0.00384,1,0.019178260869565218,3.77,BP
GO:1901673,regulation of mitotic spindle assembly,22,6,1.59,0.00384,1,0.019178260869565218,3.77,BP
GO:0051225,spindle assembly,106,16,7.66,0.00385,1,0.019178260869565218,2.09,BP
GO:0051984,positive regulation of chromosome segreg...,29,7,2.09,0.00385,1,0.019178260869565218,3.35,BP
GO:0060260,regulation of transcription initiation f...,29,7,2.09,0.00385,1,0.019178260869565218,3.35,BP
GO:0071353,cellular response to interleukin-4,29,7,2.09,0.00385,1,0.019178260869565218,3.35,BP
GO:0090169,regulation of spindle assembly,29,7,2.09,0.00385,1,0.019178260869565218,3.35,BP
GO:0032868,response to insulin,227,28,16.4,0.00388,1,0.019307714581178907,1.71,BP
GO:0006749,glutathione metabolic process,61,11,4.41,0.00394,1,0.01956582043343653,2.49,BP
GO:0010659,cardiac muscle cell apoptotic process,61,11,4.41,0.00394,1,0.01956582043343653,2.49,BP
GO:0051094,positive regulation of developmental pro...,1560,140,112.69,0.00399,1,0.019793690721649482,1.24,BP
GO:0030004,cellular monovalent inorganic cation hom...,97,15,7.01,0.00400,1,0.019822863027806385,2.14,BP
GO:0007163,establishment or maintenance of cell pol...,217,27,15.68,0.00401,1,0.019851975308641974,1.72,BP
GO:2001023,regulation of response to drug,116,17,8.38,0.00402,1,0.019881027749229188,2.03,BP
GO:0030003,cellular cation homeostasis,645,65,46.59,0.00404,1,0.019959425051334703,1.4,BP
GO:0034470,ncRNA processing,336,38,24.27,0.00406,1,0.020037661538461538,1.57,BP
GO:0032024,positive regulation of insulin secretion,88,14,6.36,0.00410,1,0.020214344262295087,2.2,BP
GO:0051347,positive regulation of transferase activ...,552,57,39.88,0.00411,1,0.020242906857727738,1.43,BP
GO:0048585,negative regulation of response to stimu...,1599,143,115.51,0.00412,1,0.020271411042944786,1.24,BP
GO:0072330,monocarboxylic acid biosynthetic process,260,31,18.78,0.00413,1,0.02029985699693565,1.65,BP
GO:0031529,ruffle organization,53,10,3.83,0.00419,1,0.020552782874617738,2.61,BP
GO:0043666,regulation of phosphoprotein phosphatase...,53,10,3.83,0.00419,1,0.020552782874617738,2.61,BP
GO:1904064,positive regulation of cation transmembr...,166,22,11.99,0.00420,1,0.020580855397148674,1.83,BP
GO:0043266,regulation of potassium ion transport,107,16,7.73,0.00423,1,0.02070677517802645,2.07,BP
GO:0035794,positive regulation of mitochondrial mem...,37,8,2.67,0.00425,1,0.020762436548223354,3,BP
GO:0048169,regulation of long-term neuronal synapti...,37,8,2.67,0.00425,1,0.020762436548223354,3,BP
GO:0007626,locomotory behavior,250,30,18.06,0.00431,1,0.02099781818181818,1.66,BP
GO:1903532,positive regulation of secretion by cell,484,51,34.96,0.00432,1,0.02099781818181818,1.46,BP
GO:0014046,dopamine secretion,45,9,3.25,0.00432,1,0.02099781818181818,2.77,BP
GO:0014059,regulation of dopamine secretion,45,9,3.25,0.00432,1,0.02099781818181818,2.77,BP
GO:0042987,amyloid precursor protein catabolic proc...,45,9,3.25,0.00432,1,0.02099781818181818,2.77,BP
GO:0050796,regulation of insulin secretion,187,24,13.51,0.00435,1,0.021122300706357212,1.78,BP
GO:0006873,cellular ion homeostasis,659,66,47.6,0.00437,1,0.021198024193548385,1.39,BP
GO:0023061,signal release,531,55,38.36,0.00447,1,0.021661268882175226,1.43,BP
GO:0009968,negative regulation of signal transducti...,1192,110,86.11,0.00449,1,0.021736297786720322,1.28,BP
GO:0061013,regulation of mRNA catabolic process,127,18,9.17,0.00450,1,0.021762814070351758,1.96,BP
GO:0000226,microtubule cytoskeleton organization,578,59,41.75,0.00455,1,0.021960481444333,1.41,BP
GO:0051937,catecholamine transport,89,14,6.43,0.00455,1,0.021960481444333,2.18,BP
GO:0051170,import into nucleus,157,21,11.34,0.00456,1,0.021986693386773545,1.85,BP
GO:0006513,protein monoubiquitination,71,12,5.13,0.00462,1,0.022253693693693694,2.34,BP
GO:0060560,developmental growth involved in morphog...,273,32,19.72,0.00468,1,0.02252016,1.62,BP
GO:1902003,regulation of amyloid-beta formation,30,7,2.17,0.00471,1,0.022641878121878123,3.23,BP
GO:0048813,dendrite morphogenesis,178,23,12.86,0.00476,1,0.022859401197604795,1.79,BP
GO:0071407,cellular response to organic cyclic comp...,487,51,35.18,0.00487,1,0.02316011811023622,1.45,BP
GO:0010592,positive regulation of lamellipodium ass...,23,6,1.66,0.00488,1,0.02316011811023622,3.61,BP
GO:0035493,SNARE complex assembly,23,6,1.66,0.00488,1,0.02316011811023622,3.61,BP
GO:0036010,protein localization to endosome,23,6,1.66,0.00488,1,0.02316011811023622,3.61,BP
GO:0060261,positive regulation of transcription ini...,23,6,1.66,0.00488,1,0.02316011811023622,3.61,BP
GO:0071868,cellular response to monoamine stimulus,23,6,1.66,0.00488,1,0.02316011811023622,3.61,BP
GO:0071869,response to catecholamine,23,6,1.66,0.00488,1,0.02316011811023622,3.61,BP
GO:0098869,cellular oxidant detoxification,23,6,1.66,0.00488,1,0.02316011811023622,3.61,BP
GO:1900242,regulation of synaptic vesicle endocytos...,23,6,1.66,0.00488,1,0.02316011811023622,3.61,BP
GO:1902884,positive regulation of response to oxida...,23,6,1.66,0.00488,1,0.02316011811023622,3.61,BP
GO:1903540,establishment of protein localization to...,23,6,1.66,0.00488,1,0.02316011811023622,3.61,BP
GO:0030218,erythrocyte differentiation,128,18,9.25,0.00489,1,0.02316011811023622,1.95,BP
GO:0061387,regulation of extent of cell growth,128,18,9.25,0.00489,1,0.02316011811023622,1.95,BP
GO:0048588,developmental cell growth,263,31,19,0.00489,1,0.02316011811023622,1.63,BP
GO:0006357,regulation of transcription by RNA polym...,2012,175,145.34,0.00491,1,0.02323197640117994,1.2,BP
GO:0007269,neurotransmitter secretion,189,24,13.65,0.00498,1,0.023540039292730842,1.76,BP
GO:0051260,protein homooligomerization,385,42,27.81,0.00499,1,0.023564160942100097,1.51,BP
GO:0035264,multicellular organism growth,210,26,15.17,0.00501,1,0.02363541176470588,1.71,BP
GO:0006378,mRNA polyadenylation,46,9,3.32,0.00504,1,0.023637894736842108,2.71,BP
GO:0017001,antibiotic catabolic process,46,9,3.32,0.00504,1,0.023637894736842108,2.71,BP
GO:0031111,negative regulation of microtubule polym...,46,9,3.32,0.00504,1,0.023637894736842108,2.71,BP
GO:0032873,negative regulation of stress-activated ...,46,9,3.32,0.00504,1,0.023637894736842108,2.71,BP
GO:0035036,sperm-egg recognition,46,9,3.32,0.00504,1,0.023637894736842108,2.71,BP
GO:0070303,negative regulation of stress-activated ...,46,9,3.32,0.00504,1,0.023637894736842108,2.71,BP
GO:0032506,cytokinetic process,38,8,2.75,0.00505,1,0.023661733203505352,2.91,BP
GO:0034660,ncRNA metabolic process,465,49,33.59,0.00507,1,0.023732334630350196,1.46,BP
GO:0008344,adult locomotory behavior,109,16,7.87,0.00508,1,0.02373297087378641,2.03,BP
GO:0048259,regulation of receptor-mediated endocyto...,109,16,7.87,0.00508,1,0.02373297087378641,2.03,BP
GO:0055080,cation homeostasis,736,72,53.17,0.00529,1,0.024690087293889426,1.35,BP
GO:0006974,cellular response to DNA damage stimulus,748,73,54.03,0.00530,1,0.02471279069767442,1.35,BP
GO:0051092,positive regulation of NF-kappaB transcr...,129,18,9.32,0.00531,1,0.02473545014520813,1.93,BP
GO:0099643,signal release from synapse,190,24,13.73,0.00532,1,0.024758065764023212,1.75,BP
GO:0017158,regulation of calcium ion-dependent exoc...,139,19,10.04,0.00534,1,0.024827130434782612,1.89,BP
GO:0071900,regulation of protein serine/threonine k...,432,46,31.21,0.00536,1,0.024896061776061774,1.47,BP
GO:0045597,positive regulation of cell differentiat...,1113,103,80.4,0.00540,1,0.025057666345226617,1.28,BP
GO:0000082,G1/S transition of mitotic cell cycle,180,23,13,0.00546,1,0.025311676300578033,1.77,BP
GO:1900024,regulation of substrate adhesion-depende...,55,10,3.97,0.00552,1,0.025540615384615387,2.52,BP
GO:0008284,positive regulation of cell proliferatio...,979,92,70.72,0.00552,1,0.025540615384615387,1.3,BP
GO:1902533,positive regulation of intracellular sig...,1016,95,73.39,0.00557,1,0.02574720461095101,1.29,BP
GO:0098771,inorganic ion homeostasis,750,73,54.18,0.00564,1,0.026045758157389635,1.35,BP
GO:1904062,regulation of cation transmembrane trans...,354,39,25.57,0.00565,1,0.026066922339405562,1.53,BP
GO:0043276,anoikis,31,7,2.24,0.00572,1,0.026289054441260746,3.12,BP
GO:0051085,chaperone cofactor-dependent protein ref...,31,7,2.24,0.00572,1,0.026289054441260746,3.12,BP
GO:0070670,response to interleukin-4,31,7,2.24,0.00572,1,0.026289054441260746,3.12,BP
GO:1903421,regulation of synaptic vesicle recycling,31,7,2.24,0.00572,1,0.026289054441260746,3.12,BP
GO:0009988,cell-cell recognition,64,11,4.62,0.00575,1,0.02635142857142857,2.38,BP
GO:0061951,establishment of protein localization to...,64,11,4.62,0.00575,1,0.02635142857142857,2.38,BP
GO:1903391,regulation of adherens junction organiza...,64,11,4.62,0.00575,1,0.02635142857142857,2.38,BP
GO:0051101,regulation of DNA binding,130,18,9.39,0.00576,1,0.026372140818268316,1.92,BP
GO:0016079,synaptic vesicle exocytosis,140,19,10.11,0.00578,1,0.026438555133079848,1.88,BP
GO:0048667,cell morphogenesis involved in neuron di...,632,63,45.65,0.00583,1,0.02661181818181818,1.38,BP
GO:0001941,postsynaptic membrane organization,47,9,3.4,0.00584,1,0.02661181818181818,2.65,BP
GO:0019674,NAD metabolic process,47,9,3.4,0.00584,1,0.02661181818181818,2.65,BP
GO:0060135,maternal process involved in female preg...,47,9,3.4,0.00584,1,0.02661181818181818,2.65,BP
GO:0045921,positive regulation of exocytosis,101,15,7.3,0.00587,1,0.026723216650898773,2.05,BP
GO:0070570,regulation of neuron projection regenera...,39,8,2.82,0.00596,1,0.02708169971671388,2.84,BP
GO:1900026,positive regulation of substrate adhesio...,39,8,2.82,0.00596,1,0.02708169971671388,2.84,BP
GO:0048858,cell projection morphogenesis,704,69,50.86,0.00598,1,0.027146943396226413,1.36,BP
GO:0007064,mitotic sister chromatid cohesion,24,6,1.73,0.00611,1,0.02760687323943662,3.47,BP
GO:0051457,maintenance of protein location in nucle...,24,6,1.73,0.00611,1,0.02760687323943662,3.47,BP
GO:0070584,mitochondrion morphogenesis,24,6,1.73,0.00611,1,0.02760687323943662,3.47,BP
GO:0071867,response to monoamine,24,6,1.73,0.00611,1,0.02760687323943662,3.47,BP
GO:1903204,negative regulation of oxidative stress-...,24,6,1.73,0.00611,1,0.02760687323943662,3.47,BP
GO:0045685,regulation of glial cell differentiation,92,14,6.65,0.00614,1,0.02771639774859287,2.11,BP
GO:1903409,reactive oxygen species biosynthetic pro...,121,17,8.74,0.00619,1,0.027915913776944704,1.95,BP
GO:0051091,positive regulation of DNA-binding trans...,246,29,17.77,0.00633,1,0.028520561797752805,1.63,BP
GO:0018105,peptidyl-serine phosphorylation,323,36,23.33,0.00637,1,0.028673938260056125,1.54,BP
GO:0051090,regulation of DNA-binding transcription ...,402,43,29.04,0.00640,1,0.028782056074766357,1.48,BP
GO:0031401,positive regulation of protein modificat...,1219,111,88.06,0.00645,1,0.02897983193277311,1.26,BP
GO:0034762,regulation of transmembrane transport,576,58,41.61,0.00646,1,0.028997686567164175,1.39,BP
GO:0071479,cellular response to ionizing radiation,65,11,4.7,0.00648,1,0.02903329608938547,2.34,BP
GO:1903793,positive regulation of anion transport,65,11,4.7,0.00648,1,0.02903329608938547,2.34,BP
GO:0050432,catecholamine secretion,74,12,5.35,0.00649,1,0.029051051162790695,2.24,BP
GO:0014013,regulation of gliogenesis,152,20,10.98,0.00665,1,0.029739591078066913,1.82,BP
GO:0008286,insulin receptor signaling pathway,122,17,8.81,0.00672,1,0.03002473537604457,1.93,BP
GO:0008089,anterograde axonal transport,48,9,3.47,0.00674,1,0.03005827618164968,2.59,BP
GO:0043631,RNA polyadenylation,48,9,3.47,0.00674,1,0.03005827618164968,2.59,BP
GO:0009166,nucleotide catabolic process,132,18,9.54,0.00675,1,0.030075,1.89,BP
GO:0001893,maternal placenta development,32,7,2.31,0.00687,1,0.030524875346260392,3.03,BP
GO:0008608,attachment of spindle microtubules to ki...,32,7,2.31,0.00687,1,0.030524875346260392,3.03,BP
GO:0010591,regulation of lamellipodium assembly,32,7,2.31,0.00687,1,0.030524875346260392,3.03,BP
GO:0010661,positive regulation of muscle cell apopt...,40,8,2.89,0.00699,1,0.030943771849126035,2.77,BP
GO:0032594,protein transport within lipid bilayer,40,8,2.89,0.00699,1,0.030943771849126035,2.77,BP
GO:0045851,pH reduction,40,8,2.89,0.00699,1,0.030943771849126035,2.77,BP
GO:0046825,regulation of protein export from nucleu...,40,8,2.89,0.00699,1,0.030943771849126035,2.77,BP
GO:0055072,iron ion homeostasis,84,13,6.07,0.00704,1,0.03110787878787879,2.14,BP
GO:0043488,regulation of mRNA stability,103,15,7.44,0.00704,1,0.03110787878787879,2.02,BP
GO:0046434,organophosphate catabolic process,205,25,14.81,0.00706,1,0.031167633027522935,1.69,BP
GO:0006836,neurotransmitter transport,303,34,21.89,0.00710,1,0.031286813186813194,1.55,BP
GO:0046394,carboxylic acid biosynthetic process,359,39,25.93,0.00710,1,0.031286813186813194,1.5,BP
GO:0001824,blastocyst development,153,20,11.05,0.00715,1,0.03139215328467153,1.81,BP
GO:0006606,protein import into nucleus,153,20,11.05,0.00715,1,0.03139215328467153,1.81,BP
GO:0010665,regulation of cardiac muscle cell apopto...,57,10,4.12,0.00715,1,0.03139215328467153,2.43,BP
GO:0010823,negative regulation of mitochondrion org...,57,10,4.12,0.00715,1,0.03139215328467153,2.43,BP
GO:0018209,peptidyl-serine modification,348,38,25.14,0.00719,1,0.03153899726526892,1.51,BP
GO:0048639,positive regulation of developmental gro...,216,26,15.6,0.00721,1,0.03159792349726776,1.67,BP
GO:0045595,regulation of cell differentiation,1930,167,139.42,0.00722,1,0.03161295723384895,1.2,BP
GO:0048284,organelle fusion,123,17,8.89,0.00729,1,0.031890436363636365,1.91,BP
GO:0044843,cell cycle G1/S phase transition,195,24,14.09,0.00732,1,0.03199258855585831,1.7,BP
GO:0016053,organic acid biosynthetic process,360,39,26.01,0.00743,1,0.032414469628286494,1.5,BP
GO:0097061,dendritic spine organization,94,14,6.79,0.00743,1,0.032414469628286494,2.06,BP
GO:0030336,negative regulation of cell migration,271,31,19.58,0.00752,1,0.032685283018867924,1.58,BP
GO:0000303,response to superoxide,25,6,1.81,0.00756,1,0.032685283018867924,3.31,BP
GO:0035384,thioester biosynthetic process,25,6,1.81,0.00756,1,0.032685283018867924,3.31,BP
GO:0051205,protein insertion into membrane,25,6,1.81,0.00756,1,0.032685283018867924,3.31,BP
GO:0051788,response to misfolded protein,25,6,1.81,0.00756,1,0.032685283018867924,3.31,BP
GO:0071616,acyl-CoA biosynthetic process,25,6,1.81,0.00756,1,0.032685283018867924,3.31,BP
GO:0120033,negative regulation of plasma membrane b...,25,6,1.81,0.00756,1,0.032685283018867924,3.31,BP
GO:1901032,negative regulation of response to react...,25,6,1.81,0.00756,1,0.032685283018867924,3.31,BP
GO:1903206,negative regulation of hydrogen peroxide...,25,6,1.81,0.00756,1,0.032685283018867924,3.31,BP
GO:2001039,negative regulation of cellular response...,25,6,1.81,0.00756,1,0.032685283018867924,3.31,BP
GO:0051588,regulation of neurotransmitter transport,185,23,13.36,0.00758,1,0.03274233393177738,1.72,BP
GO:0050764,regulation of phagocytosis,104,15,7.51,0.00769,1,0.03318769506726457,2,BP
GO:0097581,lamellipodium organization,85,13,6.14,0.00778,1,0.03354602150537634,2.12,BP
GO:0018210,peptidyl-threonine modification,134,18,9.68,0.00788,1,0.033946786034019696,1.86,BP
GO:0032411,positive regulation of transporter activ...,124,17,8.96,0.00789,1,0.0339594633273703,1.9,BP
GO:0051224,negative regulation of protein transport,207,25,14.95,0.00796,1,0.03423013404825737,1.67,BP
GO:0006259,DNA metabolic process,920,86,66.46,0.00814,1,0.03495347593582888,1.29,BP
GO:0006418,tRNA aminoacylation for protein translat...,41,8,2.96,0.00815,1,0.03495347593582888,2.7,BP
GO:0048873,homeostasis of number of cells within a ...,41,8,2.96,0.00815,1,0.03495347593582888,2.7,BP
GO:0070897,transcription preinitiation complex asse...,33,7,2.38,0.00819,1,0.03503136,2.94,BP
GO:1903146,regulation of autophagy of mitochondrion,33,7,2.38,0.00819,1,0.03503136,2.94,BP
GO:1903205,regulation of hydrogen peroxide-induced ...,33,7,2.38,0.00819,1,0.03503136,2.94,BP
GO:2000146,negative regulation of cell motility,284,32,20.52,0.00831,1,0.035513072824156305,1.56,BP
GO:0048856,anatomical structure development,5881,466,424.83,0.00835,1,0.03565235137533274,1.1,BP
GO:0006096,glycolytic process,86,13,6.21,0.00857,1,0.036526873339238264,2.09,BP
GO:1901379,regulation of potassium ion transmembran...,86,13,6.21,0.00857,1,0.036526873339238264,2.09,BP
GO:0033673,negative regulation of kinase activity,219,26,15.82,0.00858,1,0.036537132743362837,1.64,BP
GO:0010631,epithelial cell migration,285,32,20.59,0.00873,1,0.037143023872679044,1.55,BP
GO:0010562,positive regulation of phosphorus metabo...,1120,102,80.91,0.00877,1,0.037214497354497354,1.26,BP
GO:0045937,positive regulation of phosphate metabol...,1120,102,80.91,0.00877,1,0.037214497354497354,1.26,BP
GO:0007568,aging,252,29,18.2,0.00877,1,0.037214497354497354,1.59,BP
GO:0051783,regulation of nuclear division,198,24,14.3,0.00880,1,0.0373088986784141,1.68,BP
GO:0030865,cortical cytoskeleton organization,50,9,3.61,0.00885,1,0.03748785211267605,2.49,BP
GO:0045861,negative regulation of proteolysis,353,38,25.5,0.00899,1,0.037989473684210524,1.49,BP
GO:0000070,mitotic sister chromatid segregation,146,19,10.55,0.00900,1,0.037989473684210524,1.8,BP
GO:0050680,negative regulation of epithelial cell p...,146,19,10.55,0.00900,1,0.037989473684210524,1.8,BP
GO:2001251,negative regulation of chromosome organi...,146,19,10.55,0.00900,1,0.037989473684210524,1.8,BP
GO:0032922,circadian regulation of gene expression,68,11,4.91,0.00912,1,0.03840346153846154,2.24,BP
GO:0048678,response to axon injury,68,11,4.91,0.00912,1,0.03840346153846154,2.24,BP
GO:0015872,dopamine transport,59,10,4.26,0.00913,1,0.03840346153846154,2.35,BP
GO:1902369,negative regulation of RNA catabolic pro...,59,10,4.26,0.00913,1,0.03840346153846154,2.35,BP
GO:0030518,intracellular steroid hormone receptor s...,106,15,7.66,0.00914,1,0.038411947598253275,1.96,BP
GO:0007088,regulation of mitotic nuclear division,167,21,12.06,0.00918,1,0.038512781168265044,1.74,BP
GO:0034404,nucleobase-containing small molecule bio...,167,21,12.06,0.00918,1,0.038512781168265044,1.74,BP
GO:0051047,positive regulation of secretion,539,54,38.94,0.00922,1,0.03862978279756733,1.39,BP
GO:0018107,peptidyl-threonine phosphorylation,126,17,9.1,0.00923,1,0.03862978279756733,1.87,BP
GO:0009299,mRNA transcription,26,6,1.88,0.00924,1,0.03862978279756733,3.19,BP
GO:0090140,regulation of mitochondrial fission,26,6,1.88,0.00924,1,0.03862978279756733,3.19,BP
GO:0044283,small molecule biosynthetic process,646,63,46.67,0.00926,1,0.03867979166666666,1.35,BP
GO:0071236,cellular response to antibiotic,199,24,14.38,0.00934,1,0.03898012142237641,1.67,BP
GO:0006757,ATP generation from ADP,87,13,6.28,0.00943,1,0.039287584415584414,2.07,BP
GO:0048708,astrocyte differentiation,87,13,6.28,0.00943,1,0.039287584415584414,2.07,BP
GO:0097178,ruffle assembly,42,8,3.03,0.00944,1,0.03929522491349481,2.64,BP
GO:0048489,synaptic vesicle transport,178,22,12.86,0.00948,1,0.039393575129533676,1.71,BP
GO:0097480,establishment of synaptic vesicle locali...,178,22,12.86,0.00948,1,0.039393575129533676,1.71,BP
GO:0090132,epithelium migration,287,32,20.73,0.00963,1,0.03994867924528302,1.54,BP
GO:0007617,mating behavior,34,7,2.46,0.00968,1,0.03994867924528302,2.85,BP
GO:0018208,peptidyl-proline modification,34,7,2.46,0.00968,1,0.03994867924528302,2.85,BP
GO:0019076,viral release from host cell,34,7,2.46,0.00968,1,0.03994867924528302,2.85,BP
GO:0035890,exit from host,34,7,2.46,0.00968,1,0.03994867924528302,2.85,BP
GO:0035891,exit from host cell,34,7,2.46,0.00968,1,0.03994867924528302,2.85,BP
GO:0052126,movement in host environment,34,7,2.46,0.00968,1,0.03994867924528302,2.85,BP
GO:0052192,movement in environment of other organis...,34,7,2.46,0.00968,1,0.03994867924528302,2.85,BP
GO:0097479,synaptic vesicle localization,189,23,13.65,0.00972,1,0.04007938303341903,1.68,BP
GO:0046928,regulation of neurotransmitter secretion,137,18,9.9,0.00984,1,0.04053945205479452,1.82,BP
GO:0046785,microtubule polymerization,78,12,5.63,0.00986,1,0.040587100085543205,2.13,BP
GO:0006275,regulation of DNA replication,107,15,7.73,0.00994,1,0.04088143589743589,1.94,BP
GO:0043280,positive regulation of cysteine-type end...,127,17,9.17,0.00996,1,0.04092871050384287,1.85,BP
GO:0009132,nucleoside diphosphate metabolic process,117,16,8.45,0.01000,1,0.0410580204778157,1.89,BP
GO:0051954,positive regulation of amine transport,51,9,3.68,0.01007,1,0.04127499148211244,2.45,BP
GO:1902373,negative regulation of mRNA catabolic pr...,51,9,3.68,0.01007,1,0.04127499148211244,2.45,BP
GO:0006575,cellular modified amino acid metabolic p...,179,22,12.93,0.01009,1,0.04132177021276596,1.7,BP
GO:0050885,neuromuscular process controlling balanc...,69,11,4.98,0.01016,1,0.0415730612244898,2.21,BP
GO:0010959,regulation of metal ion transport,425,44,30.7,0.01026,1,0.04191096774193548,1.43,BP
GO:0090307,mitotic spindle assembly,60,10,4.33,0.01026,1,0.04191096774193548,2.31,BP
GO:0045892,"negative regulation of transcription, DN...",1189,107,85.89,0.01029,1,0.04199786259541985,1.25,BP
GO:0031110,regulation of microtubule polymerization...,88,13,6.36,0.01035,1,0.042135532994923855,2.04,BP
GO:0035418,protein localization to synapse,88,13,6.36,0.01035,1,0.042135532994923855,2.04,BP
GO:1900076,regulation of cellular response to insul...,88,13,6.36,0.01035,1,0.042135532994923855,2.04,BP
GO:0090130,tissue migration,289,32,20.88,0.01060,1,0.043116821639898564,1.53,BP
GO:0007018,microtubule-based movement,278,31,20.08,0.01069,1,0.04344618243243244,1.54,BP
GO:0048285,organelle fission,461,47,33.3,0.01070,1,0.04345012658227848,1.41,BP
GO:0031623,receptor internalization,128,17,9.25,0.01073,1,0.043535210792580104,1.84,BP
GO:0120039,plasma membrane bounded cell projection ...,699,67,50.49,0.01078,1,0.0437012299915754,1.33,BP
GO:0015844,monoamine transport,108,15,7.8,0.01080,1,0.043745454545454546,1.92,BP
GO:0045927,positive regulation of growth,312,34,22.54,0.01088,1,0.043884794635373016,1.51,BP
GO:0030490,maturation of SSU-rRNA,43,8,3.11,0.01088,1,0.043884794635373016,2.57,BP
GO:0031057,negative regulation of histone modificat...,43,8,3.11,0.01088,1,0.043884794635373016,2.57,BP
GO:0044743,protein transmembrane import into intrac...,43,8,3.11,0.01088,1,0.043884794635373016,2.57,BP
GO:0048255,mRNA stabilization,43,8,3.11,0.01088,1,0.043884794635373016,2.57,BP
GO:0000305,response to oxygen radical,27,6,1.95,0.01116,1,0.04490127090301003,3.08,BP
GO:0032509,endosome transport via multivesicular bo...,27,6,1.95,0.01116,1,0.04490127090301003,3.08,BP
GO:1904353,regulation of telomere capping,27,6,1.95,0.01116,1,0.04490127090301003,3.08,BP
GO:1903507,negative regulation of nucleic acid-temp...,1193,107,86.18,0.01128,1,0.045326965174129354,1.24,BP
GO:0006081,cellular aldehyde metabolic process,70,11,5.06,0.01129,1,0.045326965174129354,2.17,BP
GO:0002082,regulation of oxidative phosphorylation,35,7,2.53,0.01136,1,0.045326965174129354,2.77,BP
GO:0033866,nucleoside bisphosphate biosynthetic pro...,35,7,2.53,0.01136,1,0.045326965174129354,2.77,BP
GO:0034030,ribonucleoside bisphosphate biosynthetic...,35,7,2.53,0.01136,1,0.045326965174129354,2.77,BP
GO:0034033,purine nucleoside bisphosphate biosynthe...,35,7,2.53,0.01136,1,0.045326965174129354,2.77,BP
GO:0046686,response to cadmium ion,35,7,2.53,0.01136,1,0.045326965174129354,2.77,BP
GO:0051452,intracellular pH reduction,35,7,2.53,0.01136,1,0.045326965174129354,2.77,BP
GO:2000249,regulation of actin cytoskeleton reorgan...,35,7,2.53,0.01136,1,0.045326965174129354,2.77,BP
GO:2001038,regulation of cellular response to drug,35,7,2.53,0.01136,1,0.045326965174129354,2.77,BP
GO:0032872,regulation of stress-activated MAPK casc...,235,27,16.98,0.01137,1,0.045329279204639604,1.59,BP
GO:0001662,behavioral fear response,52,9,3.76,0.01142,1,0.045415735537190076,2.39,BP
GO:0031103,axon regeneration,52,9,3.76,0.01142,1,0.045415735537190076,2.39,BP
GO:0048713,regulation of oligodendrocyte differenti...,52,9,3.76,0.01142,1,0.045415735537190076,2.39,BP
GO:1901607,alpha-amino acid biosynthetic process,61,10,4.41,0.01150,1,0.04569611890999174,2.27,BP
GO:1902679,negative regulation of RNA biosynthetic ...,1194,107,86.25,0.01154,1,0.045817227722772275,1.24,BP
GO:0048638,regulation of developmental growth,405,42,29.26,0.01161,1,0.04605714756801319,1.44,BP
GO:1902803,regulation of synaptic vesicle transport,109,15,7.87,0.01171,1,0.04641558484349259,1.91,BP
GO:0030073,insulin secretion,225,26,16.25,0.01196,1,0.04736750617283951,1.6,BP
GO:0032890,regulation of organic acid transport,80,12,5.78,0.01198,1,0.04740769736842105,2.08,BP
GO:0042127,regulation of cell proliferation,1676,145,121.07,0.01200,1,0.04744782251437962,1.2,BP
GO:0007035,vacuolar acidification,20,5,1.44,0.01213,1,0.047609755301794454,3.47,BP
GO:0019430,removal of superoxide radicals,20,5,1.44,0.01213,1,0.047609755301794454,3.47,BP
GO:0033617,mitochondrial respiratory chain complex ...,20,5,1.44,0.01213,1,0.047609755301794454,3.47,BP
GO:0044783,G1 DNA damage checkpoint,20,5,1.44,0.01213,1,0.047609755301794454,3.47,BP
GO:0044819,mitotic G1/S transition checkpoint,20,5,1.44,0.01213,1,0.047609755301794454,3.47,BP
GO:0048199,"vesicle targeting, to, from or within Go...",20,5,1.44,0.01213,1,0.047609755301794454,3.47,BP
GO:1900409,positive regulation of cellular response...,20,5,1.44,0.01213,1,0.047609755301794454,3.47,BP
GO:1901028,regulation of mitochondrial outer membra...,20,5,1.44,0.01213,1,0.047609755301794454,3.47,BP
GO:1902254,negative regulation of intrinsic apoptot...,20,5,1.44,0.01213,1,0.047609755301794454,3.47,BP
GO:0045859,regulation of protein kinase activity,667,64,48.18,0.01223,1,0.04796312958435208,1.33,BP
GO:0009755,hormone-mediated signaling pathway,161,20,11.63,0.01228,1,0.048119999999999996,1.72,BP
GO:0051254,positive regulation of RNA metabolic pro...,1652,143,119.34,0.01234,1,0.048315768917819364,1.2,BP
GO:0042866,pyruvate biosynthetic process,90,13,6.5,0.01241,1,0.04855034146341463,2,BP
GO:0007417,central nervous system development,887,82,64.07,0.01247,1,0.04874493506493507,1.28,BP
GO:0043039,tRNA aminoacylation,44,8,3.18,0.01248,1,0.04874493506493507,2.52,BP
GO:0050433,regulation of catecholamine secretion,71,11,5.13,0.01251,1,0.04882248175182482,2.14,BP
GO:2000045,regulation of G1/S transition of mitotic...,120,16,8.67,0.01260,1,0.049133873581847655,1.85,BP
GO:0070302,regulation of stress-activated protein k...,237,27,17.12,0.01262,1,0.04917201619433198,1.58,BP
GO:0038061,NIK/NF-kappaB signaling,110,15,7.95,0.01268,1,0.04936582524271845,1.89,BP
GO:0002209,behavioral defense response,53,9,3.83,0.01290,1,0.050181729991915926,2.35,BP
GO:0016052,carbohydrate catabolic process,141,18,10.19,0.01304,1,0.05068536348949919,1.77,BP
GO:0014070,response to organic cyclic compound,742,70,53.6,0.01309,1,0.05083864406779661,1.31,BP
GO:0033143,regulation of intracellular steroid horm...,81,12,5.85,0.01317,1,0.05106691377921031,2.05,BP
GO:0051403,stress-activated MAPK cascade,260,29,18.78,0.01317,1,0.05106691377921031,1.54,BP
GO:0000184,nuclear-transcribed mRNA catabolic proce...,36,7,2.6,0.01325,1,0.0512532154340836,2.69,BP
GO:0043516,"regulation of DNA damage response, signa...",36,7,2.6,0.01325,1,0.0512532154340836,2.69,BP
GO:0072583,clathrin-dependent endocytosis,36,7,2.6,0.01325,1,0.0512532154340836,2.69,BP
GO:0010632,regulation of epithelial cell migration,227,26,16.4,0.01330,1,0.05140530120481927,1.59,BP
GO:0044788,modulation by host of viral process,28,6,2.02,0.01336,1,0.05147183346677342,2.97,BP
GO:2000178,negative regulation of neural precursor ...,28,6,2.02,0.01336,1,0.05147183346677342,2.97,BP
GO:2000310,regulation of NMDA receptor activity,28,6,2.02,0.01336,1,0.05147183346677342,2.97,BP
GO:0050801,ion homeostasis,816,76,58.95,0.01336,1,0.05147183346677342,1.29,BP
GO:0014015,positive regulation of gliogenesis,91,13,6.57,0.01355,1,0.05216208,1.98,BP
GO:1901216,positive regulation of neuron death,121,16,8.74,0.01358,1,0.0522357793764988,1.83,BP
GO:0046939,nucleotide phosphorylation,101,14,7.3,0.01372,1,0.05273214057507987,1.92,BP
GO:0048812,neuron projection morphogenesis,683,65,49.34,0.01374,1,0.052766863527533917,1.32,BP
GO:0009653,anatomical structure morphogenesis,2759,228,199.3,0.01416,1,0.05433645933014354,1.14,BP
GO:0043038,amino acid activation,45,8,3.25,0.01424,1,0.054599904382470116,2.46,BP
GO:0032787,monocarboxylic acid metabolic process,564,55,40.74,0.01431,1,0.05481928400954654,1.35,BP
GO:0043388,positive regulation of DNA binding,63,10,4.55,0.01432,1,0.05481928400954654,2.2,BP
GO:0072698,protein localization to microtubule cyto...,54,9,3.9,0.01451,1,0.05550248012718601,2.31,BP
GO:1903313,positive regulation of mRNA metabolic pr...,92,13,6.65,0.01477,1,0.0564521366163622,1.95,BP
GO:0043487,regulation of RNA stability,112,15,8.09,0.01481,1,0.056515241871530536,1.85,BP
GO:0051028,mRNA transport,112,15,8.09,0.01481,1,0.056515241871530536,1.85,BP
GO:0031123,RNA 3'-end processing,102,14,7.37,0.01488,1,0.05669244655581948,1.9,BP
GO:0033555,multicellular organismal response to str...,102,14,7.37,0.01488,1,0.05669244655581948,1.9,BP
GO:1901292,nucleoside phosphate catabolic process,143,18,10.33,0.01493,1,0.05683794303797468,1.74,BP
GO:0042053,regulation of dopamine metabolic process,21,5,1.52,0.01500,1,0.056969218626677184,3.29,BP
GO:0046697,decidualization,21,5,1.52,0.01500,1,0.056969218626677184,3.29,BP
GO:2000209,regulation of anoikis,21,5,1.52,0.01500,1,0.056969218626677184,3.29,BP
GO:0097120,receptor localization to synapse,73,11,5.27,0.01525,1,0.05787302839116719,2.09,BP
GO:0010664,negative regulation of striated muscle c...,37,7,2.67,0.01535,1,0.05819867716535434,2.62,BP
GO:0051348,negative regulation of transferase activ...,252,28,18.2,0.01536,1,0.05819867716535434,1.54,BP
GO:0031056,regulation of histone modification,154,19,11.12,0.01541,1,0.05834218725413061,1.71,BP
GO:0006997,nucleus organization,123,16,8.89,0.01571,1,0.05938454045561665,1.8,BP
GO:1900180,regulation of protein localization to nu...,123,16,8.89,0.01571,1,0.05938454045561665,1.8,BP
GO:0000027,ribosomal large subunit assembly,29,6,2.09,0.01584,1,0.05968839467501958,2.87,BP
GO:0031116,positive regulation of microtubule polym...,29,6,2.09,0.01584,1,0.05968839467501958,2.87,BP
GO:0071480,cellular response to gamma radiation,29,6,2.09,0.01584,1,0.05968839467501958,2.87,BP
GO:1902042,negative regulation of extrinsic apoptot...,29,6,2.09,0.01584,1,0.05968839467501958,2.87,BP
GO:0008652,cellular amino acid biosynthetic process,64,10,4.62,0.01590,1,0.05986760563380282,2.16,BP
GO:2001056,positive regulation of cysteine-type end...,144,18,10.4,0.01595,1,0.059990351288056215,1.73,BP
GO:0043401,steroid hormone mediated signaling pathw...,113,15,8.16,0.01597,1,0.059990351288056215,1.84,BP
GO:2000177,regulation of neural precursor cell prol...,113,15,8.16,0.01597,1,0.059990351288056215,1.84,BP
GO:2000026,regulation of multicellular organismal d...,2207,185,159.43,0.01602,1,0.060131232449297974,1.16,BP
GO:0035305,negative regulation of dephosphorylation,93,13,6.72,0.01607,1,0.060271893998441156,1.93,BP
GO:0019359,nicotinamide nucleotide biosynthetic pro...,103,14,7.44,0.01611,1,0.06032787548638132,1.88,BP
GO:0062012,regulation of small molecule metabolic p...,367,38,26.51,0.01611,1,0.06032787548638132,1.43,BP
GO:1903580,positive regulation of ATP metabolic pro...,46,8,3.32,0.01618,1,0.06054289269051322,2.41,BP
GO:0036293,response to decreased oxygen levels,231,26,16.69,0.01634,1,0.06109407925407925,1.56,BP
GO:0007267,cell-cell signaling,1617,139,116.81,0.01670,1,0.062391614906832295,1.19,BP
GO:1901990,regulation of mitotic cell cycle phase t...,265,29,19.14,0.01672,1,0.0624178743211792,1.52,BP
GO:0050766,positive regulation of phagocytosis,74,11,5.35,0.01678,1,0.0625933023255814,2.06,BP
GO:0042157,lipoprotein metabolic process,124,16,8.96,0.01687,1,0.06288027885360185,1.79,BP
GO:0000904,cell morphogenesis involved in different...,813,75,58.73,0.01707,1,0.06357650154798761,1.28,BP
GO:0048814,regulation of dendrite morphogenesis,114,15,8.24,0.01721,1,0.06404835266821346,1.82,BP
GO:1902275,regulation of chromatin organization,199,23,14.38,0.01727,1,0.06422197836166925,1.6,BP
GO:0051289,protein homotetramerization,104,14,7.51,0.01742,1,0.06462994602929839,1.86,BP
GO:1901222,regulation of NIK/NF-kappaB signaling,104,14,7.51,0.01742,1,0.06462994602929839,1.86,BP
GO:2000300,regulation of synaptic vesicle exocytosi...,104,14,7.51,0.01742,1,0.06462994602929839,1.86,BP
GO:0071248,cellular response to metal ion,156,19,11.27,0.01746,1,0.0647284437596302,1.69,BP
GO:1902806,regulation of cell cycle G1/S phase tran...,135,17,9.75,0.01759,1,0.0651339892390469,1.74,BP
GO:0030032,lamellipodium assembly,65,10,4.7,0.01761,1,0.0651339892390469,2.13,BP
GO:0099024,plasma membrane invagination,65,10,4.7,0.01761,1,0.0651339892390469,2.13,BP
GO:0010762,regulation of fibroblast migration,38,7,2.75,0.01767,1,0.06520555214723926,2.55,BP
GO:0042149,cellular response to glucose starvation,38,7,2.75,0.01767,1,0.06520555214723926,2.55,BP
GO:0046329,negative regulation of JNK cascade,38,7,2.75,0.01767,1,0.06520555214723926,2.55,BP
GO:1903305,regulation of regulated secretory pathwa...,189,22,13.65,0.01816,1,0.06668943138741472,1.61,BP
GO:0006879,cellular iron ion homeostasis,56,9,4.05,0.01818,1,0.06668943138741472,2.22,BP
GO:0042596,fear response,56,9,4.05,0.01818,1,0.06668943138741472,2.22,BP
GO:0000423,mitophagy,22,5,1.59,0.01828,1,0.06668943138741472,3.14,BP
GO:0032462,regulation of protein homooligomerizatio...,22,5,1.59,0.01828,1,0.06668943138741472,3.14,BP
GO:0032930,positive regulation of superoxide anion ...,22,5,1.59,0.01828,1,0.06668943138741472,3.14,BP
GO:0046628,positive regulation of insulin receptor ...,22,5,1.59,0.01828,1,0.06668943138741472,3.14,BP
GO:0046823,negative regulation of nucleocytoplasmic...,22,5,1.59,0.01828,1,0.06668943138741472,3.14,BP
GO:0051654,establishment of mitochondrion localizat...,22,5,1.59,0.01828,1,0.06668943138741472,3.14,BP
GO:0071450,cellular response to oxygen radical,22,5,1.59,0.01828,1,0.06668943138741472,3.14,BP
GO:0071451,cellular response to superoxide,22,5,1.59,0.01828,1,0.06668943138741472,3.14,BP
GO:0071800,podosome assembly,22,5,1.59,0.01828,1,0.06668943138741472,3.14,BP
GO:0090201,negative regulation of release of cytoch...,22,5,1.59,0.01828,1,0.06668943138741472,3.14,BP
GO:0097062,dendritic spine maintenance,22,5,1.59,0.01828,1,0.06668943138741472,3.14,BP
GO:0099170,postsynaptic modulation of chemical syna...,22,5,1.59,0.01828,1,0.06668943138741472,3.14,BP
GO:1902041,regulation of extrinsic apoptotic signal...,47,8,3.4,0.01830,1,0.06671181818181818,2.35,BP
GO:0008625,extrinsic apoptotic signaling pathway vi...,75,11,5.42,0.01843,1,0.06713486752460257,2.03,BP
GO:0032368,regulation of lipid transport,115,15,8.31,0.01851,1,0.06737527987897125,1.81,BP
GO:0016242,negative regulation of macroautophagy,30,6,2.17,0.01862,1,0.06757122171945702,2.76,BP
GO:0048026,"positive regulation of mRNA splicing, vi...",30,6,2.17,0.01862,1,0.06757122171945702,2.76,BP
GO:0048714,positive regulation of oligodendrocyte d...,30,6,2.17,0.01862,1,0.06757122171945702,2.76,BP
GO:1902751,positive regulation of cell cycle G2/M p...,30,6,2.17,0.01862,1,0.06757122171945702,2.76,BP
GO:0032606,type I interferon production,85,12,6.14,0.01883,1,0.06823039156626506,1.95,BP
GO:0034333,adherens junction assembly,85,12,6.14,0.01883,1,0.06823039156626506,1.95,BP
GO:0071902,positive regulation of protein serine/th...,279,30,20.15,0.01891,1,0.06846871331828443,1.49,BP
GO:0045069,regulation of viral genome replication,95,13,6.86,0.01893,1,0.0684895939849624,1.9,BP
GO:0051241,negative regulation of multicellular org...,1357,118,98.03,0.01931,1,0.06981196093163035,1.2,BP
GO:0033135,regulation of peptidyl-serine phosphoryl...,158,19,11.41,0.01973,1,0.07127684684684685,1.67,BP
GO:0050673,epithelial cell proliferation,431,43,31.13,0.01976,1,0.07133167291822956,1.38,BP
GO:0030641,regulation of cellular pH,76,11,5.49,0.02018,1,0.07244792873051224,2,BP
GO:0051193,regulation of cofactor metabolic process,76,11,5.49,0.02018,1,0.07244792873051224,2,BP
GO:0006998,nuclear envelope organization,39,7,2.82,0.02024,1,0.07244792873051224,2.48,BP
GO:0010613,positive regulation of cardiac muscle hy...,39,7,2.82,0.02024,1,0.07244792873051224,2.48,BP
GO:0016233,telomere capping,39,7,2.82,0.02024,1,0.07244792873051224,2.48,BP
GO:0030521,androgen receptor signaling pathway,39,7,2.82,0.02024,1,0.07244792873051224,2.48,BP
GO:0061462,protein localization to lysosome,39,7,2.82,0.02024,1,0.07244792873051224,2.48,BP
GO:1900087,positive regulation of G1/S transition o...,39,7,2.82,0.02024,1,0.07244792873051224,2.48,BP
GO:2000142,regulation of DNA-templated transcriptio...,39,7,2.82,0.02024,1,0.07244792873051224,2.48,BP
GO:0051893,regulation of focal adhesion assembly,57,9,4.12,0.02025,1,0.07244792873051224,2.18,BP
GO:0090109,regulation of cell-substrate junction as...,57,9,4.12,0.02025,1,0.07244792873051224,2.18,BP
GO:1903539,protein localization to postsynaptic mem...,57,9,4.12,0.02025,1,0.07244792873051224,2.18,BP
GO:0019363,pyridine nucleotide biosynthetic process,106,14,7.66,0.02028,1,0.07244792873051224,1.83,BP
GO:0051983,regulation of chromosome segregation,106,14,7.66,0.02028,1,0.07244792873051224,1.83,BP
GO:0042158,lipoprotein biosynthetic process,96,13,6.93,0.02050,1,0.07316094885100075,1.88,BP
GO:0051093,negative regulation of developmental pro...,1082,96,78.16,0.02051,1,0.07316094885100075,1.23,BP
GO:0032892,positive regulation of organic acid tran...,48,8,3.47,0.02061,1,0.07330031042128603,2.31,BP
GO:0051653,spindle localization,48,8,3.47,0.02061,1,0.07330031042128603,2.31,BP
GO:0090311,regulation of protein deacetylation,48,8,3.47,0.02061,1,0.07330031042128603,2.31,BP
GO:1902808,positive regulation of cell cycle G1/S p...,48,8,3.47,0.02061,1,0.07330031042128603,2.31,BP
GO:0010212,response to ionizing radiation,127,16,9.17,0.02074,1,0.07370818316100443,1.74,BP
GO:0019318,hexose metabolic process,225,25,16.25,0.02109,1,0.07489673800738007,1.54,BP
GO:0009416,response to light stimulus,293,31,21.17,0.02116,1,0.07508991150442479,1.46,BP
GO:0016579,protein deubiquitination,117,15,8.45,0.02134,1,0.075617142857142855,1.78,BP
GO:0032414,positive regulation of ion transmembrane...,117,15,8.45,0.02134,1,0.075617142857142855,1.78,BP
GO:0070482,response to oxygen levels,282,30,20.37,0.02157,1,0.07637589403973509,1.47,BP
GO:0050678,regulation of epithelial cell proliferat...,363,37,26.22,0.02164,1,0.07640105263157895,1.41,BP
GO:0009225,nucleotide-sugar metabolic process,31,6,2.24,0.02172,1,0.07640105263157895,2.68,BP
GO:0060074,synapse maturation,31,6,2.24,0.02172,1,0.07640105263157895,2.68,BP
GO:0060632,regulation of microtubule-based movement,31,6,2.24,0.02172,1,0.07640105263157895,2.68,BP
GO:0099632,protein transport within plasma membrane,31,6,2.24,0.02172,1,0.07640105263157895,2.68,BP
GO:0099637,neurotransmitter receptor transport,31,6,2.24,0.02172,1,0.07640105263157895,2.68,BP
GO:1903393,positive regulation of adherens junction...,31,6,2.24,0.02172,1,0.07640105263157895,2.68,BP
GO:1905476,negative regulation of protein localizat...,31,6,2.24,0.02172,1,0.07640105263157895,2.68,BP
GO:2000144,positive regulation of DNA-templated tra...,31,6,2.24,0.02172,1,0.07640105263157895,2.68,BP
GO:0000956,nuclear-transcribed mRNA catabolic proce...,107,14,7.73,0.02183,1,0.07673189189189189,1.81,BP
GO:0008535,respiratory chain complex IV assembly,23,5,1.66,0.02200,1,0.0769360465116279,3.01,BP
GO:0010874,regulation of cholesterol efflux,23,5,1.66,0.02200,1,0.0769360465116279,3.01,BP
GO:0033145,positive regulation of intracellular ste...,23,5,1.66,0.02200,1,0.0769360465116279,3.01,BP
GO:0046475,glycerophospholipid catabolic process,23,5,1.66,0.02200,1,0.0769360465116279,3.01,BP
GO:0046931,pore complex assembly,23,5,1.66,0.02200,1,0.0769360465116279,3.01,BP
GO:0071218,cellular response to misfolded protein,23,5,1.66,0.02200,1,0.0769360465116279,3.01,BP
GO:0071276,cellular response to cadmium ion,23,5,1.66,0.02200,1,0.0769360465116279,3.01,BP
GO:0051303,establishment of chromosome localization,77,11,5.56,0.02206,1,0.07703390420899855,1.98,BP
GO:1901224,positive regulation of NIK/NF-kappaB sig...,77,11,5.56,0.02206,1,0.07703390420899855,1.98,BP
GO:0009792,embryo development ending in birth or eg...,848,77,61.26,0.02211,1,0.07715251631617115,1.26,BP
GO:0002690,positive regulation of leukocyte chemota...,87,12,6.28,0.02227,1,0.07765452173913044,1.91,BP
GO:0098813,nuclear chromosome segregation,260,28,18.78,0.02232,1,0.07771623733719248,1.49,BP
GO:0140014,mitotic nuclear division,260,28,18.78,0.02232,1,0.07771623733719248,1.49,BP
GO:0001667,ameboidal-type cell migration,411,41,29.69,0.02245,1,0.07811236442516269,1.38,BP
GO:0008333,endosome to lysosome transport,58,9,4.19,0.02249,1,0.078195,2.15,BP
GO:0002040,sprouting angiogenesis,118,15,8.52,0.02288,1,0.0794935451263538,1.76,BP
GO:0001835,blastocyst hatching,40,7,2.89,0.02304,1,0.07964689655172415,2.42,BP
GO:0014742,positive regulation of muscle hypertroph...,40,7,2.89,0.02304,1,0.07964689655172415,2.42,BP
GO:0032008,positive regulation of TOR signaling,40,7,2.89,0.02304,1,0.07964689655172415,2.42,BP
GO:0035188,hatching,40,7,2.89,0.02304,1,0.07964689655172415,2.42,BP
GO:0044091,membrane biogenesis,40,7,2.89,0.02304,1,0.07964689655172415,2.42,BP
GO:0051339,regulation of lyase activity,40,7,2.89,0.02304,1,0.07964689655172415,2.42,BP
GO:0071684,organism emergence from protective struc...,40,7,2.89,0.02304,1,0.07964689655172415,2.42,BP
GO:0043489,RNA stabilization,49,8,3.54,0.02313,1,0.07990061737257718,2.26,BP
GO:0007275,multicellular organism development,5380,422,388.64,0.02323,1,0.08016550537634408,1.09,BP
GO:0055067,monovalent inorganic cation homeostasis,150,18,10.84,0.02324,1,0.08016550537634408,1.66,BP
GO:0019216,regulation of lipid metabolic process,342,35,24.71,0.02366,1,0.08155581661891118,1.42,BP
GO:0043271,negative regulation of ion transport,172,20,12.42,0.02371,1,0.08166966356478167,1.61,BP
GO:0050000,chromosome localization,78,11,5.63,0.02407,1,0.08279116511794139,1.95,BP
GO:0015850,organic hydroxy compound transport,239,26,17.26,0.02407,1,0.08279116511794139,1.51,BP
GO:0055065,metal ion homeostasis,667,62,48.18,0.02449,1,0.08417562857142857,1.29,BP
GO:0006909,phagocytosis,206,23,14.88,0.02486,1,0.08530675213675212,1.55,BP
GO:0007029,endoplasmic reticulum organization,59,9,4.26,0.02489,1,0.08530675213675212,2.11,BP
GO:0043954,cellular component maintenance,59,9,4.26,0.02489,1,0.08530675213675212,2.11,BP
GO:0070936,protein K48-linked ubiquitination,59,9,4.26,0.02489,1,0.08530675213675212,2.11,BP
GO:0007565,female pregnancy,162,19,11.7,0.02493,1,0.08538303202846975,1.62,BP
GO:1901987,regulation of cell cycle phase transitio...,297,31,21.45,0.02502,1,0.08563032716927454,1.45,BP
GO:0043537,negative regulation of blood vessel endo...,32,6,2.31,0.02515,1,0.0857702338766832,2.6,BP
GO:0048668,collateral sprouting,32,6,2.31,0.02515,1,0.0857702338766832,2.6,BP
GO:0071985,multivesicular body sorting pathway,32,6,2.31,0.02515,1,0.0857702338766832,2.6,BP
GO:1901797,negative regulation of signal transducti...,32,6,2.31,0.02515,1,0.0857702338766832,2.6,BP
GO:1902186,regulation of viral release from host ce...,32,6,2.31,0.02515,1,0.0857702338766832,2.6,BP
GO:0006165,nucleoside diphosphate phosphorylation,99,13,7.15,0.02578,1,0.08785648725212465,1.82,BP
GO:0033047,regulation of mitotic sister chromatid s...,69,10,4.98,0.02584,1,0.08797043847241867,2.01,BP
GO:0010761,fibroblast migration,50,8,3.61,0.02585,1,0.08797043847241867,2.22,BP
GO:0002832,negative regulation of response to bioti...,41,7,2.96,0.02611,1,0.08868844475721324,2.36,BP
GO:2000273,positive regulation of signaling recepto...,41,7,2.96,0.02611,1,0.08868844475721324,2.36,BP
GO:0016578,histone deubiquitination,24,5,1.73,0.02618,1,0.08868844475721324,2.89,BP
GO:0032770,positive regulation of monooxygenase act...,24,5,1.73,0.02618,1,0.08868844475721324,2.89,BP
GO:0050687,negative regulation of defense response ...,24,5,1.73,0.02618,1,0.08868844475721324,2.89,BP
GO:1901984,negative regulation of protein acetylati...,24,5,1.73,0.02618,1,0.08868844475721324,2.89,BP
GO:0031109,microtubule polymerization or depolymeri...,120,15,8.67,0.02619,1,0.08868844475721324,1.73,BP
GO:0042180,cellular ketone metabolic process,196,22,14.16,0.02632,1,0.08906599156118143,1.55,BP
GO:0018205,peptidyl-lysine modification,345,35,24.92,0.02652,1,0.08967971890372453,1.4,BP
GO:0043009,chordate embryonic development,831,75,60.03,0.02671,1,0.09025879213483147,1.25,BP
GO:0006875,cellular metal ion homeostasis,585,55,42.26,0.02701,1,0.0912085052631579,1.3,BP
GO:0072525,pyridine-containing compound biosyntheti...,110,14,7.95,0.02704,1,0.09124577840112202,1.76,BP
GO:0000122,negative regulation of transcription by ...,869,78,62.77,0.02710,1,0.09138416257883672,1.24,BP
GO:0031124,mRNA 3'-end processing,60,9,4.33,0.02747,1,0.09250219734079777,2.08,BP
GO:0044380,protein localization to cytoskeleton,60,9,4.33,0.02747,1,0.09250219734079777,2.08,BP
GO:0010771,negative regulation of cell morphogenesi...,100,13,7.22,0.02775,1,0.09337972027972027,1.8,BP
GO:0010633,negative regulation of epithelial cell m...,70,10,5.06,0.02827,1,0.09503027932960895,1.98,BP
GO:0040013,negative regulation of locomotion,335,34,24.2,0.02828,1,0.09503027932960895,1.4,BP
GO:0043525,positive regulation of neuron apoptotic ...,80,11,5.78,0.02847,1,0.09560198185624563,1.9,BP
GO:0010332,response to gamma radiation,51,8,3.68,0.02878,1,0.09657556485355649,2.17,BP
GO:0031112,positive regulation of microtubule polym...,33,6,2.38,0.02891,1,0.09667471855455179,2.52,BP
GO:0033598,mammary gland epithelial cell proliferat...,33,6,2.38,0.02891,1,0.09667471855455179,2.52,BP
GO:0061842,microtubule organizing center localizati...,33,6,2.38,0.02891,1,0.09667471855455179,2.52,BP
GO:1901890,positive regulation of cell junction ass...,33,6,2.38,0.02891,1,0.09667471855455179,2.52,BP
GO:1904646,cellular response to amyloid-beta,33,6,2.38,0.02891,1,0.09667471855455179,2.52,BP
GO:0002688,regulation of leukocyte chemotaxis,111,14,8.02,0.02896,1,0.09677466666666668,1.75,BP
GO:0006338,chromatin remodeling,143,17,10.33,0.02909,1,0.09710762829403606,1.65,BP
GO:0006469,negative regulation of protein kinase ac...,198,22,14.3,0.02910,1,0.09710762829403606,1.54,BP
GO:0010948,negative regulation of cell cycle proces...,232,25,16.76,0.02936,1,0.0978395567867036,1.49,BP
GO:0090276,regulation of peptide hormone secretion,232,25,16.76,0.02936,1,0.0978395567867036,1.49,BP
GO:0000266,mitochondrial fission,42,7,3.03,0.02945,1,0.09800373443983403,2.31,BP
GO:0032459,regulation of protein oligomerization,42,7,3.03,0.02945,1,0.09800373443983403,2.31,BP
GO:0090174,organelle membrane fusion,101,13,7.3,0.02982,1,0.0991664409122322,1.78,BP
GO:0090277,positive regulation of peptide hormone s...,122,15,8.81,0.02985,1,0.09919765193370167,1.7,BP
GO:0031102,neuron projection regeneration,61,9,4.41,0.03024,1,0.10028592694693315,2.04,BP
GO:0071156,regulation of cell cycle arrest,61,9,4.41,0.03024,1,0.10028592694693315,2.04,BP
GO:1901016,regulation of potassium ion transmembran...,61,9,4.41,0.03024,1,0.10028592694693315,2.04,BP
GO:0006476,protein deacetylation,91,12,6.57,0.03049,1,0.10104537190082644,1.83,BP
GO:0043543,protein acylation,233,25,16.83,0.03072,1,0.10125865030674847,1.49,BP
GO:0010640,regulation of platelet-derived growth fa...,25,5,1.81,0.03084,1,0.10125865030674847,2.76,BP
GO:0014048,regulation of glutamate secretion,25,5,1.81,0.03084,1,0.10125865030674847,2.76,BP
GO:0032515,negative regulation of phosphoprotein ph...,25,5,1.81,0.03084,1,0.10125865030674847,2.76,BP
GO:0032928,regulation of superoxide anion generatio...,25,5,1.81,0.03084,1,0.10125865030674847,2.76,BP
GO:0051894,positive regulation of focal adhesion as...,25,5,1.81,0.03084,1,0.10125865030674847,2.76,BP
GO:1901798,positive regulation of signal transducti...,25,5,1.81,0.03084,1,0.10125865030674847,2.76,BP
GO:0030534,adult behavior,188,21,13.58,0.03084,1,0.10125865030674847,1.55,BP
GO:0007632,visual behavior,71,10,5.13,0.03085,1,0.10125865030674847,1.95,BP
GO:0016575,histone deacetylation,71,10,5.13,0.03085,1,0.10125865030674847,1.95,BP
GO:0006333,chromatin assembly or disassembly,144,17,10.4,0.03085,1,0.10125865030674847,1.63,BP
GO:0032479,regulation of type I interferon producti...,81,11,5.85,0.03087,1,0.10125865030674847,1.88,BP
GO:0042147,"retrograde transport, endosome to Golgi",81,11,5.85,0.03087,1,0.10125865030674847,1.88,BP
GO:0050805,negative regulation of synaptic transmis...,81,11,5.85,0.03087,1,0.10125865030674847,1.88,BP
GO:0051702,interaction with symbiont,81,11,5.85,0.03087,1,0.10125865030674847,1.88,BP
GO:0032680,regulation of tumor necrosis factor prod...,166,19,11.99,0.03111,1,0.10197637602179836,1.58,BP
GO:0007623,circadian rhythm,211,23,15.24,0.03169,1,0.10380686181075563,1.51,BP
GO:0045981,positive regulation of nucleotide metabo...,52,8,3.76,0.03194,1,0.10441255434782609,2.13,BP
GO:0070542,response to fatty acid,52,8,3.76,0.03194,1,0.10441255434782609,2.13,BP
GO:1900544,positive regulation of purine nucleotide...,52,8,3.76,0.03194,1,0.10441255434782609,2.13,BP
GO:0031532,actin cytoskeleton reorganization,102,13,7.37,0.03200,1,0.1045376782077393,1.76,BP
GO:0034763,negative regulation of transmembrane tra...,134,16,9.68,0.03236,1,0.10564200814111262,1.65,BP
GO:0051017,actin filament bundle assembly,167,19,12.06,0.03282,1,0.10698367182246132,1.58,BP
GO:0002028,regulation of sodium ion transport,92,12,6.65,0.03284,1,0.10698367182246132,1.8,BP
GO:0006356,regulation of transcription by RNA polym...,34,6,2.46,0.03304,1,0.10698367182246132,2.44,BP
GO:0010667,negative regulation of cardiac muscle ce...,34,6,2.46,0.03304,1,0.10698367182246132,2.44,BP
GO:0032786,positive regulation of DNA-templated tra...,34,6,2.46,0.03304,1,0.10698367182246132,2.44,BP
GO:0033032,regulation of myeloid cell apoptotic pro...,34,6,2.46,0.03304,1,0.10698367182246132,2.44,BP
GO:0048194,Golgi vesicle budding,34,6,2.46,0.03304,1,0.10698367182246132,2.44,BP
GO:0097242,amyloid-beta clearance,34,6,2.46,0.03304,1,0.10698367182246132,2.44,BP
GO:1905898,positive regulation of response to endop...,34,6,2.46,0.03304,1,0.10698367182246132,2.44,BP
GO:0007080,mitotic metaphase plate congression,43,7,3.11,0.03306,1,0.10698367182246132,2.25,BP
GO:0031670,cellular response to nutrient,43,7,3.11,0.03306,1,0.10698367182246132,2.25,BP
GO:0090224,regulation of spindle organization,43,7,3.11,0.03306,1,0.10698367182246132,2.25,BP
GO:1901031,regulation of response to reactive oxyge...,43,7,3.11,0.03306,1,0.10698367182246132,2.25,BP
GO:1905268,negative regulation of chromatin organiz...,62,9,4.48,0.03319,1,0.10732472800537275,2.01,BP
GO:2001020,regulation of response to DNA damage sti...,212,23,15.31,0.03321,1,0.10732472800537275,1.5,BP
GO:0061061,muscle structure development,704,64,50.86,0.03374,1,0.10896434899328859,1.26,BP
GO:0031098,stress-activated protein kinase signalin...,293,30,21.17,0.03392,1,0.1094721931589537,1.42,BP
GO:1903555,regulation of tumor necrosis factor supe...,168,19,12.14,0.03459,1,0.11154944407233758,1.57,BP
GO:0007613,memory,146,17,10.55,0.03461,1,0.11154944407233758,1.61,BP
GO:0051896,regulation of protein kinase B signaling,157,18,11.34,0.03468,1,0.11170024096385543,1.59,BP
GO:0001817,regulation of cytokine production,693,63,50.06,0.03493,1,0.11243020735785954,1.26,BP
GO:0061564,axon development,509,48,36.77,0.03518,1,0.11315919786096258,1.31,BP
GO:0031396,regulation of protein ubiquitination,202,22,14.59,0.03531,1,0.11330656,1.51,BP
GO:0002720,positive regulation of cytokine producti...,53,8,3.83,0.03532,1,0.11330656,2.09,BP
GO:1904705,regulation of vascular smooth muscle cel...,53,8,3.83,0.03532,1,0.11330656,2.09,BP
GO:1990874,vascular smooth muscle cell proliferatio...,53,8,3.83,0.03532,1,0.11330656,2.09,BP
GO:0001956,positive regulation of neurotransmitter ...,26,5,1.88,0.03598,1,0.11496398406374501,2.66,BP
GO:0010155,regulation of proton transport,26,5,1.88,0.03598,1,0.11496398406374501,2.66,BP
GO:0010829,negative regulation of glucose transmemb...,26,5,1.88,0.03598,1,0.11496398406374501,2.66,BP
GO:0072574,hepatocyte proliferation,26,5,1.88,0.03598,1,0.11496398406374501,2.66,BP
GO:0072575,epithelial cell proliferation involved i...,26,5,1.88,0.03598,1,0.11496398406374501,2.66,BP
GO:1900078,positive regulation of cellular response...,26,5,1.88,0.03598,1,0.11496398406374501,2.66,BP
GO:0033138,positive regulation of peptidyl-serine p...,125,15,9.03,0.03602,1,0.11501542136695422,1.66,BP
GO:1901888,regulation of cell junction assembly,83,11,6,0.03611,1,0.11522633952254642,1.83,BP
GO:0015800,acidic amino acid transport,63,9,4.55,0.03634,1,0.11580667549668874,1.98,BP
GO:2000756,regulation of peptidyl-lysine acetylatio...,63,9,4.55,0.03634,1,0.11580667549668874,1.98,BP
GO:0032640,tumor necrosis factor production,169,19,12.21,0.03644,1,0.11604849768365322,1.56,BP
GO:0010824,regulation of centrosome duplication,44,7,3.18,0.03695,1,0.11759484126984125,2.2,BP
GO:0043542,endothelial cell migration,203,22,14.66,0.03701,1,0.11770794448116326,1.5,BP
GO:0051271,negative regulation of cellular componen...,319,32,23.04,0.03736,1,0.11874261558784675,1.39,BP
GO:0018345,protein palmitoylation,35,6,2.53,0.03752,1,0.11893691699604741,2.37,BP
GO:0036230,granulocyte activation,35,6,2.53,0.03752,1,0.11893691699604741,2.37,BP
GO:0090322,regulation of superoxide metabolic proce...,35,6,2.53,0.03752,1,0.11893691699604741,2.37,BP
GO:2000171,negative regulation of dendrite developm...,35,6,2.53,0.03752,1,0.11893691699604741,2.37,BP
GO:0001816,cytokine production,771,69,55.7,0.03784,1,0.11982513157894738,1.24,BP
GO:1901342,regulation of vasculature development,343,34,24.78,0.03785,1,0.11982513157894738,1.37,BP
GO:0000819,sister chromatid segregation,181,20,13.07,0.03800,1,0.12022090729783037,1.53,BP
GO:0034332,adherens junction organization,126,15,9.1,0.03826,1,0.12096394218134035,1.65,BP
GO:0061572,actin filament bundle organization,170,19,12.28,0.03836,1,0.12120047275114905,1.55,BP
GO:0033674,positive regulation of kinase activity,476,45,34.39,0.03894,1,0.12274223968565816,1.31,BP
GO:0035065,regulation of histone acetylation,54,8,3.9,0.03894,1,0.12274223968565816,2.05,BP
GO:0043268,positive regulation of potassium ion tra...,54,8,3.9,0.03894,1,0.12274223968565816,2.05,BP
GO:1903321,negative regulation of protein modificat...,84,11,6.07,0.03895,1,0.12274223968565816,1.81,BP
GO:0051346,negative regulation of hydrolase activit...,404,39,29.18,0.03954,1,0.12435187989556136,1.34,BP
GO:0002532,production of molecular mediator involve...,74,10,5.35,0.03959,1,0.12435187989556136,1.87,BP
GO:0031397,negative regulation of protein ubiquitin...,74,10,5.35,0.03959,1,0.12435187989556136,1.87,BP
GO:0046626,regulation of insulin receptor signaling...,74,10,5.35,0.03959,1,0.12435187989556136,1.87,BP
GO:1901983,regulation of protein acetylation,74,10,5.35,0.03959,1,0.12435187989556136,1.87,BP
GO:0006515,protein quality control for misfolded or...,27,5,1.95,0.04162,1,0.13030282368249835,2.56,BP
GO:0010971,positive regulation of G2/M transition o...,27,5,1.95,0.04162,1,0.13030282368249835,2.56,BP
GO:0034067,protein localization to Golgi apparatus,27,5,1.95,0.04162,1,0.13030282368249835,2.56,BP
GO:0045730,respiratory burst,27,5,1.95,0.04162,1,0.13030282368249835,2.56,BP
GO:0061003,positive regulation of dendritic spine m...,27,5,1.95,0.04162,1,0.13030282368249835,2.56,BP
GO:0071706,tumor necrosis factor superfamily cytoki...,172,19,12.42,0.04242,1,0.1327210923276983,1.53,BP
GO:0050770,regulation of axonogenesis,206,22,14.88,0.04247,1,0.13279118908382068,1.48,BP
GO:0006650,glycerophospholipid metabolic process,229,24,16.54,0.04257,1,0.13301742857142856,1.45,BP
GO:0006900,vesicle budding from membrane,55,8,3.97,0.04280,1,0.13347608554763446,2.02,BP
GO:0050775,positive regulation of dendrite morphoge...,55,8,3.97,0.04280,1,0.13347608554763446,2.02,BP
GO:0051187,cofactor catabolic process,55,8,3.97,0.04280,1,0.13347608554763446,2.02,BP
GO:0006354,"DNA-templated transcription, elongation",65,9,4.7,0.04322,1,0.13461141747572816,1.91,BP
GO:0030330,"DNA damage response, signal transduction...",65,9,4.7,0.04322,1,0.13461141747572816,1.91,BP
GO:0000165,MAPK cascade,802,71,57.93,0.04330,1,0.13477335058214748,1.23,BP
GO:0006928,movement of cell or subcellular componen...,2039,167,147.29,0.04371,1,0.1359615513897867,1.13,BP
GO:0051262,protein tetramerization,184,20,13.29,0.04395,1,0.1366197674418605,1.5,BP
GO:0042692,muscle cell differentiation,396,38,28.61,0.04495,1,0.13963808908973532,1.33,BP
GO:0010827,regulation of glucose transmembrane tran...,86,11,6.21,0.04508,1,0.1399515870967742,1.77,BP
GO:1903727,positive regulation of phospholipid meta...,46,7,3.32,0.04561,1,0.14150568665377175,2.11,BP
GO:0005996,monosaccharide metabolic process,254,26,18.35,0.04583,1,0.14209662371134021,1.42,BP
GO:0045893,"positive regulation of transcription, DN...",1547,129,111.75,0.04586,1,0.1420980811332904,1.15,BP
GO:0048468,cell development,2424,196,175.1,0.04608,1,0.14268787644787645,1.12,BP
GO:0007045,cell-substrate adherens junction assembl...,76,10,5.49,0.04627,1,0.1430920565552699,1.82,BP
GO:0048041,focal adhesion assembly,76,10,5.49,0.04627,1,0.1430920565552699,1.82,BP
GO:0006520,cellular amino acid metabolic process,266,27,19.22,0.04639,1,0.14337102119460501,1.4,BP
GO:0140029,exocytic process,97,12,7.01,0.04660,1,0.1439275994865212,1.71,BP
GO:0099172,presynapse organization,56,8,4.05,0.04690,1,0.1447612572161642,1.98,BP
GO:0046324,regulation of glucose import,66,9,4.77,0.04698,1,0.14491523076923077,1.89,BP
GO:0043901,negative regulation of multi-organism pr...,163,18,11.77,0.04739,1,0.14608627802690582,1.53,BP
GO:0033028,myeloid cell apoptotic process,37,6,2.67,0.04760,1,0.14613429116338209,2.25,BP
GO:0071398,cellular response to fatty acid,37,6,2.67,0.04760,1,0.14613429116338209,2.25,BP
GO:0023014,signal transduction by protein phosphory...,819,72,59.16,0.04768,1,0.14613429116338209,1.22,BP
GO:0031063,regulation of histone deacetylation,28,5,2.02,0.04777,1,0.14613429116338209,2.48,BP
GO:0031440,regulation of mRNA 3'-end processing,28,5,2.02,0.04777,1,0.14613429116338209,2.48,BP
GO:0032369,negative regulation of lipid transport,28,5,2.02,0.04777,1,0.14613429116338209,2.48,BP
GO:0035335,peptidyl-tyrosine dephosphorylation,28,5,2.02,0.04777,1,0.14613429116338209,2.48,BP
GO:0051957,positive regulation of amino acid transp...,28,5,2.02,0.04777,1,0.14613429116338209,2.48,BP
GO:0071108,protein K48-linked deubiquitination,28,5,2.02,0.04777,1,0.14613429116338209,2.48,BP
GO:0072576,liver morphogenesis,28,5,2.02,0.04777,1,0.14613429116338209,2.48,BP
GO:0090200,positive regulation of release of cytoch...,28,5,2.02,0.04777,1,0.14613429116338209,2.48,BP
GO:0090312,positive regulation of protein deacetyla...,28,5,2.02,0.04777,1,0.14613429116338209,2.48,BP
GO:0051952,regulation of amine transport,119,14,8.6,0.04809,1,0.1470197458703939,1.63,BP
GO:1903320,regulation of protein modification by sm...,232,24,16.76,0.04826,1,0.14738276649746193,1.43,BP
GO:0007093,mitotic cell cycle checkpoint,130,15,9.39,0.04827,1,0.14738276649746193,1.6,BP
GO:0060079,excitatory postsynaptic potential,87,11,6.28,0.04838,1,0.1476249587824984,1.75,BP
GO:1903508,positive regulation of nucleic acid-temp...,1551,129,112.04,0.04884,1,0.148934144486692,1.15,BP
GO:0009790,embryo development,1241,105,89.65,0.04897,1,0.1492359974667511,1.17,BP
GO:0051704,multi-organism process,2245,182,162.17,0.04945,1,0.15060341772151897,1.12,BP
GO:1902680,positive regulation of RNA biosynthetic ...,1552,129,112.11,0.04961,1,0.15099094816687736,1.15,BP
GO:0001819,positive regulation of cytokine producti...,460,43,33.23,0.04964,1,0.15099094816687736,1.29,BP
GO:0032760,positive regulation of tumor necrosis fa...,98,12,7.08,0.04977,1,0.15129073910296906,1.69,BP
GO:0034765,regulation of ion transmembrane transpor...,485,45,35.04,0.05037,1,0.15298213249211354,1.28,BP
GO:0019098,reproductive behavior,47,7,3.4,0.05039,1,0.15298213249211354,2.06,BP
GO:0000280,nuclear division,412,39,29.76,0.05070,1,0.15382622950819672,1.31,BP
GO:0006801,superoxide metabolic process,67,9,4.84,0.05094,1,0.15445701323251418,1.86,BP
GO:0048260,positive regulation of receptor-mediated...,57,8,4.12,0.05126,1,0.15532942065491184,1.94,BP
GO:0033599,regulation of mammary gland epithelial c...,20,4,1.44,0.05184,1,0.15620167814652472,2.78,BP
GO:0033605,positive regulation of catecholamine sec...,20,4,1.44,0.05184,1,0.15620167814652472,2.78,BP
GO:0034377,plasma lipoprotein particle assembly,20,4,1.44,0.05184,1,0.15620167814652472,2.78,BP
GO:0048490,anterograde synaptic vesicle transport,20,4,1.44,0.05184,1,0.15620167814652472,2.78,BP
GO:0051481,negative regulation of cytosolic calcium...,20,4,1.44,0.05184,1,0.15620167814652472,2.78,BP
GO:0099514,synaptic vesicle cytoskeletal transport,20,4,1.44,0.05184,1,0.15620167814652472,2.78,BP
GO:0099517,synaptic vesicle transport along microtu...,20,4,1.44,0.05184,1,0.15620167814652472,2.78,BP
GO:1903392,negative regulation of adherens junction...,20,4,1.44,0.05184,1,0.15620167814652472,2.78,BP
GO:1903798,regulation of production of miRNAs invol...,20,4,1.44,0.05184,1,0.15620167814652472,2.78,BP
GO:0009914,hormone transport,377,36,27.23,0.05283,1,0.15908508135168964,1.32,BP
GO:0061351,neural precursor cell proliferation,188,20,13.58,0.05288,1,0.15913606003752345,1.47,BP
GO:0099072,regulation of postsynaptic membrane neur...,99,12,7.15,0.05307,1,0.15950833229231728,1.68,BP
GO:1903557,positive regulation of tumor necrosis fa...,99,12,7.15,0.05307,1,0.15950833229231728,1.68,BP
GO:0006903,vesicle targeting,38,6,2.75,0.05322,1,0.15956052336448598,2.18,BP
GO:0016601,Rac protein signal transduction,38,6,2.75,0.05322,1,0.15956052336448598,2.18,BP
GO:0042554,superoxide anion generation,38,6,2.75,0.05322,1,0.15956052336448598,2.18,BP
GO:2000403,positive regulation of lymphocyte migrat...,38,6,2.75,0.05322,1,0.15956052336448598,2.18,BP
GO:0060322,head development,686,61,49.55,0.05360,1,0.1605997509339975,1.23,BP
GO:1900182,positive regulation of protein localizat...,78,10,5.63,0.05369,1,0.16076930927193528,1.78,BP
GO:2000379,positive regulation of reactive oxygen s...,110,13,7.95,0.05375,1,0.1608488805970149,1.64,BP
GO:0043409,negative regulation of MAPK cascade,177,19,12.79,0.05391,1,0.16122742075823493,1.49,BP
GO:0031497,chromatin assembly,121,14,8.74,0.05399,1,0.1612662197392924,1.6,BP
GO:0031929,TOR signaling,121,14,8.74,0.05399,1,0.1612662197392924,1.6,BP
GO:0030072,peptide hormone secretion,282,28,20.37,0.05429,1,0.16204767326732675,1.37,BP
GO:0051589,negative regulation of neurotransmitter ...,29,5,2.09,0.05442,1,0.16204767326732675,2.39,BP
GO:1900027,regulation of ruffle assembly,29,5,2.09,0.05442,1,0.16204767326732675,2.39,BP
GO:1901018,positive regulation of potassium ion tra...,29,5,2.09,0.05442,1,0.16204767326732675,2.39,BP
GO:1990126,"retrograde transport, endosome to plasma...",29,5,2.09,0.05442,1,0.16204767326732675,2.39,BP
GO:0043113,receptor clustering,68,9,4.91,0.05512,1,0.16403057513914657,1.83,BP
GO:0007229,integrin-mediated signaling pathway,89,11,6.43,0.05547,1,0.16456327990135636,1.71,BP
GO:0001504,neurotransmitter uptake,48,7,3.47,0.05547,1,0.16456327990135636,2.02,BP
GO:0032456,endocytic recycling,48,7,3.47,0.05547,1,0.16456327990135636,2.02,BP
GO:0045646,regulation of erythrocyte differentiatio...,48,7,3.47,0.05547,1,0.16456327990135636,2.02,BP
GO:0047496,vesicle transport along microtubule,48,7,3.47,0.05547,1,0.16456327990135636,2.02,BP
GO:0071478,cellular response to radiation,155,17,11.2,0.05570,1,0.16514380776340112,1.52,BP
GO:0015909,long-chain fatty acid transport,58,8,4.19,0.05586,1,0.16531261992619925,1.91,BP
GO:0061512,protein localization to cilium,58,8,4.19,0.05586,1,0.16531261992619925,1.91,BP
GO:1900449,regulation of glutamate receptor signali...,58,8,4.19,0.05586,1,0.16531261992619925,1.91,BP
GO:0002687,positive regulation of leukocyte migrati...,144,16,10.4,0.05638,1,0.16674896127842656,1.54,BP
GO:0046887,positive regulation of hormone secretion,167,18,12.06,0.05753,1,0.17004567567567566,1.49,BP
GO:0030808,regulation of nucleotide biosynthetic pr...,79,10,5.71,0.05767,1,0.17025033128834355,1.75,BP
GO:1900371,regulation of purine nucleotide biosynth...,79,10,5.71,0.05767,1,0.17025033128834355,1.75,BP
GO:0043491,protein kinase B signaling,190,20,13.73,0.05780,1,0.1705294911097486,1.46,BP
GO:0003015,heart process,225,23,16.25,0.05827,1,0.17181080882352942,1.42,BP
GO:0030522,intracellular receptor signaling pathway,202,21,14.59,0.05892,1,0.17362096754439682,1.44,BP
GO:0006826,iron ion transport,39,6,2.82,0.05921,1,0.1740491875381796,2.13,BP
GO:0060236,regulation of mitotic spindle organizati...,39,6,2.82,0.05921,1,0.1740491875381796,2.13,BP
GO:1902229,regulation of intrinsic apoptotic signal...,39,6,2.82,0.05921,1,0.1740491875381796,2.13,BP
GO:1904645,response to amyloid-beta,39,6,2.82,0.05921,1,0.1740491875381796,2.13,BP
GO:0060997,dendritic spine morphogenesis,69,9,4.98,0.05951,1,0.1748242490842491,1.81,BP
GO:0006633,fatty acid biosynthetic process,134,15,9.68,0.05996,1,0.17591217550274224,1.55,BP
GO:0010469,regulation of signaling receptor activit...,134,15,9.68,0.05996,1,0.17591217550274224,1.55,BP
GO:0046879,hormone secretion,369,35,26.66,0.05999,1,0.17591217550274224,1.31,BP
GO:0060359,response to ammonium ion,101,12,7.3,0.06013,1,0.1761488929219601,1.64,BP
GO:0006323,DNA packaging,168,18,12.14,0.06028,1,0.1761488929219601,1.48,BP
GO:0001934,positive regulation of protein phosphory...,996,85,71.95,0.06033,1,0.1761488929219601,1.18,BP
GO:0015837,amine transport,123,14,8.89,0.06037,1,0.1761488929219601,1.57,BP
GO:0006089,lactate metabolic process,21,4,1.52,0.06051,1,0.1761488929219601,2.63,BP
GO:0006541,glutamine metabolic process,21,4,1.52,0.06051,1,0.1761488929219601,2.63,BP
GO:0006783,heme biosynthetic process,21,4,1.52,0.06051,1,0.1761488929219601,2.63,BP
GO:0008053,mitochondrial fusion,21,4,1.52,0.06051,1,0.1761488929219601,2.63,BP
GO:0017000,antibiotic biosynthetic process,21,4,1.52,0.06051,1,0.1761488929219601,2.63,BP
GO:0031065,positive regulation of histone deacetyla...,21,4,1.52,0.06051,1,0.1761488929219601,2.63,BP
GO:0036336,dendritic cell migration,21,4,1.52,0.06051,1,0.1761488929219601,2.63,BP
GO:0070920,regulation of production of small RNA in...,21,4,1.52,0.06051,1,0.1761488929219601,2.63,BP
GO:0010656,negative regulation of muscle cell apopt...,59,8,4.26,0.06072,1,0.1763335184067592,1.88,BP
GO:0045744,negative regulation of G protein-coupled...,59,8,4.26,0.06072,1,0.1763335184067592,1.88,BP
GO:0045806,negative regulation of endocytosis,59,8,4.26,0.06072,1,0.1763335184067592,1.88,BP
GO:0046128,purine ribonucleoside metabolic process,59,8,4.26,0.06072,1,0.1763335184067592,1.88,BP
GO:0061912,selective autophagy,49,7,3.54,0.06087,1,0.1764496626506024,1.98,BP
GO:0099054,presynapse assembly,49,7,3.54,0.06087,1,0.1764496626506024,1.98,BP
GO:0120031,plasma membrane bounded cell projection ...,492,45,35.54,0.06087,1,0.1764496626506024,1.27,BP
GO:0006536,glutamate metabolic process,30,5,2.17,0.06158,1,0.17765165467625899,2.3,BP
GO:0009303,rRNA transcription,30,5,2.17,0.06158,1,0.17765165467625899,2.3,BP
GO:0035066,positive regulation of histone acetylati...,30,5,2.17,0.06158,1,0.17765165467625899,2.3,BP
GO:0042168,heme metabolic process,30,5,2.17,0.06158,1,0.17765165467625899,2.3,BP
GO:0043951,negative regulation of cAMP-mediated sig...,30,5,2.17,0.06158,1,0.17765165467625899,2.3,BP
GO:0046365,monosaccharide catabolic process,30,5,2.17,0.06158,1,0.17765165467625899,2.3,BP
GO:0051569,regulation of histone H3-K4 methylation,30,5,2.17,0.06158,1,0.17765165467625899,2.3,BP
GO:0070266,necroptotic process,30,5,2.17,0.06158,1,0.17765165467625899,2.3,BP
GO:0045596,negative regulation of cell differentiat...,806,70,58.22,0.06171,1,0.17792002396644696,1.2,BP
GO:0031099,regeneration,146,16,10.55,0.06236,1,0.17968641916167666,1.52,BP
GO:0072358,cardiovascular system development,769,67,55.55,0.06302,1,0.18137095693779906,1.21,BP
GO:0044706,multi-multicellular organism process,192,20,13.87,0.06302,1,0.18137095693779906,1.44,BP
GO:0006399,tRNA metabolic process,169,18,12.21,0.06312,1,0.1814417204301075,1.47,BP
GO:0071897,DNA biosynthetic process,169,18,12.21,0.06312,1,0.1814417204301075,1.47,BP
GO:0006497,protein lipidation,91,11,6.57,0.06322,1,0.18162068059701492,1.67,BP
GO:0042327,positive regulation of phosphorylation,1050,89,75.85,0.06338,1,0.18197169451073988,1.17,BP
GO:1905269,positive regulation of chromatin organiz...,113,13,8.16,0.06401,1,0.1836709123434705,1.59,BP
GO:1904018,positive regulation of vasculature devel...,204,21,14.74,0.06406,1,0.18370483909415974,1.42,BP
GO:1903670,regulation of sprouting angiogenesis,70,9,5.06,0.06412,1,0.18376738534842169,1.78,BP
GO:0062013,positive regulation of small molecule me...,158,17,11.41,0.06437,1,0.18437407142857143,1.49,BP
GO:0006360,transcription by RNA polymerase I,50,7,3.61,0.06657,1,0.19033561497326207,1.94,BP
GO:0035088,establishment or maintenance of apical/b...,50,7,3.61,0.06657,1,0.19033561497326207,1.94,BP
GO:0061245,establishment or maintenance of bipolar ...,50,7,3.61,0.06657,1,0.19033561497326207,1.94,BP
GO:0006066,alcohol metabolic process,312,30,22.54,0.06692,1,0.19122270783847978,1.33,BP
GO:0010594,regulation of endothelial cell migration,159,17,11.49,0.06746,1,0.1926513471810089,1.48,BP
GO:0046822,regulation of nucleocytoplasmic transpor...,114,13,8.24,0.06770,1,0.19322118483412323,1.58,BP
GO:0048709,oligodendrocyte differentiation,103,12,7.44,0.06778,1,0.19322118483412323,1.61,BP
GO:0051897,positive regulation of protein kinase B ...,103,12,7.44,0.06778,1,0.19322118483412323,1.61,BP
GO:0009119,ribonucleoside metabolic process,71,9,5.13,0.06895,1,0.19644014209591473,1.75,BP
GO:0007612,learning,171,18,12.35,0.06907,1,0.1966655857988166,1.46,BP
GO:0000387,spliceosomal snRNP assembly,31,5,2.24,0.06924,1,0.19691659574468084,2.23,BP
GO:0043090,amino acid import,31,5,2.24,0.06924,1,0.19691659574468084,2.23,BP
GO:0031032,actomyosin structure organization,206,21,14.88,0.06949,1,0.19751085646780864,1.41,BP
GO:0000470,maturation of LSU-rRNA,22,4,1.59,0.06989,1,0.19788642352941177,2.52,BP
GO:0032780,negative regulation of ATPase activity,22,4,1.59,0.06989,1,0.19788642352941177,2.52,BP
GO:0071359,cellular response to dsRNA,22,4,1.59,0.06989,1,0.19788642352941177,2.52,BP
GO:0090382,phagosome maturation,22,4,1.59,0.06989,1,0.19788642352941177,2.52,BP
GO:2000010,positive regulation of protein localizat...,22,4,1.59,0.06989,1,0.19788642352941177,2.52,BP
GO:2000757,negative regulation of peptidyl-lysine a...,22,4,1.59,0.06989,1,0.19788642352941177,2.52,BP
GO:0034728,nucleosome organization,137,15,9.9,0.06991,1,0.19788642352941177,1.52,BP
GO:0071383,cellular response to steroid hormone sti...,160,17,11.56,0.07064,1,0.19982225352112676,1.47,BP
GO:0007409,axonogenesis,473,43,34.17,0.07074,1,0.19982225352112676,1.26,BP
GO:0006637,acyl-CoA metabolic process,82,10,5.92,0.07076,1,0.19982225352112676,1.69,BP
GO:0035383,thioester metabolic process,82,10,5.92,0.07076,1,0.19982225352112676,1.69,BP
GO:0051235,maintenance of location,326,31,23.55,0.07115,1,0.20080574780058652,1.32,BP
GO:1902305,regulation of sodium ion transmembrane t...,61,8,4.41,0.07120,1,0.20082907385697538,1.81,BP
GO:0006885,regulation of pH,93,11,6.72,0.07163,1,0.20192358523725834,1.64,BP
GO:0033344,cholesterol efflux,41,6,2.96,0.07236,1,0.20338570093457942,2.03,BP
GO:0044764,multi-organism cellular process,41,6,2.96,0.07236,1,0.20338570093457942,2.03,BP
GO:0046326,positive regulation of glucose import,41,6,2.96,0.07236,1,0.20338570093457942,2.03,BP
GO:0086009,membrane repolarization,41,6,2.96,0.07236,1,0.20338570093457942,2.03,BP
GO:2000008,regulation of protein localization to ce...,41,6,2.96,0.07236,1,0.20338570093457942,2.03,BP
GO:0031663,lipopolysaccharide-mediated signaling pa...,51,7,3.68,0.07258,1,0.20352853146853148,1.9,BP
GO:0032784,regulation of DNA-templated transcriptio...,51,7,3.68,0.07258,1,0.20352853146853148,1.9,BP
GO:0051590,positive regulation of neurotransmitter ...,51,7,3.68,0.07258,1,0.20352853146853148,1.9,BP
GO:0061001,regulation of dendritic spine morphogene...,51,7,3.68,0.07258,1,0.20352853146853148,1.9,BP
GO:0009411,response to UV,138,15,9.97,0.07346,1,0.20587624927198603,1.5,BP
GO:0010611,regulation of cardiac muscle hypertrophy,72,9,5.2,0.07400,1,0.20726891734575087,1.73,BP
GO:0006629,lipid metabolic process,1266,105,91.45,0.07407,1,0.20734429319371725,1.15,BP
GO:0006006,glucose metabolic process,196,20,14.16,0.07444,1,0.20825888372093024,1.41,BP
GO:0045860,positive regulation of protein kinase ac...,438,40,31.64,0.07483,1,0.20922833236490412,1.26,BP
GO:0006644,phospholipid metabolic process,352,33,25.43,0.07489,1,0.20927449477351917,1.3,BP
GO:0033045,regulation of sister chromatid segregati...,83,10,6,0.07550,1,0.21073433874709976,1.67,BP
GO:1901019,regulation of calcium ion transmembrane ...,83,10,6,0.07550,1,0.21073433874709976,1.67,BP
GO:0002831,regulation of response to biotic stimulu...,150,16,10.84,0.07558,1,0.21083533913043476,1.48,BP
GO:0007009,plasma membrane organization,105,12,7.58,0.07604,1,0.21199564310544614,1.58,BP
GO:0007215,glutamate receptor signaling pathway,94,11,6.79,0.07610,1,0.21204006948465548,1.62,BP
GO:0046605,regulation of centrosome cycle,62,8,4.48,0.07684,1,0.21373068208092486,1.79,BP
GO:0048008,platelet-derived growth factor receptor ...,62,8,4.48,0.07684,1,0.21373068208092486,1.79,BP
GO:0097006,regulation of plasma lipoprotein particl...,62,8,4.48,0.07684,1,0.21373068208092486,1.79,BP
GO:0051147,regulation of muscle cell differentiatio...,162,17,11.7,0.07731,1,0.21457195852534564,1.45,BP
GO:0000462,maturation of SSU-rRNA from tricistronic...,32,5,2.31,0.07741,1,0.21457195852534564,2.16,BP
GO:0002861,regulation of inflammatory response to a...,32,5,2.31,0.07741,1,0.21457195852534564,2.16,BP
GO:0051150,regulation of smooth muscle cell differe...,32,5,2.31,0.07741,1,0.21457195852534564,2.16,BP
GO:0051642,centrosome localization,32,5,2.31,0.07741,1,0.21457195852534564,2.16,BP
GO:2000191,regulation of fatty acid transport,32,5,2.31,0.07741,1,0.21457195852534564,2.16,BP
GO:0030308,negative regulation of cell growth,197,20,14.23,0.07750,1,0.21469775474956823,1.41,BP
GO:0032481,positive regulation of type I interferon...,52,7,3.76,0.07890,1,0.2183247843588269,1.86,BP
GO:0061014,positive regulation of mRNA catabolic pr...,52,7,3.76,0.07890,1,0.2183247843588269,1.86,BP
GO:0030866,cortical actin cytoskeleton organization,42,6,3.03,0.07952,1,0.21953542168674697,1.98,BP
GO:0032768,regulation of monooxygenase activity,42,6,3.03,0.07952,1,0.21953542168674697,1.98,BP
GO:0050685,positive regulation of mRNA processing,42,6,3.03,0.07952,1,0.21953542168674697,1.98,BP
GO:1905521,regulation of macrophage migration,42,6,3.03,0.07952,1,0.21953542168674697,1.98,BP
GO:0010666,positive regulation of cardiac muscle ce...,23,4,1.66,0.07998,1,0.2197965505425471,2.41,BP
GO:0010996,response to auditory stimulus,23,4,1.66,0.07998,1,0.2197965505425471,2.41,BP
GO:0014912,negative regulation of smooth muscle cel...,23,4,1.66,0.07998,1,0.2197965505425471,2.41,BP
GO:0030252,growth hormone secretion,23,4,1.66,0.07998,1,0.2197965505425471,2.41,BP
GO:0043501,skeletal muscle adaptation,23,4,1.66,0.07998,1,0.2197965505425471,2.41,BP
GO:0045056,transcytosis,23,4,1.66,0.07998,1,0.2197965505425471,2.41,BP
GO:0050765,negative regulation of phagocytosis,23,4,1.66,0.07998,1,0.2197965505425471,2.41,BP
GO:0051220,cytoplasmic sequestering of protein,23,4,1.66,0.07998,1,0.2197965505425471,2.41,BP
GO:0050708,regulation of protein secretion,503,45,36.34,0.08044,1,0.22079233751425312,1.24,BP
GO:2001057,reactive nitrogen species metabolic proc...,84,10,6.07,0.08044,1,0.22079233751425312,1.65,BP
GO:0046486,glycerolipid metabolic process,330,31,23.84,0.08048,1,0.22079233751425312,1.3,BP
GO:0006906,vesicle fusion,95,11,6.86,0.08074,1,0.22137941880341883,1.6,BP
GO:0008277,regulation of G protein-coupled receptor...,129,14,9.32,0.08248,1,0.22602150341685648,1.5,BP
GO:0042246,tissue regeneration,63,8,4.55,0.08273,1,0.22657755264655663,1.76,BP
GO:0016042,lipid catabolic process,307,29,22.18,0.08390,1,0.22965119453924915,1.31,BP
GO:0030031,cell projection assembly,505,45,36.48,0.08443,1,0.23097052870949406,1.23,BP
GO:1903036,positive regulation of response to wound...,74,9,5.35,0.08476,1,0.23156043132803633,1.68,BP
GO:0007338,single fertilization,141,15,10.19,0.08479,1,0.23156043132803633,1.47,BP
GO:0034341,response to interferon-gamma,141,15,10.19,0.08479,1,0.23156043132803633,1.47,BP
GO:0014812,muscle cell migration,107,12,7.73,0.08491,1,0.2317566193987521,1.55,BP
GO:0014014,negative regulation of gliogenesis,53,7,3.83,0.08553,1,0.2329204074702886,1.83,BP
GO:0045777,positive regulation of blood pressure,53,7,3.83,0.08553,1,0.2329204074702886,1.83,BP
GO:0071242,cellular response to ammonium ion,53,7,3.83,0.08553,1,0.2329204074702886,1.83,BP
GO:0099518,vesicle cytoskeletal trafficking,53,7,3.83,0.08553,1,0.2329204074702886,1.83,BP
GO:0006084,acetyl-CoA metabolic process,33,5,2.38,0.08607,1,0.23346608793686582,2.1,BP
GO:0071709,membrane assembly,33,5,2.38,0.08607,1,0.23346608793686582,2.1,BP
GO:0071827,plasma lipoprotein particle organization,33,5,2.38,0.08607,1,0.23346608793686582,2.1,BP
GO:0090218,positive regulation of lipid kinase acti...,33,5,2.38,0.08607,1,0.23346608793686582,2.1,BP
GO:0099563,modification of synaptic structure,33,5,2.38,0.08607,1,0.23346608793686582,2.1,BP
GO:1905606,regulation of presynapse assembly,33,5,2.38,0.08607,1,0.23346608793686582,2.1,BP
GO:2001171,positive regulation of ATP biosynthetic ...,33,5,2.38,0.08607,1,0.23346608793686582,2.1,BP
GO:0044839,cell cycle G2/M phase transition,130,14,9.39,0.08661,1,0.2347984901408451,1.49,BP
GO:0001937,negative regulation of endothelial cell ...,43,6,3.11,0.08705,1,0.23493247335950643,1.93,BP
GO:0009395,phospholipid catabolic process,43,6,3.11,0.08705,1,0.23493247335950643,1.93,BP
GO:0032371,regulation of sterol transport,43,6,3.11,0.08705,1,0.23493247335950643,1.93,BP
GO:0032374,regulation of cholesterol transport,43,6,3.11,0.08705,1,0.23493247335950643,1.93,BP
GO:0042771,intrinsic apoptotic signaling pathway in...,43,6,3.11,0.08705,1,0.23493247335950643,1.93,BP
GO:0043403,skeletal muscle tissue regeneration,43,6,3.11,0.08705,1,0.23493247335950643,1.93,BP
GO:0051293,establishment of spindle localization,43,6,3.11,0.08705,1,0.23493247335950643,1.93,BP
GO:0097484,dendrite extension,43,6,3.11,0.08705,1,0.23493247335950643,1.93,BP
GO:0016569,covalent chromatin modification,444,40,32.07,0.08747,1,0.2359336547085202,1.25,BP
GO:0071346,cellular response to interferon-gamma,119,13,8.6,0.08823,1,0.23785028571428574,1.51,BP
GO:0007566,embryo implantation,64,8,4.62,0.08888,1,0.23920053691275167,1.73,BP
GO:0042278,purine nucleoside metabolic process,64,8,4.62,0.08888,1,0.23920053691275167,1.73,BP
GO:0090398,cellular senescence,64,8,4.62,0.08888,1,0.23920053691275167,1.73,BP
GO:0045765,regulation of angiogenesis,309,29,22.32,0.08922,1,0.2399813527110117,1.3,BP
GO:0014743,regulation of muscle hypertrophy,75,9,5.42,0.09048,1,0.241478296460177,1.66,BP
GO:0046323,glucose import,75,9,5.42,0.09048,1,0.241478296460177,1.66,BP
GO:0051851,modification by host of symbiont morphol...,75,9,5.42,0.09048,1,0.241478296460177,1.66,BP
GO:0099565,"chemical synaptic transmission, postsyna...",97,11,7.01,0.09053,1,0.241478296460177,1.57,BP
GO:0002685,regulation of leukocyte migration,201,20,14.52,0.09057,1,0.241478296460177,1.38,BP
GO:0009154,purine ribonucleotide catabolic process,24,4,1.73,0.09073,1,0.241478296460177,2.31,BP
GO:0009261,ribonucleotide catabolic process,24,4,1.73,0.09073,1,0.241478296460177,2.31,BP
GO:0010663,positive regulation of striated muscle c...,24,4,1.73,0.09073,1,0.241478296460177,2.31,BP
GO:0031061,negative regulation of histone methylati...,24,4,1.73,0.09073,1,0.241478296460177,2.31,BP
GO:0032461,positive regulation of protein oligomeri...,24,4,1.73,0.09073,1,0.241478296460177,2.31,BP
GO:0039528,cytoplasmic pattern recognition receptor...,24,4,1.73,0.09073,1,0.241478296460177,2.31,BP
GO:0043921,modulation by host of viral transcriptio...,24,4,1.73,0.09073,1,0.241478296460177,2.31,BP
GO:0045922,negative regulation of fatty acid metabo...,24,4,1.73,0.09073,1,0.241478296460177,2.31,BP
GO:0048670,regulation of collateral sprouting,24,4,1.73,0.09073,1,0.241478296460177,2.31,BP
GO:0051882,mitochondrial depolarization,24,4,1.73,0.09073,1,0.241478296460177,2.31,BP
GO:0052312,modulation of transcription in other org...,24,4,1.73,0.09073,1,0.241478296460177,2.31,BP
GO:0052472,modulation by host of symbiont transcrip...,24,4,1.73,0.09073,1,0.241478296460177,2.31,BP
GO:0065005,protein-lipid complex assembly,24,4,1.73,0.09073,1,0.241478296460177,2.31,BP
GO:1902683,regulation of receptor localization to s...,24,4,1.73,0.09073,1,0.241478296460177,2.31,BP
GO:0015696,ammonium transport,131,14,9.46,0.09087,1,0.24169001104972376,1.48,BP
GO:0007044,cell-substrate junction assembly,86,10,6.21,0.09091,1,0.24169001104972376,1.61,BP
GO:0033002,muscle cell proliferation,237,23,17.12,0.09119,1,0.24230054113749308,1.34,BP
GO:0007618,mating,54,7,3.9,0.09247,1,0.24462102253985707,1.79,BP
GO:0010517,regulation of phospholipase activity,54,7,3.9,0.09247,1,0.24462102253985707,1.79,BP
GO:0043392,negative regulation of DNA binding,54,7,3.9,0.09247,1,0.24462102253985707,1.79,BP
GO:0046503,glycerolipid catabolic process,54,7,3.9,0.09247,1,0.24462102253985707,1.79,BP
GO:0051496,positive regulation of stress fiber asse...,54,7,3.9,0.09247,1,0.24462102253985707,1.79,BP
GO:0055078,sodium ion homeostasis,54,7,3.9,0.09247,1,0.24462102253985707,1.79,BP
GO:0070265,necrotic cell death,54,7,3.9,0.09247,1,0.24462102253985707,1.79,BP
GO:1900271,regulation of long-term synaptic potenti...,54,7,3.9,0.09247,1,0.24462102253985707,1.79,BP
GO:0000075,cell cycle checkpoint,178,18,12.86,0.09285,1,0.24543312843029638,1.4,BP
GO:0106106,cold-induced thermogenesis,143,15,10.33,0.09293,1,0.24543312843029638,1.45,BP
GO:0120161,regulation of cold-induced thermogenesis,143,15,10.33,0.09293,1,0.24543312843029638,1.45,BP
GO:0048731,system development,4759,365,343.78,0.09440,1,0.24912125,1.06,BP
GO:0071241,cellular response to inorganic substance,226,22,16.33,0.09443,1,0.24912125,1.35,BP
GO:0008285,negative regulation of cell proliferatio...,700,60,50.57,0.09456,1,0.2493275178082192,1.19,BP
GO:0050714,positive regulation of protein secretion,311,29,22.47,0.09476,1,0.24967330790190737,1.29,BP
GO:0016925,protein sumoylation,44,6,3.18,0.09496,1,0.24967330790190737,1.89,BP
GO:0033048,negative regulation of mitotic sister ch...,44,6,3.18,0.09496,1,0.24967330790190737,1.89,BP
GO:0043277,apoptotic cell clearance,44,6,3.18,0.09496,1,0.24967330790190737,1.89,BP
GO:0060964,regulation of gene silencing by miRNA,44,6,3.18,0.09496,1,0.24967330790190737,1.89,BP
GO:0014047,glutamate secretion,34,5,2.46,0.09521,1,0.24967330790190737,2.03,BP
GO:0043243,positive regulation of protein complex d...,34,5,2.46,0.09521,1,0.24967330790190737,2.03,BP
GO:0140115,export across plasma membrane,34,5,2.46,0.09521,1,0.24967330790190737,2.03,BP
GO:2000406,positive regulation of T cell migration,34,5,2.46,0.09521,1,0.24967330790190737,2.03,BP
GO:2000758,positive regulation of peptidyl-lysine a...,34,5,2.46,0.09521,1,0.24967330790190737,2.03,BP
GO:0071214,cellular response to abiotic stimulus,299,28,21.6,0.09543,1,0.2499777681001633,1.3,BP
GO:0104004,cellular response to environmental stimu...,299,28,21.6,0.09543,1,0.2499777681001633,1.3,BP
GO:0010595,positive regulation of endothelial cell ...,98,11,7.08,0.09568,1,0.250224,1.55,BP
GO:0031058,positive regulation of histone modificat...,98,11,7.08,0.09568,1,0.250224,1.55,BP
GO:0043502,regulation of muscle adaptation,98,11,7.08,0.09568,1,0.250224,1.55,BP
GO:0001659,temperature homeostasis,179,18,12.93,0.09663,1,0.25257118957088537,1.39,BP
GO:0010634,positive regulation of epithelial cell m...,144,15,10.4,0.09719,1,0.25389700325732895,1.44,BP
GO:0060047,heart contraction,215,21,15.53,0.09779,1,0.25532581660336406,1.35,BP
GO:0051604,protein maturation,300,28,21.67,0.09836,1,0.25667479392624726,1.29,BP
GO:0014009,glial cell proliferation,55,7,3.97,0.09971,1,0.25977505143475904,1.76,BP
GO:0046718,viral entry into host cell,55,7,3.97,0.09971,1,0.25977505143475904,1.76,BP
GO:0048662,negative regulation of smooth muscle cel...,55,7,3.97,0.09971,1,0.25977505143475904,1.76,BP
GO:0030177,positive regulation of Wnt signaling pat...,133,14,9.61,0.09977,1,0.25979071428571426,1.46,BP
GO:0032755,positive regulation of interleukin-6 pro...,99,11,7.15,0.10100,1,0.26242548596112314,1.54,BP
GO:0033865,nucleoside bisphosphate metabolic proces...,99,11,7.15,0.10100,1,0.26242548596112314,1.54,BP
GO:0033875,ribonucleoside bisphosphate metabolic pr...,99,11,7.15,0.10100,1,0.26242548596112314,1.54,BP
GO:0034032,purine nucleoside bisphosphate metabolic...,99,11,7.15,0.10100,1,0.26242548596112314,1.54,BP
GO:0009064,glutamine family amino acid metabolic pr...,66,8,4.77,0.10195,1,0.26339639871382636,1.68,BP
GO:0042440,pigment metabolic process,66,8,4.77,0.10195,1,0.26339639871382636,1.68,BP
GO:0006925,inflammatory cell apoptotic process,25,4,1.81,0.10214,1,0.26339639871382636,2.21,BP
GO:0031629,synaptic vesicle fusion to presynaptic a...,25,4,1.81,0.10214,1,0.26339639871382636,2.21,BP
GO:0032480,negative regulation of type I interferon...,25,4,1.81,0.10214,1,0.26339639871382636,2.21,BP
GO:0035455,response to interferon-alpha,25,4,1.81,0.10214,1,0.26339639871382636,2.21,BP
GO:0045648,positive regulation of erythrocyte diffe...,25,4,1.81,0.10214,1,0.26339639871382636,2.21,BP
GO:0046426,negative regulation of JAK-STAT cascade,25,4,1.81,0.10214,1,0.26339639871382636,2.21,BP
GO:0051580,regulation of neurotransmitter uptake,25,4,1.81,0.10214,1,0.26339639871382636,2.21,BP
GO:0055094,response to lipoprotein particle,25,4,1.81,0.10214,1,0.26339639871382636,2.21,BP
GO:0090114,COPII-coated vesicle budding,25,4,1.81,0.10214,1,0.26339639871382636,2.21,BP
GO:0098810,neurotransmitter reuptake,25,4,1.81,0.10214,1,0.26339639871382636,2.21,BP
GO:2000637,positive regulation of gene silencing by...,25,4,1.81,0.10214,1,0.26339639871382636,2.21,BP
GO:0040014,regulation of multicellular organism gro...,88,10,6.36,0.10214,1,0.26339639871382636,1.57,BP
GO:0044255,cellular lipid metabolic process,936,78,67.61,0.10254,1,0.2642862774504553,1.15,BP
GO:1901381,positive regulation of potassium ion tra...,45,6,3.25,0.10324,1,0.2659480085653105,1.85,BP
GO:0001944,vasculature development,756,64,54.61,0.10359,1,0.2667068378812199,1.17,BP
GO:0043122,regulation of I-kappaB kinase/NF-kappaB ...,169,17,12.21,0.10383,1,0.2671817967914439,1.39,BP
GO:0061025,membrane fusion,134,14,9.68,0.10441,1,0.2685306894708712,1.45,BP
GO:0060828,regulation of canonical Wnt signaling pa...,229,22,16.54,0.10476,1,0.269035712,1.33,BP
GO:0016572,histone phosphorylation,35,5,2.53,0.10483,1,0.269035712,1.98,BP
GO:1901068,guanosine-containing compound metabolic ...,35,5,2.53,0.10483,1,0.269035712,1.98,BP
GO:1904707,positive regulation of vascular smooth m...,35,5,2.53,0.10483,1,0.269035712,1.98,BP
GO:0001935,endothelial cell proliferation,146,15,10.55,0.10604,1,0.2718510815130527,1.42,BP
GO:1905952,regulation of lipid localization,146,15,10.55,0.10604,1,0.2718510815130527,1.42,BP
GO:0016570,histone modification,427,38,30.85,0.10672,1,0.27344869009584666,1.23,BP
GO:0010921,regulation of phosphatase activity,123,13,8.89,0.10718,1,0.27424820403825717,1.46,BP
GO:1990845,adaptive thermogenesis,158,16,11.41,0.10722,1,0.27424820403825717,1.4,BP
GO:0006911,"phagocytosis, engulfment",56,7,4.05,0.10726,1,0.27424820403825717,1.73,BP
GO:0007062,sister chromatid cohesion,56,7,4.05,0.10726,1,0.27424820403825717,1.73,BP
GO:0006281,DNA repair,465,41,33.59,0.10754,1,0.27481809877854485,1.22,BP
GO:0097164,ammonium ion metabolic process,170,17,12.28,0.10803,1,0.2759237579617835,1.38,BP
GO:0070371,ERK1 and ERK2 cascade,328,30,23.69,0.10850,1,0.2769771883289125,1.27,BP
GO:0045739,positive regulation of DNA repair,67,8,4.84,0.10886,1,0.2777488441145281,1.65,BP
GO:0043408,regulation of MAPK cascade,746,63,53.89,0.10919,1,0.27844317965023846,1.17,BP
GO:0021782,glial cell development,112,12,8.09,0.10980,1,0.2798504237288136,1.48,BP
GO:0001525,angiogenesis,517,45,37.35,0.11120,1,0.2832686077289571,1.2,BP
GO:0006576,cellular biogenic amine metabolic proces...,46,6,3.32,0.11189,1,0.2841106105263158,1.81,BP
GO:0010799,regulation of peptidyl-threonine phospho...,46,6,3.32,0.11189,1,0.2841106105263158,1.81,BP
GO:0033046,negative regulation of sister chromatid ...,46,6,3.32,0.11189,1,0.2841106105263158,1.81,BP
GO:0060323,head morphogenesis,46,6,3.32,0.11189,1,0.2841106105263158,1.81,BP
GO:0072666,establishment of protein localization to...,46,6,3.32,0.11189,1,0.2841106105263158,1.81,BP
GO:1990928,response to amino acid starvation,46,6,3.32,0.11189,1,0.2841106105263158,1.81,BP
GO:0097191,extrinsic apoptotic signaling pathway,231,22,16.69,0.11203,1,0.2841106105263158,1.32,BP
GO:0032006,regulation of TOR signaling,101,11,7.3,0.11217,1,0.2841106105263158,1.51,BP
GO:0090263,positive regulation of canonical Wnt sig...,101,11,7.3,0.11217,1,0.2841106105263158,1.51,BP
GO:0110020,regulation of actomyosin structure organ...,101,11,7.3,0.11217,1,0.2841106105263158,1.51,BP
GO:0007420,brain development,632,54,45.65,0.11218,1,0.2841106105263158,1.18,BP
GO:0043500,muscle adaptation,124,13,8.96,0.11227,1,0.28418897422409256,1.45,BP
GO:0048659,smooth muscle cell proliferation,171,17,12.35,0.11233,1,0.28419135646687693,1.38,BP
GO:0006779,porphyrin-containing compound biosynthet...,26,4,1.88,0.11417,1,0.28718559330893884,2.13,BP
GO:0007176,regulation of epidermal growth factor-ac...,26,4,1.88,0.11417,1,0.28718559330893884,2.13,BP
GO:0019320,hexose catabolic process,26,4,1.88,0.11417,1,0.28718559330893884,2.13,BP
GO:0045761,regulation of adenylate cyclase activity,26,4,1.88,0.11417,1,0.28718559330893884,2.13,BP
GO:0051570,regulation of histone H3-K9 methylation,26,4,1.88,0.11417,1,0.28718559330893884,2.13,BP
GO:0060148,positive regulation of posttranscription...,26,4,1.88,0.11417,1,0.28718559330893884,2.13,BP
GO:0099010,modification of postsynaptic structure,26,4,1.88,0.11417,1,0.28718559330893884,2.13,BP
GO:0099500,vesicle fusion to plasma membrane,26,4,1.88,0.11417,1,0.28718559330893884,2.13,BP
GO:1902473,regulation of protein localization to sy...,26,4,1.88,0.11417,1,0.28718559330893884,2.13,BP
GO:1903671,negative regulation of sprouting angioge...,26,4,1.88,0.11417,1,0.28718559330893884,2.13,BP
GO:1904893,negative regulation of STAT cascade,26,4,1.88,0.11417,1,0.28718559330893884,2.13,BP
GO:0001963,"synaptic transmission, dopaminergic",36,5,2.6,0.11490,1,0.28786964656964653,1.92,BP
GO:0035886,vascular smooth muscle cell differentiat...,36,5,2.6,0.11490,1,0.28786964656964653,1.92,BP
GO:0051294,establishment of spindle orientation,36,5,2.6,0.11490,1,0.28786964656964653,1.92,BP
GO:0070873,regulation of glycogen metabolic process,36,5,2.6,0.11490,1,0.28786964656964653,1.92,BP
GO:1903959,regulation of anion transmembrane transp...,36,5,2.6,0.11490,1,0.28786964656964653,1.92,BP
GO:0006584,catecholamine metabolic process,57,7,4.12,0.11510,1,0.28786964656964653,1.7,BP
GO:0009712,catechol-containing compound metabolic p...,57,7,4.12,0.11510,1,0.28786964656964653,1.7,BP
GO:0043470,regulation of carbohydrate catabolic pro...,57,7,4.12,0.11510,1,0.28786964656964653,1.7,BP
GO:0044773,mitotic DNA damage checkpoint,57,7,4.12,0.11510,1,0.28786964656964653,1.7,BP
GO:0051196,regulation of coenzyme metabolic process,57,7,4.12,0.11510,1,0.28786964656964653,1.7,BP
GO:1905517,macrophage migration,57,7,4.12,0.11510,1,0.28786964656964653,1.7,BP
GO:0000086,G2/M transition of mitotic cell cycle,113,12,8.16,0.11524,1,0.2880700675324675,1.47,BP
GO:0006835,dicarboxylic acid transport,79,9,5.71,0.11554,1,0.288670031152648,1.58,BP
GO:0008542,visual learning,68,8,4.91,0.11603,1,0.28974382978723406,1.63,BP
GO:2001257,regulation of cation channel activity,172,17,12.42,0.11673,1,0.291340643153527,1.37,BP
GO:0006638,neutral lipid metabolic process,125,13,9.03,0.11750,1,0.29311041990668735,1.44,BP
GO:0005975,carbohydrate metabolic process,545,47,39.37,0.11758,1,0.2931580103626943,1.19,BP
GO:0034330,cell junction organization,257,24,18.57,0.11797,1,0.2937734712881531,1.29,BP
GO:0008306,associative learning,102,11,7.37,0.11801,1,0.2937734712881531,1.49,BP
GO:0062014,negative regulation of small molecule me...,102,11,7.37,0.11801,1,0.2937734712881531,1.49,BP
GO:0009306,protein secretion,622,53,44.93,0.11853,1,0.2949153877973113,1.18,BP
GO:0071363,cellular response to growth factor stimu...,610,52,44.06,0.12041,1,0.2986256057494866,1.18,BP
GO:0006112,energy reserve metabolic process,91,10,6.57,0.12044,1,0.2986256057494866,1.52,BP
GO:0046883,regulation of hormone secretion,307,28,22.18,0.12048,1,0.2986256057494866,1.26,BP
GO:0008630,intrinsic apoptotic signaling pathway in...,114,12,8.24,0.12084,1,0.2986256057494866,1.46,BP
GO:0043123,positive regulation of I-kappaB kinase/N...,114,12,8.24,0.12084,1,0.2986256057494866,1.46,BP
GO:0070848,response to growth factor,623,53,45,0.12087,1,0.2986256057494866,1.18,BP
GO:0050798,activated T cell proliferation,47,6,3.4,0.12089,1,0.2986256057494866,1.76,BP
GO:0060147,regulation of posttranscriptional gene s...,47,6,3.4,0.12089,1,0.2986256057494866,1.76,BP
GO:0060966,regulation of gene silencing by RNA,47,6,3.4,0.12089,1,0.2986256057494866,1.76,BP
GO:0061028,establishment of endothelial barrier,47,6,3.4,0.12089,1,0.2986256057494866,1.76,BP
GO:0072604,interleukin-6 secretion,47,6,3.4,0.12089,1,0.2986256057494866,1.76,BP
GO:0090659,walking behavior,47,6,3.4,0.12089,1,0.2986256057494866,1.76,BP
GO:0120163,negative regulation of cold-induced ther...,47,6,3.4,0.12089,1,0.2986256057494866,1.76,BP
GO:1903018,regulation of glycoprotein metabolic pro...,47,6,3.4,0.12089,1,0.2986256057494866,1.76,BP
GO:0045766,positive regulation of angiogenesis,185,18,13.36,0.12130,1,0.29948465879938435,1.35,BP
GO:0006919,activation of cysteine-type endopeptidas...,80,9,5.78,0.12235,1,0.3016128073770492,1.56,BP
GO:0044272,sulfur compound biosynthetic process,80,9,5.78,0.12235,1,0.3016128073770492,1.56,BP
GO:0051785,positive regulation of nuclear division,80,9,5.78,0.12235,1,0.3016128073770492,1.56,BP
GO:0051310,metaphase plate congression,58,7,4.19,0.12323,1,0.30362660522273427,1.67,BP
GO:0032482,Rab protein signal transduction,69,8,4.98,0.12344,1,0.30367754601226993,1.61,BP
GO:0051298,centrosome duplication,69,8,4.98,0.12344,1,0.30367754601226993,1.61,BP
GO:0051453,regulation of intracellular pH,69,8,4.98,0.12344,1,0.30367754601226993,1.61,BP
GO:0002702,positive regulation of production of mol...,103,11,7.44,0.12401,1,0.3046126186830015,1.48,BP
GO:0034446,substrate adhesion-dependent cell spread...,103,11,7.44,0.12401,1,0.3046126186830015,1.48,BP
GO:0140053,mitochondrial gene expression,103,11,7.44,0.12401,1,0.3046126186830015,1.48,BP
GO:0071103,DNA conformation change,210,20,15.17,0.12493,1,0.30606955375253553,1.32,BP
GO:0042737,drug catabolic process,150,15,10.84,0.12517,1,0.30606955375253553,1.38,BP
GO:0048511,rhythmic process,296,27,21.38,0.12526,1,0.30606955375253553,1.26,BP
GO:0021799,cerebral cortex radially oriented cell m...,37,5,2.67,0.12541,1,0.30606955375253553,1.87,BP
GO:0031279,regulation of cyclase activity,37,5,2.67,0.12541,1,0.30606955375253553,1.87,BP
GO:0033146,regulation of intracellular estrogen rec...,37,5,2.67,0.12541,1,0.30606955375253553,1.87,BP
GO:0034243,regulation of transcription elongation f...,37,5,2.67,0.12541,1,0.30606955375253553,1.87,BP
GO:0043628,ncRNA 3'-end processing,37,5,2.67,0.12541,1,0.30606955375253553,1.87,BP
GO:0046470,phosphatidylcholine metabolic process,37,5,2.67,0.12541,1,0.30606955375253553,1.87,BP
GO:0071825,protein-lipid complex subunit organizati...,37,5,2.67,0.12541,1,0.30606955375253553,1.87,BP
GO:0098751,bone cell development,37,5,2.67,0.12541,1,0.30606955375253553,1.87,BP
GO:0099174,regulation of presynapse organization,37,5,2.67,0.12541,1,0.30606955375253553,1.87,BP
GO:1901605,alpha-amino acid metabolic process,198,19,14.3,0.12543,1,0.30606955375253553,1.33,BP
GO:2001236,regulation of extrinsic apoptotic signal...,162,16,11.7,0.12567,1,0.30649976685250885,1.37,BP
GO:0009566,fertilization,186,18,13.44,0.12575,1,0.30653951367781157,1.34,BP
GO:0071901,negative regulation of protein serine/th...,115,12,8.31,0.12658,1,0.30736195465994964,1.44,BP
GO:0007549,dosage compensation,27,4,1.95,0.12679,1,0.30736195465994964,2.05,BP
GO:0009163,nucleoside biosynthetic process,27,4,1.95,0.12679,1,0.30736195465994964,2.05,BP
GO:0021697,cerebellar cortex formation,27,4,1.95,0.12679,1,0.30736195465994964,2.05,BP
GO:0032069,regulation of nuclease activity,27,4,1.95,0.12679,1,0.30736195465994964,2.05,BP
GO:0032801,receptor catabolic process,27,4,1.95,0.12679,1,0.30736195465994964,2.05,BP
GO:0033014,tetrapyrrole biosynthetic process,27,4,1.95,0.12679,1,0.30736195465994964,2.05,BP
GO:0039694,viral RNA genome replication,27,4,1.95,0.12679,1,0.30736195465994964,2.05,BP
GO:0042455,ribonucleoside biosynthetic process,27,4,1.95,0.12679,1,0.30736195465994964,2.05,BP
GO:0051125,regulation of actin nucleation,27,4,1.95,0.12679,1,0.30736195465994964,2.05,BP
GO:0071402,cellular response to lipoprotein particl...,27,4,1.95,0.12679,1,0.30736195465994964,2.05,BP
GO:0030111,regulation of Wnt signaling pathway,297,27,21.45,0.12881,1,0.3121015709969789,1.26,BP
GO:0016477,cell migration,1463,117,105.68,0.12946,1,0.31351863110216405,1.11,BP
GO:0030038,contractile actin filament bundle assemb...,104,11,7.51,0.13018,1,0.31459174698795184,1.46,BP
GO:0032231,regulation of actin filament bundle asse...,104,11,7.51,0.13018,1,0.31459174698795184,1.46,BP
GO:0043149,stress fiber assembly,104,11,7.51,0.13018,1,0.31459174698795184,1.46,BP
GO:0006368,transcription elongation from RNA polyme...,48,6,3.47,0.13023,1,0.31459174698795184,1.73,BP
GO:0031648,protein destabilization,48,6,3.47,0.13023,1,0.31459174698795184,1.73,BP
GO:0001885,endothelial cell development,70,8,5.06,0.13110,1,0.31637572718154466,1.58,BP
GO:0002090,regulation of receptor internalization,70,8,5.06,0.13110,1,0.31637572718154466,1.58,BP
GO:0030260,entry into host cell,59,7,4.26,0.13164,1,0.31688428214107056,1.64,BP
GO:0044409,entry into host,59,7,4.26,0.13164,1,0.31688428214107056,1.64,BP
GO:0051806,entry into cell of other organism involv...,59,7,4.26,0.13164,1,0.31688428214107056,1.64,BP
GO:0051828,entry into other organism involved in sy...,59,7,4.26,0.13164,1,0.31688428214107056,1.64,BP
GO:2000401,regulation of lymphocyte migration,59,7,4.26,0.13164,1,0.31688428214107056,1.64,BP
GO:0014909,smooth muscle cell migration,93,10,6.72,0.13358,1,0.32139348,1.49,BP
GO:0010565,regulation of cellular ketone metabolic ...,128,13,9.25,0.13401,1,0.32210595404595405,1.41,BP
GO:0050852,T cell receptor signaling pathway,128,13,9.25,0.13401,1,0.32210595404595405,1.41,BP
GO:0006473,protein acetylation,188,18,13.58,0.13493,1,0.3241553469795307,1.33,BP
GO:0032635,interleukin-6 production,164,16,11.85,0.13555,1,0.32532,1.35,BP
GO:0043433,negative regulation of DNA-binding trans...,164,16,11.85,0.13555,1,0.32532,1.35,BP
GO:0001953,negative regulation of cell-matrix adhes...,38,5,2.75,0.13635,1,0.32642597014925373,1.82,BP
GO:0006636,unsaturated fatty acid biosynthetic proc...,38,5,2.75,0.13635,1,0.32642597014925373,1.82,BP
GO:0006778,porphyrin-containing compound metabolic ...,38,5,2.75,0.13635,1,0.32642597014925373,1.82,BP
GO:0071158,positive regulation of cell cycle arrest,38,5,2.75,0.13635,1,0.32642597014925373,1.82,BP
GO:2001025,positive regulation of response to drug,38,5,2.75,0.13635,1,0.32642597014925373,1.82,BP
GO:0045926,negative regulation of growth,262,24,18.93,0.13702,1,0.32786685231228246,1.27,BP
GO:0003012,muscle system process,400,35,28.89,0.13803,1,0.330119463220676,1.21,BP
GO:0043534,blood vessel endothelial cell migration,117,12,8.45,0.13852,1,0.3311267958271237,1.42,BP
GO:1904589,regulation of protein import,71,8,5.13,0.13899,1,0.3320853426017875,1.56,BP
GO:0051592,response to calcium ion,129,13,9.32,0.13978,1,0.33242227048371176,1.39,BP
GO:1902652,secondary alcohol metabolic process,129,13,9.32,0.13978,1,0.33242227048371176,1.39,BP
GO:0030520,intracellular estrogen receptor signalin...,49,6,3.54,0.13991,1,0.33242227048371176,1.69,BP
GO:0051985,negative regulation of chromosome segreg...,49,6,3.54,0.13991,1,0.33242227048371176,1.69,BP
GO:0070169,positive regulation of biomineral tissue...,49,6,3.54,0.13991,1,0.33242227048371176,1.69,BP
GO:0090342,regulation of cell aging,49,6,3.54,0.13991,1,0.33242227048371176,1.69,BP
GO:0006195,purine nucleotide catabolic process,28,4,2.02,0.13996,1,0.33242227048371176,1.98,BP
GO:0016082,synaptic vesicle priming,28,4,2.02,0.13996,1,0.33242227048371176,1.98,BP
GO:0045956,positive regulation of calcium ion-depen...,28,4,2.02,0.13996,1,0.33242227048371176,1.98,BP
GO:0051354,negative regulation of oxidoreductase ac...,28,4,2.02,0.13996,1,0.33242227048371176,1.98,BP
GO:0060765,regulation of androgen receptor signalin...,28,4,2.02,0.13996,1,0.33242227048371176,1.98,BP
GO:0089718,amino acid import across plasma membrane,28,4,2.02,0.13996,1,0.33242227048371176,1.98,BP
GO:0060324,face development,60,7,4.33,0.14034,1,0.3331603749383325,1.62,BP
GO:0050921,positive regulation of chemotaxis,141,14,10.19,0.14049,1,0.3333520118343195,1.37,BP
GO:0034097,response to cytokine,1037,84,74.91,0.14567,1,0.34547266633809753,1.12,BP
GO:0048660,regulation of smooth muscle cell prolife...,166,16,11.99,0.14585,1,0.3457291625615764,1.33,BP
GO:1903725,regulation of phospholipid metabolic pro...,72,8,5.2,0.14711,1,0.3485442245199409,1.54,BP
GO:0051817,modification of morphology or physiology...,95,10,6.86,0.14744,1,0.3485691025012261,1.46,BP
GO:0007616,long-term memory,39,5,2.82,0.14770,1,0.3485691025012261,1.77,BP
GO:0014002,astrocyte development,39,5,2.82,0.14770,1,0.3485691025012261,1.77,BP
GO:0030810,positive regulation of nucleotide biosyn...,39,5,2.82,0.14770,1,0.3485691025012261,1.77,BP
GO:0060337,type I interferon signaling pathway,39,5,2.82,0.14770,1,0.3485691025012261,1.77,BP
GO:0070528,protein kinase C signaling,39,5,2.82,0.14770,1,0.3485691025012261,1.77,BP
GO:0071357,cellular response to type I interferon,39,5,2.82,0.14770,1,0.3485691025012261,1.77,BP
GO:1900373,positive regulation of purine nucleotide...,39,5,2.82,0.14770,1,0.3485691025012261,1.77,BP
GO:0090257,regulation of muscle system process,240,22,17.34,0.14849,1,0.350261705882353,1.27,BP
GO:0002791,regulation of peptide secretion,544,46,39.3,0.14923,1,0.3516552129221733,1.17,BP
GO:0021695,cerebellar cortex development,61,7,4.41,0.14930,1,0.3516552129221733,1.59,BP
GO:0051058,negative regulation of small GTPase medi...,61,7,4.41,0.14930,1,0.3516552129221733,1.59,BP
GO:0046328,regulation of JNK cascade,191,18,13.8,0.14939,1,0.3516950489236791,1.3,BP
GO:0010828,positive regulation of glucose transmemb...,50,6,3.61,0.14991,1,0.3524020127015144,1.66,BP
GO:0051955,regulation of amino acid transport,50,6,3.61,0.14991,1,0.3524020127015144,1.66,BP
GO:0098586,cellular response to virus,50,6,3.61,0.14991,1,0.3524020127015144,1.66,BP
GO:0032675,regulation of interleukin-6 production,155,15,11.2,0.15170,1,0.3564357421875,1.34,BP
GO:0007050,cell cycle arrest,143,14,10.33,0.15191,1,0.3567549633967789,1.36,BP
GO:0001919,regulation of receptor recycling,29,4,2.09,0.15365,1,0.3589144660194175,1.91,BP
GO:0005979,regulation of glycogen biosynthetic proc...,29,4,2.09,0.15365,1,0.3589144660194175,1.91,BP
GO:0010962,regulation of glucan biosynthetic proces...,29,4,2.09,0.15365,1,0.3589144660194175,1.91,BP
GO:0030511,positive regulation of transforming grow...,29,4,2.09,0.15365,1,0.3589144660194175,1.91,BP
GO:0033137,negative regulation of peptidyl-serine p...,29,4,2.09,0.15365,1,0.3589144660194175,1.91,BP
GO:0034390,smooth muscle cell apoptotic process,29,4,2.09,0.15365,1,0.3589144660194175,1.91,BP
GO:0034391,regulation of smooth muscle cell apoptot...,29,4,2.09,0.15365,1,0.3589144660194175,1.91,BP
GO:0034629,cellular protein-containing complex loca...,29,4,2.09,0.15365,1,0.3589144660194175,1.91,BP
GO:0090181,regulation of cholesterol metabolic proc...,29,4,2.09,0.15365,1,0.3589144660194175,1.91,BP
GO:1903846,positive regulation of cellular response...,29,4,2.09,0.15365,1,0.3589144660194175,1.91,BP
GO:1904031,positive regulation of cyclin-dependent ...,29,4,2.09,0.15365,1,0.3589144660194175,1.91,BP
GO:0046578,regulation of Ras protein signal transdu...,229,21,16.54,0.15468,1,0.36114515283842796,1.27,BP
GO:0051145,smooth muscle cell differentiation,73,8,5.27,0.15546,1,0.36279026188166824,1.52,BP
GO:0002793,positive regulation of peptide secretion,342,30,24.71,0.15615,1,0.36422384876393604,1.21,BP
GO:1904659,glucose transmembrane transport,108,11,7.8,0.15649,1,0.3648400581395349,1.41,BP
GO:0018394,peptidyl-lysine acetylation,156,15,11.27,0.15734,1,0.36664410653753027,1.33,BP
GO:0051048,negative regulation of secretion,267,24,19.29,0.15777,1,0.3674681703775411,1.24,BP
GO:0001936,regulation of endothelial cell prolifera...,132,13,9.54,0.15790,1,0.3675930333817127,1.36,BP
GO:0007254,JNK cascade,205,19,14.81,0.15799,1,0.3676247001934236,1.28,BP
GO:0010171,body morphogenesis,62,7,4.48,0.15852,1,0.3685015652173913,1.56,BP
GO:0010812,negative regulation of cell-substrate ad...,62,7,4.48,0.15852,1,0.3685015652173913,1.56,BP
GO:0071345,cellular response to cytokine stimulus,938,76,67.76,0.15885,1,0.36909039111540315,1.12,BP
GO:0001881,receptor recycling,40,5,2.89,0.15942,1,0.36987899710703953,1.73,BP
GO:0021696,cerebellar cortex morphogenesis,40,5,2.89,0.15942,1,0.36987899710703953,1.73,BP
GO:0086004,regulation of cardiac muscle cell contra...,40,5,2.89,0.15942,1,0.36987899710703953,1.73,BP
GO:0007032,endosome organization,51,6,3.68,0.16023,1,0.37050781355117735,1.63,BP
GO:0008038,neuron recognition,51,6,3.68,0.16023,1,0.37050781355117735,1.63,BP
GO:0010596,negative regulation of endothelial cell ...,51,6,3.68,0.16023,1,0.37050781355117735,1.63,BP
GO:0021587,cerebellum morphogenesis,51,6,3.68,0.16023,1,0.37050781355117735,1.63,BP
GO:0032648,regulation of interferon-beta production,51,6,3.68,0.16023,1,0.37050781355117735,1.63,BP
GO:0043550,regulation of lipid kinase activity,51,6,3.68,0.16023,1,0.37050781355117735,1.63,BP
GO:1904591,positive regulation of protein import,51,6,3.68,0.16023,1,0.37050781355117735,1.63,BP
GO:0008610,lipid biosynthetic process,548,46,39.59,0.16110,1,0.37234063400576367,1.16,BP
GO:0070374,positive regulation of ERK1 and ERK2 cas...,218,20,15.75,0.16119,1,0.37236979356697075,1.27,BP
GO:0072359,circulatory system development,1150,92,83.07,0.16164,1,0.3732301727447217,1.11,BP
GO:0010466,negative regulation of peptidase activit...,243,22,17.55,0.16199,1,0.37385893525179853,1.25,BP
GO:0045834,positive regulation of lipid metabolic p...,157,15,11.34,0.16309,1,0.37621720038350914,1.32,BP
GO:0008645,hexose transmembrane transport,109,11,7.87,0.16346,1,0.37689004312410157,1.4,BP
GO:0060191,regulation of lipase activity,74,8,5.35,0.16403,1,0.37802316091954025,1.5,BP
GO:0016125,sterol metabolic process,133,13,9.61,0.16420,1,0.3782337960746769,1.35,BP
GO:0048871,multicellular organismal homeostasis,485,41,35.04,0.16555,1,0.38116105263157896,1.17,BP
GO:0003013,circulatory system process,498,42,35.97,0.16599,1,0.38199133428981347,1.17,BP
GO:0014910,regulation of smooth muscle cell migrati...,86,9,6.21,0.16750,1,0.38438796005706133,1.45,BP
GO:0042632,cholesterol homeostasis,86,9,6.21,0.16750,1,0.38438796005706133,1.45,BP
GO:0000132,establishment of mitotic spindle orienta...,30,4,2.17,0.16781,1,0.38438796005706133,1.84,BP
GO:0010922,positive regulation of phosphatase activ...,30,4,2.17,0.16781,1,0.38438796005706133,1.84,BP
GO:0034260,negative regulation of GTPase activity,30,4,2.17,0.16781,1,0.38438796005706133,1.84,BP
GO:0061082,myeloid leukocyte cytokine production,30,4,2.17,0.16781,1,0.38438796005706133,1.84,BP
GO:1900543,negative regulation of purine nucleotide...,30,4,2.17,0.16781,1,0.38438796005706133,1.84,BP
GO:0032722,positive regulation of chemokine product...,63,7,4.55,0.16799,1,0.38438796005706133,1.54,BP
GO:0043331,response to dsRNA,63,7,4.55,0.16799,1,0.38438796005706133,1.54,BP
GO:0043949,regulation of cAMP-mediated signaling,63,7,4.55,0.16799,1,0.38438796005706133,1.54,BP
GO:1903307,positive regulation of regulated secreto...,63,7,4.55,0.16799,1,0.38438796005706133,1.54,BP
GO:1905818,regulation of chromosome separation,63,7,4.55,0.16799,1,0.38438796005706133,1.54,BP
GO:0001894,tissue homeostasis,232,21,16.76,0.16887,1,0.3859699813432836,1.25,BP
GO:0006334,nucleosome assembly,98,10,7.08,0.16955,1,0.3859699813432836,1.41,BP
GO:2001237,negative regulation of extrinsic apoptot...,98,10,7.08,0.16955,1,0.3859699813432836,1.41,BP
GO:0035924,cellular response to vascular endothelia...,52,6,3.76,0.17083,1,0.3859699813432836,1.6,BP
GO:2001222,regulation of neuron migration,52,6,3.76,0.17083,1,0.3859699813432836,1.6,BP
GO:0046777,protein autophosphorylation,245,22,17.7,0.17135,1,0.3859699813432836,1.24,BP
GO:0009409,response to cold,41,5,2.96,0.17152,1,0.3859699813432836,1.69,BP
GO:0030501,positive regulation of bone mineralizati...,41,5,2.96,0.17152,1,0.3859699813432836,1.69,BP
GO:0034105,positive regulation of tissue remodeling,41,5,2.96,0.17152,1,0.3859699813432836,1.69,BP
GO:0046164,alcohol catabolic process,41,5,2.96,0.17152,1,0.3859699813432836,1.69,BP
GO:0046782,regulation of viral transcription,41,5,2.96,0.17152,1,0.3859699813432836,1.69,BP
GO:0050856,regulation of T cell receptor signaling ...,41,5,2.96,0.17152,1,0.3859699813432836,1.69,BP
GO:0097300,programmed necrotic cell death,41,5,2.96,0.17152,1,0.3859699813432836,1.69,BP
GO:0098801,regulation of renal system process,41,5,2.96,0.17152,1,0.3859699813432836,1.69,BP
GO:1905953,negative regulation of lipid localizatio...,41,5,2.96,0.17152,1,0.3859699813432836,1.69,BP
GO:2000816,negative regulation of mitotic sister ch...,41,5,2.96,0.17152,1,0.3859699813432836,1.69,BP
GO:0010039,response to iron ion,20,3,1.44,0.17197,1,0.3859699813432836,2.08,BP
GO:0010869,regulation of receptor biosynthetic proc...,20,3,1.44,0.17197,1,0.3859699813432836,2.08,BP
GO:0032148,activation of protein kinase B activity,20,3,1.44,0.17197,1,0.3859699813432836,2.08,BP
GO:0033033,negative regulation of myeloid cell apop...,20,3,1.44,0.17197,1,0.3859699813432836,2.08,BP
GO:0034368,protein-lipid complex remodeling,20,3,1.44,0.17197,1,0.3859699813432836,2.08,BP
GO:0034369,plasma lipoprotein particle remodeling,20,3,1.44,0.17197,1,0.3859699813432836,2.08,BP
GO:0035584,calcium-mediated signaling using intrace...,20,3,1.44,0.17197,1,0.3859699813432836,2.08,BP
GO:0035855,megakaryocyte development,20,3,1.44,0.17197,1,0.3859699813432836,2.08,BP
GO:0036344,platelet morphogenesis,20,3,1.44,0.17197,1,0.3859699813432836,2.08,BP
GO:0042451,purine nucleoside biosynthetic process,20,3,1.44,0.17197,1,0.3859699813432836,2.08,BP
GO:0045838,positive regulation of membrane potentia...,20,3,1.44,0.17197,1,0.3859699813432836,2.08,BP
GO:0046129,purine ribonucleoside biosynthetic proce...,20,3,1.44,0.17197,1,0.3859699813432836,2.08,BP
GO:0048172,regulation of short-term neuronal synapt...,20,3,1.44,0.17197,1,0.3859699813432836,2.08,BP
GO:0048261,negative regulation of receptor-mediated...,20,3,1.44,0.17197,1,0.3859699813432836,2.08,BP
GO:0051349,positive regulation of lyase activity,20,3,1.44,0.17197,1,0.3859699813432836,2.08,BP
GO:0051905,establishment of pigment granule localiz...,20,3,1.44,0.17197,1,0.3859699813432836,2.08,BP
GO:0060123,regulation of growth hormone secretion,20,3,1.44,0.17197,1,0.3859699813432836,2.08,BP
GO:0071605,monocyte chemotactic protein-1 productio...,20,3,1.44,0.17197,1,0.3859699813432836,2.08,BP
GO:0071637,regulation of monocyte chemotactic prote...,20,3,1.44,0.17197,1,0.3859699813432836,2.08,BP
GO:0072520,seminiferous tubule development,20,3,1.44,0.17197,1,0.3859699813432836,2.08,BP
GO:0097320,plasma membrane tubulation,20,3,1.44,0.17197,1,0.3859699813432836,2.08,BP
GO:1900451,positive regulation of glutamate recepto...,20,3,1.44,0.17197,1,0.3859699813432836,2.08,BP
GO:1902993,positive regulation of amyloid precursor...,20,3,1.44,0.17197,1,0.3859699813432836,2.08,BP
GO:1903975,regulation of glial cell migration,20,3,1.44,0.17197,1,0.3859699813432836,2.08,BP
GO:1904385,cellular response to angiotensin,20,3,1.44,0.17197,1,0.3859699813432836,2.08,BP
GO:0061097,regulation of protein tyrosine kinase ac...,75,8,5.42,0.17281,1,0.3876744615384615,1.48,BP
GO:0034329,cell junction assembly,208,19,15.03,0.17323,1,0.38843558247903076,1.26,BP
GO:0031349,positive regulation of defense response,372,32,26.87,0.17376,1,0.3894425337680485,1.19,BP
GO:0045786,negative regulation of cell cycle,462,39,33.37,0.17479,1,0.3915686592178771,1.17,BP
GO:0007569,cell aging,159,15,11.49,0.17492,1,0.39167754304327596,1.31,BP
GO:0055092,sterol homeostasis,87,9,6.28,0.17570,1,0.3932411162790697,1.43,BP
GO:0050905,neuromuscular process,135,13,9.75,0.17717,1,0.3959735376044568,1.33,BP
GO:0040011,locomotion,1837,143,132.7,0.17724,1,0.3959735376044568,1.08,BP
GO:0034440,lipid oxidation,99,10,7.15,0.17725,1,0.3959735376044568,1.4,BP
GO:0043473,pigmentation,99,10,7.15,0.17725,1,0.3959735376044568,1.4,BP
GO:0032233,positive regulation of actin filament bu...,64,7,4.62,0.17771,1,0.39639379342288095,1.52,BP
GO:0045840,positive regulation of mitotic nuclear d...,64,7,4.62,0.17771,1,0.39639379342288095,1.52,BP
GO:0003158,endothelium development,123,12,8.89,0.17777,1,0.39639379342288095,1.35,BP
GO:0006639,acylglycerol metabolic process,123,12,8.89,0.17777,1,0.39639379342288095,1.35,BP
GO:0015749,monosaccharide transmembrane transport,111,11,8.02,0.17785,1,0.39639379342288095,1.37,BP
GO:0015893,drug transport,209,19,15.1,0.17847,1,0.3975915,1.26,BP
GO:0002790,peptide secretion,671,55,48.47,0.17949,1,0.3996787968533087,1.13,BP
GO:1905114,cell surface receptor signaling pathway ...,528,44,38.14,0.17967,1,0.3998945605920444,1.15,BP
GO:0007249,I-kappaB kinase/NF-kappaB signaling,197,18,14.23,0.18077,1,0.4015576578225069,1.26,BP
GO:0007266,Rho protein signal transduction,197,18,14.23,0.18077,1,0.4015576578225069,1.26,BP
GO:1903169,regulation of calcium ion transmembrane ...,160,15,11.56,0.18099,1,0.4015576578225069,1.3,BP
GO:0032608,interferon-beta production,53,6,3.83,0.18172,1,0.4015576578225069,1.57,BP
GO:0045214,sarcomere organization,53,6,3.83,0.18172,1,0.4015576578225069,1.57,BP
GO:0046148,pigment biosynthetic process,53,6,3.83,0.18172,1,0.4015576578225069,1.57,BP
GO:0032418,lysosome localization,76,8,5.49,0.18180,1,0.4015576578225069,1.46,BP
GO:0032543,mitochondrial translation,76,8,5.49,0.18180,1,0.4015576578225069,1.46,BP
GO:0097327,response to antineoplastic agent,76,8,5.49,0.18180,1,0.4015576578225069,1.46,BP
GO:0048870,cell motility,1612,126,116.45,0.18182,1,0.4015576578225069,1.08,BP
GO:0051674,localization of cell,1612,126,116.45,0.18182,1,0.4015576578225069,1.08,BP
GO:0002026,regulation of the force of heart contrac...,31,4,2.24,0.18242,1,0.4015576578225069,1.79,BP
GO:0010758,regulation of macrophage chemotaxis,31,4,2.24,0.18242,1,0.4015576578225069,1.79,BP
GO:0032232,negative regulation of actin filament bu...,31,4,2.24,0.18242,1,0.4015576578225069,1.79,BP
GO:0045662,negative regulation of myoblast differen...,31,4,2.24,0.18242,1,0.4015576578225069,1.79,BP
GO:0045920,negative regulation of exocytosis,31,4,2.24,0.18242,1,0.4015576578225069,1.79,BP
GO:0045980,negative regulation of nucleotide metabo...,31,4,2.24,0.18242,1,0.4015576578225069,1.79,BP
GO:0050999,regulation of nitric-oxide synthase acti...,31,4,2.24,0.18242,1,0.4015576578225069,1.79,BP
GO:0055075,potassium ion homeostasis,31,4,2.24,0.18242,1,0.4015576578225069,1.79,BP
GO:0090075,relaxation of muscle,31,4,2.24,0.18242,1,0.4015576578225069,1.79,BP
GO:0099560,synaptic membrane adhesion,31,4,2.24,0.18242,1,0.4015576578225069,1.79,BP
GO:1901020,negative regulation of calcium ion trans...,31,4,2.24,0.18242,1,0.4015576578225069,1.79,BP
GO:1901659,glycosyl compound biosynthetic process,31,4,2.24,0.18242,1,0.4015576578225069,1.79,BP
GO:2000778,positive regulation of interleukin-6 sec...,31,4,2.24,0.18242,1,0.4015576578225069,1.79,BP
GO:0006475,internal protein amino acid acetylation,148,14,10.69,0.18254,1,0.4016380795610425,1.31,BP
GO:0051056,regulation of small GTPase mediated sign...,260,23,18.78,0.18303,1,0.40253215722120655,1.22,BP
GO:0009066,aspartate family amino acid metabolic pr...,42,5,3.03,0.18395,1,0.4038172445255474,1.65,BP
GO:0042417,dopamine metabolic process,42,5,3.03,0.18395,1,0.4038172445255474,1.65,BP
GO:0045197,establishment or maintenance of epitheli...,42,5,3.03,0.18395,1,0.4038172445255474,1.65,BP
GO:1900015,regulation of cytokine production involv...,42,5,3.03,0.18395,1,0.4038172445255474,1.65,BP
GO:0019217,regulation of fatty acid metabolic proce...,88,9,6.36,0.18408,1,0.4039183584131327,1.42,BP
GO:0070372,regulation of ERK1 and ERK2 cascade,311,27,22.47,0.18477,1,0.40490043715846996,1.2,BP
GO:0008203,cholesterol metabolic process,124,12,8.96,0.18478,1,0.40490043715846996,1.34,BP
GO:0042752,regulation of circadian rhythm,124,12,8.96,0.18478,1,0.40490043715846996,1.34,BP
GO:0034219,carbohydrate transmembrane transport,112,11,8.09,0.18526,1,0.40558285714285713,1.36,BP
GO:1901657,glycosyl compound metabolic process,112,11,8.09,0.18526,1,0.40558285714285713,1.36,BP
GO:0006631,fatty acid metabolic process,375,32,27.09,0.18559,1,0.40612054570259215,1.18,BP
GO:0015914,phospholipid transport,65,7,4.7,0.18766,1,0.409532843537415,1.49,BP
GO:0044774,mitotic DNA integrity checkpoint,65,7,4.7,0.18766,1,0.409532843537415,1.49,BP
GO:0051926,negative regulation of calcium ion trans...,65,7,4.7,0.18766,1,0.409532843537415,1.49,BP
GO:1901264,carbohydrate derivative transport,65,7,4.7,0.18766,1,0.409532843537415,1.49,BP
GO:2000134,negative regulation of G1/S transition o...,65,7,4.7,0.18766,1,0.409532843537415,1.49,BP
GO:2001169,regulation of ATP biosynthetic process,65,7,4.7,0.18766,1,0.409532843537415,1.49,BP
GO:0006816,calcium ion transport,427,36,30.85,0.18797,1,0.4100234088848595,1.17,BP
GO:0032103,positive regulation of response to exter...,312,27,22.54,0.18920,1,0.4118829995509654,1.2,BP
GO:0000466,maturation of 5.8S rRNA from tricistroni...,21,3,1.52,0.19055,1,0.4118829995509654,1.97,BP
GO:0000469,cleavage involved in rRNA processing,21,3,1.52,0.19055,1,0.4118829995509654,1.97,BP
GO:0001976,neurological system process involved in ...,21,3,1.52,0.19055,1,0.4118829995509654,1.97,BP
GO:0006907,pinocytosis,21,3,1.52,0.19055,1,0.4118829995509654,1.97,BP
GO:0007625,grooming behavior,21,3,1.52,0.19055,1,0.4118829995509654,1.97,BP
GO:0008356,asymmetric cell division,21,3,1.52,0.19055,1,0.4118829995509654,1.97,BP
GO:0034367,protein-containing complex remodeling,21,3,1.52,0.19055,1,0.4118829995509654,1.97,BP
GO:0045475,locomotor rhythm,21,3,1.52,0.19055,1,0.4118829995509654,1.97,BP
GO:0046174,polyol catabolic process,21,3,1.52,0.19055,1,0.4118829995509654,1.97,BP
GO:0046325,negative regulation of glucose import,21,3,1.52,0.19055,1,0.4118829995509654,1.97,BP
GO:0046716,muscle cell cellular homeostasis,21,3,1.52,0.19055,1,0.4118829995509654,1.97,BP
GO:0048143,astrocyte activation,21,3,1.52,0.19055,1,0.4118829995509654,1.97,BP
GO:0051023,regulation of immunoglobulin secretion,21,3,1.52,0.19055,1,0.4118829995509654,1.97,BP
GO:0051900,regulation of mitochondrial depolarizati...,21,3,1.52,0.19055,1,0.4118829995509654,1.97,BP
GO:1900101,regulation of endoplasmic reticulum unfo...,21,3,1.52,0.19055,1,0.4118829995509654,1.97,BP
GO:1900151,regulation of nuclear-transcribed mRNA c...,21,3,1.52,0.19055,1,0.4118829995509654,1.97,BP
GO:1901623,regulation of lymphocyte chemotaxis,21,3,1.52,0.19055,1,0.4118829995509654,1.97,BP
GO:1905153,regulation of membrane invagination,21,3,1.52,0.19055,1,0.4118829995509654,1.97,BP
GO:1990776,response to angiotensin,21,3,1.52,0.19055,1,0.4118829995509654,1.97,BP
GO:0031023,microtubule organizing center organizati...,137,13,9.9,0.19062,1,0.4118829995509654,1.31,BP
GO:0015918,sterol transport,77,8,5.56,0.19099,1,0.41231219380888295,1.44,BP
GO:0030301,cholesterol transport,77,8,5.56,0.19099,1,0.41231219380888295,1.44,BP
GO:0044242,cellular lipid catabolic process,199,18,14.38,0.19193,1,0.41415567713004486,1.25,BP
GO:0051149,positive regulation of muscle cell diffe...,89,9,6.43,0.19263,1,0.4149032454179705,1.4,BP
GO:0051492,regulation of stress fiber assembly,89,9,6.43,0.19263,1,0.4149032454179705,1.4,BP
GO:0060078,regulation of postsynaptic membrane pote...,113,11,8.16,0.19281,1,0.4149032454179705,1.35,BP
GO:0045839,negative regulation of mitotic nuclear d...,54,6,3.9,0.19288,1,0.4149032454179705,1.54,BP
GO:0051568,histone H3-K4 methylation,54,6,3.9,0.19288,1,0.4149032454179705,1.54,BP
GO:0061900,glial cell activation,54,6,3.9,0.19288,1,0.4149032454179705,1.54,BP
GO:0098815,modulation of excitatory postsynaptic po...,54,6,3.9,0.19288,1,0.4149032454179705,1.54,BP
GO:0007584,response to nutrient,101,10,7.3,0.19312,1,0.4152338873994639,1.37,BP
GO:0001764,neuron migration,187,17,13.51,0.19462,1,0.4182721929432782,1.26,BP
GO:0010907,positive regulation of glucose metabolic...,43,5,3.11,0.19670,1,0.42198858671422207,1.61,BP
GO:0048246,macrophage chemotaxis,43,5,3.11,0.19670,1,0.42198858671422207,1.61,BP
GO:1901985,positive regulation of protein acetylati...,43,5,3.11,0.19670,1,0.42198858671422207,1.61,BP
GO:1905819,negative regulation of chromosome separa...,43,5,3.11,0.19670,1,0.42198858671422207,1.61,BP
GO:0021680,cerebellar Purkinje cell layer developme...,32,4,2.31,0.19742,1,0.42266006224988883,1.73,BP
GO:0032728,positive regulation of interferon-beta p...,32,4,2.31,0.19742,1,0.42266006224988883,1.73,BP
GO:1900181,negative regulation of protein localizat...,32,4,2.31,0.19742,1,0.42266006224988883,1.73,BP
GO:1903859,regulation of dendrite extension,32,4,2.31,0.19742,1,0.42266006224988883,1.73,BP
GO:0030010,establishment of cell polarity,138,13,9.97,0.19752,1,0.42266006224988883,1.3,BP
GO:0030001,metal ion transport,848,68,61.26,0.19754,1,0.42266006224988883,1.11,BP
GO:0050679,positive regulation of epithelial cell p...,200,18,14.45,0.19763,1,0.4226646933333333,1.25,BP
GO:0034394,protein localization to cell surface,66,7,4.77,0.19783,1,0.4229044691248334,1.47,BP
GO:0044282,small molecule catabolic process,314,27,22.68,0.19822,1,0.42355001776198936,1.19,BP
GO:0050851,antigen receptor-mediated signaling path...,163,15,11.77,0.19981,1,0.42675797603195736,1.27,BP
GO:0051966,"regulation of synaptic transmission, glu...",78,8,5.63,0.20036,1,0.4275531352549889,1.42,BP
GO:0061515,myeloid cell development,78,8,5.63,0.20036,1,0.4275531352549889,1.42,BP
GO:0006109,regulation of carbohydrate metabolic pro...,188,17,13.58,0.20055,1,0.4277688829787234,1.25,BP
GO:0000077,DNA damage checkpoint,102,10,7.37,0.20129,1,0.42833607427055703,1.36,BP
GO:0003300,cardiac muscle hypertrophy,102,10,7.37,0.20129,1,0.42833607427055703,1.36,BP
GO:0021549,cerebellum development,102,10,7.37,0.20129,1,0.42833607427055703,1.36,BP
GO:0009116,nucleoside metabolic process,90,9,6.5,0.20135,1,0.42833607427055703,1.38,BP
GO:0032642,regulation of chemokine production,90,9,6.5,0.20135,1,0.42833607427055703,1.38,BP
GO:0045814,"negative regulation of gene expression, ...",90,9,6.5,0.20135,1,0.42833607427055703,1.38,BP
GO:0021575,hindbrain morphogenesis,55,6,3.97,0.20429,1,0.4340147814569536,1.51,BP
GO:0021795,cerebral cortex cell migration,55,6,3.97,0.20429,1,0.4340147814569536,1.51,BP
GO:0046580,negative regulation of Ras protein signa...,55,6,3.97,0.20429,1,0.4340147814569536,1.51,BP
GO:0010810,regulation of cell-substrate adhesion,214,19,15.46,0.20589,1,0.4372209532215357,1.23,BP
GO:0050730,regulation of peptidyl-tyrosine phosphor...,265,23,19.14,0.20781,1,0.440728768558952,1.2,BP
GO:0046824,positive regulation of nucleocytoplasmic...,67,7,4.84,0.20821,1,0.440728768558952,1.45,BP
GO:2000179,positive regulation of neural precursor ...,67,7,4.84,0.20821,1,0.440728768558952,1.45,BP
GO:0003084,positive regulation of systemic arterial...,22,3,1.59,0.20960,1,0.440728768558952,1.89,BP
GO:0009067,aspartate family amino acid biosynthetic...,22,3,1.59,0.20960,1,0.440728768558952,1.89,BP
GO:0009110,vitamin biosynthetic process,22,3,1.59,0.20960,1,0.440728768558952,1.89,BP
GO:0015813,L-glutamate transmembrane transport,22,3,1.59,0.20960,1,0.440728768558952,1.89,BP
GO:0019400,alditol metabolic process,22,3,1.59,0.20960,1,0.440728768558952,1.89,BP
GO:0031579,membrane raft organization,22,3,1.59,0.20960,1,0.440728768558952,1.89,BP
GO:0031643,positive regulation of myelination,22,3,1.59,0.20960,1,0.440728768558952,1.89,BP
GO:0032400,melanosome localization,22,3,1.59,0.20960,1,0.440728768558952,1.89,BP
GO:0042178,xenobiotic catabolic process,22,3,1.59,0.20960,1,0.440728768558952,1.89,BP
GO:0050857,positive regulation of antigen receptor-...,22,3,1.59,0.20960,1,0.440728768558952,1.89,BP
GO:0070734,histone H3-K27 methylation,22,3,1.59,0.20960,1,0.440728768558952,1.89,BP
GO:0070841,inclusion body assembly,22,3,1.59,0.20960,1,0.440728768558952,1.89,BP
GO:0071459,"protein localization to chromosome, cent...",22,3,1.59,0.20960,1,0.440728768558952,1.89,BP
GO:1901889,negative regulation of cell junction ass...,22,3,1.59,0.20960,1,0.440728768558952,1.89,BP
GO:0006479,protein methylation,177,16,12.79,0.20972,1,0.440728768558952,1.25,BP
GO:0008213,protein alkylation,177,16,12.79,0.20972,1,0.440728768558952,1.25,BP
GO:0019083,viral transcription,44,5,3.18,0.20974,1,0.440728768558952,1.57,BP
GO:0034340,response to type I interferon,44,5,3.18,0.20974,1,0.440728768558952,1.57,BP
GO:0042181,ketone biosynthetic process,44,5,3.18,0.20974,1,0.440728768558952,1.57,BP
GO:0098781,ncRNA transcription,44,5,3.18,0.20974,1,0.440728768558952,1.57,BP
GO:1900077,negative regulation of cellular response...,44,5,3.18,0.20974,1,0.440728768558952,1.57,BP
GO:0000041,transition metal ion transport,91,9,6.57,0.21023,1,0.4413729319371728,1.37,BP
GO:0021954,central nervous system neuron developmen...,91,9,6.57,0.21023,1,0.4413729319371728,1.37,BP
GO:0045944,positive regulation of transcription by ...,1238,97,89.43,0.21038,1,0.4414952289576974,1.08,BP
GO:0006623,protein targeting to vacuole,33,4,2.38,0.21278,1,0.44517276521739135,1.68,BP
GO:0007026,negative regulation of microtubule depol...,33,4,2.38,0.21278,1,0.44517276521739135,1.68,BP
GO:0021591,ventricular system development,33,4,2.38,0.21278,1,0.44517276521739135,1.68,BP
GO:0030947,regulation of vascular endothelial growt...,33,4,2.38,0.21278,1,0.44517276521739135,1.68,BP
GO:0040001,establishment of mitotic spindle localiz...,33,4,2.38,0.21278,1,0.44517276521739135,1.68,BP
GO:0046596,regulation of viral entry into host cell,33,4,2.38,0.21278,1,0.44517276521739135,1.68,BP
GO:0061157,mRNA destabilization,33,4,2.38,0.21278,1,0.44517276521739135,1.68,BP
GO:0010811,positive regulation of cell-substrate ad...,128,12,9.25,0.21410,1,0.44773976531942633,1.3,BP
GO:0048167,regulation of synaptic plasticity,369,31,26.66,0.21443,1,0.4482350825369244,1.16,BP
GO:0031641,regulation of myelination,56,6,4.05,0.21593,1,0.4511746244029527,1.48,BP
GO:0002367,cytokine production involved in immune r...,104,10,7.51,0.21804,1,0.45518806073752716,1.33,BP
GO:2001022,positive regulation of response to DNA d...,104,10,7.51,0.21804,1,0.45518806073752716,1.33,BP
GO:0002711,positive regulation of T cell mediated i...,68,7,4.91,0.21878,1,0.4561392374350087,1.43,BP
GO:0045428,regulation of nitric oxide biosynthetic ...,68,7,4.91,0.21878,1,0.4561392374350087,1.43,BP
GO:0050771,negative regulation of axonogenesis,68,7,4.91,0.21878,1,0.4561392374350087,1.43,BP
GO:0008015,blood circulation,487,40,35.18,0.21909,1,0.45637124352331604,1.14,BP
GO:0042770,signal transduction in response to DNA d...,92,9,6.65,0.21926,1,0.45637124352331604,1.35,BP
GO:0043535,regulation of blood vessel endothelial c...,92,9,6.65,0.21926,1,0.45637124352331604,1.35,BP
GO:0032410,negative regulation of transporter activ...,80,8,5.78,0.21965,1,0.45637124352331604,1.38,BP
GO:0046209,nitric oxide metabolic process,80,8,5.78,0.21965,1,0.45637124352331604,1.38,BP
GO:0050688,regulation of defense response to virus,80,8,5.78,0.21965,1,0.45637124352331604,1.38,BP
GO:0051781,positive regulation of cell division,80,8,5.78,0.21965,1,0.45637124352331604,1.38,BP
GO:2001259,positive regulation of cation channel ac...,80,8,5.78,0.21965,1,0.45637124352331604,1.38,BP
GO:0010951,negative regulation of endopeptidase act...,179,16,12.93,0.22254,1,0.46184018932874354,1.24,BP
GO:0002534,cytokine production involved in inflamma...,45,5,3.25,0.22305,1,0.46184018932874354,1.54,BP
GO:0005978,glycogen biosynthetic process,45,5,3.25,0.22305,1,0.46184018932874354,1.54,BP
GO:0007628,adult walking behavior,45,5,3.25,0.22305,1,0.46184018932874354,1.54,BP
GO:0009250,glucan biosynthetic process,45,5,3.25,0.22305,1,0.46184018932874354,1.54,BP
GO:0032881,regulation of polysaccharide metabolic p...,45,5,3.25,0.22305,1,0.46184018932874354,1.54,BP
GO:0043044,ATP-dependent chromatin remodeling,45,5,3.25,0.22305,1,0.46184018932874354,1.54,BP
GO:0051646,mitochondrion localization,45,5,3.25,0.22305,1,0.46184018932874354,1.54,BP
GO:0043405,regulation of MAP kinase activity,294,25,21.24,0.22525,1,0.4661948387096775,1.18,BP
GO:0055088,lipid homeostasis,142,13,10.26,0.22622,1,0.4680011349957008,1.27,BP
GO:0006260,DNA replication,243,21,17.55,0.22643,1,0.4682342758917061,1.2,BP
GO:0010965,regulation of mitotic sister chromatid s...,57,6,4.12,0.22779,1,0.46983518216888126,1.46,BP
GO:0045071,negative regulation of viral genome repl...,57,6,4.12,0.22779,1,0.46983518216888126,1.46,BP
GO:0046622,positive regulation of organ growth,57,6,4.12,0.22779,1,0.46983518216888126,1.46,BP
GO:0046676,negative regulation of insulin secretion,57,6,4.12,0.22779,1,0.46983518216888126,1.46,BP
GO:0050854,regulation of antigen receptor-mediated ...,57,6,4.12,0.22779,1,0.46983518216888126,1.46,BP
GO:0072347,response to anesthetic,57,6,4.12,0.22779,1,0.46983518216888126,1.46,BP
GO:0046889,positive regulation of lipid biosyntheti...,93,9,6.72,0.22844,1,0.46984032326669506,1.34,BP
GO:0000002,mitochondrial genome maintenance,34,4,2.46,0.22845,1,0.46984032326669506,1.63,BP
GO:0010573,vascular endothelial growth factor produ...,34,4,2.46,0.22845,1,0.46984032326669506,1.63,BP
GO:0071539,protein localization to centrosome,34,4,2.46,0.22845,1,0.46984032326669506,1.63,BP
GO:0097366,response to bronchodilator,34,4,2.46,0.22845,1,0.46984032326669506,1.63,BP
GO:0006346,methylation-dependent chromatin silencin...,23,3,1.66,0.22904,1,0.46984032326669506,1.81,BP
GO:0022403,cell cycle phase,23,3,1.66,0.22904,1,0.46984032326669506,1.81,BP
GO:0032968,positive regulation of transcription elo...,23,3,1.66,0.22904,1,0.46984032326669506,1.81,BP
GO:0034311,diol metabolic process,23,3,1.66,0.22904,1,0.46984032326669506,1.81,BP
GO:0045943,positive regulation of transcription by ...,23,3,1.66,0.22904,1,0.46984032326669506,1.81,BP
GO:0051875,pigment granule localization,23,3,1.66,0.22904,1,0.46984032326669506,1.81,BP
GO:1903077,negative regulation of protein localizat...,23,3,1.66,0.22904,1,0.46984032326669506,1.81,BP
GO:1901343,negative regulation of vasculature devel...,130,12,9.39,0.22945,1,0.46984032326669506,1.28,BP
GO:0005977,glycogen metabolic process,81,8,5.85,0.22955,1,0.46984032326669506,1.37,BP
GO:0006073,cellular glucan metabolic process,81,8,5.85,0.22955,1,0.46984032326669506,1.37,BP
GO:0043279,response to alkaloid,81,8,5.85,0.22955,1,0.46984032326669506,1.37,BP
GO:0044042,glucan metabolic process,81,8,5.85,0.22955,1,0.46984032326669506,1.37,BP
GO:0048146,positive regulation of fibroblast prolif...,69,7,4.98,0.22955,1,0.46984032326669506,1.41,BP
GO:0002757,immune response-activating signal transd...,321,27,23.19,0.23142,1,0.4734664285714286,1.16,BP
GO:0070588,calcium ion transmembrane transport,283,24,20.44,0.23487,1,0.4803206289842754,1.17,BP
GO:0014897,striated muscle hypertrophy,106,10,7.66,0.23533,1,0.4806485398981324,1.31,BP
GO:0034766,negative regulation of ion transmembrane...,106,10,7.66,0.23533,1,0.4806485398981324,1.31,BP
GO:0035249,"synaptic transmission, glutamatergic",106,10,7.66,0.23533,1,0.4806485398981324,1.31,BP
GO:0001774,microglial cell activation,46,5,3.32,0.23661,1,0.4820352751905164,1.51,BP
GO:0002269,leukocyte activation involved in inflamm...,46,5,3.32,0.23661,1,0.4820352751905164,1.51,BP
GO:0018198,peptidyl-cysteine modification,46,5,3.32,0.23661,1,0.4820352751905164,1.51,BP
GO:0033013,tetrapyrrole metabolic process,46,5,3.32,0.23661,1,0.4820352751905164,1.51,BP
GO:1902653,secondary alcohol biosynthetic process,46,5,3.32,0.23661,1,0.4820352751905164,1.51,BP
GO:2000404,regulation of T cell migration,46,5,3.32,0.23661,1,0.4820352751905164,1.51,BP
GO:0032602,chemokine production,94,9,6.79,0.23776,1,0.48417187817258883,1.33,BP
GO:0002429,immune response-activating cell surface ...,194,17,14.01,0.23786,1,0.48417187817258883,1.21,BP
GO:0002718,regulation of cytokine production involv...,82,8,5.92,0.23960,1,0.48666172151898734,1.35,BP
GO:0022406,membrane docking,82,8,5.92,0.23960,1,0.48666172151898734,1.35,BP
GO:0046364,monosaccharide biosynthetic process,82,8,5.92,0.23960,1,0.48666172151898734,1.35,BP
GO:1903901,negative regulation of viral life cycle,82,8,5.92,0.23960,1,0.48666172151898734,1.35,BP
GO:1904029,regulation of cyclin-dependent protein k...,82,8,5.92,0.23960,1,0.48666172151898734,1.35,BP
GO:0055001,muscle cell development,207,18,14.95,0.23969,1,0.48666172151898734,1.2,BP
GO:0002437,inflammatory response to antigenic stimu...,58,6,4.19,0.23986,1,0.48680148460565154,1.43,BP
GO:0048641,regulation of skeletal muscle tissue dev...,70,7,5.06,0.24049,1,0.4876687231352718,1.38,BP
GO:1902807,negative regulation of cell cycle G1/S p...,70,7,5.06,0.24049,1,0.4876687231352718,1.38,BP
GO:0098739,import across plasma membrane,119,11,8.6,0.24082,1,0.48813219882055603,1.28,BP
GO:0048545,response to steroid hormone,220,19,15.89,0.24121,1,0.4886731818181818,1.2,BP
GO:0030099,myeloid cell differentiation,401,33,28.97,0.24129,1,0.4886731818181818,1.14,BP
GO:0048514,blood vessel morphogenesis,625,50,45.15,0.24391,1,0.4928972338642079,1.11,BP
GO:0010737,protein kinase A signaling,35,4,2.53,0.24440,1,0.4928972338642079,1.58,BP
GO:0032228,"regulation of synaptic transmission, GAB...",35,4,2.53,0.24440,1,0.4928972338642079,1.58,BP
GO:0046320,regulation of fatty acid oxidation,35,4,2.53,0.24440,1,0.4928972338642079,1.58,BP
GO:0046461,neutral lipid catabolic process,35,4,2.53,0.24440,1,0.4928972338642079,1.58,BP
GO:0046464,acylglycerol catabolic process,35,4,2.53,0.24440,1,0.4928972338642079,1.58,BP
GO:0050779,RNA destabilization,35,4,2.53,0.24440,1,0.4928972338642079,1.58,BP
GO:0051567,histone H3-K9 methylation,35,4,2.53,0.24440,1,0.4928972338642079,1.58,BP
GO:0060292,long-term synaptic depression,35,4,2.53,0.24440,1,0.4928972338642079,1.58,BP
GO:1905508,protein localization to microtubule orga...,35,4,2.53,0.24440,1,0.4928972338642079,1.58,BP
GO:0060968,regulation of gene silencing,95,9,6.86,0.24722,1,0.49816693467336687,1.31,BP
GO:1902749,regulation of cell cycle G2/M phase tran...,95,9,6.86,0.24722,1,0.49816693467336687,1.31,BP
GO:0018393,internal peptidyl-lysine acetylation,145,13,10.47,0.24879,1,0.5000942355889725,1.24,BP
GO:0002418,immune response to tumor cell,24,3,1.73,0.24880,1,0.5000942355889725,1.73,BP
GO:0007205,protein kinase C-activating G protein-co...,24,3,1.73,0.24880,1,0.5000942355889725,1.73,BP
GO:0010738,regulation of protein kinase A signaling,24,3,1.73,0.24880,1,0.5000942355889725,1.73,BP
GO:0051602,response to electrical stimulus,24,3,1.73,0.24880,1,0.5000942355889725,1.73,BP
GO:1900120,regulation of receptor binding,24,3,1.73,0.24880,1,0.5000942355889725,1.73,BP
GO:0006942,regulation of striated muscle contractio...,83,8,6,0.24979,1,0.5018745219206681,1.33,BP
GO:0006110,regulation of glycolytic process,47,5,3.4,0.25039,1,0.5022412171738224,1.47,BP
GO:0030517,negative regulation of axon extension,47,5,3.4,0.25039,1,0.5022412171738224,1.47,BP
GO:0030811,regulation of nucleotide catabolic proce...,47,5,3.4,0.25039,1,0.5022412171738224,1.47,BP
GO:0035196,production of miRNAs involved in gene si...,47,5,3.4,0.25039,1,0.5022412171738224,1.47,BP
GO:0051924,regulation of calcium ion transport,273,23,19.72,0.25055,1,0.50235275,1.17,BP
GO:0016051,carbohydrate biosynthetic process,196,17,14.16,0.25090,1,0.5028449812578093,1.2,BP
GO:0032413,negative regulation of ion transmembrane...,71,7,5.13,0.25159,1,0.503598618968386,1.36,BP
GO:0046173,polyol biosynthetic process,71,7,5.13,0.25159,1,0.503598618968386,1.36,BP
GO:2001021,negative regulation of response to DNA d...,71,7,5.13,0.25159,1,0.503598618968386,1.36,BP
GO:1901615,organic hydroxy compound metabolic proce...,482,39,34.82,0.25172,1,0.5036493305613305,1.12,BP
GO:0051148,negative regulation of muscle cell diffe...,59,6,4.26,0.25211,1,0.5040105193186539,1.41,BP
GO:1901616,organic hydroxy compound catabolic proce...,59,6,4.26,0.25211,1,0.5040105193186539,1.41,BP
GO:0044057,regulation of system process,601,48,43.41,0.25291,1,0.5053798008298755,1.11,BP
GO:0014896,muscle hypertrophy,108,10,7.8,0.25311,1,0.5053798008298755,1.28,BP
GO:0035725,sodium ion transmembrane transport,108,10,7.8,0.25311,1,0.5053798008298755,1.28,BP
GO:0044703,multi-organism reproductive process,1015,79,73.32,0.25691,1,0.5127544255495645,1.08,BP
GO:0018022,peptidyl-lysine methylation,121,11,8.74,0.25773,1,0.5141777611940298,1.26,BP
GO:0001568,blood vessel development,722,57,52.16,0.25880,1,0.5160984666390385,1.09,BP
GO:0006342,chromatin silencing,84,8,6.07,0.26012,1,0.5166704079110012,1.32,BP
GO:0045913,positive regulation of carbohydrate meta...,84,8,6.07,0.26012,1,0.5166704079110012,1.32,BP
GO:0006383,transcription by RNA polymerase III,36,4,2.6,0.26059,1,0.5166704079110012,1.54,BP
GO:0006972,hyperosmotic response,36,4,2.6,0.26059,1,0.5166704079110012,1.54,BP
GO:0007094,mitotic spindle assembly checkpoint,36,4,2.6,0.26059,1,0.5166704079110012,1.54,BP
GO:0030574,collagen catabolic process,36,4,2.6,0.26059,1,0.5166704079110012,1.54,BP
GO:0031114,regulation of microtubule depolymerizati...,36,4,2.6,0.26059,1,0.5166704079110012,1.54,BP
GO:0034381,plasma lipoprotein particle clearance,36,4,2.6,0.26059,1,0.5166704079110012,1.54,BP
GO:0042311,vasodilation,36,4,2.6,0.26059,1,0.5166704079110012,1.54,BP
GO:0048710,regulation of astrocyte differentiation,36,4,2.6,0.26059,1,0.5166704079110012,1.54,BP
GO:0061384,heart trabecula morphogenesis,36,4,2.6,0.26059,1,0.5166704079110012,1.54,BP
GO:0071173,spindle assembly checkpoint,36,4,2.6,0.26059,1,0.5166704079110012,1.54,BP
GO:1990089,response to nerve growth factor,36,4,2.6,0.26059,1,0.5166704079110012,1.54,BP
GO:1990090,cellular response to nerve growth factor...,36,4,2.6,0.26059,1,0.5166704079110012,1.54,BP
GO:0040029,"regulation of gene expression, epigeneti...",288,24,20.8,0.26192,1,0.5190935090609555,1.15,BP
GO:0048145,regulation of fibroblast proliferation,109,10,7.87,0.26217,1,0.519375067929189,1.27,BP
GO:0030239,myofibril assembly,72,7,5.2,0.26284,1,0.5204880987654321,1.35,BP
GO:0008217,regulation of blood pressure,198,17,14.3,0.26422,1,0.521474133551823,1.19,BP
GO:0035821,modification of morphology or physiology...,147,13,10.62,0.26429,1,0.521474133551823,1.22,BP
GO:1901991,negative regulation of mitotic cell cycl...,147,13,10.62,0.26429,1,0.521474133551823,1.22,BP
GO:0010107,potassium ion import,48,5,3.47,0.26436,1,0.521474133551823,1.44,BP
GO:0044848,biological phase,48,5,3.47,0.26436,1,0.521474133551823,1.44,BP
GO:0051438,regulation of ubiquitin-protein transfer...,48,5,3.47,0.26436,1,0.521474133551823,1.44,BP
GO:0008347,glial cell migration,60,6,4.33,0.26453,1,0.521474133551823,1.39,BP
GO:0033209,tumor necrosis factor-mediated signaling...,60,6,4.33,0.26453,1,0.521474133551823,1.39,BP
GO:0051306,mitotic sister chromatid separation,60,6,4.33,0.26453,1,0.521474133551823,1.39,BP
GO:1902017,regulation of cilium assembly,60,6,4.33,0.26453,1,0.521474133551823,1.39,BP
GO:2001238,positive regulation of extrinsic apoptot...,60,6,4.33,0.26453,1,0.521474133551823,1.39,BP
GO:0010906,regulation of glucose metabolic process,122,11,8.81,0.26634,1,0.5230350181965224,1.25,BP
GO:0019395,fatty acid oxidation,97,9,7.01,0.26649,1,0.5230350181965224,1.28,BP
GO:0048525,negative regulation of viral process,97,9,7.01,0.26649,1,0.5230350181965224,1.28,BP
GO:0120162,positive regulation of cold-induced ther...,97,9,7.01,0.26649,1,0.5230350181965224,1.28,BP
GO:0042552,myelination,160,14,11.56,0.26660,1,0.5230350181965224,1.21,BP
GO:0006813,potassium ion transport,237,20,17.12,0.26665,1,0.5230350181965224,1.17,BP
GO:1903531,negative regulation of secretion by cell,237,20,17.12,0.26665,1,0.5230350181965224,1.17,BP
GO:0001516,prostaglandin biosynthetic process,25,3,1.81,0.26880,1,0.5230350181965224,1.66,BP
GO:0002438,acute inflammatory response to antigenic...,25,3,1.81,0.26880,1,0.5230350181965224,1.66,BP
GO:0009048,dosage compensation by inactivation of X...,25,3,1.81,0.26880,1,0.5230350181965224,1.66,BP
GO:0010165,response to X-ray,25,3,1.81,0.26880,1,0.5230350181965224,1.66,BP
GO:0021801,cerebral cortex radial glia guided migra...,25,3,1.81,0.26880,1,0.5230350181965224,1.66,BP
GO:0021895,cerebral cortex neuron differentiation,25,3,1.81,0.26880,1,0.5230350181965224,1.66,BP
GO:0022030,telencephalon glial cell migration,25,3,1.81,0.26880,1,0.5230350181965224,1.66,BP
GO:0032373,positive regulation of sterol transport,25,3,1.81,0.26880,1,0.5230350181965224,1.66,BP
GO:0032376,positive regulation of cholesterol trans...,25,3,1.81,0.26880,1,0.5230350181965224,1.66,BP
GO:0032800,receptor biosynthetic process,25,3,1.81,0.26880,1,0.5230350181965224,1.66,BP
GO:0033522,histone H2A ubiquitination,25,3,1.81,0.26880,1,0.5230350181965224,1.66,BP
GO:0035024,negative regulation of Rho protein signa...,25,3,1.81,0.26880,1,0.5230350181965224,1.66,BP
GO:0035813,regulation of renal sodium excretion,25,3,1.81,0.26880,1,0.5230350181965224,1.66,BP
GO:0042059,negative regulation of epidermal growth ...,25,3,1.81,0.26880,1,0.5230350181965224,1.66,BP
GO:0046457,prostanoid biosynthetic process,25,3,1.81,0.26880,1,0.5230350181965224,1.66,BP
GO:0048148,behavioral response to cocaine,25,3,1.81,0.26880,1,0.5230350181965224,1.66,BP
GO:0051443,positive regulation of ubiquitin-protein...,25,3,1.81,0.26880,1,0.5230350181965224,1.66,BP
GO:0071711,basement membrane organization,25,3,1.81,0.26880,1,0.5230350181965224,1.66,BP
GO:0095500,acetylcholine receptor signaling pathway,25,3,1.81,0.26880,1,0.5230350181965224,1.66,BP
GO:1902230,negative regulation of intrinsic apoptot...,25,3,1.81,0.26880,1,0.5230350181965224,1.66,BP
GO:1903831,signal transduction involved in cellular...,25,3,1.81,0.26880,1,0.5230350181965224,1.66,BP
GO:1904376,negative regulation of protein localizat...,25,3,1.81,0.26880,1,0.5230350181965224,1.66,BP
GO:1904738,vascular associated smooth muscle cell m...,25,3,1.81,0.26880,1,0.5230350181965224,1.66,BP
GO:1904752,regulation of vascular associated smooth...,25,3,1.81,0.26880,1,0.5230350181965224,1.66,BP
GO:2000679,positive regulation of transcription reg...,25,3,1.81,0.26880,1,0.5230350181965224,1.66,BP
GO:0001837,epithelial to mesenchymal transition,135,12,9.75,0.26960,1,0.5243796281325789,1.23,BP
GO:0015748,organophosphate ester transport,85,8,6.14,0.27057,1,0.5260536727272727,1.3,BP
GO:0032649,regulation of interferon-gamma productio...,110,10,7.95,0.27132,1,0.5272988045234249,1.26,BP
GO:0050900,leukocyte migration,342,28,24.71,0.27177,1,0.5278247457627119,1.13,BP
GO:0030595,leukocyte chemotaxis,212,18,15.31,0.27181,1,0.5278247457627119,1.18,BP
GO:0008643,carbohydrate transport,148,13,10.69,0.27216,1,0.5280781935483871,1.22,BP
GO:0042133,neurotransmitter metabolic process,148,13,10.69,0.27216,1,0.5280781935483871,1.22,BP
GO:0006941,striated muscle contraction,161,14,11.63,0.27416,1,0.5316658984689766,1.2,BP
GO:0006094,gluconeogenesis,73,7,5.27,0.27423,1,0.5316658984689766,1.33,BP
GO:0072503,cellular divalent inorganic cation homeo...,501,40,36.19,0.27636,1,0.5355796697543295,1.11,BP
GO:0010955,negative regulation of protein processin...,37,4,2.67,0.27697,1,0.536114094931617,1.5,BP
GO:0033144,negative regulation of intracellular ste...,37,4,2.67,0.27697,1,0.536114094931617,1.5,BP
GO:1903318,negative regulation of protein maturatio...,37,4,2.67,0.27697,1,0.536114094931617,1.5,BP
GO:0035023,regulation of Rho protein signal transdu...,136,12,9.82,0.27790,1,0.53769794933655,1.22,BP
GO:0014888,striated muscle adaptation,49,5,3.54,0.27850,1,0.5379935768767564,1.41,BP
GO:0031050,dsRNA processing,49,5,3.54,0.27850,1,0.5379935768767564,1.41,BP
GO:0070918,production of small RNA involved in gene...,49,5,3.54,0.27850,1,0.5379935768767564,1.41,BP
GO:1903115,regulation of actin filament-based movem...,49,5,3.54,0.27850,1,0.5379935768767564,1.41,BP
GO:0003231,cardiac ventricle development,149,13,10.76,0.28011,1,0.5408865650080257,1.21,BP
GO:0006820,anion transport,555,44,40.09,0.28046,1,0.541345174488568,1.1,BP
GO:0048144,fibroblast proliferation,111,10,8.02,0.28058,1,0.5413596471531675,1.25,BP
GO:0015908,fatty acid transport,86,8,6.21,0.28115,1,0.542242004008016,1.29,BP
GO:0006874,cellular calcium ion homeostasis,476,38,34.39,0.28280,1,0.5452057692307692,1.1,BP
GO:0002699,positive regulation of immune effector p...,253,21,18.28,0.28529,1,0.5497859351221466,1.15,BP
GO:0031060,regulation of histone methylation,74,7,5.35,0.28574,1,0.5504326981585268,1.31,BP
GO:0070838,divalent metal ion transport,477,38,34.46,0.28727,1,0.5520141484716157,1.1,BP
GO:0000289,nuclear-transcribed mRNA poly(A) tail sh...,26,3,1.88,0.28897,1,0.5520141484716157,1.6,BP
GO:0000460,maturation of 5.8S rRNA,26,3,1.88,0.28897,1,0.5520141484716157,1.6,BP
GO:0003299,muscle hypertrophy in response to stress,26,3,1.88,0.28897,1,0.5520141484716157,1.6,BP
GO:0006817,phosphate ion transport,26,3,1.88,0.28897,1,0.5520141484716157,1.6,BP
GO:0014898,cardiac muscle hypertrophy in response t...,26,3,1.88,0.28897,1,0.5520141484716157,1.6,BP
GO:0021533,cell differentiation in hindbrain,26,3,1.88,0.28897,1,0.5520141484716157,1.6,BP
GO:0032104,regulation of response to extracellular ...,26,3,1.88,0.28897,1,0.5520141484716157,1.6,BP
GO:0032107,regulation of response to nutrient level...,26,3,1.88,0.28897,1,0.5520141484716157,1.6,BP
GO:0032528,microvillus organization,26,3,1.88,0.28897,1,0.5520141484716157,1.6,BP
GO:0034114,regulation of heterotypic cell-cell adhe...,26,3,1.88,0.28897,1,0.5520141484716157,1.6,BP
GO:0034123,positive regulation of toll-like recepto...,26,3,1.88,0.28897,1,0.5520141484716157,1.6,BP
GO:0043171,peptide catabolic process,26,3,1.88,0.28897,1,0.5520141484716157,1.6,BP
GO:0045737,positive regulation of cyclin-dependent ...,26,3,1.88,0.28897,1,0.5520141484716157,1.6,BP
GO:0048642,negative regulation of skeletal muscle t...,26,3,1.88,0.28897,1,0.5520141484716157,1.6,BP
GO:0050858,negative regulation of antigen receptor-...,26,3,1.88,0.28897,1,0.5520141484716157,1.6,BP
GO:0051497,negative regulation of stress fiber asse...,26,3,1.88,0.28897,1,0.5520141484716157,1.6,BP
GO:0060716,labyrinthine layer blood vessel developm...,26,3,1.88,0.28897,1,0.5520141484716157,1.6,BP
GO:1904357,negative regulation of telomere maintena...,26,3,1.88,0.28897,1,0.5520141484716157,1.6,BP
GO:2000737,negative regulation of stem cell differe...,26,3,1.88,0.28897,1,0.5520141484716157,1.6,BP
GO:2000765,regulation of cytoplasmic translation,26,3,1.88,0.28897,1,0.5520141484716157,1.6,BP
GO:0007272,ensheathment of neurons,163,14,11.77,0.28950,1,0.5520946418678275,1.19,BP
GO:0008366,axon ensheathment,163,14,11.77,0.28950,1,0.5520946418678275,1.19,BP
GO:0003229,ventricular cardiac muscle tissue develo...,62,6,4.48,0.28980,1,0.5520946418678275,1.34,BP
GO:0014911,positive regulation of smooth muscle cel...,62,6,4.48,0.28980,1,0.5520946418678275,1.34,BP
GO:0034308,primary alcohol metabolic process,62,6,4.48,0.28980,1,0.5520946418678275,1.34,BP
GO:0070206,protein trimerization,62,6,4.48,0.28980,1,0.5520946418678275,1.34,BP
GO:0031570,DNA integrity checkpoint,112,10,8.09,0.28992,1,0.5520946418678275,1.24,BP
GO:0030900,forebrain development,385,31,27.81,0.28993,1,0.5520946418678275,1.11,BP
GO:0009611,response to wounding,491,39,35.47,0.29057,1,0.5530944778481013,1.1,BP
GO:0060612,adipose tissue development,50,5,3.61,0.29279,1,0.5570998339264531,1.39,BP
GO:0002753,cytoplasmic pattern recognition receptor...,38,4,2.75,0.29352,1,0.5576068851164627,1.45,BP
GO:0032885,regulation of polysaccharide biosyntheti...,38,4,2.75,0.29352,1,0.5576068851164627,1.45,BP
GO:0071174,mitotic spindle checkpoint,38,4,2.75,0.29352,1,0.5576068851164627,1.45,BP
GO:0071320,cellular response to cAMP,38,4,2.75,0.29352,1,0.5576068851164627,1.45,BP
GO:0055074,calcium ion homeostasis,492,39,35.54,0.29502,1,0.5602352959747435,1.1,BP
GO:0045843,negative regulation of striated muscle t...,75,7,5.42,0.29737,1,0.5644751242603551,1.29,BP
GO:0008016,regulation of heart contraction,177,15,12.79,0.29797,1,0.5653910252365931,1.17,BP
GO:0002764,immune response-regulating signaling pat...,334,27,24.13,0.29900,1,0.5671217973985021,1.12,BP
GO:0001952,regulation of cell-matrix adhesion,113,10,8.16,0.29935,1,0.5675619385342789,1.23,BP
GO:0072511,divalent inorganic cation transport,480,38,34.67,0.30083,1,0.5701433477747144,1.1,BP
GO:0043410,positive regulation of MAPK cascade,520,41,37.56,0.30122,1,0.5706577322834646,1.09,BP
GO:1901988,negative regulation of cell cycle phase ...,165,14,11.92,0.30510,1,0.5777808736717828,1.17,BP
GO:0034612,response to tumor necrosis factor,178,15,12.86,0.30550,1,0.5783107789142408,1.17,BP
GO:0016126,sterol biosynthetic process,51,5,3.68,0.30720,1,0.578787584597433,1.36,BP
GO:2000649,regulation of sodium ion transmembrane t...,51,5,3.68,0.30720,1,0.578787584597433,1.36,BP
GO:0000187,activation of MAPK activity,114,10,8.24,0.30886,1,0.578787584597433,1.21,BP
GO:0022037,metencephalon development,114,10,8.24,0.30886,1,0.578787584597433,1.21,BP
GO:0006809,nitric oxide biosynthetic process,76,7,5.49,0.30909,1,0.578787584597433,1.28,BP
GO:0007260,tyrosine phosphorylation of STAT protein,76,7,5.49,0.30909,1,0.578787584597433,1.28,BP
GO:0019319,hexose biosynthetic process,76,7,5.49,0.30909,1,0.578787584597433,1.28,BP
GO:0045453,bone resorption,76,7,5.49,0.30909,1,0.578787584597433,1.28,BP
GO:0002347,response to tumor cell,27,3,1.95,0.30924,1,0.578787584597433,1.54,BP
GO:0007214,gamma-aminobutyric acid signaling pathwa...,27,3,1.95,0.30924,1,0.578787584597433,1.54,BP
GO:0007263,nitric oxide mediated signal transductio...,27,3,1.95,0.30924,1,0.578787584597433,1.54,BP
GO:0014829,vascular smooth muscle contraction,27,3,1.95,0.30924,1,0.578787584597433,1.54,BP
GO:0014887,cardiac muscle adaptation,27,3,1.95,0.30924,1,0.578787584597433,1.54,BP
GO:0016556,mRNA modification,27,3,1.95,0.30924,1,0.578787584597433,1.54,BP
GO:0018195,peptidyl-arginine modification,27,3,1.95,0.30924,1,0.578787584597433,1.54,BP
GO:0031365,N-terminal protein amino acid modificati...,27,3,1.95,0.30924,1,0.578787584597433,1.54,BP
GO:0034453,microtubule anchoring,27,3,1.95,0.30924,1,0.578787584597433,1.54,BP
GO:0035812,renal sodium excretion,27,3,1.95,0.30924,1,0.578787584597433,1.54,BP
GO:0048305,immunoglobulin secretion,27,3,1.95,0.30924,1,0.578787584597433,1.54,BP
GO:0051767,nitric-oxide synthase biosynthetic proce...,27,3,1.95,0.30924,1,0.578787584597433,1.54,BP
GO:0051769,regulation of nitric-oxide synthase bios...,27,3,1.95,0.30924,1,0.578787584597433,1.54,BP
GO:0061099,negative regulation of protein tyrosine ...,27,3,1.95,0.30924,1,0.578787584597433,1.54,BP
GO:1900273,positive regulation of long-term synapti...,27,3,1.95,0.30924,1,0.578787584597433,1.54,BP
GO:1901185,negative regulation of ERBB signaling pa...,27,3,1.95,0.30924,1,0.578787584597433,1.54,BP
GO:1905144,response to acetylcholine,27,3,1.95,0.30924,1,0.578787584597433,1.54,BP
GO:1905145,cellular response to acetylcholine,27,3,1.95,0.30924,1,0.578787584597433,1.54,BP
GO:1905523,positive regulation of macrophage migrat...,27,3,1.95,0.30924,1,0.578787584597433,1.54,BP
GO:2000272,negative regulation of signaling recepto...,27,3,1.95,0.30924,1,0.578787584597433,1.54,BP
GO:2000727,positive regulation of cardiac muscle ce...,27,3,1.95,0.30924,1,0.578787584597433,1.54,BP
GO:0019934,cGMP-mediated signaling,39,4,2.82,0.31018,1,0.5794200931677018,1.42,BP
GO:0046006,regulation of activated T cell prolifera...,39,4,2.82,0.31018,1,0.5794200931677018,1.42,BP
GO:0060251,regulation of glial cell proliferation,39,4,2.82,0.31018,1,0.5794200931677018,1.42,BP
GO:1901021,positive regulation of calcium ion trans...,39,4,2.82,0.31018,1,0.5794200931677018,1.42,BP
GO:1902475,L-alpha-amino acid transmembrane transpo...,39,4,2.82,0.31018,1,0.5794200931677018,1.42,BP
GO:0060048,cardiac muscle contraction,127,11,9.17,0.31065,1,0.5800728754365541,1.2,BP
GO:0016573,histone acetylation,140,12,10.11,0.31185,1,0.5820877424359969,1.19,BP
GO:0045087,innate immune response,710,55,51.29,0.31253,1,0.5831308103916246,1.07,BP
GO:0010676,positive regulation of cellular carbohyd...,64,6,4.62,0.31555,1,0.5883094149554436,1.3,BP
GO:0032720,negative regulation of tumor necrosis fa...,64,6,4.62,0.31555,1,0.5883094149554436,1.3,BP
GO:0001101,response to acid chemical,364,29,26.29,0.31821,1,0.5930389310611929,1.1,BP
GO:0008033,tRNA processing,115,10,8.31,0.31843,1,0.5932191869918699,1.2,BP
GO:0043406,positive regulation of MAP kinase activi...,219,18,15.82,0.31913,1,0.5942931733746131,1.14,BP
GO:0032101,regulation of response to external stimu...,779,60,56.27,0.31927,1,0.5943238839458415,1.07,BP
GO:0002768,immune response-regulating cell surface ...,206,17,14.88,0.31980,1,0.5948502512562813,1.14,BP
GO:0071560,cellular response to transforming growth...,206,17,14.88,0.31980,1,0.5948502512562813,1.14,BP
GO:0046165,alcohol biosynthetic process,141,12,10.19,0.32049,1,0.5953226831148805,1.18,BP
GO:0050729,positive regulation of inflammatory resp...,141,12,10.19,0.32049,1,0.5953226831148805,1.18,BP
GO:0007416,synapse assembly,180,15,13,0.32073,1,0.5953226831148805,1.15,BP
GO:0010675,regulation of cellular carbohydrate meta...,154,13,11.12,0.32086,1,0.5953226831148805,1.17,BP
GO:0014855,striated muscle cell proliferation,77,7,5.56,0.32090,1,0.5953226831148805,1.26,BP
GO:0048635,negative regulation of muscle organ deve...,77,7,5.56,0.32090,1,0.5953226831148805,1.26,BP
GO:0002218,activation of innate immune response,167,14,12.06,0.32092,1,0.5953226831148805,1.16,BP
GO:0001954,positive regulation of cell-matrix adhes...,52,5,3.76,0.32170,1,0.5953924615384615,1.33,BP
GO:0007019,microtubule depolymerization,52,5,3.76,0.32170,1,0.5953924615384615,1.33,BP
GO:0010712,regulation of collagen metabolic process,52,5,3.76,0.32170,1,0.5953924615384615,1.33,BP
GO:0030071,regulation of mitotic metaphase/anaphase...,52,5,3.76,0.32170,1,0.5953924615384615,1.33,BP
GO:0030901,midbrain development,52,5,3.76,0.32170,1,0.5953924615384615,1.33,BP
GO:0048066,developmental pigmentation,52,5,3.76,0.32170,1,0.5953924615384615,1.33,BP
GO:0018212,peptidyl-tyrosine modification,325,26,23.48,0.32247,1,0.5965880968858132,1.11,BP
GO:0072507,divalent inorganic cation homeostasis,525,41,37.92,0.32341,1,0.5980972021521906,1.08,BP
GO:0045833,negative regulation of lipid metabolic p...,90,8,6.5,0.32440,1,0.5994672811059909,1.23,BP
GO:1904063,negative regulation of cation transmembr...,90,8,6.5,0.32440,1,0.5994672811059909,1.23,BP
GO:0009069,serine family amino acid metabolic proce...,40,4,2.89,0.32694,1,0.6015912746585736,1.38,BP
GO:0031577,spindle checkpoint,40,4,2.89,0.32694,1,0.6015912746585736,1.38,BP
GO:0045747,positive regulation of Notch signaling p...,40,4,2.89,0.32694,1,0.6015912746585736,1.38,BP
GO:0045841,negative regulation of mitotic metaphase...,40,4,2.89,0.32694,1,0.6015912746585736,1.38,BP
GO:0048265,response to pain,40,4,2.89,0.32694,1,0.6015912746585736,1.38,BP
GO:0051968,positive regulation of synaptic transmis...,40,4,2.89,0.32694,1,0.6015912746585736,1.38,BP
GO:0060325,face morphogenesis,40,4,2.89,0.32694,1,0.6015912746585736,1.38,BP
GO:0070207,protein homotrimerization,40,4,2.89,0.32694,1,0.6015912746585736,1.38,BP
GO:0072523,purine-containing compound catabolic pro...,40,4,2.89,0.32694,1,0.6015912746585736,1.38,BP
GO:0071804,cellular potassium ion transport,194,16,14.01,0.32776,1,0.6015912746585736,1.14,BP
GO:0071805,potassium ion transmembrane transport,194,16,14.01,0.32776,1,0.6015912746585736,1.14,BP
GO:0048278,vesicle docking,65,6,4.7,0.32855,1,0.6015912746585736,1.28,BP
GO:0051784,negative regulation of nuclear division,65,6,4.7,0.32855,1,0.6015912746585736,1.28,BP
GO:0099601,regulation of neurotransmitter receptor ...,65,6,4.7,0.32855,1,0.6015912746585736,1.28,BP
GO:0150076,neuroinflammatory response,65,6,4.7,0.32855,1,0.6015912746585736,1.28,BP
GO:1903556,negative regulation of tumor necrosis fa...,65,6,4.7,0.32855,1,0.6015912746585736,1.28,BP
GO:2000736,regulation of stem cell differentiation,65,6,4.7,0.32855,1,0.6015912746585736,1.28,BP
GO:0050709,negative regulation of protein secretion,155,13,11.2,0.32918,1,0.6015912746585736,1.16,BP
GO:0006929,substrate-dependent cell migration,28,3,2.02,0.32955,1,0.6015912746585736,1.49,BP
GO:0010458,exit from mitosis,28,3,2.02,0.32955,1,0.6015912746585736,1.49,BP
GO:0010719,negative regulation of epithelial to mes...,28,3,2.02,0.32955,1,0.6015912746585736,1.49,BP
GO:0030878,thyroid gland development,28,3,2.02,0.32955,1,0.6015912746585736,1.49,BP
GO:0032647,regulation of interferon-alpha productio...,28,3,2.02,0.32955,1,0.6015912746585736,1.49,BP
GO:0032891,negative regulation of organic acid tran...,28,3,2.02,0.32955,1,0.6015912746585736,1.49,BP
GO:0045408,regulation of interleukin-6 biosynthetic...,28,3,2.02,0.32955,1,0.6015912746585736,1.49,BP
GO:0045724,positive regulation of cilium assembly,28,3,2.02,0.32955,1,0.6015912746585736,1.49,BP
GO:0045780,positive regulation of bone resorption,28,3,2.02,0.32955,1,0.6015912746585736,1.49,BP
GO:0045822,negative regulation of heart contraction,28,3,2.02,0.32955,1,0.6015912746585736,1.49,BP
GO:0046852,positive regulation of bone remodeling,28,3,2.02,0.32955,1,0.6015912746585736,1.49,BP
GO:0051194,positive regulation of cofactor metaboli...,28,3,2.02,0.32955,1,0.6015912746585736,1.49,BP
GO:0061050,regulation of cell growth involved in ca...,28,3,2.02,0.32955,1,0.6015912746585736,1.49,BP
GO:0071168,protein localization to chromatin,28,3,2.02,0.32955,1,0.6015912746585736,1.49,BP
GO:0000079,regulation of cyclin-dependent protein s...,78,7,5.63,0.33279,1,0.6068152633573323,1.24,BP
GO:0034644,cellular response to UV,78,7,5.63,0.33279,1,0.6068152633573323,1.24,BP
GO:1901862,negative regulation of muscle tissue dev...,78,7,5.63,0.33279,1,0.6068152633573323,1.24,BP
GO:0002709,regulation of T cell mediated immunity,91,8,6.57,0.33540,1,0.6113427272727272,1.22,BP
GO:0098656,anion transmembrane transport,182,15,13.15,0.33614,1,0.6115568253968254,1.14,BP
GO:1903034,regulation of response to wounding,182,15,13.15,0.33614,1,0.6115568253968254,1.14,BP
GO:0030219,megakaryocyte differentiation,53,5,3.83,0.33628,1,0.6115568253968254,1.31,BP
GO:0051932,"synaptic transmission, GABAergic",53,5,3.83,0.33628,1,0.6115568253968254,1.31,BP
GO:0055010,ventricular cardiac muscle tissue morpho...,53,5,3.83,0.33628,1,0.6115568253968254,1.31,BP
GO:0061383,trabecula morphogenesis,53,5,3.83,0.33628,1,0.6115568253968254,1.31,BP
GO:0006282,regulation of DNA repair,117,10,8.45,0.33777,1,0.6140344692104269,1.18,BP
GO:0032102,negative regulation of response to exter...,341,27,24.63,0.33791,1,0.6140569939577039,1.1,BP
GO:0045089,positive regulation of innate immune res...,235,19,16.98,0.33867,1,0.6152057531143829,1.12,BP
GO:0031347,regulation of defense response,650,50,46.95,0.34124,1,0.6196403320754716,1.06,BP
GO:0042306,regulation of protein import into nucleu...,66,6,4.77,0.34163,1,0.6196470260082925,1.26,BP
GO:0051591,response to cAMP,66,6,4.77,0.34163,1,0.6196470260082925,1.26,BP
GO:1901184,regulation of ERBB signaling pathway,66,6,4.77,0.34163,1,0.6196470260082925,1.26,BP
GO:0050731,positive regulation of peptidyl-tyrosine...,196,16,14.16,0.34271,1,0.6213662208865515,1.13,BP
GO:0006692,prostanoid metabolic process,41,4,2.96,0.34374,1,0.6213662208865515,1.35,BP
GO:0006693,prostaglandin metabolic process,41,4,2.96,0.34374,1,0.6213662208865515,1.35,BP
GO:0014037,Schwann cell differentiation,41,4,2.96,0.34374,1,0.6213662208865515,1.35,BP
GO:0021955,central nervous system neuron axonogenes...,41,4,2.96,0.34374,1,0.6213662208865515,1.35,BP
GO:1903170,negative regulation of calcium ion trans...,41,4,2.96,0.34374,1,0.6213662208865515,1.35,BP
GO:1903672,positive regulation of sprouting angioge...,41,4,2.96,0.34374,1,0.6213662208865515,1.35,BP
GO:2000772,regulation of cellular senescence,41,4,2.96,0.34374,1,0.6213662208865515,1.35,BP
GO:2001258,negative regulation of cation channel ac...,41,4,2.96,0.34374,1,0.6213662208865515,1.35,BP
GO:0003208,cardiac ventricle morphogenesis,79,7,5.71,0.34473,1,0.6222208402100524,1.23,BP
GO:0010389,regulation of G2/M transition of mitotic...,79,7,5.71,0.34473,1,0.6222208402100524,1.23,BP
GO:0070373,negative regulation of ERK1 and ERK2 cas...,79,7,5.71,0.34473,1,0.6222208402100524,1.23,BP
GO:0071277,cellular response to calcium ion,79,7,5.71,0.34473,1,0.6222208402100524,1.23,BP
GO:0021953,central nervous system neuron differenti...,223,18,16.11,0.34712,1,0.6260650074962518,1.12,BP
GO:0031348,negative regulation of defense response,223,18,16.11,0.34712,1,0.6260650074962518,1.12,BP
GO:0019751,polyol metabolic process,118,10,8.52,0.34751,1,0.6262989213483146,1.17,BP
GO:2000181,negative regulation of blood vessel morp...,118,10,8.52,0.34751,1,0.6262989213483146,1.17,BP
GO:0071559,response to transforming growth factor b...,210,17,15.17,0.34870,1,0.6276950782997762,1.12,BP
GO:0033273,response to vitamin,29,3,2.09,0.34985,1,0.6276950782997762,1.44,BP
GO:0034508,centromere complex assembly,29,3,2.09,0.34985,1,0.6276950782997762,1.44,BP
GO:0042119,neutrophil activation,29,3,2.09,0.34985,1,0.6276950782997762,1.44,BP
GO:0042226,interleukin-6 biosynthetic process,29,3,2.09,0.34985,1,0.6276950782997762,1.44,BP
GO:0043552,positive regulation of phosphatidylinosi...,29,3,2.09,0.34985,1,0.6276950782997762,1.44,BP
GO:0046039,GTP metabolic process,29,3,2.09,0.34985,1,0.6276950782997762,1.44,BP
GO:0060117,auditory receptor cell development,29,3,2.09,0.34985,1,0.6276950782997762,1.44,BP
GO:0098698,postsynaptic specialization assembly,29,3,2.09,0.34985,1,0.6276950782997762,1.44,BP
GO:1903579,negative regulation of ATP metabolic pro...,29,3,2.09,0.34985,1,0.6276950782997762,1.44,BP
GO:1903861,positive regulation of dendrite extensio...,29,3,2.09,0.34985,1,0.6276950782997762,1.44,BP
GO:1904861,excitatory synapse assembly,29,3,2.09,0.34985,1,0.6276950782997762,1.44,BP
GO:0003044,regulation of systemic arterial blood pr...,54,5,3.9,0.35092,1,0.628911374301676,1.28,BP
GO:0043297,apical junction assembly,54,5,3.9,0.35092,1,0.628911374301676,1.28,BP
GO:0051930,regulation of sensory perception of pain,54,5,3.9,0.35092,1,0.628911374301676,1.28,BP
GO:0046890,regulation of lipid biosynthetic process,171,14,12.35,0.35312,1,0.632618555472822,1.13,BP
GO:0014706,striated muscle tissue development,451,35,32.58,0.35382,1,0.6336367100855974,1.07,BP
GO:0006635,fatty acid beta-oxidation,67,6,4.84,0.35475,1,0.6350658482142857,1.24,BP
GO:0007169,transmembrane receptor protein tyrosine ...,559,43,40.38,0.35554,1,0.6362433915953887,1.06,BP
GO:0010923,negative regulation of phosphatase activ...,80,7,5.78,0.35673,1,0.637661500742942,1.21,BP
GO:0034637,cellular carbohydrate biosynthetic proce...,80,7,5.78,0.35673,1,0.637661500742942,1.21,BP
GO:1904427,positive regulation of calcium ion trans...,80,7,5.78,0.35673,1,0.637661500742942,1.21,BP
GO:0007498,mesoderm development,119,10,8.6,0.35730,1,0.638192169076752,1.16,BP
GO:0009062,fatty acid catabolic process,93,8,6.72,0.35757,1,0.638192169076752,1.19,BP
GO:0045445,myoblast differentiation,93,8,6.72,0.35757,1,0.638192169076752,1.19,BP
GO:0051304,chromosome separation,93,8,6.72,0.35757,1,0.638192169076752,1.19,BP
GO:1903844,regulation of cellular response to trans...,106,9,7.66,0.35769,1,0.638192169076752,1.17,BP
GO:0045930,negative regulation of mitotic cell cycl...,238,19,17.19,0.35929,1,0.6408092957746478,1.11,BP
GO:0009615,response to virus,278,22,20.08,0.35966,1,0.6412315376065209,1.1,BP
GO:0000959,mitochondrial RNA metabolic process,42,4,3.03,0.36056,1,0.6416474556213018,1.32,BP
GO:0010559,regulation of glycoprotein biosynthetic ...,42,4,3.03,0.36056,1,0.6416474556213018,1.32,BP
GO:0033059,cellular pigmentation,42,4,3.03,0.36056,1,0.6416474556213018,1.32,BP
GO:0034198,cellular response to amino acid starvati...,42,4,3.03,0.36056,1,0.6416474556213018,1.32,BP
GO:1902100,negative regulation of metaphase/anaphas...,42,4,3.03,0.36056,1,0.6416474556213018,1.32,BP
GO:0001906,cell killing,172,14,12.42,0.36126,1,0.6426554972273568,1.13,BP
GO:0006869,lipid transport,332,26,23.98,0.36300,1,0.6455121951219512,1.08,BP
GO:0006936,muscle contraction,292,23,21.09,0.36378,1,0.6466602733653491,1.09,BP
GO:0050732,negative regulation of peptidyl-tyrosine...,55,5,3.97,0.36558,1,0.6489011287347842,1.26,BP
GO:0051931,regulation of sensory perception,55,5,3.97,0.36558,1,0.6489011287347842,1.26,BP
GO:0060193,positive regulation of lipase activity,55,5,3.97,0.36558,1,0.6489011287347842,1.26,BP
GO:1902099,regulation of metaphase/anaphase transit...,55,5,3.97,0.36558,1,0.6489011287347842,1.26,BP
GO:1901136,carbohydrate derivative catabolic proces...,120,10,8.67,0.36713,1,0.6508863157894738,1.15,BP
GO:0006305,DNA alkylation,68,6,4.91,0.36791,1,0.6508863157894738,1.22,BP
GO:0006306,DNA methylation,68,6,4.91,0.36791,1,0.6508863157894738,1.22,BP
GO:0090278,negative regulation of peptide hormone s...,68,6,4.91,0.36791,1,0.6508863157894738,1.22,BP
GO:0038127,ERBB signaling pathway,107,9,7.73,0.36811,1,0.6508863157894738,1.16,BP
GO:0046474,glycerophospholipid biosynthetic process,107,9,7.73,0.36811,1,0.6508863157894738,1.16,BP
GO:0048661,positive regulation of smooth muscle cel...,107,9,7.73,0.36811,1,0.6508863157894738,1.16,BP
GO:0042116,macrophage activation,94,8,6.79,0.36872,1,0.6508863157894738,1.18,BP
GO:0043506,regulation of JUN kinase activity,94,8,6.79,0.36872,1,0.6508863157894738,1.18,BP
GO:0070555,response to interleukin-1,94,8,6.79,0.36872,1,0.6508863157894738,1.18,BP
GO:0006664,glycolipid metabolic process,81,7,5.85,0.36876,1,0.6508863157894738,1.2,BP
GO:0010817,regulation of hormone levels,562,43,40.6,0.36911,1,0.6508863157894738,1.06,BP
GO:0002724,regulation of T cell cytokine production,30,3,2.17,0.37008,1,0.6508863157894738,1.38,BP
GO:0022011,myelination in peripheral nervous system,30,3,2.17,0.37008,1,0.6508863157894738,1.38,BP
GO:0031295,T cell costimulation,30,3,2.17,0.37008,1,0.6508863157894738,1.38,BP
GO:0031297,replication fork processing,30,3,2.17,0.37008,1,0.6508863157894738,1.38,BP
GO:0032292,peripheral nervous system axon ensheathm...,30,3,2.17,0.37008,1,0.6508863157894738,1.38,BP
GO:0032607,interferon-alpha production,30,3,2.17,0.37008,1,0.6508863157894738,1.38,BP
GO:0044030,regulation of DNA methylation,30,3,2.17,0.37008,1,0.6508863157894738,1.38,BP
GO:0048643,positive regulation of skeletal muscle t...,30,3,2.17,0.37008,1,0.6508863157894738,1.38,BP
GO:0055022,negative regulation of cardiac muscle ti...,30,3,2.17,0.37008,1,0.6508863157894738,1.38,BP
GO:0060218,hematopoietic stem cell differentiation,30,3,2.17,0.37008,1,0.6508863157894738,1.38,BP
GO:0060317,cardiac epithelial to mesenchymal transi...,30,3,2.17,0.37008,1,0.6508863157894738,1.38,BP
GO:0061117,negative regulation of heart growth,30,3,2.17,0.37008,1,0.6508863157894738,1.38,BP
GO:1900117,regulation of execution phase of apoptos...,30,3,2.17,0.37008,1,0.6508863157894738,1.38,BP
GO:0002684,positive regulation of immune system pro...,942,71,68.05,0.37042,1,0.6512462696382901,1.04,BP
GO:0002697,regulation of immune effector process,414,32,29.91,0.37098,1,0.6519926077428779,1.07,BP
GO:0008654,phospholipid biosynthetic process,160,13,11.56,0.37142,1,0.6525275794085432,1.12,BP
GO:0050778,positive regulation of immune response,617,47,44.57,0.37310,1,0.6552398540145985,1.05,BP
GO:0007167,enzyme linked receptor protein signaling...,903,68,65.23,0.37687,1,0.6615141420765027,1.04,BP
GO:0007212,dopamine receptor signaling pathway,43,4,3.11,0.37736,1,0.6615141420765027,1.29,BP
GO:0010518,positive regulation of phospholipase act...,43,4,3.11,0.37736,1,0.6615141420765027,1.29,BP
GO:0038202,TORC1 signaling,43,4,3.11,0.37736,1,0.6615141420765027,1.29,BP
GO:1990573,potassium ion import across plasma membr...,43,4,3.11,0.37736,1,0.6615141420765027,1.29,BP
GO:1901654,response to ketone,174,14,12.57,0.37764,1,0.6617639038601602,1.11,BP
GO:0072676,lymphocyte migration,95,8,6.86,0.37989,1,0.6651264994547437,1.17,BP
GO:0071356,cellular response to tumor necrosis fact...,161,13,11.63,0.37997,1,0.6651264994547437,1.12,BP
GO:0007091,metaphase/anaphase transition of mitotic...,56,5,4.05,0.38025,1,0.6651264994547437,1.23,BP
GO:0043330,response to exogenous dsRNA,56,5,4.05,0.38025,1,0.6651264994547437,1.23,BP
GO:0048538,thymus development,56,5,4.05,0.38025,1,0.6651264994547437,1.23,BP
GO:1903509,liposaccharide metabolic process,82,7,5.92,0.38081,1,0.6656279782214156,1.18,BP
GO:0032370,positive regulation of lipid transport,69,6,4.98,0.38109,1,0.6656279782214156,1.2,BP
GO:0043407,negative regulation of MAP kinase activi...,69,6,4.98,0.38109,1,0.6656279782214156,1.2,BP
GO:0055117,regulation of cardiac muscle contraction,69,6,4.98,0.38109,1,0.6656279782214156,1.2,BP
GO:0043200,response to amino acid,188,15,13.58,0.38323,1,0.6691229172714078,1.1,BP
GO:0018108,peptidyl-tyrosine phosphorylation,322,25,23.26,0.38339,1,0.6691594776931448,1.07,BP
GO:0050920,regulation of chemotaxis,215,17,15.53,0.38552,1,0.6726331544597534,1.09,BP
GO:0001889,liver development,122,10,8.81,0.38686,1,0.6746040434782609,1.14,BP
GO:0045785,positive regulation of cell adhesion,417,32,30.12,0.38693,1,0.6746040434782609,1.06,BP
GO:0071396,cellular response to lipid,607,46,43.85,0.38874,1,0.6751334627831715,1.05,BP
GO:0021987,cerebral cortex development,109,9,7.87,0.38904,1,0.6751334627831715,1.14,BP
GO:0034968,histone lysine methylation,109,9,7.87,0.38904,1,0.6751334627831715,1.14,BP
GO:0048869,cellular developmental process,4475,328,323.26,0.38957,1,0.6751334627831715,1.01,BP
GO:0001779,natural killer cell differentiation,31,3,2.24,0.39018,1,0.6751334627831715,1.34,BP
GO:0006506,GPI anchor biosynthetic process,31,3,2.24,0.39018,1,0.6751334627831715,1.34,BP
GO:0006884,cell volume homeostasis,31,3,2.24,0.39018,1,0.6751334627831715,1.34,BP
GO:0032816,positive regulation of natural killer ce...,31,3,2.24,0.39018,1,0.6751334627831715,1.34,BP
GO:0034110,regulation of homotypic cell-cell adhesi...,31,3,2.24,0.39018,1,0.6751334627831715,1.34,BP
GO:0042558,pteridine-containing compound metabolic ...,31,3,2.24,0.39018,1,0.6751334627831715,1.34,BP
GO:0043302,positive regulation of leukocyte degranu...,31,3,2.24,0.39018,1,0.6751334627831715,1.34,BP
GO:0044062,regulation of excretion,31,3,2.24,0.39018,1,0.6751334627831715,1.34,BP
GO:0045932,negative regulation of muscle contractio...,31,3,2.24,0.39018,1,0.6751334627831715,1.34,BP
GO:0050482,arachidonic acid secretion,31,3,2.24,0.39018,1,0.6751334627831715,1.34,BP
GO:0070536,protein K63-linked deubiquitination,31,3,2.24,0.39018,1,0.6751334627831715,1.34,BP
GO:0099633,protein localization to postsynaptic spe...,31,3,2.24,0.39018,1,0.6751334627831715,1.34,BP
GO:0099645,neurotransmitter receptor localization t...,31,3,2.24,0.39018,1,0.6751334627831715,1.34,BP
GO:1901661,quinone metabolic process,31,3,2.24,0.39018,1,0.6751334627831715,1.34,BP
GO:1903963,arachidonate transport,31,3,2.24,0.39018,1,0.6751334627831715,1.34,BP
GO:2000781,positive regulation of double-strand bre...,31,3,2.24,0.39018,1,0.6751334627831715,1.34,BP
GO:2001014,regulation of skeletal muscle cell diffe...,31,3,2.24,0.39018,1,0.6751334627831715,1.34,BP
GO:0006952,defense response,1481,110,106.98,0.39214,1,0.6782809777138749,1.03,BP
GO:0018023,peptidyl-lysine trimethylation,44,4,3.18,0.39412,1,0.6812160344827587,1.26,BP
GO:0051898,negative regulation of protein kinase B ...,44,4,3.18,0.39412,1,0.6812160344827587,1.26,BP
GO:0022029,telencephalon cell migration,70,6,5.06,0.39427,1,0.6812306068222621,1.19,BP
GO:0019932,second-messenger-mediated signaling,432,33,31.21,0.39475,1,0.681357805665113,1.06,BP
GO:0002042,cell migration involved in sprouting ang...,57,5,4.12,0.39491,1,0.681357805665113,1.21,BP
GO:0009247,glycolipid biosynthetic process,57,5,4.12,0.39491,1,0.681357805665113,1.21,BP
GO:0072678,T cell migration,57,5,4.12,0.39491,1,0.681357805665113,1.21,BP
GO:0032609,interferon-gamma production,123,10,8.89,0.39676,1,0.6843043440860215,1.12,BP
GO:0030902,hindbrain development,163,13,11.77,0.39711,1,0.6846626012182014,1.1,BP
GO:0060070,canonical Wnt signaling pathway,284,22,20.52,0.39840,1,0.6866188184747584,1.07,BP
GO:0019953,sexual reproduction,868,65,62.7,0.39853,1,0.6866188184747584,1.04,BP
GO:0045446,endothelial cell differentiation,110,9,7.95,0.39953,1,0.6880953328561202,1.13,BP
GO:0002700,regulation of production of molecular me...,150,12,10.84,0.40021,1,0.6890198640429338,1.11,BP
GO:0060537,muscle tissue development,474,36,34.24,0.40163,1,0.691217296137339,1.05,BP
GO:0007173,epidermal growth factor receptor signali...,97,8,7.01,0.40228,1,0.6918410864903503,1.14,BP
GO:0021761,limbic system development,97,8,7.01,0.40228,1,0.6918410864903503,1.14,BP
GO:0016055,Wnt signaling pathway,434,33,31.35,0.40531,1,0.6968030439442658,1.05,BP
GO:0051153,regulation of striated muscle cell diffe...,124,10,8.96,0.40666,1,0.6988742571428572,1.12,BP
GO:0051057,positive regulation of small GTPase medi...,71,6,5.13,0.40744,1,0.6999647554444841,1.17,BP
GO:0018958,phenol-containing compound metabolic pro...,111,9,8.02,0.41003,1,0.7024938592750534,1.12,BP
GO:0003081,regulation of systemic arterial blood pr...,32,3,2.31,0.41012,1,0.7024938592750534,1.3,BP
GO:0006505,GPI anchor metabolic process,32,3,2.31,0.41012,1,0.7024938592750534,1.3,BP
GO:0010574,regulation of vascular endothelial growt...,32,3,2.31,0.41012,1,0.7024938592750534,1.3,BP
GO:0019884,antigen processing and presentation of e...,32,3,2.31,0.41012,1,0.7024938592750534,1.3,BP
GO:0031294,lymphocyte costimulation,32,3,2.31,0.41012,1,0.7024938592750534,1.3,BP
GO:0032689,negative regulation of interferon-gamma ...,32,3,2.31,0.41012,1,0.7024938592750534,1.3,BP
GO:0060306,regulation of membrane repolarization,32,3,2.31,0.41012,1,0.7024938592750534,1.3,BP
GO:0006695,cholesterol biosynthetic process,45,4,3.25,0.41081,1,0.7024938592750534,1.23,BP
GO:0010464,regulation of mesenchymal cell prolifera...,45,4,3.25,0.41081,1,0.7024938592750534,1.23,BP
GO:0030261,chromosome condensation,45,4,3.25,0.41081,1,0.7024938592750534,1.23,BP
GO:0032965,regulation of collagen biosynthetic proc...,45,4,3.25,0.41081,1,0.7024938592750534,1.23,BP
GO:0061647,histone H3-K9 modification,45,4,3.25,0.41081,1,0.7024938592750534,1.23,BP
GO:0002792,negative regulation of peptide secretion,165,13,11.92,0.41431,1,0.7082272539964477,1.09,BP
GO:0198738,cell-cell signaling by wnt,436,33,31.5,0.41591,1,0.71070984375,1.05,BP
GO:0007166,cell surface receptor signaling pathway,2396,176,173.08,0.41623,1,0.7110041746538871,1.02,BP
GO:0061008,hepaticobiliary system development,125,10,9.03,0.41657,1,0.7113324485450674,1.11,BP
GO:0002253,activation of immune response,396,30,28.61,0.42027,1,0.7173959702021994,1.05,BP
GO:0072329,monocarboxylic acid catabolic process,112,9,8.09,0.42052,1,0.7174161503013117,1.11,BP
GO:0042509,regulation of tyrosine phosphorylation o...,72,6,5.2,0.42058,1,0.7174161503013117,1.15,BP
GO:0032147,activation of protein kinase activity,247,19,17.84,0.42229,1,0.7198745184135977,1.07,BP
GO:0019221,cytokine-mediated signaling pathway,342,26,24.71,0.42247,1,0.7198745184135977,1.05,BP
GO:0031589,cell-substrate adhesion,342,26,24.71,0.42247,1,0.7198745184135977,1.05,BP
GO:0006643,membrane lipid metabolic process,166,13,11.99,0.42292,1,0.7203526539278131,1.08,BP
GO:0055002,striated muscle cell development,193,15,13.94,0.42305,1,0.7203526539278131,1.08,BP
GO:0044784,metaphase/anaphase transition of cell cy...,59,5,4.26,0.42412,1,0.7208443066202089,1.17,BP
GO:0098661,inorganic anion transmembrane transport,59,5,4.26,0.42412,1,0.7208443066202089,1.17,BP
GO:0045639,positive regulation of myeloid cell diff...,99,8,7.15,0.42467,1,0.7208443066202089,1.12,BP
GO:0016458,gene silencing,261,20,18.85,0.42541,1,0.7208443066202089,1.06,BP
GO:0048738,cardiac muscle tissue development,261,20,18.85,0.42541,1,0.7208443066202089,1.06,BP
GO:0001916,positive regulation of T cell mediated c...,46,4,3.32,0.42741,1,0.7208443066202089,1.2,BP
GO:0006904,vesicle docking involved in exocytosis,46,4,3.32,0.42741,1,0.7208443066202089,1.2,BP
GO:0042307,positive regulation of protein import in...,46,4,3.32,0.42741,1,0.7208443066202089,1.2,BP
GO:0043124,negative regulation of I-kappaB kinase/N...,46,4,3.32,0.42741,1,0.7208443066202089,1.2,BP
GO:0002275,myeloid cell activation involved in immu...,86,7,6.21,0.42905,1,0.7208443066202089,1.13,BP
GO:0098659,inorganic cation import across plasma me...,86,7,6.21,0.42905,1,0.7208443066202089,1.13,BP
GO:0099587,inorganic ion import across plasma membr...,86,7,6.21,0.42905,1,0.7208443066202089,1.13,BP
GO:0001573,ganglioside metabolic process,20,2,1.44,0.42923,1,0.7208443066202089,1.39,BP
GO:0002523,leukocyte migration involved in inflamma...,20,2,1.44,0.42923,1,0.7208443066202089,1.39,BP
GO:0005980,glycogen catabolic process,20,2,1.44,0.42923,1,0.7208443066202089,1.39,BP
GO:0009251,glucan catabolic process,20,2,1.44,0.42923,1,0.7208443066202089,1.39,BP
GO:0014075,response to amine,20,2,1.44,0.42923,1,0.7208443066202089,1.39,BP
GO:0016973,poly(A)+ mRNA export from nucleus,20,2,1.44,0.42923,1,0.7208443066202089,1.39,BP
GO:0018279,protein N-linked glycosylation via aspar...,20,2,1.44,0.42923,1,0.7208443066202089,1.39,BP
GO:0032095,regulation of response to food,20,2,1.44,0.42923,1,0.7208443066202089,1.39,BP
GO:0032211,negative regulation of telomere maintena...,20,2,1.44,0.42923,1,0.7208443066202089,1.39,BP
GO:0034143,regulation of toll-like receptor 4 signa...,20,2,1.44,0.42923,1,0.7208443066202089,1.39,BP
GO:0045821,positive regulation of glycolytic proces...,20,2,1.44,0.42923,1,0.7208443066202089,1.39,BP
GO:0046514,ceramide catabolic process,20,2,1.44,0.42923,1,0.7208443066202089,1.39,BP
GO:0050434,positive regulation of viral transcripti...,20,2,1.44,0.42923,1,0.7208443066202089,1.39,BP
GO:0050966,detection of mechanical stimulus involve...,20,2,1.44,0.42923,1,0.7208443066202089,1.39,BP
GO:0051383,kinetochore organization,20,2,1.44,0.42923,1,0.7208443066202089,1.39,BP
GO:0060099,"regulation of phagocytosis, engulfment",20,2,1.44,0.42923,1,0.7208443066202089,1.39,BP
GO:0070498,interleukin-1-mediated signaling pathway,20,2,1.44,0.42923,1,0.7208443066202089,1.39,BP
GO:0070828,heterochromatin organization,20,2,1.44,0.42923,1,0.7208443066202089,1.39,BP
GO:0090502,"RNA phosphodiester bond hydrolysis, endo...",20,2,1.44,0.42923,1,0.7208443066202089,1.39,BP
GO:0098840,protein transport along microtubule,20,2,1.44,0.42923,1,0.7208443066202089,1.39,BP
GO:0099118,microtubule-based protein transport,20,2,1.44,0.42923,1,0.7208443066202089,1.39,BP
GO:1904994,regulation of leukocyte adhesion to vasc...,20,2,1.44,0.42923,1,0.7208443066202089,1.39,BP
GO:2000136,regulation of cell proliferation involve...,20,2,1.44,0.42923,1,0.7208443066202089,1.39,BP
GO:0007097,nuclear migration,33,3,2.38,0.42986,1,0.7208443066202089,1.26,BP
GO:0014044,Schwann cell development,33,3,2.38,0.42986,1,0.7208443066202089,1.26,BP
GO:0034142,toll-like receptor 4 signaling pathway,33,3,2.38,0.42986,1,0.7208443066202089,1.26,BP
GO:0045672,positive regulation of osteoclast differ...,33,3,2.38,0.42986,1,0.7208443066202089,1.26,BP
GO:0045879,negative regulation of smoothened signal...,33,3,2.38,0.42986,1,0.7208443066202089,1.26,BP
GO:1901099,negative regulation of signal transducti...,33,3,2.38,0.42986,1,0.7208443066202089,1.26,BP
GO:1902624,positive regulation of neutrophil migrat...,33,3,2.38,0.42986,1,0.7208443066202089,1.26,BP
GO:2001240,negative regulation of extrinsic apoptot...,33,3,2.38,0.42986,1,0.7208443066202089,1.26,BP
GO:0007517,muscle organ development,425,32,30.7,0.42993,1,0.7208443066202089,1.04,BP
GO:0002221,pattern recognition receptor signaling p...,140,11,10.11,0.43162,1,0.72342578892372,1.09,BP
GO:0021766,hippocampus development,73,6,5.27,0.43369,1,0.7263892377305952,1.14,BP
GO:0021885,forebrain cell migration,73,6,5.27,0.43369,1,0.7263892377305952,1.14,BP
GO:0051146,striated muscle cell differentiation,317,24,22.9,0.43603,1,0.7299845843478261,1.05,BP
GO:0006937,regulation of muscle contraction,154,12,11.12,0.43614,1,0.7299845843478261,1.08,BP
GO:0021537,telencephalon development,249,19,17.99,0.43641,1,0.7301825173852574,1.06,BP
GO:0015807,L-amino acid transport,60,5,4.33,0.43862,1,0.7333702015288396,1.15,BP
GO:0031122,cytoplasmic microtubule organization,60,5,4.33,0.43862,1,0.7333702015288396,1.15,BP
GO:0015849,organic acid transport,304,23,21.96,0.44001,1,0.7354387356721084,1.05,BP
GO:0051607,defense response to virus,236,18,17.05,0.44072,1,0.7363696666666667,1.06,BP
GO:0015698,inorganic anion transport,141,11,10.19,0.44103,1,0.7366318500520652,1.08,BP
GO:0016525,negative regulation of angiogenesis,114,9,8.24,0.44148,1,0.7368719250780437,1.09,BP
GO:0031398,positive regulation of protein ubiquitin...,114,9,8.24,0.44148,1,0.7368719250780437,1.09,BP
GO:0045429,positive regulation of nitric oxide bios...,47,4,3.4,0.44387,1,0.7403474662045061,1.18,BP
GO:0070534,protein K63-linked ubiquitination,47,4,3.4,0.44387,1,0.7403474662045061,1.18,BP
GO:0010876,lipid localization,373,28,26.94,0.44452,1,0.7411747193347193,1.04,BP
GO:0007098,centrosome cycle,128,10,9.25,0.44627,1,0.7438348597159682,1.08,BP
GO:0002021,response to dietary excess,34,3,2.46,0.44935,1,0.74845005192108,1.22,BP
GO:0099068,postsynapse assembly,34,3,2.46,0.44935,1,0.74845005192108,1.22,BP
GO:0002758,innate immune response-activating signal...,142,11,10.26,0.45042,1,0.7497132618471117,1.07,BP
GO:0045017,glycerolipid biosynthetic process,142,11,10.26,0.45042,1,0.7497132618471117,1.07,BP
GO:0042058,regulation of epidermal growth factor re...,61,5,4.41,0.45305,1,0.7505431513903192,1.13,BP
GO:0042267,natural killer cell mediated cytotoxicit...,61,5,4.41,0.45305,1,0.7505431513903192,1.13,BP
GO:0048512,circadian behavior,61,5,4.41,0.45305,1,0.7505431513903192,1.13,BP
GO:1903428,positive regulation of reactive oxygen s...,61,5,4.41,0.45305,1,0.7505431513903192,1.13,BP
GO:0006516,glycoprotein catabolic process,21,2,1.52,0.45435,1,0.7505431513903192,1.32,BP
GO:0007095,mitotic G2 DNA damage checkpoint,21,2,1.52,0.45435,1,0.7505431513903192,1.32,BP
GO:0010759,positive regulation of macrophage chemot...,21,2,1.52,0.45435,1,0.7505431513903192,1.32,BP
GO:0015732,prostaglandin transport,21,2,1.52,0.45435,1,0.7505431513903192,1.32,BP
GO:0018196,peptidyl-asparagine modification,21,2,1.52,0.45435,1,0.7505431513903192,1.32,BP
GO:0022010,central nervous system myelination,21,2,1.52,0.45435,1,0.7505431513903192,1.32,BP
GO:0030813,positive regulation of nucleotide catabo...,21,2,1.52,0.45435,1,0.7505431513903192,1.32,BP
GO:0032291,axon ensheathment in central nervous sys...,21,2,1.52,0.45435,1,0.7505431513903192,1.32,BP
GO:0034694,response to prostaglandin,21,2,1.52,0.45435,1,0.7505431513903192,1.32,BP
GO:0044346,fibroblast apoptotic process,21,2,1.52,0.45435,1,0.7505431513903192,1.32,BP
GO:0051195,negative regulation of cofactor metaboli...,21,2,1.52,0.45435,1,0.7505431513903192,1.32,BP
GO:0051197,positive regulation of coenzyme metaboli...,21,2,1.52,0.45435,1,0.7505431513903192,1.32,BP
GO:0051450,myoblast proliferation,21,2,1.52,0.45435,1,0.7505431513903192,1.32,BP
GO:0061323,cell proliferation involved in heart mor...,21,2,1.52,0.45435,1,0.7505431513903192,1.32,BP
GO:1901017,negative regulation of potassium ion tra...,21,2,1.52,0.45435,1,0.7505431513903192,1.32,BP
GO:2000193,positive regulation of fatty acid transp...,21,2,1.52,0.45435,1,0.7505431513903192,1.32,BP
GO:2001032,regulation of double-strand break repair...,21,2,1.52,0.45435,1,0.7505431513903192,1.32,BP
GO:2001224,positive regulation of neuron migration,21,2,1.52,0.45435,1,0.7505431513903192,1.32,BP
GO:0016485,protein processing,238,18,17.19,0.45524,1,0.7517552779684282,1.05,BP
GO:0048640,negative regulation of developmental gro...,129,10,9.32,0.45613,1,0.7529665728987993,1.07,BP
GO:0010522,regulation of calcium ion transport into...,102,8,7.37,0.45810,1,0.755700102845389,1.09,BP
GO:0050848,regulation of calcium-mediated signaling,102,8,7.37,0.45810,1,0.755700102845389,1.09,BP
GO:0051705,multi-organism behavior,75,6,5.42,0.45973,1,0.7574292065663475,1.11,BP
GO:0007157,heterophilic cell-cell adhesion via plas...,48,4,3.47,0.46019,1,0.7574292065663475,1.15,BP
GO:0048010,vascular endothelial growth factor recep...,48,4,3.47,0.46019,1,0.7574292065663475,1.15,BP
GO:1904407,positive regulation of nitric oxide meta...,48,4,3.47,0.46019,1,0.7574292065663475,1.15,BP
GO:2000725,regulation of cardiac muscle cell differ...,48,4,3.47,0.46019,1,0.7574292065663475,1.15,BP
GO:2001239,regulation of extrinsic apoptotic signal...,48,4,3.47,0.46019,1,0.7574292065663475,1.15,BP
GO:0050806,positive regulation of synaptic transmis...,362,27,26.15,0.46025,1,0.7574292065663475,1.03,BP
GO:1903522,regulation of blood circulation,239,18,17.26,0.46249,1,0.7608553435897436,1.04,BP
GO:0007519,skeletal muscle tissue development,198,15,14.3,0.46294,1,0.7609468032786885,1.05,BP
GO:0021543,pallium development,157,12,11.34,0.46302,1,0.7609468032786885,1.06,BP
GO:0050715,positive regulation of cytokine secretio...,157,12,11.34,0.46302,1,0.7609468032786885,1.06,BP
GO:0006814,sodium ion transport,212,16,15.31,0.46538,1,0.7645642062137249,1.05,BP
GO:0060038,cardiac muscle cell proliferation,62,5,4.48,0.46736,1,0.767169350119088,1.12,BP
GO:0002931,response to ischemia,35,3,2.53,0.46856,1,0.767169350119088,1.19,BP
GO:0007031,peroxisome organization,35,3,2.53,0.46856,1,0.767169350119088,1.19,BP
GO:0009311,oligosaccharide metabolic process,35,3,2.53,0.46856,1,0.767169350119088,1.19,BP
GO:0032094,response to food,35,3,2.53,0.46856,1,0.767169350119088,1.19,BP
GO:0038084,vascular endothelial growth factor signa...,35,3,2.53,0.46856,1,0.767169350119088,1.19,BP
GO:0045686,negative regulation of glial cell differ...,35,3,2.53,0.46856,1,0.767169350119088,1.19,BP
GO:0055090,acylglycerol homeostasis,35,3,2.53,0.46856,1,0.767169350119088,1.19,BP
GO:0070328,triglyceride homeostasis,35,3,2.53,0.46856,1,0.767169350119088,1.19,BP
GO:0097352,autophagosome maturation,35,3,2.53,0.46856,1,0.767169350119088,1.19,BP
GO:0003073,regulation of systemic arterial blood pr...,117,9,8.45,0.47272,1,0.773717224489796,1.07,BP
GO:0019935,cyclic-nucleotide-mediated signaling,213,16,15.39,0.47307,1,0.7740268072084325,1.04,BP
GO:0032874,positive regulation of stress-activated ...,172,13,12.42,0.47446,1,0.7758013333333333,1.05,BP
GO:0071229,cellular response to acid chemical,282,21,20.37,0.47522,1,0.7758013333333333,1.03,BP
GO:0001961,positive regulation of cytokine-mediated...,49,4,3.54,0.47634,1,0.7758013333333333,1.13,BP
GO:0090102,cochlea development,49,4,3.54,0.47634,1,0.7758013333333333,1.13,BP
GO:1905954,positive regulation of lipid localizatio...,90,7,6.5,0.47679,1,0.7758013333333333,1.08,BP
GO:0002834,regulation of response to tumor cell,22,2,1.59,0.47883,1,0.7758013333333333,1.26,BP
GO:0002837,regulation of immune response to tumor c...,22,2,1.59,0.47883,1,0.7758013333333333,1.26,BP
GO:0006837,serotonin transport,22,2,1.59,0.47883,1,0.7758013333333333,1.26,BP
GO:0007063,regulation of sister chromatid cohesion,22,2,1.59,0.47883,1,0.7758013333333333,1.26,BP
GO:0015874,norepinephrine transport,22,2,1.59,0.47883,1,0.7758013333333333,1.26,BP
GO:0018230,peptidyl-L-cysteine S-palmitoylation,22,2,1.59,0.47883,1,0.7758013333333333,1.26,BP
GO:0018231,peptidyl-S-diacylglycerol-L-cysteine bio...,22,2,1.59,0.47883,1,0.7758013333333333,1.26,BP
GO:0032042,mitochondrial DNA metabolic process,22,2,1.59,0.47883,1,0.7758013333333333,1.26,BP
GO:0032303,regulation of icosanoid secretion,22,2,1.59,0.47883,1,0.7758013333333333,1.26,BP
GO:0032366,intracellular sterol transport,22,2,1.59,0.47883,1,0.7758013333333333,1.26,BP
GO:0032367,intracellular cholesterol transport,22,2,1.59,0.47883,1,0.7758013333333333,1.26,BP
GO:0032682,negative regulation of chemokine product...,22,2,1.59,0.47883,1,0.7758013333333333,1.26,BP
GO:0032897,negative regulation of viral transcripti...,22,2,1.59,0.47883,1,0.7758013333333333,1.26,BP
GO:0034405,response to fluid shear stress,22,2,1.59,0.47883,1,0.7758013333333333,1.26,BP
GO:0044247,cellular polysaccharide catabolic proces...,22,2,1.59,0.47883,1,0.7758013333333333,1.26,BP
GO:0044851,hair cycle phase,22,2,1.59,0.47883,1,0.7758013333333333,1.26,BP
GO:0045606,positive regulation of epidermal cell di...,22,2,1.59,0.47883,1,0.7758013333333333,1.26,BP
GO:0046597,negative regulation of viral entry into ...,22,2,1.59,0.47883,1,0.7758013333333333,1.26,BP
GO:0051043,regulation of membrane protein ectodomai...,22,2,1.59,0.47883,1,0.7758013333333333,1.26,BP
GO:0060438,trachea development,22,2,1.59,0.47883,1,0.7758013333333333,1.26,BP
GO:0060749,mammary gland alveolus development,22,2,1.59,0.47883,1,0.7758013333333333,1.26,BP
GO:0061377,mammary gland lobule development,22,2,1.59,0.47883,1,0.7758013333333333,1.26,BP
GO:0097107,postsynaptic density assembly,22,2,1.59,0.47883,1,0.7758013333333333,1.26,BP
GO:1901223,negative regulation of NIK/NF-kappaB sig...,22,2,1.59,0.47883,1,0.7758013333333333,1.26,BP
GO:0017015,regulation of transforming growth factor...,104,8,7.51,0.48018,1,0.7772035519677094,1.07,BP
GO:0042136,neurotransmitter biosynthetic process,104,8,7.51,0.48018,1,0.7772035519677094,1.07,BP
GO:0043255,regulation of carbohydrate biosynthetic ...,104,8,7.51,0.48018,1,0.7772035519677094,1.07,BP
GO:0051302,regulation of cell division,159,12,11.49,0.48085,1,0.7780262945527908,1.04,BP
GO:0002228,natural killer cell mediated immunity,63,5,4.55,0.48157,1,0.778144674278039,1.1,BP
GO:0002673,regulation of acute inflammatory respons...,63,5,4.55,0.48157,1,0.778144674278039,1.1,BP
GO:0043967,histone H4 acetylation,63,5,4.55,0.48157,1,0.778144674278039,1.1,BP
GO:0045661,regulation of myoblast differentiation,63,5,4.55,0.48157,1,0.778144674278039,1.1,BP
GO:0002252,immune effector process,752,55,54.32,0.48226,1,0.778998026183283,1.01,BP
GO:0070304,positive regulation of stress-activated ...,173,13,12.5,0.48300,1,0.7797667628312647,1.04,BP
GO:0042476,odontogenesis,118,9,8.52,0.48306,1,0.7797667628312647,1.06,BP
GO:0045088,regulation of innate immune response,297,22,21.45,0.48336,1,0.7799893762575453,1.03,BP
GO:0055021,regulation of cardiac muscle tissue grow...,77,6,5.56,0.48547,1,0.7828691823056301,1.08,BP
GO:0140056,organelle localization by membrane tethe...,77,6,5.56,0.48547,1,0.7828691823056301,1.08,BP
GO:0032259,methylation,339,25,24.49,0.48733,1,0.7832072253756261,1.02,BP
GO:0006471,protein ADP-ribosylation,36,3,2.6,0.48747,1,0.7832072253756261,1.15,BP
GO:0006739,NADP metabolic process,36,3,2.6,0.48747,1,0.7832072253756261,1.15,BP
GO:0032205,negative regulation of telomere maintena...,36,3,2.6,0.48747,1,0.7832072253756261,1.15,BP
GO:0033363,secretory granule organization,36,3,2.6,0.48747,1,0.7832072253756261,1.15,BP
GO:0040020,regulation of meiotic nuclear division,36,3,2.6,0.48747,1,0.7832072253756261,1.15,BP
GO:0044275,cellular carbohydrate catabolic process,36,3,2.6,0.48747,1,0.7832072253756261,1.15,BP
GO:0045815,"positive regulation of gene expression, ...",36,3,2.6,0.48747,1,0.7832072253756261,1.15,BP
GO:0051181,cofactor transport,36,3,2.6,0.48747,1,0.7832072253756261,1.15,BP
GO:0060969,negative regulation of gene silencing,36,3,2.6,0.48747,1,0.7832072253756261,1.15,BP
GO:1905209,positive regulation of cardiocyte differ...,36,3,2.6,0.48747,1,0.7832072253756261,1.15,BP
GO:0043087,regulation of GTPase activity,298,22,21.53,0.48987,1,0.7868005473965287,1.02,BP
GO:0046849,bone remodeling,105,8,7.58,0.49114,1,0.7878109743930828,1.06,BP
GO:1903825,organic acid transmembrane transport,105,8,7.58,0.49114,1,0.7878109743930828,1.06,BP
GO:1905039,carboxylic acid transmembrane transport,105,8,7.58,0.49114,1,0.7878109743930828,1.06,BP
GO:0006303,double-strand break repair via nonhomolo...,50,4,3.61,0.49230,1,0.7878109743930828,1.11,BP
GO:0042491,inner ear auditory receptor cell differe...,50,4,3.61,0.49230,1,0.7878109743930828,1.11,BP
GO:0051055,negative regulation of lipid biosyntheti...,50,4,3.61,0.49230,1,0.7878109743930828,1.11,BP
GO:0060043,regulation of cardiac muscle cell prolif...,50,4,3.61,0.49230,1,0.7878109743930828,1.11,BP
GO:0071622,regulation of granulocyte chemotaxis,50,4,3.61,0.49230,1,0.7878109743930828,1.11,BP
GO:0071675,regulation of mononuclear cell migration,50,4,3.61,0.49230,1,0.7878109743930828,1.11,BP
GO:0090329,regulation of DNA-dependent DNA replicat...,50,4,3.61,0.49230,1,0.7878109743930828,1.11,BP
GO:1902930,regulation of alcohol biosynthetic proce...,50,4,3.61,0.49230,1,0.7878109743930828,1.11,BP
GO:0051963,regulation of synapse assembly,119,9,8.6,0.49335,1,0.789228789893617,1.05,BP
GO:0043414,macromolecule methylation,285,21,20.59,0.49522,1,0.7915763956189844,1.02,BP
GO:0002456,T cell mediated immunity,133,10,9.61,0.49528,1,0.7915763956189844,1.04,BP
GO:0007622,rhythmic behavior,64,5,4.62,0.49564,1,0.7915763956189844,1.08,BP
GO:0034121,regulation of toll-like receptor signali...,64,5,4.62,0.49564,1,0.7915763956189844,1.08,BP
GO:0046579,positive regulation of Ras protein signa...,64,5,4.62,0.49564,1,0.7915763956189844,1.08,BP
GO:0033993,response to lipid,811,59,58.58,0.49738,1,0.7940917584605176,1.01,BP
GO:0032729,positive regulation of interferon-gamma ...,78,6,5.63,0.49819,1,0.7948575198938992,1.07,BP
GO:0061180,mammary gland epithelium development,78,6,5.63,0.49819,1,0.7948575198938992,1.07,BP
GO:0031644,regulation of neurological system proces...,175,13,12.64,0.49998,1,0.7969052520593081,1.03,BP
GO:0001938,positive regulation of endothelial cell ...,92,7,6.65,0.50027,1,0.7969052520593081,1.05,BP
GO:0070252,actin-mediated cell contraction,92,7,6.65,0.50027,1,0.7969052520593081,1.05,BP
GO:0002093,auditory receptor cell morphogenesis,23,2,1.66,0.50262,1,0.7969052520593081,1.2,BP
GO:0006144,purine nucleobase metabolic process,23,2,1.66,0.50262,1,0.7969052520593081,1.2,BP
GO:0008211,glucocorticoid metabolic process,23,2,1.66,0.50262,1,0.7969052520593081,1.2,BP
GO:0032495,response to muramyl dipeptide,23,2,1.66,0.50262,1,0.7969052520593081,1.2,BP
GO:0032727,positive regulation of interferon-alpha ...,23,2,1.66,0.50262,1,0.7969052520593081,1.2,BP
GO:0035743,"CD4-positive, alpha-beta T cell cytokine...",23,2,1.66,0.50262,1,0.7969052520593081,1.2,BP
GO:0043153,entrainment of circadian clock by photop...,23,2,1.66,0.50262,1,0.7969052520593081,1.2,BP
GO:0046599,regulation of centriole replication,23,2,1.66,0.50262,1,0.7969052520593081,1.2,BP
GO:0046641,positive regulation of alpha-beta T cell...,23,2,1.66,0.50262,1,0.7969052520593081,1.2,BP
GO:0048532,anatomical structure arrangement,23,2,1.66,0.50262,1,0.7969052520593081,1.2,BP
GO:0060333,interferon-gamma-mediated signaling path...,23,2,1.66,0.50262,1,0.7969052520593081,1.2,BP
GO:0099149,regulation of postsynaptic neurotransmit...,23,2,1.66,0.50262,1,0.7969052520593081,1.2,BP
GO:0101023,vascular endothelial cell proliferation,23,2,1.66,0.50262,1,0.7969052520593081,1.2,BP
GO:1903020,positive regulation of glycoprotein meta...,23,2,1.66,0.50262,1,0.7969052520593081,1.2,BP
GO:1903306,negative regulation of regulated secreto...,23,2,1.66,0.50262,1,0.7969052520593081,1.2,BP
GO:1905562,regulation of vascular endothelial cell ...,23,2,1.66,0.50262,1,0.7969052520593081,1.2,BP
GO:0002053,positive regulation of mesenchymal cell ...,37,3,2.67,0.50604,1,0.7999554796320631,1.12,BP
GO:0014003,oligodendrocyte development,37,3,2.67,0.50604,1,0.7999554796320631,1.12,BP
GO:0021884,forebrain neuron development,37,3,2.67,0.50604,1,0.7999554796320631,1.12,BP
GO:0048147,negative regulation of fibroblast prolif...,37,3,2.67,0.50604,1,0.7999554796320631,1.12,BP
GO:0060674,placenta blood vessel development,37,3,2.67,0.50604,1,0.7999554796320631,1.12,BP
GO:0061756,leukocyte adhesion to vascular endotheli...,37,3,2.67,0.50604,1,0.7999554796320631,1.12,BP
GO:1901385,regulation of voltage-gated calcium chan...,37,3,2.67,0.50604,1,0.7999554796320631,1.12,BP
GO:1903432,regulation of TORC1 signaling,37,3,2.67,0.50604,1,0.7999554796320631,1.12,BP
GO:1903792,negative regulation of anion transport,37,3,2.67,0.50604,1,0.7999554796320631,1.12,BP
GO:0050727,regulation of inflammatory response,356,26,25.72,0.50643,1,0.8003090837438424,1.01,BP
GO:0001914,regulation of T cell mediated cytotoxici...,51,4,3.68,0.50806,1,0.8013060373647983,1.09,BP
GO:0031146,SCF-dependent proteasomal ubiquitin-depe...,51,4,3.68,0.50806,1,0.8013060373647983,1.09,BP
GO:0032715,negative regulation of interleukin-6 pro...,51,4,3.68,0.50806,1,0.8013060373647983,1.09,BP
GO:0043618,regulation of transcription from RNA pol...,51,4,3.68,0.50806,1,0.8013060373647983,1.09,BP
GO:0048247,lymphocyte chemotaxis,51,4,3.68,0.50806,1,0.8013060373647983,1.09,BP
GO:1901570,fatty acid derivative biosynthetic proce...,51,4,3.68,0.50806,1,0.8013060373647983,1.09,BP
GO:0016202,regulation of striated muscle tissue dev...,176,13,12.71,0.50843,1,0.8016268545216253,1.02,BP
GO:0002376,immune system process,2407,174,173.88,0.50885,1,0.8020262692433673,1,BP
GO:0001707,mesoderm formation,65,5,4.7,0.50956,1,0.8028823575638507,1.06,BP
GO:0007160,cell-matrix adhesion,204,15,14.74,0.51035,1,0.8038638952536824,1.02,BP
GO:0032465,regulation of cytokinesis,79,6,5.71,0.51080,1,0.8043094240837697,1.05,BP
GO:0044264,cellular polysaccharide metabolic proces...,107,8,7.73,0.51286,1,0.8072889499509323,1.03,BP
GO:0046620,regulation of organ growth,121,9,8.74,0.51376,1,0.8084411772400261,1.03,BP
GO:0048609,multicellular organismal reproductive pr...,843,61,60.9,0.51434,1,0.8089536360666449,1,BP
GO:0001909,leukocyte mediated cytotoxicity,135,10,9.75,0.51459,1,0.8089536360666449,1.03,BP
GO:1901655,cellular response to ketone,135,10,9.75,0.51459,1,0.8089536360666449,1.03,BP
GO:0046942,carboxylic acid transport,303,22,21.89,0.52221,1,0.8183824911032028,1.01,BP
GO:0001912,positive regulation of leukocyte mediate...,80,6,5.78,0.52329,1,0.8183824911032028,1.04,BP
GO:0060425,lung morphogenesis,66,5,4.77,0.52332,1,0.8183824911032028,1.05,BP
GO:0071260,cellular response to mechanical stimulus,66,5,4.77,0.52332,1,0.8183824911032028,1.05,BP
GO:0086003,cardiac muscle cell contraction,66,5,4.77,0.52332,1,0.8183824911032028,1.05,BP
GO:1903845,negative regulation of cellular response...,66,5,4.77,0.52332,1,0.8183824911032028,1.05,BP
GO:0060428,lung epithelium development,52,4,3.76,0.52359,1,0.8183824911032028,1.06,BP
GO:0061614,pri-miRNA transcription by RNA polymeras...,52,4,3.76,0.52359,1,0.8183824911032028,1.06,BP
GO:2000677,regulation of transcription regulatory r...,52,4,3.76,0.52359,1,0.8183824911032028,1.06,BP
GO:2000106,regulation of leukocyte apoptotic proces...,108,8,7.8,0.52360,1,0.8183824911032028,1.03,BP
GO:1903322,positive regulation of protein modificat...,136,10,9.82,0.52417,1,0.8183824911032028,1.02,BP
GO:0000096,sulfur amino acid metabolic process,38,3,2.75,0.52426,1,0.8183824911032028,1.09,BP
GO:0006284,base-excision repair,38,3,2.75,0.52426,1,0.8183824911032028,1.09,BP
GO:0031935,regulation of chromatin silencing,38,3,2.75,0.52426,1,0.8183824911032028,1.09,BP
GO:0032392,DNA geometric change,38,3,2.75,0.52426,1,0.8183824911032028,1.09,BP
GO:0043267,negative regulation of potassium ion tra...,38,3,2.75,0.52426,1,0.8183824911032028,1.09,BP
GO:0045005,DNA-dependent DNA replication maintenanc...,38,3,2.75,0.52426,1,0.8183824911032028,1.09,BP
GO:0051647,nucleus localization,38,3,2.75,0.52426,1,0.8183824911032028,1.09,BP
GO:0071391,cellular response to estrogen stimulus,38,3,2.75,0.52426,1,0.8183824911032028,1.09,BP
GO:0071514,genetic imprinting,38,3,2.75,0.52426,1,0.8183824911032028,1.09,BP
GO:0006955,immune response,1387,100,100.19,0.52437,1,0.8183824911032028,1,BP
GO:0002374,cytokine secretion involved in immune re...,24,2,1.73,0.52569,1,0.8183824911032028,1.16,BP
GO:0006582,melanin metabolic process,24,2,1.73,0.52569,1,0.8183824911032028,1.16,BP
GO:0006706,steroid catabolic process,24,2,1.73,0.52569,1,0.8183824911032028,1.16,BP
GO:0009648,photoperiodism,24,2,1.73,0.52569,1,0.8183824911032028,1.16,BP
GO:0019048,modulation by virus of host morphology o...,24,2,1.73,0.52569,1,0.8183824911032028,1.16,BP
GO:0032878,regulation of establishment or maintenan...,24,2,1.73,0.52569,1,0.8183824911032028,1.16,BP
GO:0034383,low-density lipoprotein particle clearan...,24,2,1.73,0.52569,1,0.8183824911032028,1.16,BP
GO:0043496,regulation of protein homodimerization a...,24,2,1.73,0.52569,1,0.8183824911032028,1.16,BP
GO:0050995,negative regulation of lipid catabolic p...,24,2,1.73,0.52569,1,0.8183824911032028,1.16,BP
GO:1901861,regulation of muscle tissue development,179,13,12.93,0.53353,1,0.8297629337641358,1.01,BP
GO:0006865,amino acid transport,151,11,10.91,0.53355,1,0.8297629337641358,1.01,BP
GO:0015718,monocarboxylic acid transport,151,11,10.91,0.53355,1,0.8297629337641358,1.01,BP
GO:0060538,skeletal muscle organ development,207,15,14.95,0.53369,1,0.8297629337641358,1,BP
GO:0032963,collagen metabolic process,109,8,7.87,0.53426,1,0.8301436135265701,1.02,BP
GO:0001818,negative regulation of cytokine producti...,263,19,19,0.53435,1,0.8301436135265701,1,BP
GO:0007162,negative regulation of cell adhesion,291,21,21.02,0.53478,1,0.8301436135265701,1,BP
GO:0002444,myeloid leukocyte mediated immunity,95,7,6.86,0.53482,1,0.8301436135265701,1.02,BP
GO:0050795,regulation of behavior,95,7,6.86,0.53482,1,0.8301436135265701,1.02,BP
GO:0006720,isoprenoid metabolic process,81,6,5.85,0.53566,1,0.8301436135265701,1.03,BP
GO:0038034,signal transduction in absence of ligand,81,6,5.85,0.53566,1,0.8301436135265701,1.03,BP
GO:0070613,regulation of protein processing,81,6,5.85,0.53566,1,0.8301436135265701,1.03,BP
GO:0097192,extrinsic apoptotic signaling pathway in...,81,6,5.85,0.53566,1,0.8301436135265701,1.03,BP
GO:2000243,positive regulation of reproductive proc...,81,6,5.85,0.53566,1,0.8301436135265701,1.03,BP
GO:0006487,protein N-linked glycosylation,67,5,4.84,0.53692,1,0.8310257446124155,1.03,BP
GO:0032623,interleukin-2 production,67,5,4.84,0.53692,1,0.8310257446124155,1.03,BP
GO:0060688,regulation of morphogenesis of a branchi...,67,5,4.84,0.53692,1,0.8310257446124155,1.03,BP
GO:0097194,execution phase of apoptosis,67,5,4.84,0.53692,1,0.8310257446124155,1.03,BP
GO:0030850,prostate gland development,53,4,3.83,0.53888,1,0.8337911768488746,1.04,BP
GO:0097529,myeloid leukocyte migration,208,15,15.03,0.54140,1,0.8366212957023733,1,BP
GO:0048634,regulation of muscle organ development,180,13,13,0.54180,1,0.8366212957023733,1,BP
GO:0007257,activation of JUN kinase activity,39,3,2.82,0.54210,1,0.8366212957023733,1.06,BP
GO:0030431,sleep,39,3,2.82,0.54210,1,0.8366212957023733,1.06,BP
GO:0046456,icosanoid biosynthetic process,39,3,2.82,0.54210,1,0.8366212957023733,1.06,BP
GO:0048741,skeletal muscle fiber development,39,3,2.82,0.54210,1,0.8366212957023733,1.06,BP
GO:0050931,pigment cell differentiation,39,3,2.82,0.54210,1,0.8366212957023733,1.06,BP
GO:0097009,energy homeostasis,39,3,2.82,0.54210,1,0.8366212957023733,1.06,BP
GO:0050728,negative regulation of inflammatory resp...,152,11,10.98,0.54255,1,0.8370473228598909,1,BP
GO:0016441,posttranscriptional gene silencing,138,10,9.97,0.54312,1,0.8373897596924063,1,BP
GO:0016571,histone methylation,138,10,9.97,0.54312,1,0.8373897596924063,1,BP
GO:0090090,negative regulation of canonical Wnt sig...,124,9,8.96,0.54386,1,0.8381015561959655,1,BP
GO:0051716,cellular response to stimulus,7732,557,558.54,0.54393,1,0.8381015561959655,1,BP
GO:0046683,response to organophosphorus,96,7,6.93,0.54613,1,0.8390456124721604,1.01,BP
GO:0030155,regulation of cell adhesion,698,50,50.42,0.54676,1,0.8390456124721604,0.99,BP
GO:0031646,positive regulation of neurological syst...,82,6,5.92,0.54788,1,0.8390456124721604,1.01,BP
GO:0051899,membrane depolarization,82,6,5.92,0.54788,1,0.8390456124721604,1.01,BP
GO:0071674,mononuclear cell migration,82,6,5.92,0.54788,1,0.8390456124721604,1.01,BP
GO:0000272,polysaccharide catabolic process,25,2,1.81,0.54803,1,0.8390456124721604,1.1,BP
GO:0009065,glutamine family amino acid catabolic pr...,25,2,1.81,0.54803,1,0.8390456124721604,1.1,BP
GO:0010742,macrophage derived foam cell differentia...,25,2,1.81,0.54803,1,0.8390456124721604,1.1,BP
GO:0010894,negative regulation of steroid biosynthe...,25,2,1.81,0.54803,1,0.8390456124721604,1.1,BP
GO:0031100,animal organ regeneration,25,2,1.81,0.54803,1,0.8390456124721604,1.1,BP
GO:0031639,plasminogen activation,25,2,1.81,0.54803,1,0.8390456124721604,1.1,BP
GO:0032703,negative regulation of interleukin-2 pro...,25,2,1.81,0.54803,1,0.8390456124721604,1.1,BP
GO:0045939,negative regulation of steroid metabolic...,25,2,1.81,0.54803,1,0.8390456124721604,1.1,BP
GO:0048266,behavioral response to pain,25,2,1.81,0.54803,1,0.8390456124721604,1.1,BP
GO:0060338,regulation of type I interferon-mediated...,25,2,1.81,0.54803,1,0.8390456124721604,1.1,BP
GO:0070193,synaptonemal complex organization,25,2,1.81,0.54803,1,0.8390456124721604,1.1,BP
GO:0071312,cellular response to alkaloid,25,2,1.81,0.54803,1,0.8390456124721604,1.1,BP
GO:0071677,positive regulation of mononuclear cell ...,25,2,1.81,0.54803,1,0.8390456124721604,1.1,BP
GO:0090023,positive regulation of neutrophil chemot...,25,2,1.81,0.54803,1,0.8390456124721604,1.1,BP
GO:1901658,glycosyl compound catabolic process,25,2,1.81,0.54803,1,0.8390456124721604,1.1,BP
GO:0048002,antigen processing and presentation of p...,68,5,4.91,0.55033,1,0.842031147853736,1.02,BP
GO:1905515,non-motile cilium assembly,68,5,4.91,0.55033,1,0.842031147853736,1.02,BP
GO:0015711,organic anion transport,420,30,30.34,0.55338,1,0.8464286586141132,0.99,BP
GO:0006665,sphingolipid metabolic process,125,9,9.03,0.55373,1,0.8464321752937441,1,BP
GO:0032964,collagen biosynthetic process,54,4,3.9,0.55391,1,0.8464321752937441,1.03,BP
GO:0034113,heterotypic cell-cell adhesion,54,4,3.9,0.55391,1,0.8464321752937441,1.03,BP
GO:0014074,response to purine-containing compound,111,8,8.02,0.55530,1,0.8482868571428572,1,BP
GO:0032504,multicellular organism reproduction,854,61,61.69,0.55698,1,0.850114916006339,0.99,BP
GO:0046888,negative regulation of hormone secretion,97,7,7.01,0.55731,1,0.850114916006339,1,BP
GO:0070167,regulation of biomineral tissue developm...,97,7,7.01,0.55731,1,0.850114916006339,1,BP
GO:0071482,cellular response to light stimulus,97,7,7.01,0.55731,1,0.850114916006339,1,BP
GO:0003205,cardiac chamber development,196,14,14.16,0.55738,1,0.850114916006339,0.99,BP
GO:0042060,wound healing,365,26,26.37,0.55932,1,0.8504594440934934,0.99,BP
GO:0002369,T cell cytokine production,40,3,2.89,0.55955,1,0.8504594440934934,1.04,BP
GO:0002686,negative regulation of leukocyte migrati...,40,3,2.89,0.55955,1,0.8504594440934934,1.04,BP
GO:0007099,centriole replication,40,3,2.89,0.55955,1,0.8504594440934934,1.04,BP
GO:0031640,killing of cells of other organism,40,3,2.89,0.55955,1,0.8504594440934934,1.04,BP
GO:0044364,disruption of cells of other organism,40,3,2.89,0.55955,1,0.8504594440934934,1.04,BP
GO:0046627,negative regulation of insulin receptor ...,40,3,2.89,0.55955,1,0.8504594440934934,1.04,BP
GO:0048520,positive regulation of behavior,40,3,2.89,0.55955,1,0.8504594440934934,1.04,BP
GO:0071542,dopaminergic neuron differentiation,40,3,2.89,0.55955,1,0.8504594440934934,1.04,BP
GO:0090049,regulation of cell migration involved in...,40,3,2.89,0.55955,1,0.8504594440934934,1.04,BP
GO:0099590,neurotransmitter receptor internalizatio...,40,3,2.89,0.55955,1,0.8504594440934934,1.04,BP
GO:1903317,regulation of protein maturation,83,6,6,0.55996,1,0.8508138680138934,1,BP
GO:0007631,feeding behavior,126,9,9.1,0.56352,1,0.8549188524590163,0.99,BP
GO:0033692,cellular polysaccharide biosynthetic pro...,69,5,4.98,0.56355,1,0.8549188524590163,1,BP
GO:0043299,leukocyte degranulation,69,5,4.98,0.56355,1,0.8549188524590163,1,BP
GO:0048332,mesoderm morphogenesis,69,5,4.98,0.56355,1,0.8549188524590163,1,BP
GO:2000107,negative regulation of leukocyte apoptot...,69,5,4.98,0.56355,1,0.8549188524590163,1,BP
GO:0019722,calcium-mediated signaling,211,15,15.24,0.56426,1,0.855726164513079,0.98,BP
GO:0002705,positive regulation of leukocyte mediate...,169,12,12.21,0.56763,1,0.8568338355736168,0.98,BP
GO:0045132,meiotic chromosome segregation,98,7,7.08,0.56838,1,0.8568338355736168,0.99,BP
GO:0007528,neuromuscular junction development,55,4,3.97,0.56869,1,0.8568338355736168,1.01,BP
GO:0035315,hair cell differentiation,55,4,3.97,0.56869,1,0.8568338355736168,1.01,BP
GO:0043030,regulation of macrophage activation,55,4,3.97,0.56869,1,0.8568338355736168,1.01,BP
GO:0050663,cytokine secretion,254,18,18.35,0.56900,1,0.8568338355736168,0.98,BP
GO:0002478,antigen processing and presentation of e...,26,2,1.88,0.56962,1,0.8568338355736168,1.06,BP
GO:0006882,cellular zinc ion homeostasis,26,2,1.88,0.56962,1,0.8568338355736168,1.06,BP
GO:0009394,2'-deoxyribonucleotide metabolic process,26,2,1.88,0.56962,1,0.8568338355736168,1.06,BP
GO:0009649,entrainment of circadian clock,26,2,1.88,0.56962,1,0.8568338355736168,1.06,BP
GO:0009713,catechol-containing compound biosyntheti...,26,2,1.88,0.56962,1,0.8568338355736168,1.06,BP
GO:0019692,deoxyribose phosphate metabolic process,26,2,1.88,0.56962,1,0.8568338355736168,1.06,BP
GO:0035809,regulation of urine volume,26,2,1.88,0.56962,1,0.8568338355736168,1.06,BP
GO:0035929,steroid hormone secretion,26,2,1.88,0.56962,1,0.8568338355736168,1.06,BP
GO:0042044,fluid transport,26,2,1.88,0.56962,1,0.8568338355736168,1.06,BP
GO:0042423,catecholamine biosynthetic process,26,2,1.88,0.56962,1,0.8568338355736168,1.06,BP
GO:0043486,histone exchange,26,2,1.88,0.56962,1,0.8568338355736168,1.06,BP
GO:0045117,azole transport,26,2,1.88,0.56962,1,0.8568338355736168,1.06,BP
GO:0050927,positive regulation of positive chemotax...,26,2,1.88,0.56962,1,0.8568338355736168,1.06,BP
GO:0061436,establishment of skin barrier,26,2,1.88,0.56962,1,0.8568338355736168,1.06,BP
GO:0090077,foam cell differentiation,26,2,1.88,0.56962,1,0.8568338355736168,1.06,BP
GO:0090344,negative regulation of cell aging,26,2,1.88,0.56962,1,0.8568338355736168,1.06,BP
GO:0098901,regulation of cardiac muscle cell action...,26,2,1.88,0.56962,1,0.8568338355736168,1.06,BP
GO:1901380,negative regulation of potassium ion tra...,26,2,1.88,0.56962,1,0.8568338355736168,1.06,BP
GO:1901739,regulation of myoblast fusion,26,2,1.88,0.56962,1,0.8568338355736168,1.06,BP
GO:2000050,regulation of non-canonical Wnt signalin...,26,2,1.88,0.56962,1,0.8568338355736168,1.06,BP
GO:0044728,DNA methylation or demethylation,84,6,6.07,0.57188,1,0.8596958950328023,0.99,BP
GO:0060420,regulation of heart growth,84,6,6.07,0.57188,1,0.8596958950328023,0.99,BP
GO:0030048,actin filament-based movement,113,8,8.16,0.57593,1,0.8619145573159366,0.98,BP
GO:0006855,drug transmembrane transport,70,5,5.06,0.57658,1,0.8619145573159366,0.99,BP
GO:0002888,positive regulation of myeloid leukocyte...,41,3,2.96,0.57658,1,0.8619145573159366,1.01,BP
GO:0003298,physiological muscle hypertrophy,41,3,2.96,0.57658,1,0.8619145573159366,1.01,BP
GO:0003301,physiological cardiac muscle hypertrophy,41,3,2.96,0.57658,1,0.8619145573159366,1.01,BP
GO:0006509,membrane protein ectodomain proteolysis,41,3,2.96,0.57658,1,0.8619145573159366,1.01,BP
GO:0021522,spinal cord motor neuron differentiation,41,3,2.96,0.57658,1,0.8619145573159366,1.01,BP
GO:0033628,regulation of cell adhesion mediated by ...,41,3,2.96,0.57658,1,0.8619145573159366,1.01,BP
GO:0038179,neurotrophin signaling pathway,41,3,2.96,0.57658,1,0.8619145573159366,1.01,BP
GO:0042304,regulation of fatty acid biosynthetic pr...,41,3,2.96,0.57658,1,0.8619145573159366,1.01,BP
GO:0043551,regulation of phosphatidylinositol 3-kin...,41,3,2.96,0.57658,1,0.8619145573159366,1.01,BP
GO:0051154,negative regulation of striated muscle c...,41,3,2.96,0.57658,1,0.8619145573159366,1.01,BP
GO:0051281,positive regulation of release of seques...,41,3,2.96,0.57658,1,0.8619145573159366,1.01,BP
GO:0055026,negative regulation of cardiac muscle ti...,41,3,2.96,0.57658,1,0.8619145573159366,1.01,BP
GO:0061049,cell growth involved in cardiac muscle c...,41,3,2.96,0.57658,1,0.8619145573159366,1.01,BP
GO:0098534,centriole assembly,41,3,2.96,0.57658,1,0.8619145573159366,1.01,BP
GO:1900744,regulation of p38MAPK cascade,41,3,2.96,0.57658,1,0.8619145573159366,1.01,BP
GO:1902622,regulation of neutrophil migration,41,3,2.96,0.57658,1,0.8619145573159366,1.01,BP
GO:0030178,negative regulation of Wnt signaling pat...,156,11,11.27,0.57790,1,0.86361950310559,0.98,BP
GO:0006641,triglyceride metabolic process,99,7,7.15,0.57931,1,0.8654578453896306,0.98,BP
GO:0002833,positive regulation of response to bioti...,56,4,4.05,0.58318,1,0.8701588093023257,0.99,BP
GO:0042531,positive regulation of tyrosine phosphor...,56,4,4.05,0.58318,1,0.8701588093023257,0.99,BP
GO:0043620,regulation of DNA-templated transcriptio...,56,4,4.05,0.58318,1,0.8701588093023257,0.99,BP
GO:0060760,positive regulation of response to cytok...,56,4,4.05,0.58318,1,0.8701588093023257,0.99,BP
GO:0001913,T cell mediated cytotoxicity,71,5,5.13,0.58939,1,0.8766570194384449,0.97,BP
GO:0006821,chloride transport,100,7,7.22,0.59011,1,0.8766570194384449,0.97,BP
GO:0003071,renal system process involved in regulat...,27,2,1.95,0.59045,1,0.8766570194384449,1.03,BP
GO:0003085,negative regulation of systemic arterial...,27,2,1.95,0.59045,1,0.8766570194384449,1.03,BP
GO:0006730,one-carbon metabolic process,27,2,1.95,0.59045,1,0.8766570194384449,1.03,BP
GO:0010460,positive regulation of heart rate,27,2,1.95,0.59045,1,0.8766570194384449,1.03,BP
GO:0032365,intracellular lipid transport,27,2,1.95,0.59045,1,0.8766570194384449,1.03,BP
GO:0033688,regulation of osteoblast proliferation,27,2,1.95,0.59045,1,0.8766570194384449,1.03,BP
GO:0042104,positive regulation of activated T cell ...,27,2,1.95,0.59045,1,0.8766570194384449,1.03,BP
GO:0048745,smooth muscle tissue development,27,2,1.95,0.59045,1,0.8766570194384449,1.03,BP
GO:0050926,regulation of positive chemotaxis,27,2,1.95,0.59045,1,0.8766570194384449,1.03,BP
GO:0055069,zinc ion homeostasis,27,2,1.95,0.59045,1,0.8766570194384449,1.03,BP
GO:0070129,regulation of mitochondrial translation,27,2,1.95,0.59045,1,0.8766570194384449,1.03,BP
GO:0071474,cellular hyperosmotic response,27,2,1.95,0.59045,1,0.8766570194384449,1.03,BP
GO:0071624,positive regulation of granulocyte chemo...,27,2,1.95,0.59045,1,0.8766570194384449,1.03,BP
GO:1901532,regulation of hematopoietic progenitor c...,27,2,1.95,0.59045,1,0.8766570194384449,1.03,BP
GO:0014065,phosphatidylinositol 3-kinase signaling,129,9,9.32,0.59232,1,0.8788418719211822,0.97,BP
GO:0035195,gene silencing by miRNA,129,9,9.32,0.59232,1,0.8788418719211822,0.97,BP
GO:0006687,glycosphingolipid metabolic process,42,3,3.03,0.59320,1,0.8788418719211822,0.99,BP
GO:0042220,response to cocaine,42,3,3.03,0.59320,1,0.8788418719211822,0.99,BP
GO:0042398,cellular modified amino acid biosyntheti...,42,3,3.03,0.59320,1,0.8788418719211822,0.99,BP
GO:0055023,positive regulation of cardiac muscle ti...,42,3,3.03,0.59320,1,0.8788418719211822,0.99,BP
GO:1903523,negative regulation of blood circulation,42,3,3.03,0.59320,1,0.8788418719211822,0.99,BP
GO:0006970,response to osmotic stress,86,6,6.21,0.59524,1,0.8815927608494922,0.97,BP
GO:0046467,membrane lipid biosynthetic process,115,8,8.31,0.59611,1,0.8826038317470064,0.96,BP
GO:0000726,non-recombinational repair,57,4,4.12,0.59739,1,0.8826038317470064,0.97,BP
GO:0007588,excretion,57,4,4.12,0.59739,1,0.8826038317470064,0.97,BP
GO:0010463,mesenchymal cell proliferation,57,4,4.12,0.59739,1,0.8826038317470064,0.97,BP
GO:0021517,ventral spinal cord development,57,4,4.12,0.59739,1,0.8826038317470064,0.97,BP
GO:0050994,regulation of lipid catabolic process,57,4,4.12,0.59739,1,0.8826038317470064,0.97,BP
GO:0072577,endothelial cell apoptotic process,57,4,4.12,0.59739,1,0.8826038317470064,0.97,BP
GO:0090303,positive regulation of wound healing,57,4,4.12,0.59739,1,0.8826038317470064,0.97,BP
GO:0019233,sensory perception of pain,144,10,10.4,0.59815,1,0.8831843510279226,0.96,BP
GO:0055007,cardiac muscle cell differentiation,144,10,10.4,0.59815,1,0.8831843510279226,0.96,BP
GO:0060326,cell chemotaxis,301,21,21.74,0.59859,1,0.88356290797546,0.97,BP
GO:0001890,placenta development,173,12,12.5,0.60073,1,0.8862370447578173,0.96,BP
GO:0110110,positive regulation of animal organ morp...,101,7,7.3,0.60077,1,0.8862370447578173,0.96,BP
GO:0010927,cellular component assembly involved in ...,116,8,8.38,0.60601,1,0.8936929574011646,0.95,BP
GO:0044262,cellular carbohydrate metabolic process,288,20,20.8,0.60621,1,0.8937140073529413,0.96,BP
GO:0014904,myotube cell development,43,3,3.11,0.60939,1,0.8954045230112769,0.96,BP
GO:0040018,positive regulation of multicellular org...,43,3,3.11,0.60939,1,0.8954045230112769,0.96,BP
GO:0046621,negative regulation of organ growth,43,3,3.11,0.60939,1,0.8954045230112769,0.96,BP
GO:0002360,T cell lineage commitment,28,2,2.02,0.61052,1,0.8954045230112769,0.99,BP
GO:0016577,histone demethylation,28,2,2.02,0.61052,1,0.8954045230112769,0.99,BP
GO:0021952,central nervous system projection neuron...,28,2,2.02,0.61052,1,0.8954045230112769,0.99,BP
GO:0032925,regulation of activin receptor signaling...,28,2,2.02,0.61052,1,0.8954045230112769,0.99,BP
GO:0042538,hyperosmotic salinity response,28,2,2.02,0.61052,1,0.8954045230112769,0.99,BP
GO:0044003,modification by symbiont of host morphol...,28,2,2.02,0.61052,1,0.8954045230112769,0.99,BP
GO:0048820,hair follicle maturation,28,2,2.02,0.61052,1,0.8954045230112769,0.99,BP
GO:0050849,negative regulation of calcium-mediated ...,28,2,2.02,0.61052,1,0.8954045230112769,0.99,BP
GO:0051446,positive regulation of meiotic cell cycl...,28,2,2.02,0.61052,1,0.8954045230112769,0.99,BP
GO:0060444,branching involved in mammary gland duct...,28,2,2.02,0.61052,1,0.8954045230112769,0.99,BP
GO:0070076,histone lysine demethylation,28,2,2.02,0.61052,1,0.8954045230112769,0.99,BP
GO:1900745,positive regulation of p38MAPK cascade,28,2,2.02,0.61052,1,0.8954045230112769,0.99,BP
GO:1902932,positive regulation of alcohol biosynthe...,28,2,2.02,0.61052,1,0.8954045230112769,0.99,BP
GO:2000311,regulation of AMPA receptor activity,28,2,2.02,0.61052,1,0.8954045230112769,0.99,BP
GO:0021510,spinal cord development,102,7,7.37,0.61128,1,0.8957294762484774,0.95,BP
GO:0050886,endocrine process,102,7,7.37,0.61128,1,0.8957294762484774,0.95,BP
GO:0098900,regulation of action potential,58,4,4.19,0.61130,1,0.8957294762484774,0.95,BP
GO:0071216,cellular response to biotic stimulus,304,21,21.96,0.61703,1,0.9038503378995434,0.96,BP
GO:0071887,leukocyte apoptotic process,132,9,9.54,0.62019,1,0.9082027632379794,0.94,BP
GO:0045778,positive regulation of ossification,103,7,7.44,0.62164,1,0.9100491877091572,0.94,BP
GO:0048762,mesenchymal cell differentiation,219,15,15.82,0.62298,1,0.911733503649635,0.95,BP
GO:0032663,regulation of interleukin-2 production,59,4,4.26,0.62492,1,0.9126740533980583,0.94,BP
GO:0032835,glomerulus development,59,4,4.26,0.62492,1,0.9126740533980583,0.94,BP
GO:0030890,positive regulation of B cell proliferat...,44,3,3.18,0.62514,1,0.9126740533980583,0.94,BP
GO:0032814,regulation of natural killer cell activa...,44,3,3.18,0.62514,1,0.9126740533980583,0.94,BP
GO:0048854,brain morphogenesis,44,3,3.18,0.62514,1,0.9126740533980583,0.94,BP
GO:0050918,positive chemotaxis,44,3,3.18,0.62514,1,0.9126740533980583,0.94,BP
GO:0061098,positive regulation of protein tyrosine ...,44,3,3.18,0.62514,1,0.9126740533980583,0.94,BP
GO:0070830,bicellular tight junction assembly,44,3,3.18,0.62514,1,0.9126740533980583,0.94,BP
GO:0005976,polysaccharide metabolic process,118,8,8.52,0.62545,1,0.9128496815286623,0.94,BP
GO:0007193,adenylate cyclase-inhibiting G protein-c...,74,5,5.35,0.62651,1,0.9138424128523795,0.93,BP
GO:0051155,positive regulation of striated muscle c...,74,5,5.35,0.62651,1,0.9138424128523795,0.93,BP
GO:0021872,forebrain generation of neurons,89,6,6.43,0.62896,1,0.9142509683257918,0.93,BP
GO:0002092,positive regulation of receptor internal...,29,2,2.09,0.62983,1,0.9142509683257918,0.96,BP
GO:0010586,miRNA metabolic process,29,2,2.09,0.62983,1,0.9142509683257918,0.96,BP
GO:0010800,positive regulation of peptidyl-threonin...,29,2,2.09,0.62983,1,0.9142509683257918,0.96,BP
GO:0030149,sphingolipid catabolic process,29,2,2.09,0.62983,1,0.9142509683257918,0.96,BP
GO:0030224,monocyte differentiation,29,2,2.09,0.62983,1,0.9142509683257918,0.96,BP
GO:0043032,positive regulation of macrophage activa...,29,2,2.09,0.62983,1,0.9142509683257918,0.96,BP
GO:0050820,positive regulation of coagulation,29,2,2.09,0.62983,1,0.9142509683257918,0.96,BP
GO:0060384,innervation,29,2,2.09,0.62983,1,0.9142509683257918,0.96,BP
GO:0070296,sarcoplasmic reticulum calcium ion trans...,29,2,2.09,0.62983,1,0.9142509683257918,0.96,BP
GO:0071880,adenylate cyclase-activating adrenergic ...,29,2,2.09,0.62983,1,0.9142509683257918,0.96,BP
GO:0072395,signal transduction involved in cell cyc...,29,2,2.09,0.62983,1,0.9142509683257918,0.96,BP
GO:0072401,signal transduction involved in DNA inte...,29,2,2.09,0.62983,1,0.9142509683257918,0.96,BP
GO:0072422,signal transduction involved in DNA dama...,29,2,2.09,0.62983,1,0.9142509683257918,0.96,BP
GO:1903131,mononuclear cell differentiation,29,2,2.09,0.62983,1,0.9142509683257918,0.96,BP
GO:1904030,negative regulation of cyclin-dependent ...,29,2,2.09,0.62983,1,0.9142509683257918,0.96,BP
GO:0031047,gene silencing by RNA,163,11,11.77,0.63673,1,0.9238952983725136,0.93,BP
GO:0030258,lipid modification,221,15,15.96,0.63705,1,0.9238952983725136,0.94,BP
GO:0050707,regulation of cytokine secretion,221,15,15.96,0.63705,1,0.9238952983725136,0.94,BP
GO:0051928,positive regulation of calcium ion trans...,134,9,9.68,0.63821,1,0.9247559891598915,0.93,BP
GO:0001825,blastocyst formation,60,4,4.33,0.63822,1,0.9247559891598915,0.92,BP
GO:0060119,inner ear receptor cell development,60,4,4.33,0.63822,1,0.9247559891598915,0.92,BP
GO:0060563,neuroepithelial cell differentiation,75,5,5.42,0.63842,1,0.9247673208910294,0.92,BP
GO:0050776,regulation of immune response,777,54,56.13,0.63865,1,0.9248220884742703,0.96,BP
GO:0035295,tube development,1130,79,81.63,0.63921,1,0.925354548736462,0.97,BP
GO:0003254,regulation of membrane depolarization,45,3,3.25,0.64045,1,0.925479099099099,0.92,BP
GO:0050974,detection of mechanical stimulus involve...,45,3,3.25,0.64045,1,0.925479099099099,0.92,BP
GO:0060421,positive regulation of heart growth,45,3,3.25,0.64045,1,0.925479099099099,0.92,BP
GO:0090207,regulation of triglyceride metabolic pro...,45,3,3.25,0.64045,1,0.925479099099099,0.92,BP
GO:0120192,tight junction assembly,45,3,3.25,0.64045,1,0.925479099099099,0.92,BP
GO:1902893,regulation of pri-miRNA transcription by...,45,3,3.25,0.64045,1,0.925479099099099,0.92,BP
GO:0002224,toll-like receptor signaling pathway,105,7,7.58,0.64190,1,0.9270176470588235,0.92,BP
GO:0055017,cardiac muscle tissue growth,105,7,7.58,0.64190,1,0.9270176470588235,0.92,BP
GO:0035194,posttranscriptional gene silencing by RN...,135,9,9.75,0.64703,1,0.9330157177033492,0.92,BP
GO:0097305,response to alcohol,208,14,15.03,0.64744,1,0.9330157177033492,0.93,BP
GO:0140013,meiotic nuclear division,179,12,12.93,0.64805,1,0.9330157177033492,0.93,BP
GO:0000038,very long-chain fatty acid metabolic pro...,30,2,2.17,0.64838,1,0.9330157177033492,0.92,BP
GO:0001958,endochondral ossification,30,2,2.17,0.64838,1,0.9330157177033492,0.92,BP
GO:0010803,regulation of tumor necrosis factor-medi...,30,2,2.17,0.64838,1,0.9330157177033492,0.92,BP
GO:0031645,negative regulation of neurological syst...,30,2,2.17,0.64838,1,0.9330157177033492,0.92,BP
GO:0033687,osteoblast proliferation,30,2,2.17,0.64838,1,0.9330157177033492,0.92,BP
GO:0036075,replacement ossification,30,2,2.17,0.64838,1,0.9330157177033492,0.92,BP
GO:0042533,tumor necrosis factor biosynthetic proce...,30,2,2.17,0.64838,1,0.9330157177033492,0.92,BP
GO:0042534,regulation of tumor necrosis factor bios...,30,2,2.17,0.64838,1,0.9330157177033492,0.92,BP
GO:0071354,cellular response to interleukin-6,30,2,2.17,0.64838,1,0.9330157177033492,0.92,BP
GO:0021879,forebrain neuron differentiation,76,5,5.49,0.65010,1,0.9349316198445905,0.91,BP
GO:0055008,cardiac muscle tissue morphogenesis,76,5,5.49,0.65010,1,0.9349316198445905,0.91,BP
GO:0001736,establishment of planar polarity,61,4,4.41,0.65122,1,0.9359828673835126,0.91,BP
GO:1905207,regulation of cardiocyte differentiation,61,4,4.41,0.65122,1,0.9359828673835126,0.91,BP
GO:0030154,cell differentiation,4243,301,306.5,0.65294,1,0.9381747626157061,0.98,BP
GO:0001990,regulation of systemic arterial blood pr...,46,3,3.32,0.65531,1,0.9404568207575306,0.9,BP
GO:0010259,multicellular organism aging,46,3,3.32,0.65531,1,0.9404568207575306,0.9,BP
GO:0016574,histone ubiquitination,46,3,3.32,0.65531,1,0.9404568207575306,0.9,BP
GO:0042073,intraciliary transport,46,3,3.32,0.65531,1,0.9404568207575306,0.9,BP
GO:0002708,positive regulation of lymphocyte mediat...,136,9,9.82,0.65574,1,0.9407933452593918,0.92,BP
GO:0055006,cardiac cell development,107,7,7.73,0.66152,1,0.9475927519952704,0.91,BP
GO:0000271,polysaccharide biosynthetic process,77,5,5.56,0.66153,1,0.9475927519952704,0.9,BP
GO:0035239,tube morphogenesis,911,63,65.81,0.66232,1,0.9475927519952704,0.96,BP
GO:0046717,acid secretion,122,8,8.81,0.66271,1,0.9475927519952704,0.91,BP
GO:0019933,cAMP-mediated signaling,181,12,13.07,0.66314,1,0.9475927519952704,0.92,BP
GO:0007164,establishment of tissue polarity,62,4,4.48,0.66390,1,0.9475927519952704,0.89,BP
GO:0045143,homologous chromosome segregation,62,4,4.48,0.66390,1,0.9475927519952704,0.89,BP
GO:0045600,positive regulation of fat cell differen...,62,4,4.48,0.66390,1,0.9475927519952704,0.89,BP
GO:0001832,blastocyst growth,31,2,2.24,0.66619,1,0.9475927519952704,0.89,BP
GO:0002230,positive regulation of defense response ...,31,2,2.24,0.66619,1,0.9475927519952704,0.89,BP
GO:0002428,antigen processing and presentation of p...,31,2,2.24,0.66619,1,0.9475927519952704,0.89,BP
GO:0003309,type B pancreatic cell differentiation,31,2,2.24,0.66619,1,0.9475927519952704,0.89,BP
GO:0006482,protein demethylation,31,2,2.24,0.66619,1,0.9475927519952704,0.89,BP
GO:0006767,water-soluble vitamin metabolic process,31,2,2.24,0.66619,1,0.9475927519952704,0.89,BP
GO:0007602,phototransduction,31,2,2.24,0.66619,1,0.9475927519952704,0.89,BP
GO:0008214,protein dealkylation,31,2,2.24,0.66619,1,0.9475927519952704,0.89,BP
GO:0009262,deoxyribonucleotide metabolic process,31,2,2.24,0.66619,1,0.9475927519952704,0.89,BP
GO:0010043,response to zinc ion,31,2,2.24,0.66619,1,0.9475927519952704,0.89,BP
GO:0032967,positive regulation of collagen biosynth...,31,2,2.24,0.66619,1,0.9475927519952704,0.89,BP
GO:0033561,regulation of water loss via skin,31,2,2.24,0.66619,1,0.9475927519952704,0.89,BP
GO:0035767,endothelial cell chemotaxis,31,2,2.24,0.66619,1,0.9475927519952704,0.89,BP
GO:0044818,mitotic G2/M transition checkpoint,31,2,2.24,0.66619,1,0.9475927519952704,0.89,BP
GO:0045652,regulation of megakaryocyte differentiat...,31,2,2.24,0.66619,1,0.9475927519952704,0.89,BP
GO:0060914,heart formation,31,2,2.24,0.66619,1,0.9475927519952704,0.89,BP
GO:0071875,adrenergic receptor signaling pathway,31,2,2.24,0.66619,1,0.9475927519952704,0.89,BP
GO:0090022,regulation of neutrophil chemotaxis,31,2,2.24,0.66619,1,0.9475927519952704,0.89,BP
GO:0098884,postsynaptic neurotransmitter receptor i...,31,2,2.24,0.66619,1,0.9475927519952704,0.89,BP
GO:0140239,postsynaptic endocytosis,31,2,2.24,0.66619,1,0.9475927519952704,0.89,BP
GO:2000352,negative regulation of endothelial cell ...,31,2,2.24,0.66619,1,0.9475927519952704,0.89,BP
GO:0002682,regulation of immune system process,1351,94,97.59,0.66770,1,0.9494599290780141,0.96,BP
GO:0010677,negative regulation of cellular carbohyd...,47,3,3.4,0.66973,1,0.9509415048686929,0.88,BP
GO:0021532,neural tube patterning,47,3,3.4,0.66973,1,0.9509415048686929,0.88,BP
GO:0032309,icosanoid secretion,47,3,3.4,0.66973,1,0.9509415048686929,0.88,BP
GO:0045907,positive regulation of vasoconstriction,47,3,3.4,0.66973,1,0.9509415048686929,0.88,BP
GO:0071300,cellular response to retinoic acid,47,3,3.4,0.66973,1,0.9509415048686929,0.88,BP
GO:0003014,renal system process,108,7,7.8,0.67108,1,0.9525772743362831,0.9,BP
GO:0060759,regulation of response to cytokine stimu...,123,8,8.89,0.67167,1,0.9531336007077558,0.9,BP
GO:0043507,positive regulation of JUN kinase activi...,78,5,5.63,0.67272,1,0.9539782911019447,0.89,BP
GO:1901606,alpha-amino acid catabolic process,78,5,5.63,0.67272,1,0.9539782911019447,0.89,BP
GO:1903046,meiotic cell cycle process,197,13,14.23,0.67286,1,0.9539782911019447,0.91,BP
GO:0030858,positive regulation of epithelial cell d...,63,4,4.55,0.67626,1,0.9579520518104209,0.88,BP
GO:0043966,histone H3 acetylation,63,4,4.55,0.67626,1,0.9579520518104209,0.88,BP
GO:2000242,negative regulation of reproductive proc...,63,4,4.55,0.67626,1,0.9579520518104209,0.88,BP
GO:0009612,response to mechanical stimulus,183,12,13.22,0.67786,1,0.9596535216240071,0.91,BP
GO:0035051,cardiocyte differentiation,183,12,13.22,0.67786,1,0.9596535216240071,0.91,BP
GO:0008202,steroid metabolic process,300,20,21.67,0.67848,1,0.9602487529411764,0.92,BP
GO:0031343,positive regulation of cell killing,94,6,6.79,0.68135,1,0.9614156633547634,0.88,BP
GO:0001964,startle response,32,2,2.31,0.68326,1,0.9614156633547634,0.87,BP
GO:0002675,positive regulation of acute inflammator...,32,2,2.31,0.68326,1,0.9614156633547634,0.87,BP
GO:0002828,regulation of type 2 immune response,32,2,2.31,0.68326,1,0.9614156633547634,0.87,BP
GO:0010614,negative regulation of cardiac muscle hy...,32,2,2.31,0.68326,1,0.9614156633547634,0.87,BP
GO:0031572,G2 DNA damage checkpoint,32,2,2.31,0.68326,1,0.9614156633547634,0.87,BP
GO:0035329,hippo signaling,32,2,2.31,0.68326,1,0.9614156633547634,0.87,BP
GO:0045616,regulation of keratinocyte differentiati...,32,2,2.31,0.68326,1,0.9614156633547634,0.87,BP
GO:0046466,membrane lipid catabolic process,32,2,2.31,0.68326,1,0.9614156633547634,0.87,BP
GO:0048011,neurotrophin TRK receptor signaling path...,32,2,2.31,0.68326,1,0.9614156633547634,0.87,BP
GO:0070741,response to interleukin-6,32,2,2.31,0.68326,1,0.9614156633547634,0.87,BP
GO:0032088,negative regulation of NF-kappaB transcr...,79,5,5.71,0.68366,1,0.9614156633547634,0.88,BP
GO:0051279,regulation of release of sequestered cal...,79,5,5.71,0.68366,1,0.9614156633547634,0.88,BP
GO:0061844,antimicrobial humoral immune response me...,79,5,5.71,0.68366,1,0.9614156633547634,0.88,BP
GO:0002474,antigen processing and presentation of p...,48,3,3.47,0.68370,1,0.9614156633547634,0.86,BP
GO:0007131,reciprocal meiotic recombination,48,3,3.47,0.68370,1,0.9614156633547634,0.86,BP
GO:0031952,regulation of protein autophosphorylatio...,48,3,3.47,0.68370,1,0.9614156633547634,0.86,BP
GO:0038066,p38MAPK cascade,48,3,3.47,0.68370,1,0.9614156633547634,0.86,BP
GO:0042755,eating behavior,48,3,3.47,0.68370,1,0.9614156633547634,0.86,BP
GO:0045104,intermediate filament cytoskeleton organ...,48,3,3.47,0.68370,1,0.9614156633547634,0.86,BP
GO:0048701,embryonic cranial skeleton morphogenesis,48,3,3.47,0.68370,1,0.9614156633547634,0.86,BP
GO:0050853,B cell receptor signaling pathway,48,3,3.47,0.68370,1,0.9614156633547634,0.86,BP
GO:0006486,protein glycosylation,199,13,14.38,0.68681,1,0.9652248014018692,0.9,BP
GO:0043413,macromolecule glycosylation,199,13,14.38,0.68681,1,0.9652248014018692,0.9,BP
GO:0010830,regulation of myotube differentiation,64,4,4.62,0.68830,1,0.96675411558669,0.87,BP
GO:0030512,negative regulation of transforming grow...,64,4,4.62,0.68830,1,0.96675411558669,0.87,BP
GO:0030316,osteoclast differentiation,110,7,7.95,0.68968,1,0.9684097344616283,0.88,BP
GO:0007507,heart development,634,43,45.8,0.69083,1,0.9696271216097987,0.94,BP
GO:0060401,cytosolic calcium ion transport,170,11,12.28,0.69095,1,0.9696271216097987,0.9,BP
GO:0001704,formation of primary germ layer,95,6,6.86,0.69123,1,0.9697372478134111,0.87,BP
GO:0030500,regulation of bone mineralization,80,5,5.78,0.69435,1,0.973830428446517,0.87,BP
GO:0002274,myeloid leukocyte activation,215,14,15.53,0.69524,1,0.9742268142108328,0.9,BP
GO:0016054,organic acid catabolic process,215,14,15.53,0.69524,1,0.9742268142108328,0.9,BP
GO:0046395,carboxylic acid catabolic process,215,14,15.53,0.69524,1,0.9742268142108328,0.9,BP
GO:0090287,regulation of cellular response to growt...,274,18,19.79,0.69669,1,0.9747305752469494,0.91,BP
GO:1901617,organic hydroxy compound biosynthetic pr...,230,15,16.61,0.69694,1,0.9747305752469494,0.9,BP
GO:0007520,myoblast fusion,49,3,3.54,0.69722,1,0.9747305752469494,0.85,BP
GO:0035825,homologous recombination,49,3,3.54,0.69722,1,0.9747305752469494,0.85,BP
GO:0042088,T-helper 1 type immune response,49,3,3.54,0.69722,1,0.9747305752469494,0.85,BP
GO:0043300,regulation of leukocyte degranulation,49,3,3.54,0.69722,1,0.9747305752469494,0.85,BP
GO:0045103,intermediate filament-based process,49,3,3.54,0.69722,1,0.9747305752469494,0.85,BP
GO:1904036,negative regulation of epithelial cell a...,49,3,3.54,0.69722,1,0.9747305752469494,0.85,BP
GO:0003016,respiratory system process,33,2,2.38,0.69961,1,0.9752385052143685,0.84,BP
GO:0032467,positive regulation of cytokinesis,33,2,2.38,0.69961,1,0.9752385052143685,0.84,BP
GO:0032660,regulation of interleukin-17 production,33,2,2.38,0.69961,1,0.9752385052143685,0.84,BP
GO:0032692,negative regulation of interleukin-1 pro...,33,2,2.38,0.69961,1,0.9752385052143685,0.84,BP
GO:0032743,positive regulation of interleukin-2 pro...,33,2,2.38,0.69961,1,0.9752385052143685,0.84,BP
GO:0035094,response to nicotine,33,2,2.38,0.69961,1,0.9752385052143685,0.84,BP
GO:0043950,positive regulation of cAMP-mediated sig...,33,2,2.38,0.69961,1,0.9752385052143685,0.84,BP
GO:1901976,regulation of cell cycle checkpoint,33,2,2.38,0.69961,1,0.9752385052143685,0.84,BP
GO:1903429,regulation of cell maturation,33,2,2.38,0.69961,1,0.9752385052143685,0.84,BP
GO:2000108,positive regulation of leukocyte apoptot...,33,2,2.38,0.69961,1,0.9752385052143685,0.84,BP
GO:0002763,positive regulation of myeloid leukocyte...,65,4,4.7,0.70002,1,0.9752450028951939,0.85,BP
GO:0033627,cell adhesion mediated by integrin,65,4,4.7,0.70002,1,0.9752450028951939,0.85,BP
GO:0045637,regulation of myeloid cell differentiati...,216,14,15.6,0.70175,1,0.9773722141823443,0.9,BP
GO:0060113,inner ear receptor cell differentiation,81,5,5.85,0.70479,1,0.9813221875000001,0.85,BP
GO:0007369,gastrulation,172,11,12.42,0.70550,1,0.9820266126699451,0.89,BP
GO:0001959,regulation of cytokine-mediated signalin...,112,7,8.09,0.70760,1,0.984380225498699,0.87,BP
GO:0007127,meiosis I,112,7,8.09,0.70760,1,0.984380225498699,0.87,BP
GO:0035265,organ growth,217,14,15.68,0.70817,1,0.9848884508670519,0.89,BP
GO:0060348,bone development,232,15,16.76,0.70943,1,0.9853372459204124,0.89,BP
GO:0002639,positive regulation of immunoglobulin pr...,50,3,3.61,0.71030,1,0.9853372459204124,0.83,BP
GO:0032941,secretion by tissue,50,3,3.61,0.71030,1,0.9853372459204124,0.83,BP
GO:0033173,calcineurin-NFAT signaling cascade,50,3,3.61,0.71030,1,0.9853372459204124,0.83,BP
GO:0050891,multicellular organismal water homeostas...,50,3,3.61,0.71030,1,0.9853372459204124,0.83,BP
GO:0120193,tight junction organization,50,3,3.61,0.71030,1,0.9853372459204124,0.83,BP
GO:0006304,DNA modification,97,6,7.01,0.71038,1,0.9853372459204124,0.86,BP
GO:0014066,regulation of phosphatidylinositol 3-kin...,97,6,7.01,0.71038,1,0.9853372459204124,0.86,BP
GO:0048644,muscle organ morphogenesis,97,6,7.01,0.71038,1,0.9853372459204124,0.86,BP
GO:0019748,secondary metabolic process,66,4,4.77,0.71142,1,0.9853372459204124,0.84,BP
GO:0035456,response to interferon-beta,66,4,4.77,0.71142,1,0.9853372459204124,0.84,BP
GO:0043647,inositol phosphate metabolic process,66,4,4.77,0.71142,1,0.9853372459204124,0.84,BP
GO:1904888,cranial skeletal system development,66,4,4.77,0.71142,1,0.9853372459204124,0.84,BP
GO:0035296,regulation of tube diameter,173,11,12.5,0.71262,1,0.9853372459204124,0.88,BP
GO:0050880,regulation of blood vessel size,173,11,12.5,0.71262,1,0.9853372459204124,0.88,BP
GO:0097746,regulation of blood vessel diameter,173,11,12.5,0.71262,1,0.9853372459204124,0.88,BP
GO:0002440,production of molecular mediator of immu...,218,14,15.75,0.71451,1,0.9853372459204124,0.89,BP
GO:0001738,morphogenesis of a polarized epithelium,82,5,5.92,0.71498,1,0.9853372459204124,0.84,BP
GO:0046530,photoreceptor cell differentiation,82,5,5.92,0.71498,1,0.9853372459204124,0.84,BP
GO:0002446,neutrophil mediated immunity,34,2,2.46,0.71525,1,0.9853372459204124,0.81,BP
GO:0002717,positive regulation of natural killer ce...,34,2,2.46,0.71525,1,0.9853372459204124,0.81,BP
GO:0010543,regulation of platelet activation,34,2,2.46,0.71525,1,0.9853372459204124,0.81,BP
GO:0010714,positive regulation of collagen metaboli...,34,2,2.46,0.71525,1,0.9853372459204124,0.81,BP
GO:0010837,regulation of keratinocyte proliferation,34,2,2.46,0.71525,1,0.9853372459204124,0.81,BP
GO:0014741,negative regulation of muscle hypertroph...,34,2,2.46,0.71525,1,0.9853372459204124,0.81,BP
GO:0015804,neutral amino acid transport,34,2,2.46,0.71525,1,0.9853372459204124,0.81,BP
GO:0035116,embryonic hindlimb morphogenesis,34,2,2.46,0.71525,1,0.9853372459204124,0.81,BP
GO:0035883,enteroendocrine cell differentiation,34,2,2.46,0.71525,1,0.9853372459204124,0.81,BP
GO:0042832,defense response to protozoan,34,2,2.46,0.71525,1,0.9853372459204124,0.81,BP
GO:0045954,positive regulation of natural killer ce...,34,2,2.46,0.71525,1,0.9853372459204124,0.81,BP
GO:0060487,lung epithelial cell differentiation,34,2,2.46,0.71525,1,0.9853372459204124,0.81,BP
GO:0071634,regulation of transforming growth factor...,34,2,2.46,0.71525,1,0.9853372459204124,0.81,BP
GO:1904467,regulation of tumor necrosis factor secr...,34,2,2.46,0.71525,1,0.9853372459204124,0.81,BP
GO:0032612,interleukin-1 production,113,7,8.16,0.71629,1,0.986487544361763,0.86,BP
GO:0035150,regulation of tube size,174,11,12.57,0.71962,1,0.9906144425385935,0.88,BP
GO:0050870,positive regulation of T cell activation,189,12,13.65,0.71971,1,0.9906144425385935,0.88,BP
GO:0048015,phosphatidylinositol-mediated signaling,159,10,11.49,0.71993,1,0.9906144425385935,0.87,BP
GO:0003018,vascular process in circulatory system,204,13,14.74,0.72011,1,0.9906144425385935,0.88,BP
GO:0043547,positive regulation of GTPase activity,219,14,15.82,0.72076,1,0.9909557828571428,0.88,BP
GO:0046330,positive regulation of JNK cascade,144,9,10.4,0.72077,1,0.9909557828571428,0.87,BP
GO:0006940,regulation of smooth muscle contraction,67,4,4.84,0.72250,1,0.9922382430119795,0.83,BP
GO:0001974,blood vessel remodeling,51,3,3.68,0.72294,1,0.9922382430119795,0.82,BP
GO:0006111,regulation of gluconeogenesis,51,3,3.68,0.72294,1,0.9922382430119795,0.82,BP
GO:0032355,response to estradiol,51,3,3.68,0.72294,1,0.9922382430119795,0.82,BP
GO:0033619,membrane protein proteolysis,51,3,3.68,0.72294,1,0.9922382430119795,0.82,BP
GO:0046189,phenol-containing compound biosynthetic ...,51,3,3.68,0.72294,1,0.9922382430119795,0.82,BP
GO:0060419,heart growth,114,7,8.24,0.72481,1,0.9942376624857467,0.85,BP
GO:1904019,epithelial cell apoptotic process,114,7,8.24,0.72481,1,0.9942376624857467,0.85,BP
GO:1903037,regulation of leukocyte cell-cell adhesi...,294,19,21.24,0.72622,1,0.9957043577328397,0.89,BP
GO:0007188,adenylate cyclase-modulating G protein-c...,205,13,14.81,0.72650,1,0.9957043577328397,0.88,BP
GO:1903039,positive regulation of leukocyte cell-ce...,205,13,14.81,0.72650,1,0.9957043577328397,0.88,BP
GO:0002475,antigen processing and presentation via ...,35,2,2.53,0.73020,1,0.9982165909090908,0.79,BP
GO:0007143,female meiotic nuclear division,35,2,2.53,0.73020,1,0.9982165909090908,0.79,BP
GO:0008045,motor neuron axon guidance,35,2,2.53,0.73020,1,0.9982165909090908,0.79,BP
GO:0019432,triglyceride biosynthetic process,35,2,2.53,0.73020,1,0.9982165909090908,0.79,BP
GO:0031338,regulation of vesicle fusion,35,2,2.53,0.73020,1,0.9982165909090908,0.79,BP
GO:0045940,positive regulation of steroid metabolic...,35,2,2.53,0.73020,1,0.9982165909090908,0.79,BP
GO:0060479,lung cell differentiation,35,2,2.53,0.73020,1,0.9982165909090908,0.79,BP
GO:1902895,positive regulation of pri-miRNA transcr...,35,2,2.53,0.73020,1,0.9982165909090908,0.79,BP
GO:2000036,regulation of stem cell population maint...,35,2,2.53,0.73020,1,0.9982165909090908,0.79,BP
GO:0034109,homotypic cell-cell adhesion,68,4,4.91,0.73326,1,1,0.81,BP
GO:0006672,ceramide metabolic process,84,5,6.07,0.73460,1,1,0.82,BP
GO:0045844,positive regulation of striated muscle t...,84,5,6.07,0.73460,1,1,0.82,BP
GO:0048636,positive regulation of muscle organ deve...,84,5,6.07,0.73460,1,1,0.82,BP
GO:0000288,nuclear-transcribed mRNA catabolic proce...,52,3,3.76,0.73515,1,1,0.8,BP
GO:0031018,endocrine pancreas development,52,3,3.76,0.73515,1,1,0.8,BP
GO:0045124,regulation of bone resorption,52,3,3.76,0.73515,1,1,0.8,BP
GO:0045912,negative regulation of carbohydrate meta...,52,3,3.76,0.73515,1,1,0.8,BP
GO:1902750,negative regulation of cell cycle G2/M p...,52,3,3.76,0.73515,1,1,0.8,BP
GO:0071219,cellular response to molecule of bacteri...,281,18,20.3,0.73575,1,1,0.89,BP
GO:0030101,natural killer cell activation,100,6,7.22,0.73753,1,1,0.83,BP
GO:0032652,regulation of interleukin-1 production,100,6,7.22,0.73753,1,1,0.83,BP
GO:0035710,"CD4-positive, alpha-beta T cell activati...",100,6,7.22,0.73753,1,1,0.83,BP
GO:0061458,reproductive system development,458,30,33.08,0.73883,1,1,0.91,BP
GO:0006310,DNA recombination,282,18,20.37,0.74106,1,1,0.88,BP
GO:0048017,inositol lipid-mediated signaling,162,10,11.7,0.74114,1,1,0.85,BP
GO:0045216,cell-cell junction organization,147,9,10.62,0.74294,1,1,0.85,BP
GO:0001541,ovarian follicle development,69,4,4.98,0.74371,1,1,0.8,BP
GO:0007405,neuroblast proliferation,69,4,4.98,0.74371,1,1,0.8,BP
GO:0021536,diencephalon development,69,4,4.98,0.74371,1,1,0.8,BP
GO:1901863,positive regulation of muscle tissue dev...,85,5,6.14,0.74403,1,1,0.81,BP
GO:0003401,axis elongation,36,2,2.6,0.74448,1,1,0.77,BP
GO:0009112,nucleobase metabolic process,36,2,2.6,0.74448,1,1,0.77,BP
GO:0043114,regulation of vascular permeability,36,2,2.6,0.74448,1,1,0.77,BP
GO:0048009,insulin-like growth factor receptor sign...,36,2,2.6,0.74448,1,1,0.77,BP
GO:0051953,negative regulation of amine transport,36,2,2.6,0.74448,1,1,0.77,BP
GO:0071604,transforming growth factor beta producti...,36,2,2.6,0.74448,1,1,0.77,BP
GO:1904037,positive regulation of epithelial cell a...,36,2,2.6,0.74448,1,1,0.77,BP
GO:1990774,tumor necrosis factor secretion,36,2,2.6,0.74448,1,1,0.77,BP
GO:2000516,"positive regulation of CD4-positive, alp...",36,2,2.6,0.74448,1,1,0.77,BP
GO:0033559,unsaturated fatty acid metabolic process,101,6,7.3,0.74617,1,1,0.82,BP
GO:0042310,vasoconstriction,101,6,7.3,0.74617,1,1,0.82,BP
GO:0055013,cardiac muscle cell development,101,6,7.3,0.74617,1,1,0.82,BP
GO:0055024,regulation of cardiac muscle tissue deve...,101,6,7.3,0.74617,1,1,0.82,BP
GO:0071715,icosanoid transport,53,3,3.83,0.74692,1,1,0.78,BP
GO:0097720,calcineurin-mediated signaling,53,3,3.83,0.74692,1,1,0.78,BP
GO:1901571,fatty acid derivative transport,53,3,3.83,0.74692,1,1,0.78,BP
GO:0061982,meiosis I cell cycle process,117,7,8.45,0.74931,1,1,0.83,BP
GO:0003206,cardiac chamber morphogenesis,148,9,10.69,0.75006,1,1,0.84,BP
GO:0007219,Notch signaling pathway,179,11,12.93,0.75298,1,1,0.85,BP
GO:0034103,regulation of tissue remodeling,86,5,6.21,0.75322,1,1,0.81,BP
GO:0001562,response to protozoan,37,2,2.67,0.75811,1,1,0.75,BP
GO:0001782,B cell homeostasis,37,2,2.67,0.75811,1,1,0.75,BP
GO:0002483,antigen processing and presentation of e...,37,2,2.67,0.75811,1,1,0.75,BP
GO:0019885,antigen processing and presentation of e...,37,2,2.67,0.75811,1,1,0.75,BP
GO:0035850,epithelial cell differentiation involved...,37,2,2.67,0.75811,1,1,0.75,BP
GO:0045601,regulation of endothelial cell different...,37,2,2.67,0.75811,1,1,0.75,BP
GO:0045684,positive regulation of epidermis develop...,37,2,2.67,0.75811,1,1,0.75,BP
GO:0060142,regulation of syncytium formation by pla...,37,2,2.67,0.75811,1,1,0.75,BP
GO:0086065,cell communication involved in cardiac c...,37,2,2.67,0.75811,1,1,0.75,BP
GO:0006289,nucleotide-excision repair,54,3,3.9,0.75828,1,1,0.77,BP
GO:0045604,regulation of epidermal cell differentia...,54,3,3.9,0.75828,1,1,0.77,BP
GO:0051290,protein heterotetramerization,54,3,3.9,0.75828,1,1,0.77,BP
GO:0055025,positive regulation of cardiac muscle ti...,54,3,3.9,0.75828,1,1,0.77,BP
GO:2000351,regulation of endothelial cell apoptotic...,54,3,3.9,0.75828,1,1,0.77,BP
GO:0002698,negative regulation of immune effector p...,134,8,9.68,0.76030,1,1,0.83,BP
GO:0043583,ear development,241,15,17.41,0.76162,1,1,0.86,BP
GO:0003281,ventricular septum development,87,5,6.28,0.76216,1,1,0.8,BP
GO:0042475,odontogenesis of dentin-containing tooth,87,5,6.28,0.76216,1,1,0.8,BP
GO:0042490,mechanoreceptor differentiation,87,5,6.28,0.76216,1,1,0.8,BP
GO:0048839,inner ear development,211,13,15.24,0.76283,1,1,0.85,BP
GO:0001910,regulation of leukocyte mediated cytotox...,103,6,7.44,0.76283,1,1,0.81,BP
GO:0019218,regulation of steroid metabolic process,103,6,7.44,0.76283,1,1,0.81,BP
GO:0045669,positive regulation of osteoblast differ...,71,4,5.13,0.76365,1,1,0.78,BP
GO:0070192,chromosome organization involved in meio...,71,4,5.13,0.76365,1,1,0.78,BP
GO:0048771,tissue remodeling,196,12,14.16,0.76395,1,1,0.85,BP
GO:0002526,acute inflammatory response,119,7,8.6,0.76475,1,1,0.81,BP
GO:0051282,regulation of sequestering of calcium io...,119,7,8.6,0.76475,1,1,0.81,BP
GO:0097306,cellular response to alcohol,135,8,9.75,0.76743,1,1,0.82,BP
GO:0007179,transforming growth factor beta receptor...,166,10,11.99,0.76770,1,1,0.83,BP
GO:0001523,retinoid metabolic process,55,3,3.97,0.76921,1,1,0.76,BP
GO:0045058,T cell selection,55,3,3.97,0.76921,1,1,0.76,BP
GO:0050922,negative regulation of chemotaxis,55,3,3.97,0.76921,1,1,0.76,BP
GO:0010717,regulation of epithelial to mesenchymal ...,88,5,6.36,0.77085,1,1,0.79,BP
GO:0040019,positive regulation of embryonic develop...,38,2,2.75,0.77110,1,1,0.73,BP
GO:0042092,type 2 immune response,38,2,2.75,0.77110,1,1,0.73,BP
GO:0043368,positive T cell selection,38,2,2.75,0.77110,1,1,0.73,BP
GO:0046460,neutral lipid biosynthetic process,38,2,2.75,0.77110,1,1,0.73,BP
GO:0046463,acylglycerol biosynthetic process,38,2,2.75,0.77110,1,1,0.73,BP
GO:0046640,regulation of alpha-beta T cell prolifer...,38,2,2.75,0.77110,1,1,0.73,BP
GO:0060259,regulation of feeding behavior,38,2,2.75,0.77110,1,1,0.73,BP
GO:0097028,dendritic cell differentiation,38,2,2.75,0.77110,1,1,0.73,BP
GO:2000463,positive regulation of excitatory postsy...,38,2,2.75,0.77110,1,1,0.73,BP
GO:0071222,cellular response to lipopolysaccharide,273,17,19.72,0.77156,1,1,0.86,BP
GO:0051208,sequestering of calcium ion,120,7,8.67,0.77221,1,1,0.81,BP
GO:0097755,positive regulation of blood vessel diam...,72,4,5.2,0.77316,1,1,0.77,BP
GO:2000779,regulation of double-strand break repair,72,4,5.2,0.77316,1,1,0.77,BP
GO:0070085,glycosylation,213,13,15.39,0.77418,1,1,0.84,BP
GO:0097553,calcium ion transmembrane import into cy...,136,8,9.82,0.77441,1,1,0.81,BP
GO:0002313,mature B cell differentiation involved i...,20,1,1.44,0.77693,1,1,0.69,BP
GO:0002755,MyD88-dependent toll-like receptor signa...,20,1,1.44,0.77693,1,1,0.69,BP
GO:0006525,arginine metabolic process,20,1,1.44,0.77693,1,1,0.69,BP
GO:0006625,protein targeting to peroxisome,20,1,1.44,0.77693,1,1,0.69,BP
GO:0006688,glycosphingolipid biosynthetic process,20,1,1.44,0.77693,1,1,0.69,BP
GO:0010842,retina layer formation,20,1,1.44,0.77693,1,1,0.69,BP
GO:0043574,peroxisomal transport,20,1,1.44,0.77693,1,1,0.69,BP
GO:0043931,ossification involved in bone maturation,20,1,1.44,0.77693,1,1,0.69,BP
GO:0045649,regulation of macrophage differentiation,20,1,1.44,0.77693,1,1,0.69,BP
GO:0045986,negative regulation of smooth muscle con...,20,1,1.44,0.77693,1,1,0.69,BP
GO:0046131,pyrimidine ribonucleoside metabolic proc...,20,1,1.44,0.77693,1,1,0.69,BP
GO:0048557,embryonic digestive tract morphogenesis,20,1,1.44,0.77693,1,1,0.69,BP
GO:0055064,chloride ion homeostasis,20,1,1.44,0.77693,1,1,0.69,BP
GO:0060307,regulation of ventricular cardiac muscle...,20,1,1.44,0.77693,1,1,0.69,BP
GO:0061162,establishment of monopolar cell polarity,20,1,1.44,0.77693,1,1,0.69,BP
GO:0072662,protein localization to peroxisome,20,1,1.44,0.77693,1,1,0.69,BP
GO:0072663,establishment of protein localization to...,20,1,1.44,0.77693,1,1,0.69,BP
GO:0090036,regulation of protein kinase C signaling,20,1,1.44,0.77693,1,1,0.69,BP
GO:0098743,cell aggregation,20,1,1.44,0.77693,1,1,0.69,BP
GO:2000678,negative regulation of transcription reg...,20,1,1.44,0.77693,1,1,0.69,BP
GO:2000726,negative regulation of cardiac muscle ce...,20,1,1.44,0.77693,1,1,0.69,BP
GO:0060415,muscle tissue morphogenesis,89,5,6.43,0.77929,1,1,0.78,BP
GO:1903035,negative regulation of response to wound...,89,5,6.43,0.77929,1,1,0.78,BP
GO:1904035,regulation of epithelial cell apoptotic ...,89,5,6.43,0.77929,1,1,0.78,BP
GO:0007585,respiratory gaseous exchange,56,3,4.05,0.77974,1,1,0.74,BP
GO:0030104,water homeostasis,56,3,4.05,0.77974,1,1,0.74,BP
GO:0046513,ceramide biosynthetic process,56,3,4.05,0.77974,1,1,0.74,BP
GO:0009791,post-embryonic development,137,8,9.9,0.78124,1,1,0.81,BP
GO:0048608,reproductive structure development,454,29,32.8,0.78168,1,1,0.88,BP
GO:0007422,peripheral nervous system development,73,4,5.27,0.78237,1,1,0.76,BP
GO:0007340,acrosome reaction,39,2,2.82,0.78348,1,1,0.71,BP
GO:0010831,positive regulation of myotube different...,39,2,2.82,0.78348,1,1,0.71,BP
GO:0016339,calcium-dependent cell-cell adhesion via...,39,2,2.82,0.78348,1,1,0.71,BP
GO:0048821,erythrocyte development,39,2,2.82,0.78348,1,1,0.71,BP
GO:1902476,chloride transmembrane transport,39,2,2.82,0.78348,1,1,0.71,BP
GO:0048646,anatomical structure formation involved ...,1168,78,84.37,0.78638,1,1,0.92,BP
GO:0008584,male gonad development,122,7,8.81,0.78660,1,1,0.79,BP
GO:0042089,cytokine biosynthetic process,122,7,8.81,0.78660,1,1,0.79,BP
GO:1903524,positive regulation of blood circulation,90,5,6.5,0.78750,1,1,0.77,BP
GO:0016101,diterpenoid metabolic process,57,3,4.12,0.78987,1,1,0.73,BP
GO:0042551,neuron maturation,57,3,4.12,0.78987,1,1,0.73,BP
GO:0043536,positive regulation of blood vessel endo...,57,3,4.12,0.78987,1,1,0.73,BP
GO:0051445,regulation of meiotic cell cycle,57,3,4.12,0.78987,1,1,0.73,BP
GO:0002237,response to molecule of bacterial origin,367,23,26.51,0.79010,1,1,0.87,BP
GO:0002066,columnar/cuboidal epithelial cell develo...,74,4,5.35,0.79128,1,1,0.75,BP
GO:0042108,positive regulation of cytokine biosynth...,74,4,5.35,0.79128,1,1,0.75,BP
GO:2000241,regulation of reproductive process,170,10,12.28,0.79228,1,1,0.81,BP
GO:0002097,tRNA wobble base modification,21,1,1.52,0.79306,1,1,0.66,BP
GO:0002495,antigen processing and presentation of p...,21,1,1.52,0.79306,1,1,0.66,BP
GO:0003283,atrial septum development,21,1,1.52,0.79306,1,1,0.66,BP
GO:0006349,regulation of gene expression by genetic...,21,1,1.52,0.79306,1,1,0.66,BP
GO:0008210,estrogen metabolic process,21,1,1.52,0.79306,1,1,0.66,BP
GO:0010560,positive regulation of glycoprotein bios...,21,1,1.52,0.79306,1,1,0.66,BP
GO:0010743,regulation of macrophage derived foam ce...,21,1,1.52,0.79306,1,1,0.66,BP
GO:0010866,regulation of triglyceride biosynthetic ...,21,1,1.52,0.79306,1,1,0.66,BP
GO:0014808,release of sequestered calcium ion into ...,21,1,1.52,0.79306,1,1,0.66,BP
GO:0035357,peroxisome proliferator activated recept...,21,1,1.52,0.79306,1,1,0.66,BP
GO:0042535,positive regulation of tumor necrosis fa...,21,1,1.52,0.79306,1,1,0.66,BP
GO:0043369,"CD4-positive or CD8-positive, alpha-beta...",21,1,1.52,0.79306,1,1,0.66,BP
GO:0043586,tongue development,21,1,1.52,0.79306,1,1,0.66,BP
GO:0043984,histone H4-K16 acetylation,21,1,1.52,0.79306,1,1,0.66,BP
GO:0045948,positive regulation of translational ini...,21,1,1.52,0.79306,1,1,0.66,BP
GO:0048569,post-embryonic animal organ development,21,1,1.52,0.79306,1,1,0.66,BP
GO:0051770,positive regulation of nitric-oxide synt...,21,1,1.52,0.79306,1,1,0.66,BP
GO:0060457,negative regulation of digestive system ...,21,1,1.52,0.79306,1,1,0.66,BP
GO:0061339,establishment or maintenance of monopola...,21,1,1.52,0.79306,1,1,0.66,BP
GO:0070230,positive regulation of lymphocyte apopto...,21,1,1.52,0.79306,1,1,0.66,BP
GO:0070633,transepithelial transport,21,1,1.52,0.79306,1,1,0.66,BP
GO:0080111,DNA demethylation,21,1,1.52,0.79306,1,1,0.66,BP
GO:0140058,neuron projection arborization,21,1,1.52,0.79306,1,1,0.66,BP
GO:1900017,positive regulation of cytokine producti...,21,1,1.52,0.79306,1,1,0.66,BP
GO:1901522,positive regulation of transcription fro...,21,1,1.52,0.79306,1,1,0.66,BP
GO:1904666,regulation of ubiquitin protein ligase a...,21,1,1.52,0.79306,1,1,0.66,BP
GO:0046546,development of primary male sexual chara...,123,7,8.89,0.79354,1,1,0.79,BP
GO:0097756,negative regulation of blood vessel diam...,107,6,7.73,0.79368,1,1,0.78,BP
GO:1904894,positive regulation of STAT cascade,107,6,7.73,0.79368,1,1,0.78,BP
GO:0009268,response to pH,40,2,2.89,0.79526,1,1,0.69,BP
GO:0019883,antigen processing and presentation of e...,40,2,2.89,0.79526,1,1,0.69,BP
GO:0030225,macrophage differentiation,40,2,2.89,0.79526,1,1,0.69,BP
GO:0032620,interleukin-17 production,40,2,2.89,0.79526,1,1,0.69,BP
GO:0060603,mammary gland duct morphogenesis,40,2,2.89,0.79526,1,1,0.69,BP
GO:0110111,negative regulation of animal organ morp...,40,2,2.89,0.79526,1,1,0.69,BP
GO:0003170,heart valve development,58,3,4.19,0.79961,1,1,0.72,BP
GO:0048016,inositol phosphate-mediated signaling,58,3,4.19,0.79961,1,1,0.72,BP
GO:0070231,T cell apoptotic process,58,3,4.19,0.79961,1,1,0.72,BP
GO:0002637,regulation of immunoglobulin production,75,4,5.42,0.79989,1,1,0.74,BP
GO:0003333,amino acid transmembrane transport,75,4,5.42,0.79989,1,1,0.74,BP
GO:0045670,regulation of osteoclast differentiation,75,4,5.42,0.79989,1,1,0.74,BP
GO:0048645,animal organ formation,75,4,5.42,0.79989,1,1,0.74,BP
GO:0014902,myotube differentiation,124,7,8.96,0.80030,1,1,0.78,BP
GO:0001676,long-chain fatty acid metabolic process,92,5,6.65,0.80319,1,1,0.75,BP
GO:0009063,cellular amino acid catabolic process,92,5,6.65,0.80319,1,1,0.75,BP
GO:0051251,positive regulation of lymphocyte activa...,265,16,19.14,0.80577,1,1,0.84,BP
GO:0002227,innate immune response in mucosa,41,2,2.96,0.80648,1,1,0.68,BP
GO:0009651,response to salt stress,41,2,2.96,0.80648,1,1,0.68,BP
GO:0010470,regulation of gastrulation,41,2,2.96,0.80648,1,1,0.68,BP
GO:0010972,negative regulation of G2/M transition o...,41,2,2.96,0.80648,1,1,0.68,BP
GO:0031062,positive regulation of histone methylati...,41,2,2.96,0.80648,1,1,0.68,BP
GO:0046633,alpha-beta T cell proliferation,41,2,2.96,0.80648,1,1,0.68,BP
GO:0070884,regulation of calcineurin-NFAT signaling...,41,2,2.96,0.80648,1,1,0.68,BP
GO:0106056,regulation of calcineurin-mediated signa...,41,2,2.96,0.80648,1,1,0.68,BP
GO:0031341,regulation of cell killing,125,7,9.03,0.80689,1,1,0.78,BP
GO:0007159,leukocyte cell-cell adhesion,326,20,23.55,0.80690,1,1,0.85,BP
GO:0001942,hair follicle development,109,6,7.87,0.80791,1,1,0.76,BP
GO:0019882,antigen processing and presentation,109,6,7.87,0.80791,1,1,0.76,BP
GO:0060402,calcium ion transport into cytosol,157,9,11.34,0.80795,1,1,0.79,BP
GO:0001780,neutrophil homeostasis,22,1,1.59,0.80803,1,1,0.63,BP
GO:0002115,store-operated calcium entry,22,1,1.59,0.80803,1,1,0.63,BP
GO:0002504,antigen processing and presentation of p...,22,1,1.59,0.80803,1,1,0.63,BP
GO:0003094,glomerular filtration,22,1,1.59,0.80803,1,1,0.63,BP
GO:0003323,type B pancreatic cell development,22,1,1.59,0.80803,1,1,0.63,BP
GO:0006353,"DNA-templated transcription, termination",22,1,1.59,0.80803,1,1,0.63,BP
GO:0007130,synaptonemal complex assembly,22,1,1.59,0.80803,1,1,0.63,BP
GO:0007141,male meiosis I,22,1,1.59,0.80803,1,1,0.63,BP
GO:0007635,chemosensory behavior,22,1,1.59,0.80803,1,1,0.63,BP
GO:0009404,toxin metabolic process,22,1,1.59,0.80803,1,1,0.63,BP
GO:0016048,detection of temperature stimulus,22,1,1.59,0.80803,1,1,0.63,BP
GO:0021516,dorsal spinal cord development,22,1,1.59,0.80803,1,1,0.63,BP
GO:0022616,DNA strand elongation,22,1,1.59,0.80803,1,1,0.63,BP
GO:0032098,regulation of appetite,22,1,1.59,0.80803,1,1,0.63,BP
GO:0032616,interleukin-13 production,22,1,1.59,0.80803,1,1,0.63,BP
GO:0033008,positive regulation of mast cell activat...,22,1,1.59,0.80803,1,1,0.63,BP
GO:0036314,response to sterol,22,1,1.59,0.80803,1,1,0.63,BP
GO:0042438,melanin biosynthetic process,22,1,1.59,0.80803,1,1,0.63,BP
GO:0042537,benzene-containing compound metabolic pr...,22,1,1.59,0.80803,1,1,0.63,BP
GO:0043306,positive regulation of mast cell degranu...,22,1,1.59,0.80803,1,1,0.63,BP
GO:0045624,positive regulation of T-helper cell dif...,22,1,1.59,0.80803,1,1,0.63,BP
GO:0046339,diacylglycerol metabolic process,22,1,1.59,0.80803,1,1,0.63,BP
GO:0060009,Sertoli cell development,22,1,1.59,0.80803,1,1,0.63,BP
GO:0060602,branch elongation of an epithelium,22,1,1.59,0.80803,1,1,0.63,BP
GO:0070242,thymocyte apoptotic process,22,1,1.59,0.80803,1,1,0.63,BP
GO:0070977,bone maturation,22,1,1.59,0.80803,1,1,0.63,BP
GO:0072111,cell proliferation involved in kidney de...,22,1,1.59,0.80803,1,1,0.63,BP
GO:0090330,regulation of platelet aggregation,22,1,1.59,0.80803,1,1,0.63,BP
GO:0099625,ventricular cardiac muscle cell membrane...,22,1,1.59,0.80803,1,1,0.63,BP
GO:1903514,release of sequestered calcium ion into ...,22,1,1.59,0.80803,1,1,0.63,BP
GO:2000353,positive regulation of endothelial cell ...,22,1,1.59,0.80803,1,1,0.63,BP
GO:0019229,regulation of vasoconstriction,76,4,5.49,0.80821,1,1,0.73,BP
GO:0071347,cellular response to interleukin-1,76,4,5.49,0.80821,1,1,0.73,BP
GO:0002067,glandular epithelial cell differentiatio...,59,3,4.26,0.80897,1,1,0.7,BP
GO:0006661,phosphatidylinositol biosynthetic proces...,59,3,4.26,0.80897,1,1,0.7,BP
GO:0010524,positive regulation of calcium ion trans...,59,3,4.26,0.80897,1,1,0.7,BP
GO:0035567,non-canonical Wnt signaling pathway,59,3,4.26,0.80897,1,1,0.7,BP
GO:0060711,labyrinthine layer development,59,3,4.26,0.80897,1,1,0.7,BP
GO:0002027,regulation of heart rate,93,5,6.72,0.81068,1,1,0.74,BP
GO:0022414,reproductive process,1467,98,105.97,0.81138,1,1,0.92,BP
GO:0000724,double-strand break repair via homologou...,126,7,9.1,0.81332,1,1,0.77,BP
GO:0000725,recombinational repair,126,7,9.1,0.81332,1,1,0.77,BP
GO:0000003,reproduction,1468,98,106.04,0.81339,1,1,0.92,BP
GO:0098742,cell-cell adhesion via plasma-membrane a...,205,12,14.81,0.81343,1,1,0.81,BP
GO:0009410,response to xenobiotic stimulus,236,14,17.05,0.81358,1,1,0.82,BP
GO:0042035,regulation of cytokine biosynthetic proc...,110,6,7.95,0.81473,1,1,0.75,BP
GO:0009605,response to external stimulus,2399,163,173.3,0.81664,1,1,0.94,BP
GO:0001709,cell fate determination,42,2,3.03,0.81714,1,1,0.66,BP
GO:0038083,peptidyl-tyrosine autophosphorylation,42,2,3.03,0.81714,1,1,0.66,BP
GO:0060122,inner ear receptor cell stereocilium org...,42,2,3.03,0.81714,1,1,0.66,BP
GO:2000826,regulation of heart morphogenesis,42,2,3.03,0.81714,1,1,0.66,BP
GO:0001947,heart looping,60,3,4.33,0.81796,1,1,0.69,BP
GO:0021515,cell differentiation in spinal cord,60,3,4.33,0.81796,1,1,0.69,BP
GO:0045776,negative regulation of blood pressure,60,3,4.33,0.81796,1,1,0.69,BP
GO:0050982,detection of mechanical stimulus,60,3,4.33,0.81796,1,1,0.69,BP
GO:0060986,endocrine hormone secretion,60,3,4.33,0.81796,1,1,0.69,BP
GO:0002821,positive regulation of adaptive immune r...,143,8,10.33,0.81903,1,1,0.77,BP
GO:0071230,cellular response to amino acid stimulus,175,10,12.64,0.82026,1,1,0.79,BP
GO:0022404,molting cycle process,111,6,8.02,0.82136,1,1,0.75,BP
GO:0022405,hair cycle process,111,6,8.02,0.82136,1,1,0.75,BP
GO:0046632,alpha-beta T cell differentiation,111,6,8.02,0.82136,1,1,0.75,BP
GO:0098773,skin epidermis development,111,6,8.02,0.82136,1,1,0.75,BP
GO:0002903,negative regulation of B cell apoptotic ...,23,1,1.66,0.82191,1,1,0.6,BP
GO:0006301,postreplication repair,23,1,1.66,0.82191,1,1,0.6,BP
GO:0007020,microtubule nucleation,23,1,1.66,0.82191,1,1,0.6,BP
GO:0010884,positive regulation of lipid storage,23,1,1.66,0.82191,1,1,0.6,BP
GO:0032959,inositol trisphosphate biosynthetic proc...,23,1,1.66,0.82191,1,1,0.6,BP
GO:0035510,DNA dealkylation,23,1,1.66,0.82191,1,1,0.6,BP
GO:0060390,regulation of SMAD protein signal transd...,23,1,1.66,0.82191,1,1,0.6,BP
GO:0071467,cellular response to pH,23,1,1.66,0.82191,1,1,0.6,BP
GO:0071475,cellular hyperosmotic salinity response,23,1,1.66,0.82191,1,1,0.6,BP
GO:0090190,positive regulation of branching involve...,23,1,1.66,0.82191,1,1,0.6,BP
GO:0097205,renal filtration,23,1,1.66,0.82191,1,1,0.6,BP
GO:1901741,positive regulation of myoblast fusion,23,1,1.66,0.82191,1,1,0.6,BP
GO:1903055,positive regulation of extracellular mat...,23,1,1.66,0.82191,1,1,0.6,BP
GO:1904469,positive regulation of tumor necrosis fa...,23,1,1.66,0.82191,1,1,0.6,BP
GO:2000831,regulation of steroid hormone secretion,23,1,1.66,0.82191,1,1,0.6,BP
GO:0030148,sphingolipid biosynthetic process,78,4,5.63,0.82400,1,1,0.71,BP
GO:0030193,regulation of blood coagulation,78,4,5.63,0.82400,1,1,0.71,BP
GO:0045471,response to ethanol,78,4,5.63,0.82400,1,1,0.71,BP
GO:0001570,vasculogenesis,95,5,6.86,0.82499,1,1,0.73,BP
GO:0042107,cytokine metabolic process,128,7,9.25,0.82567,1,1,0.76,BP
GO:0002886,regulation of myeloid leukocyte mediated...,61,3,4.41,0.82658,1,1,0.68,BP
GO:0006493,protein O-linked glycosylation,61,3,4.41,0.82658,1,1,0.68,BP
GO:0042698,ovulation cycle,61,3,4.41,0.82658,1,1,0.68,BP
GO:0006040,amino sugar metabolic process,43,2,3.11,0.82728,1,1,0.64,BP
GO:0032958,inositol phosphate biosynthetic process,43,2,3.11,0.82728,1,1,0.64,BP
GO:0045823,positive regulation of heart contraction,43,2,3.11,0.82728,1,1,0.64,BP
GO:0045911,positive regulation of DNA recombination,43,2,3.11,0.82728,1,1,0.64,BP
GO:0070232,regulation of T cell apoptotic process,43,2,3.11,0.82728,1,1,0.64,BP
GO:0043062,extracellular structure organization,316,19,22.83,0.82773,1,1,0.83,BP
GO:0090100,positive regulation of transmembrane rec...,112,6,8.09,0.82780,1,1,0.74,BP
GO:0030324,lung development,224,13,16.18,0.82982,1,1,0.8,BP
GO:0031214,biomineral tissue development,161,9,11.63,0.83020,1,1,0.77,BP
GO:0030168,platelet activation,79,4,5.71,0.83149,1,1,0.7,BP
GO:0048663,neuron fate commitment,79,4,5.71,0.83149,1,1,0.7,BP
GO:1900046,regulation of hemostasis,79,4,5.71,0.83149,1,1,0.7,BP
GO:0021915,neural tube development,193,11,13.94,0.83152,1,1,0.79,BP
GO:1903708,positive regulation of hemopoiesis,209,12,15.1,0.83278,1,1,0.79,BP
GO:0007589,body fluid secretion,113,6,8.16,0.83405,1,1,0.74,BP
GO:0002827,positive regulation of T-helper 1 type i...,24,1,1.73,0.83479,1,1,0.58,BP
GO:0003181,atrioventricular valve morphogenesis,24,1,1.73,0.83479,1,1,0.58,BP
GO:0006221,pyrimidine nucleotide biosynthetic proce...,24,1,1.73,0.83479,1,1,0.58,BP
GO:0006312,mitotic recombination,24,1,1.73,0.83479,1,1,0.58,BP
GO:0021544,subpallium development,24,1,1.73,0.83479,1,1,0.58,BP
GO:0021889,olfactory bulb interneuron differentiati...,24,1,1.73,0.83479,1,1,0.58,BP
GO:0030325,adrenal gland development,24,1,1.73,0.83479,1,1,0.58,BP
GO:0030903,notochord development,24,1,1.73,0.83479,1,1,0.58,BP
GO:0032352,positive regulation of hormone metabolic...,24,1,1.73,0.83479,1,1,0.58,BP
GO:0032691,negative regulation of interleukin-1 bet...,24,1,1.73,0.83479,1,1,0.58,BP
GO:0033233,regulation of protein sumoylation,24,1,1.73,0.83479,1,1,0.58,BP
GO:0033622,integrin activation,24,1,1.73,0.83479,1,1,0.58,BP
GO:0035561,regulation of chromatin binding,24,1,1.73,0.83479,1,1,0.58,BP
GO:0042474,middle ear morphogenesis,24,1,1.73,0.83479,1,1,0.58,BP
GO:0042572,retinol metabolic process,24,1,1.73,0.83479,1,1,0.58,BP
GO:0045723,positive regulation of fatty acid biosyn...,24,1,1.73,0.83479,1,1,0.58,BP
GO:0046856,phosphatidylinositol dephosphorylation,24,1,1.73,0.83479,1,1,0.58,BP
GO:0060216,definitive hemopoiesis,24,1,1.73,0.83479,1,1,0.58,BP
GO:0071392,cellular response to estradiol stimulus,24,1,1.73,0.83479,1,1,0.58,BP
GO:0099623,regulation of cardiac muscle cell membra...,24,1,1.73,0.83479,1,1,0.58,BP
GO:1905208,negative regulation of cardiocyte differ...,24,1,1.73,0.83479,1,1,0.58,BP
GO:0006721,terpenoid metabolic process,62,3,4.48,0.83486,1,1,0.67,BP
GO:0032732,positive regulation of interleukin-1 pro...,62,3,4.48,0.83486,1,1,0.67,BP
GO:0042461,photoreceptor cell development,62,3,4.48,0.83486,1,1,0.67,BP
GO:0046850,regulation of bone remodeling,62,3,4.48,0.83486,1,1,0.67,BP
GO:0050701,interleukin-1 secretion,62,3,4.48,0.83486,1,1,0.67,BP
GO:0090501,RNA phosphodiester bond hydrolysis,62,3,4.48,0.83486,1,1,0.67,BP
GO:0002696,positive regulation of leukocyte activat...,318,19,22.97,0.83539,1,1,0.83,BP
GO:0002065,columnar/cuboidal epithelial cell differ...,146,8,10.55,0.83594,1,1,0.76,BP
GO:0097530,granulocyte migration,146,8,10.55,0.83594,1,1,0.76,BP
GO:0007178,transmembrane receptor protein serine/th...,364,22,26.29,0.83622,1,1,0.84,BP
GO:0060271,cilium assembly,303,18,21.89,0.83667,1,1,0.82,BP
GO:0002455,humoral immune response mediated by circ...,44,2,3.18,0.83690,1,1,0.63,BP
GO:0032924,activin receptor signaling pathway,44,2,3.18,0.83690,1,1,0.63,BP
GO:0050691,regulation of defense response to virus ...,44,2,3.18,0.83690,1,1,0.63,BP
GO:2000279,negative regulation of DNA biosynthetic ...,44,2,3.18,0.83690,1,1,0.63,BP
GO:0032496,response to lipopolysaccharide,349,21,25.21,0.83702,1,1,0.83,BP
GO:0009607,response to biotic stimulus,1076,70,77.73,0.84004,1,1,0.9,BP
GO:0001892,embryonic placenta development,114,6,8.24,0.84012,1,1,0.73,BP
GO:0045667,regulation of osteoblast differentiation,147,8,10.62,0.84129,1,1,0.75,BP
GO:0042098,T cell proliferation,211,12,15.24,0.84187,1,1,0.79,BP
GO:0042093,T-helper cell differentiation,63,3,4.55,0.84279,1,1,0.66,BP
GO:0060393,regulation of pathway-restricted SMAD pr...,63,3,4.55,0.84279,1,1,0.66,BP
GO:0007189,adenylate cyclase-activating G protein-c...,131,7,9.46,0.84298,1,1,0.74,BP
GO:0030323,respiratory tube development,227,13,16.4,0.84305,1,1,0.79,BP
GO:0019730,antimicrobial humoral response,98,5,7.08,0.84479,1,1,0.71,BP
GO:0002088,lens development in camera-type eye,81,4,5.85,0.84566,1,1,0.68,BP
GO:0043367,"CD4-positive, alpha-beta T cell differen...",81,4,5.85,0.84566,1,1,0.68,BP
GO:0048747,muscle fiber development,81,4,5.85,0.84566,1,1,0.68,BP
GO:0051209,release of sequestered calcium ion into ...,115,6,8.31,0.84601,1,1,0.72,BP
GO:0043616,keratinocyte proliferation,45,2,3.25,0.84604,1,1,0.62,BP
GO:0070527,platelet aggregation,45,2,3.25,0.84604,1,1,0.62,BP
GO:0071526,semaphorin-plexin signaling pathway,45,2,3.25,0.84604,1,1,0.62,BP
GO:0090184,positive regulation of kidney developmen...,45,2,3.25,0.84604,1,1,0.62,BP
GO:2000027,regulation of animal organ morphogenesis,212,12,15.31,0.84627,1,1,0.78,BP
GO:0021700,developmental maturation,321,19,23.19,0.84640,1,1,0.82,BP
GO:0030856,regulation of epithelial cell differenti...,148,8,10.69,0.84651,1,1,0.75,BP
GO:0010575,positive regulation of vascular endothel...,25,1,1.81,0.84674,1,1,0.55,BP
GO:0010669,epithelial structure maintenance,25,1,1.81,0.84674,1,1,0.55,BP
GO:0018126,protein hydroxylation,25,1,1.81,0.84674,1,1,0.55,BP
GO:0042403,thyroid hormone metabolic process,25,1,1.81,0.84674,1,1,0.55,BP
GO:0060004,reflex,25,1,1.81,0.84674,1,1,0.55,BP
GO:0061213,positive regulation of mesonephros devel...,25,1,1.81,0.84674,1,1,0.55,BP
GO:0070050,neuron cellular homeostasis,25,1,1.81,0.84674,1,1,0.55,BP
GO:0085029,extracellular matrix assembly,25,1,1.81,0.84674,1,1,0.55,BP
GO:0086019,cell-cell signaling involved in cardiac ...,25,1,1.81,0.84674,1,1,0.55,BP
GO:0150077,regulation of neuroinflammatory response,25,1,1.81,0.84674,1,1,0.55,BP
GO:0060485,mesenchyme development,275,16,19.87,0.84775,1,1,0.81,BP
GO:1901568,fatty acid derivative metabolic process,132,7,9.54,0.84844,1,1,0.73,BP
GO:0002294,"CD4-positive, alpha-beta T cell differen...",64,3,4.62,0.85038,1,1,0.65,BP
GO:0070988,demethylation,64,3,4.62,0.85038,1,1,0.65,BP
GO:0006954,inflammatory response,699,44,50.49,0.85116,1,1,0.87,BP
GO:0002263,cell activation involved in immune respo...,276,16,19.94,0.85154,1,1,0.8,BP
GO:0021675,nerve development,82,4,5.92,0.85237,1,1,0.68,BP
GO:0032651,regulation of interleukin-1 beta product...,82,4,5.92,0.85237,1,1,0.68,BP
GO:0050818,regulation of coagulation,82,4,5.92,0.85237,1,1,0.68,BP
GO:0001841,neural tube formation,133,7,9.61,0.85374,1,1,0.73,BP
GO:0021772,olfactory bulb development,46,2,3.32,0.85471,1,1,0.6,BP
GO:0032007,negative regulation of TOR signaling,46,2,3.32,0.85471,1,1,0.6,BP
GO:0032757,positive regulation of interleukin-8 pro...,46,2,3.32,0.85471,1,1,0.6,BP
GO:0071385,cellular response to glucocorticoid stim...,46,2,3.32,0.85471,1,1,0.6,BP
GO:0048863,stem cell differentiation,230,13,16.61,0.85547,1,1,0.78,BP
GO:0022409,positive regulation of cell-cell adhesio...,246,14,17.77,0.85642,1,1,0.79,BP
GO:0042102,positive regulation of T cell proliferat...,100,5,7.22,0.85694,1,1,0.69,BP
GO:0030282,bone mineralization,117,6,8.45,0.85726,1,1,0.71,BP
GO:0051283,negative regulation of sequestering of c...,117,6,8.45,0.85726,1,1,0.71,BP
GO:0002293,alpha-beta T cell differentiation involv...,65,3,4.7,0.85766,1,1,0.64,BP
GO:0006213,pyrimidine nucleoside metabolic process,26,1,1.88,0.85782,1,1,0.53,BP
GO:0006298,mismatch repair,26,1,1.88,0.85782,1,1,0.53,BP
GO:0007289,spermatid nucleus differentiation,26,1,1.88,0.85782,1,1,0.53,BP
GO:0007413,axonal fasciculation,26,1,1.88,0.85782,1,1,0.53,BP
GO:0007620,copulation,26,1,1.88,0.85782,1,1,0.53,BP
GO:0010863,positive regulation of phospholipase C a...,26,1,1.88,0.85782,1,1,0.53,BP
GO:0018200,peptidyl-glutamic acid modification,26,1,1.88,0.85782,1,1,0.53,BP
GO:0019433,triglyceride catabolic process,26,1,1.88,0.85782,1,1,0.53,BP
GO:0030194,positive regulation of blood coagulation,26,1,1.88,0.85782,1,1,0.53,BP
GO:0036342,post-anal tail morphogenesis,26,1,1.88,0.85782,1,1,0.53,BP
GO:0048799,animal organ maturation,26,1,1.88,0.85782,1,1,0.53,BP
GO:0050951,sensory perception of temperature stimul...,26,1,1.88,0.85782,1,1,0.53,BP
GO:0070168,negative regulation of biomineral tissue...,26,1,1.88,0.85782,1,1,0.53,BP
GO:0070233,negative regulation of T cell apoptotic ...,26,1,1.88,0.85782,1,1,0.53,BP
GO:0072012,glomerulus vasculature development,26,1,1.88,0.85782,1,1,0.53,BP
GO:0090025,regulation of monocyte chemotaxis,26,1,1.88,0.85782,1,1,0.53,BP
GO:0090189,regulation of branching involved in uret...,26,1,1.88,0.85782,1,1,0.53,BP
GO:0090208,positive regulation of triglyceride meta...,26,1,1.88,0.85782,1,1,0.53,BP
GO:0106030,neuron projection fasciculation,26,1,1.88,0.85782,1,1,0.53,BP
GO:1900048,positive regulation of hemostasis,26,1,1.88,0.85782,1,1,0.53,BP
GO:1901071,glucosamine-containing compound metaboli...,26,1,1.88,0.85782,1,1,0.53,BP
GO:2000738,positive regulation of stem cell differe...,26,1,1.88,0.85782,1,1,0.53,BP
GO:0035050,embryonic heart tube development,83,4,6,0.85882,1,1,0.67,BP
GO:0009888,tissue development,1970,131,142.31,0.86015,1,1,0.92,BP
GO:0002443,leukocyte mediated immunity,372,22,26.87,0.86263,1,1,0.82,BP
GO:0003179,heart valve morphogenesis,47,2,3.4,0.86293,1,1,0.59,BP
GO:0035137,hindlimb morphogenesis,47,2,3.4,0.86293,1,1,0.59,BP
GO:0090279,regulation of calcium ion import,47,2,3.4,0.86293,1,1,0.59,BP
GO:0006261,DNA-dependent DNA replication,135,7,9.75,0.86389,1,1,0.72,BP
GO:0002287,alpha-beta T cell activation involved in...,66,3,4.77,0.86462,1,1,0.63,BP
GO:0003407,neural retina development,66,3,4.77,0.86462,1,1,0.63,BP
GO:0060389,pathway-restricted SMAD protein phosphor...,66,3,4.77,0.86462,1,1,0.63,BP
GO:0003007,heart morphogenesis,280,16,20.23,0.86597,1,1,0.79,BP
GO:0048534,hematopoietic or lymphoid organ developm...,972,62,70.21,0.86644,1,1,0.88,BP
GO:0002335,mature B cell differentiation,27,1,1.95,0.86810,1,1,0.51,BP
GO:0003171,atrioventricular valve development,27,1,1.95,0.86810,1,1,0.51,BP
GO:0010893,positive regulation of steroid biosynthe...,27,1,1.95,0.86810,1,1,0.51,BP
GO:0021871,forebrain regionalization,27,1,1.95,0.86810,1,1,0.51,BP
GO:0031342,negative regulation of cell killing,27,1,1.95,0.86810,1,1,0.51,BP
GO:0032957,inositol trisphosphate metabolic process,27,1,1.95,0.86810,1,1,0.51,BP
GO:0035987,endodermal cell differentiation,27,1,1.95,0.86810,1,1,0.51,BP
GO:0036003,positive regulation of transcription fro...,27,1,1.95,0.86810,1,1,0.51,BP
GO:0042753,positive regulation of circadian rhythm,27,1,1.95,0.86810,1,1,0.51,BP
GO:0045736,negative regulation of cyclin-dependent ...,27,1,1.95,0.86810,1,1,0.51,BP
GO:0045738,negative regulation of DNA repair,27,1,1.95,0.86810,1,1,0.51,BP
GO:0048521,negative regulation of behavior,27,1,1.95,0.86810,1,1,0.51,BP
GO:0050901,leukocyte tethering or rolling,27,1,1.95,0.86810,1,1,0.51,BP
GO:0060008,Sertoli cell differentiation,27,1,1.95,0.86810,1,1,0.51,BP
GO:0060045,positive regulation of cardiac muscle ce...,27,1,1.95,0.86810,1,1,0.51,BP
GO:0060343,trabecula formation,27,1,1.95,0.86810,1,1,0.51,BP
GO:0060536,cartilage morphogenesis,27,1,1.95,0.86810,1,1,0.51,BP
GO:0061437,renal system vasculature development,27,1,1.95,0.86810,1,1,0.51,BP
GO:0061440,kidney vasculature development,27,1,1.95,0.86810,1,1,0.51,BP
GO:0072528,pyrimidine-containing compound biosynthe...,27,1,1.95,0.86810,1,1,0.51,BP
GO:1903010,regulation of bone development,27,1,1.95,0.86810,1,1,0.51,BP
GO:0002824,positive regulation of adaptive immune r...,136,7,9.82,0.86875,1,1,0.71,BP
GO:0022407,regulation of cell-cell adhesion,405,24,29.26,0.86947,1,1,0.82,BP
GO:0006302,double-strand break repair,218,12,15.75,0.87070,1,1,0.76,BP
GO:0010718,positive regulation of epithelial to mes...,48,2,3.47,0.87072,1,1,0.58,BP
GO:0021988,olfactory lobe development,48,2,3.47,0.87072,1,1,0.58,BP
GO:0030857,negative regulation of epithelial cell d...,48,2,3.47,0.87072,1,1,0.58,BP
GO:0043303,mast cell degranulation,48,2,3.47,0.87072,1,1,0.58,BP
GO:0044786,cell cycle DNA replication,48,2,3.47,0.87072,1,1,0.58,BP
GO:0050850,positive regulation of calcium-mediated ...,48,2,3.47,0.87072,1,1,0.58,BP
GO:0061005,cell differentiation involved in kidney ...,48,2,3.47,0.87072,1,1,0.58,BP
GO:0071384,cellular response to corticosteroid stim...,48,2,3.47,0.87072,1,1,0.58,BP
GO:0007187,G protein-coupled receptor signaling pat...,234,13,16.9,0.87084,1,1,0.77,BP
GO:0032526,response to retinoic acid,85,4,6.14,0.87100,1,1,0.65,BP
GO:0003143,embryonic heart tube morphogenesis,67,3,4.84,0.87129,1,1,0.62,BP
GO:0061371,determination of heart left/right asymme...,67,3,4.84,0.87129,1,1,0.62,BP
GO:0035270,endocrine system development,137,7,9.9,0.87346,1,1,0.71,BP
GO:0050671,positive regulation of lymphocyte prolif...,137,7,9.9,0.87346,1,1,0.71,BP
GO:0001708,cell fate specification,103,5,7.44,0.87366,1,1,0.67,BP
GO:0046427,positive regulation of JAK-STAT cascade,103,5,7.44,0.87366,1,1,0.67,BP
GO:0002064,epithelial cell development,251,14,18.13,0.87477,1,1,0.77,BP
GO:0046661,male sex differentiation,154,8,11.12,0.87498,1,1,0.72,BP
GO:0002706,regulation of lymphocyte mediated immuni...,187,10,13.51,0.87565,1,1,0.74,BP
GO:1904892,regulation of STAT cascade,171,9,12.35,0.87708,1,1,0.73,BP
GO:0002029,desensitization of G protein-coupled rec...,28,1,2.02,0.87764,1,1,0.5,BP
GO:0002068,glandular epithelial cell development,28,1,2.02,0.87764,1,1,0.5,BP
GO:0002089,lens morphogenesis in camera-type eye,28,1,2.02,0.87764,1,1,0.5,BP
GO:0002507,tolerance induction,28,1,2.02,0.87764,1,1,0.5,BP
GO:0010954,positive regulation of protein processin...,28,1,2.02,0.87764,1,1,0.5,BP
GO:0022401,negative adaptation of signaling pathway,28,1,2.02,0.87764,1,1,0.5,BP
GO:0033198,response to ATP,28,1,2.02,0.87764,1,1,0.5,BP
GO:0035162,embryonic hemopoiesis,28,1,2.02,0.87764,1,1,0.5,BP
GO:0036297,interstrand cross-link repair,28,1,2.02,0.87764,1,1,0.5,BP
GO:0044342,type B pancreatic cell proliferation,28,1,2.02,0.87764,1,1,0.5,BP
GO:0044550,secondary metabolite biosynthetic proces...,28,1,2.02,0.87764,1,1,0.5,BP
GO:0045061,thymic T cell selection,28,1,2.02,0.87764,1,1,0.5,BP
GO:0045187,regulation of circadian sleep/wake cycle...,28,1,2.02,0.87764,1,1,0.5,BP
GO:0045332,phospholipid translocation,28,1,2.02,0.87764,1,1,0.5,BP
GO:0045663,positive regulation of myoblast differen...,28,1,2.02,0.87764,1,1,0.5,BP
GO:0048103,somatic stem cell division,28,1,2.02,0.87764,1,1,0.5,BP
GO:0048596,embryonic camera-type eye morphogenesis,28,1,2.02,0.87764,1,1,0.5,BP
GO:0051307,meiotic chromosome separation,28,1,2.02,0.87764,1,1,0.5,BP
GO:0060219,camera-type eye photoreceptor cell diffe...,28,1,2.02,0.87764,1,1,0.5,BP
GO:0061217,regulation of mesonephros development,28,1,2.02,0.87764,1,1,0.5,BP
GO:0071549,cellular response to dexamethasone stimu...,28,1,2.02,0.87764,1,1,0.5,BP
GO:0072539,T-helper 17 cell differentiation,28,1,2.02,0.87764,1,1,0.5,BP
GO:0080154,regulation of fertilization,28,1,2.02,0.87764,1,1,0.5,BP
GO:0090103,cochlea morphogenesis,28,1,2.02,0.87764,1,1,0.5,BP
GO:1901186,positive regulation of ERBB signaling pa...,28,1,2.02,0.87764,1,1,0.5,BP
GO:0050710,negative regulation of cytokine secretio...,68,3,4.91,0.87766,1,1,0.61,BP
GO:0055081,anion homeostasis,68,3,4.91,0.87766,1,1,0.61,BP
GO:0002279,mast cell activation involved in immune ...,49,2,3.54,0.87811,1,1,0.56,BP
GO:0002448,mast cell mediated immunity,49,2,3.54,0.87811,1,1,0.56,BP
GO:0010862,positive regulation of pathway-restricte...,49,2,3.54,0.87811,1,1,0.56,BP
GO:0030195,negative regulation of blood coagulation,49,2,3.54,0.87811,1,1,0.56,BP
GO:0046638,positive regulation of alpha-beta T cell...,49,2,3.54,0.87811,1,1,0.56,BP
GO:0050873,brown fat cell differentiation,49,2,3.54,0.87811,1,1,0.56,BP
GO:0070229,negative regulation of lymphocyte apopto...,49,2,3.54,0.87811,1,1,0.56,BP
GO:0001649,osteoblast differentiation,204,11,14.74,0.87861,1,1,0.75,BP
GO:0008593,regulation of Notch signaling pathway,87,4,6.28,0.88227,1,1,0.64,BP
GO:0051384,response to glucocorticoid,87,4,6.28,0.88227,1,1,0.64,BP
GO:0070509,calcium ion import,87,4,6.28,0.88227,1,1,0.64,BP
GO:0032946,positive regulation of mononuclear cell ...,139,7,10.04,0.88247,1,1,0.7,BP
GO:1903706,regulation of hemopoiesis,410,24,29.62,0.88318,1,1,0.81,BP
GO:0030097,hemopoiesis,922,58,66.6,0.88333,1,1,0.87,BP
GO:0000768,syncytium formation by plasma membrane f...,69,3,4.98,0.88374,1,1,0.6,BP
GO:0006766,vitamin metabolic process,69,3,4.98,0.88374,1,1,0.6,BP
GO:0030888,regulation of B cell proliferation,69,3,4.98,0.88374,1,1,0.6,BP
GO:0140253,cell-cell fusion,69,3,4.98,0.88374,1,1,0.6,BP
GO:0021545,cranial nerve development,50,2,3.61,0.88510,1,1,0.55,BP
GO:0042269,regulation of natural killer cell mediat...,50,2,3.61,0.88510,1,1,0.55,BP
GO:1900047,negative regulation of hemostasis,50,2,3.61,0.88510,1,1,0.55,BP
GO:0007286,spermatid development,206,11,14.88,0.88591,1,1,0.74,BP
GO:0007283,spermatogenesis,549,33,39.66,0.88632,1,1,0.83,BP
GO:0002486,antigen processing and presentation of e...,29,1,2.09,0.88649,1,1,0.48,BP
GO:0030262,apoptotic nuclear changes,29,1,2.09,0.88649,1,1,0.48,BP
GO:0030318,melanocyte differentiation,29,1,2.09,0.88649,1,1,0.48,BP
GO:0030488,tRNA methylation,29,1,2.09,0.88649,1,1,0.48,BP
GO:0034204,lipid translocation,29,1,2.09,0.88649,1,1,0.48,BP
GO:0050802,"circadian sleep/wake cycle, sleep",29,1,2.09,0.88649,1,1,0.48,BP
GO:0060039,pericardium development,29,1,2.09,0.88649,1,1,0.48,BP
GO:0071472,cellular response to salt stress,29,1,2.09,0.88649,1,1,0.48,BP
GO:0099622,cardiac muscle cell membrane repolarizat...,29,1,2.09,0.88649,1,1,0.48,BP
GO:0007259,JAK-STAT cascade,190,10,13.73,0.88710,1,1,0.73,BP
GO:0046631,alpha-beta T cell activation,157,8,11.34,0.88750,1,1,0.71,BP
GO:0050867,positive regulation of cell activation,334,19,24.13,0.88779,1,1,0.79,BP
GO:0060541,respiratory system development,255,14,18.42,0.88807,1,1,0.76,BP
GO:0046635,positive regulation of alpha-beta T cell...,70,3,5.06,0.88956,1,1,0.59,BP
GO:1990868,response to chemokine,70,3,5.06,0.88956,1,1,0.59,BP
GO:1990869,cellular response to chemokine,70,3,5.06,0.88956,1,1,0.59,BP
GO:0002244,hematopoietic progenitor cell differenti...,158,8,11.41,0.89143,1,1,0.7,BP
GO:0007596,blood coagulation,158,8,11.41,0.89143,1,1,0.7,BP
GO:0050896,response to stimulus,9311,650,672.6,0.89170,1,1,0.97,BP
GO:0002715,regulation of natural killer cell mediat...,51,2,3.68,0.89172,1,1,0.54,BP
GO:0007129,synapsis,51,2,3.68,0.89172,1,1,0.54,BP
GO:0048806,genitalia development,51,2,3.68,0.89172,1,1,0.54,BP
GO:0050819,negative regulation of coagulation,51,2,3.68,0.89172,1,1,0.54,BP
GO:0071470,cellular response to osmotic stress,51,2,3.68,0.89172,1,1,0.54,BP
GO:0007276,gamete generation,704,43,50.86,0.89419,1,1,0.85,BP
GO:0001556,oocyte maturation,30,1,2.17,0.89470,1,1,0.46,BP
GO:0002476,antigen processing and presentation of e...,30,1,2.17,0.89470,1,1,0.46,BP
GO:0002484,antigen processing and presentation of e...,30,1,2.17,0.89470,1,1,0.46,BP
GO:0002902,regulation of B cell apoptotic process,30,1,2.17,0.89470,1,1,0.46,BP
GO:0006336,DNA replication-independent nucleosome a...,30,1,2.17,0.89470,1,1,0.46,BP
GO:0006921,cellular component disassembly involved ...,30,1,2.17,0.89470,1,1,0.46,BP
GO:0006958,"complement activation, classical pathway",30,1,2.17,0.89470,1,1,0.46,BP
GO:0008299,isoprenoid biosynthetic process,30,1,2.17,0.89470,1,1,0.46,BP
GO:0010390,histone monoubiquitination,30,1,2.17,0.89470,1,1,0.46,BP
GO:0021904,dorsal/ventral neural tube patterning,30,1,2.17,0.89470,1,1,0.46,BP
GO:0023058,adaptation of signaling pathway,30,1,2.17,0.89470,1,1,0.46,BP
GO:0033005,positive regulation of mast cell activat...,30,1,2.17,0.89470,1,1,0.46,BP
GO:0035640,exploration behavior,30,1,2.17,0.89470,1,1,0.46,BP
GO:0042481,regulation of odontogenesis,30,1,2.17,0.89470,1,1,0.46,BP
GO:0043372,"positive regulation of CD4-positive, alp...",30,1,2.17,0.89470,1,1,0.46,BP
GO:0044458,motile cilium assembly,30,1,2.17,0.89470,1,1,0.46,BP
GO:0048384,retinoic acid receptor signaling pathway,30,1,2.17,0.89470,1,1,0.46,BP
GO:0060571,morphogenesis of an epithelial fold,30,1,2.17,0.89470,1,1,0.46,BP
GO:0070306,lens fiber cell differentiation,30,1,2.17,0.89470,1,1,0.46,BP
GO:1900274,regulation of phospholipase C activity,30,1,2.17,0.89470,1,1,0.46,BP
GO:1903319,positive regulation of protein maturatio...,30,1,2.17,0.89470,1,1,0.46,BP
GO:0002292,T cell differentiation involved in immun...,71,3,5.13,0.89512,1,1,0.58,BP
GO:0006949,syncytium formation,71,3,5.13,0.89512,1,1,0.58,BP
GO:0007492,endoderm development,71,3,5.13,0.89512,1,1,0.58,BP
GO:0019915,lipid storage,71,3,5.13,0.89512,1,1,0.58,BP
GO:0048232,male gamete generation,569,34,41.1,0.89661,1,1,0.83,BP
GO:0022408,negative regulation of cell-cell adhesio...,193,10,13.94,0.89766,1,1,0.72,BP
GO:0001895,retina homeostasis,52,2,3.76,0.89798,1,1,0.53,BP
GO:0017145,stem cell division,52,2,3.76,0.89798,1,1,0.53,BP
GO:0061041,regulation of wound healing,143,7,10.33,0.89887,1,1,0.68,BP
GO:0007599,hemostasis,160,8,11.56,0.89896,1,1,0.69,BP
GO:0006400,tRNA modification,72,3,5.2,0.90042,1,1,0.58,BP
GO:0014068,positive regulation of phosphatidylinosi...,72,3,5.2,0.90042,1,1,0.58,BP
GO:0002703,regulation of leukocyte mediated immunit...,243,13,17.55,0.90066,1,1,0.74,BP
GO:0006690,icosanoid metabolic process,109,5,7.87,0.90216,1,1,0.64,BP
GO:0007043,cell-cell junction assembly,109,5,7.87,0.90216,1,1,0.64,BP
GO:0031960,response to corticosteroid,91,4,6.57,0.90226,1,1,0.61,BP
GO:0002825,regulation of T-helper 1 type immune res...,31,1,2.24,0.90232,1,1,0.45,BP
GO:0009584,detection of visible light,31,1,2.24,0.90232,1,1,0.45,BP
GO:0022617,extracellular matrix disassembly,31,1,2.24,0.90232,1,1,0.45,BP
GO:0033139,regulation of peptidyl-serine phosphoryl...,31,1,2.24,0.90232,1,1,0.45,BP
GO:0034724,DNA replication-independent nucleosome o...,31,1,2.24,0.90232,1,1,0.45,BP
GO:0042749,regulation of circadian sleep/wake cycle,31,1,2.24,0.90232,1,1,0.45,BP
GO:0044319,"wound healing, spreading of cells",31,1,2.24,0.90232,1,1,0.45,BP
GO:0048535,lymph node development,31,1,2.24,0.90232,1,1,0.45,BP
GO:0071548,response to dexamethasone,31,1,2.24,0.90232,1,1,0.45,BP
GO:0086010,membrane depolarization during action po...,31,1,2.24,0.90232,1,1,0.45,BP
GO:0090162,establishment of epithelial cell polarit...,31,1,2.24,0.90232,1,1,0.45,BP
GO:0090505,epiboly involved in wound healing,31,1,2.24,0.90232,1,1,0.45,BP
GO:0050817,coagulation,161,8,11.63,0.90255,1,1,0.69,BP
GO:0090288,negative regulation of cellular response...,144,7,10.4,0.90266,1,1,0.67,BP
GO:0009583,detection of light stimulus,53,2,3.83,0.90390,1,1,0.52,BP
GO:0035176,social behavior,53,2,3.83,0.90390,1,1,0.52,BP
GO:0051703,intraspecies interaction between organis...,53,2,3.83,0.90390,1,1,0.52,BP
GO:0097035,regulation of membrane lipid distributio...,53,2,3.83,0.90390,1,1,0.52,BP
GO:0097696,STAT cascade,195,10,14.09,0.90424,1,1,0.71,BP
GO:0043627,response to estrogen,73,3,5.27,0.90548,1,1,0.57,BP
GO:0009100,glycoprotein metabolic process,341,19,24.63,0.90610,1,1,0.77,BP
GO:0051707,response to other organism,1040,65,75.13,0.90620,1,1,0.87,BP
GO:0001776,leukocyte homeostasis,110,5,7.95,0.90632,1,1,0.63,BP
GO:0014033,neural crest cell differentiation,92,4,6.65,0.90677,1,1,0.6,BP
GO:0009582,detection of abiotic stimulus,128,6,9.25,0.90760,1,1,0.65,BP
GO:0042303,molting cycle,128,6,9.25,0.90760,1,1,0.65,BP
GO:0042633,hair cycle,128,6,9.25,0.90760,1,1,0.65,BP
GO:0007154,cell communication,6556,451,473.59,0.90789,1,1,0.95,BP
GO:0048732,gland development,467,27,33.73,0.90796,1,1,0.8,BP
GO:0098542,defense response to other organism,529,31,38.21,0.90845,1,1,0.81,BP
GO:0043207,response to external biotic stimulus,1042,65,75.27,0.90906,1,1,0.86,BP
GO:0006220,pyrimidine nucleotide metabolic process,32,1,2.31,0.90939,1,1,0.43,BP
GO:0010453,regulation of cell fate commitment,32,1,2.31,0.90939,1,1,0.43,BP
GO:0022410,circadian sleep/wake cycle process,32,1,2.31,0.90939,1,1,0.43,BP
GO:0031069,hair follicle morphogenesis,32,1,2.31,0.90939,1,1,0.43,BP
GO:0032508,DNA duplex unwinding,32,1,2.31,0.90939,1,1,0.43,BP
GO:0040036,regulation of fibroblast growth factor r...,32,1,2.31,0.90939,1,1,0.43,BP
GO:0048048,embryonic eye morphogenesis,32,1,2.31,0.90939,1,1,0.43,BP
GO:0060143,positive regulation of syncytium formati...,32,1,2.31,0.90939,1,1,0.43,BP
GO:0060561,apoptotic process involved in morphogene...,32,1,2.31,0.90939,1,1,0.43,BP
GO:0060669,embryonic placenta morphogenesis,32,1,2.31,0.90939,1,1,0.43,BP
GO:0072538,T-helper 17 type immune response,32,1,2.31,0.90939,1,1,0.43,BP
GO:0090504,epiboly,32,1,2.31,0.90939,1,1,0.43,BP
GO:0030879,mammary gland development,163,8,11.77,0.90942,1,1,0.68,BP
GO:0002385,mucosal immune response,54,2,3.9,0.90950,1,1,0.51,BP
GO:0002548,monocyte chemotaxis,54,2,3.9,0.90950,1,1,0.51,BP
GO:0032350,regulation of hormone metabolic process,54,2,3.9,0.90950,1,1,0.51,BP
GO:0032731,positive regulation of interleukin-1 bet...,54,2,3.9,0.90950,1,1,0.51,BP
GO:0050704,regulation of interleukin-1 secretion,54,2,3.9,0.90950,1,1,0.51,BP
GO:0086001,cardiac muscle cell action potential,54,2,3.9,0.90950,1,1,0.51,BP
GO:0007224,smoothened signaling pathway,146,7,10.55,0.90986,1,1,0.66,BP
GO:0070665,positive regulation of leukocyte prolife...,146,7,10.55,0.90986,1,1,0.66,BP
GO:0050810,regulation of steroid biosynthetic proce...,74,3,5.35,0.91030,1,1,0.56,BP
GO:0003279,cardiac septum development,129,6,9.32,0.91131,1,1,0.64,BP
GO:0009581,detection of external stimulus,129,6,9.32,0.91131,1,1,0.64,BP
GO:0006939,smooth muscle contraction,112,5,8.09,0.91419,1,1,0.62,BP
GO:0048515,spermatid differentiation,215,11,15.53,0.91445,1,1,0.71,BP
GO:0019369,arachidonic acid metabolic process,55,2,3.97,0.91480,1,1,0.5,BP
GO:0032655,regulation of interleukin-12 production,55,2,3.97,0.91480,1,1,0.5,BP
GO:0044060,regulation of endocrine process,55,2,3.97,0.91480,1,1,0.5,BP
GO:0045599,negative regulation of fat cell differen...,55,2,3.97,0.91480,1,1,0.5,BP
GO:0032611,interleukin-1 beta production,94,4,6.79,0.91522,1,1,0.59,BP
GO:0048477,oogenesis,94,4,6.79,0.91522,1,1,0.59,BP
GO:0009101,glycoprotein biosynthetic process,281,15,20.3,0.91579,1,1,0.74,BP
GO:0060041,retina development in camera-type eye,165,8,11.92,0.91587,1,1,0.67,BP
GO:0001706,endoderm formation,33,1,2.38,0.91594,1,1,0.42,BP
GO:0001773,myeloid dendritic cell activation,33,1,2.38,0.91594,1,1,0.42,BP
GO:0006308,DNA catabolic process,33,1,2.38,0.91594,1,1,0.42,BP
GO:0006775,fat-soluble vitamin metabolic process,33,1,2.38,0.91594,1,1,0.42,BP
GO:0035025,positive regulation of Rho protein signa...,33,1,2.38,0.91594,1,1,0.42,BP
GO:0045066,regulatory T cell differentiation,33,1,2.38,0.91594,1,1,0.42,BP
GO:0045577,regulation of B cell differentiation,33,1,2.38,0.91594,1,1,0.42,BP
GO:0048013,ephrin receptor signaling pathway,33,1,2.38,0.91594,1,1,0.42,BP
GO:0048566,embryonic digestive tract development,33,1,2.38,0.91594,1,1,0.42,BP
GO:0060706,cell differentiation involved in embryon...,33,1,2.38,0.91594,1,1,0.42,BP
GO:0086091,regulation of heart rate by cardiac cond...,33,1,2.38,0.91594,1,1,0.42,BP
GO:0009913,epidermal cell differentiation,216,11,15.6,0.91721,1,1,0.71,BP
GO:0008585,female gonad development,113,5,8.16,0.91790,1,1,0.61,BP
GO:0046425,regulation of JAK-STAT cascade,166,8,11.99,0.91894,1,1,0.67,BP
GO:0048844,artery morphogenesis,76,3,5.49,0.91929,1,1,0.55,BP
GO:0070228,regulation of lymphocyte apoptotic proce...,76,3,5.49,0.91929,1,1,0.55,BP
GO:0044782,cilium organization,331,18,23.91,0.91975,1,1,0.75,BP
GO:0002251,organ or tissue specific immune response,56,2,4.05,0.91980,1,1,0.49,BP
GO:0019731,antibacterial humoral response,56,2,4.05,0.91980,1,1,0.49,BP
GO:0035458,cellular response to interferon-beta,56,2,4.05,0.91980,1,1,0.49,BP
GO:0060761,negative regulation of response to cytok...,56,2,4.05,0.91980,1,1,0.49,BP
GO:0002819,regulation of adaptive immune response,201,10,14.52,0.92189,1,1,0.69,BP
GO:0000186,activation of MAPKK activity,34,1,2.46,0.92202,1,1,0.41,BP
GO:0003203,endocardial cushion morphogenesis,34,1,2.46,0.92202,1,1,0.41,BP
GO:0007274,neuromuscular synaptic transmission,34,1,2.46,0.92202,1,1,0.41,BP
GO:0009072,aromatic amino acid family metabolic pro...,34,1,2.46,0.92202,1,1,0.41,BP
GO:0014823,response to activity,34,1,2.46,0.92202,1,1,0.41,BP
GO:0048240,sperm capacitation,34,1,2.46,0.92202,1,1,0.41,BP
GO:0090092,regulation of transmembrane receptor pro...,235,12,16.98,0.92344,1,1,0.71,BP
GO:0051965,positive regulation of synapse assembly,77,3,5.56,0.92347,1,1,0.54,BP
GO:0002822,regulation of adaptive immune response b...,185,9,13.36,0.92441,1,1,0.67,BP
GO:0045620,negative regulation of lymphocyte differ...,57,2,4.12,0.92452,1,1,0.49,BP
GO:0050879,multicellular organismal movement,57,2,4.12,0.92452,1,1,0.49,BP
GO:0050881,musculoskeletal movement,57,2,4.12,0.92452,1,1,0.49,BP
GO:0046488,phosphatidylinositol metabolic process,133,6,9.61,0.92487,1,1,0.62,BP
GO:0002573,myeloid leukocyte differentiation,219,11,15.82,0.92506,1,1,0.7,BP
GO:0042445,hormone metabolic process,219,11,15.82,0.92506,1,1,0.7,BP
GO:0060291,long-term synaptic potentiation,253,13,18.28,0.92691,1,1,0.71,BP
GO:0002260,lymphocyte homeostasis,78,3,5.63,0.92744,1,1,0.53,BP
GO:0019827,stem cell population maintenance,169,8,12.21,0.92760,1,1,0.66,BP
GO:0002701,negative regulation of production of mol...,35,1,2.53,0.92767,1,1,0.4,BP
GO:0008156,negative regulation of DNA replication,35,1,2.53,0.92767,1,1,0.4,BP
GO:0009954,proximal/distal pattern formation,35,1,2.53,0.92767,1,1,0.4,BP
GO:0019835,cytolysis,35,1,2.53,0.92767,1,1,0.4,BP
GO:0034122,negative regulation of toll-like recepto...,35,1,2.53,0.92767,1,1,0.4,BP
GO:0035909,aorta morphogenesis,35,1,2.53,0.92767,1,1,0.4,BP
GO:0042745,circadian sleep/wake cycle,35,1,2.53,0.92767,1,1,0.4,BP
GO:0043304,regulation of mast cell degranulation,35,1,2.53,0.92767,1,1,0.4,BP
GO:0055083,monovalent inorganic anion homeostasis,35,1,2.53,0.92767,1,1,0.4,BP
GO:0046545,development of primary female sexual cha...,116,5,8.38,0.92819,1,1,0.6,BP
GO:0001754,eye photoreceptor cell differentiation,58,2,4.19,0.92898,1,1,0.48,BP
GO:0032615,interleukin-12 production,58,2,4.19,0.92898,1,1,0.48,BP
GO:0060443,mammary gland morphogenesis,58,2,4.19,0.92898,1,1,0.48,BP
GO:0061337,cardiac conduction,58,2,4.19,0.92898,1,1,0.48,BP
GO:0002449,lymphocyte mediated immunity,287,15,20.73,0.92944,1,1,0.72,BP
GO:0070227,lymphocyte apoptotic process,98,4,7.08,0.93011,1,1,0.56,BP
GO:1902107,positive regulation of leukocyte differe...,170,8,12.28,0.93030,1,1,0.65,BP
GO:0060976,coronary vasculature development,79,3,5.71,0.93123,1,1,0.53,BP
GO:0002520,immune system development,1030,63,74.4,0.93180,1,1,0.85,BP
GO:0042110,T cell activation,496,28,35.83,0.93235,1,1,0.78,BP
GO:0002366,leukocyte activation involved in immune ...,272,14,19.65,0.93241,1,1,0.71,BP
GO:0002920,regulation of humoral immune response,36,1,2.6,0.93290,1,1,0.38,BP
GO:0032735,positive regulation of interleukin-12 pr...,36,1,2.6,0.93290,1,1,0.38,BP
GO:0033006,regulation of mast cell activation invol...,36,1,2.6,0.93290,1,1,0.38,BP
GO:0042501,serine phosphorylation of STAT protein,36,1,2.6,0.93290,1,1,0.38,BP
GO:0045987,positive regulation of smooth muscle con...,36,1,2.6,0.93290,1,1,0.38,BP
GO:0046839,phospholipid dephosphorylation,36,1,2.6,0.93290,1,1,0.38,BP
GO:0050869,negative regulation of B cell activation,36,1,2.6,0.93290,1,1,0.38,BP
GO:0060441,epithelial tube branching involved in lu...,36,1,2.6,0.93290,1,1,0.38,BP
GO:0002011,morphogenesis of an epithelial sheet,59,2,4.26,0.93320,1,1,0.47,BP
GO:1903038,negative regulation of leukocyte cell-ce...,136,6,9.82,0.93382,1,1,0.61,BP
GO:0045321,leukocyte activation,866,52,62.56,0.93391,1,1,0.83,BP
GO:0014020,primary neural tube formation,118,5,8.52,0.93440,1,1,0.59,BP
GO:0045682,regulation of epidermis development,80,3,5.78,0.93484,1,1,0.52,BP
GO:0030278,regulation of ossification,240,12,17.34,0.93496,1,1,0.69,BP
GO:0042330,taxis,607,35,43.85,0.93534,1,1,0.8,BP
GO:0001775,cell activation,973,59,70.29,0.93535,1,1,0.84,BP
GO:0070661,leukocyte proliferation,339,18,24.49,0.93572,1,1,0.73,BP
GO:0045598,regulation of fat cell differentiation,137,6,9.9,0.93658,1,1,0.61,BP
GO:0001838,embryonic epithelial tube formation,155,7,11.2,0.93689,1,1,0.62,BP
GO:0051053,negative regulation of DNA metabolic pro...,155,7,11.2,0.93689,1,1,0.62,BP
GO:0045444,fat cell differentiation,241,12,17.41,0.93708,1,1,0.69,BP
GO:0007595,lactation,60,2,4.33,0.93717,1,1,0.46,BP
GO:0045824,negative regulation of innate immune res...,60,2,4.33,0.93717,1,1,0.46,BP
GO:0090183,regulation of kidney development,60,2,4.33,0.93717,1,1,0.46,BP
GO:1990266,neutrophil migration,119,5,8.6,0.93732,1,1,0.58,BP
GO:0001702,gastrulation with mouth forming second,37,1,2.67,0.93776,1,1,0.37,BP
GO:0015695,organic cation transport,37,1,2.67,0.93776,1,1,0.37,BP
GO:0032733,positive regulation of interleukin-10 pr...,37,1,2.67,0.93776,1,1,0.37,BP
GO:0033260,nuclear DNA replication,37,1,2.67,0.93776,1,1,0.37,BP
GO:0034661,ncRNA catabolic process,37,1,2.67,0.93776,1,1,0.37,BP
GO:0048665,neuron fate specification,37,1,2.67,0.93776,1,1,0.37,BP
GO:0048730,epidermis morphogenesis,37,1,2.67,0.93776,1,1,0.37,BP
GO:0050718,positive regulation of interleukin-1 bet...,37,1,2.67,0.93776,1,1,0.37,BP
GO:0072348,sulfur compound transport,37,1,2.67,0.93776,1,1,0.37,BP
GO:0098727,maintenance of cell number,173,8,12.5,0.93788,1,1,0.64,BP
GO:0048513,animal organ development,3502,232,252.98,0.93871,1,1,0.92,BP
GO:0009451,RNA modification,138,6,9.97,0.93924,1,1,0.6,BP
GO:0006694,steroid biosynthetic process,156,7,11.27,0.93940,1,1,0.62,BP
GO:0050863,regulation of T cell activation,309,16,22.32,0.94037,1,1,0.72,BP
GO:0016447,somatic recombination of immunoglobulin ...,61,2,4.41,0.94092,1,1,0.45,BP
GO:0000578,embryonic axis specification,38,1,2.75,0.94226,1,1,0.36,BP
GO:0003230,cardiac atrium development,38,1,2.75,0.94226,1,1,0.36,BP
GO:0030513,positive regulation of BMP signaling pat...,38,1,2.75,0.94226,1,1,0.36,BP
GO:0045622,regulation of T-helper cell differentiat...,38,1,2.75,0.94226,1,1,0.36,BP
GO:0050892,intestinal absorption,38,1,2.75,0.94226,1,1,0.36,BP
GO:0007423,sensory organ development,598,34,43.2,0.94397,1,1,0.79,BP
GO:0035148,tube formation,176,8,12.71,0.94472,1,1,0.63,BP
GO:1902106,negative regulation of leukocyte differe...,103,4,7.44,0.94538,1,1,0.54,BP
GO:0050878,regulation of body fluid levels,345,18,24.92,0.94585,1,1,0.72,BP
GO:0008544,epidermis development,329,17,23.77,0.94642,1,1,0.72,BP
GO:0002323,natural killer cell activation involved ...,39,1,2.82,0.94644,1,1,0.35,BP
GO:0008207,C21-steroid hormone metabolic process,39,1,2.82,0.94644,1,1,0.35,BP
GO:0031076,embryonic camera-type eye development,39,1,2.82,0.94644,1,1,0.35,BP
GO:1902692,regulation of neuroblast proliferation,39,1,2.82,0.94644,1,1,0.35,BP
GO:0046651,lymphocyte proliferation,313,16,22.61,0.94714,1,1,0.71,BP
GO:0032677,regulation of interleukin-8 production,63,2,4.55,0.94779,1,1,0.44,BP
GO:0002377,immunoglobulin production,123,5,8.89,0.94786,1,1,0.56,BP
GO:0007292,female gamete generation,142,6,10.26,0.94892,1,1,0.58,BP
GO:0007586,digestion,124,5,8.96,0.95024,1,1,0.56,BP
GO:0071621,granulocyte chemotaxis,124,5,8.96,0.95024,1,1,0.56,BP
GO:0032943,mononuclear cell proliferation,315,16,22.75,0.95028,1,1,0.7,BP
GO:0003009,skeletal muscle contraction,40,1,2.89,0.95031,1,1,0.35,BP
GO:0010092,specification of animal organ identity,40,1,2.89,0.95031,1,1,0.35,BP
GO:0044331,cell-cell adhesion mediated by cadherin,40,1,2.89,0.95031,1,1,0.35,BP
GO:0050716,positive regulation of interleukin-1 sec...,40,1,2.89,0.95031,1,1,0.35,BP
GO:0060071,"Wnt signaling pathway, planar cell polar...",40,1,2.89,0.95031,1,1,0.35,BP
GO:1905332,positive regulation of morphogenesis of ...,40,1,2.89,0.95031,1,1,0.35,BP
GO:0008589,regulation of smoothened signaling pathw...,85,3,6.14,0.95038,1,1,0.49,BP
GO:0014032,neural crest cell development,85,3,6.14,0.95038,1,1,0.49,BP
GO:0050871,positive regulation of B cell activation,85,3,6.14,0.95038,1,1,0.49,BP
GO:0051606,detection of stimulus,231,11,16.69,0.95041,1,1,0.66,BP
GO:0072175,epithelial tube formation,161,7,11.63,0.95067,1,1,0.6,BP
GO:0001510,RNA methylation,64,2,4.62,0.95093,1,1,0.43,BP
GO:0031638,zymogen activation,64,2,4.62,0.95093,1,1,0.43,BP
GO:0035904,aorta development,64,2,4.62,0.95093,1,1,0.43,BP
GO:2000514,"regulation of CD4-positive, alpha-beta T...",64,2,4.62,0.95093,1,1,0.43,BP
GO:0006935,chemotaxis,604,34,43.63,0.95107,1,1,0.78,BP
GO:0072089,stem cell proliferation,143,6,10.33,0.95111,1,1,0.58,BP
GO:0002683,negative regulation of immune system pro...,478,26,34.53,0.95148,1,1,0.75,BP
GO:0034754,cellular hormone metabolic process,106,4,7.66,0.95301,1,1,0.52,BP
GO:0045668,negative regulation of osteoblast differ...,65,2,4.7,0.95389,1,1,0.43,BP
GO:0060042,retina morphogenesis in camera-type eye,65,2,4.7,0.95389,1,1,0.43,BP
GO:0001783,B cell apoptotic process,41,1,2.96,0.95391,1,1,0.34,BP
GO:0006953,acute-phase response,41,1,2.96,0.95391,1,1,0.34,BP
GO:1903053,regulation of extracellular matrix organ...,41,1,2.96,0.95391,1,1,0.34,BP
GO:0030855,epithelial cell differentiation,638,36,46.09,0.95398,1,1,0.78,BP
GO:0008406,gonad development,216,10,15.6,0.95430,1,1,0.64,BP
GO:0060840,artery development,107,4,7.73,0.95532,1,1,0.52,BP
GO:0030217,T cell differentiation,269,13,19.43,0.95664,1,1,0.67,BP
GO:0045123,cellular extravasation,66,2,4.77,0.95668,1,1,0.42,BP
GO:0061478,response to platelet aggregation inhibit...,66,2,4.77,0.95668,1,1,0.42,BP
GO:0002761,regulation of myeloid leukocyte differen...,127,5,9.17,0.95678,1,1,0.55,BP
GO:0051321,meiotic cell cycle,303,15,21.89,0.95702,1,1,0.69,BP
GO:0045923,positive regulation of fatty acid metabo...,42,1,3.03,0.95725,1,1,0.33,BP
GO:0090175,regulation of establishment of planar po...,42,1,3.03,0.95725,1,1,0.33,BP
GO:1902742,apoptotic process involved in developmen...,42,1,3.03,0.95725,1,1,0.33,BP
GO:0022600,digestive system process,108,4,7.8,0.95753,1,1,0.51,BP
GO:0044344,cellular response to fibroblast growth f...,88,3,6.36,0.95797,1,1,0.47,BP
GO:0016445,somatic diversification of immunoglobuli...,67,2,4.84,0.95931,1,1,0.41,BP
GO:0046637,regulation of alpha-beta T cell differen...,67,2,4.84,0.95931,1,1,0.41,BP
GO:0045621,positive regulation of lymphocyte differ...,109,4,7.87,0.95964,1,1,0.51,BP
GO:0002460,adaptive immune response based on somati...,305,15,22.03,0.95970,1,1,0.68,BP
GO:0016331,morphogenesis of embryonic epithelium,184,8,13.29,0.95983,1,1,0.6,BP
GO:0033077,T cell differentiation in thymus,89,3,6.43,0.96025,1,1,0.47,BP
GO:0035914,skeletal muscle cell differentiation,89,3,6.43,0.96025,1,1,0.47,BP
GO:0010569,regulation of double-strand break repair...,43,1,3.11,0.96034,1,1,0.32,BP
GO:0010883,regulation of lipid storage,43,1,3.11,0.96034,1,1,0.32,BP
GO:0031128,developmental induction,43,1,3.11,0.96034,1,1,0.32,BP
GO:0086002,cardiac muscle cell action potential inv...,43,1,3.11,0.96034,1,1,0.32,BP
GO:0045137,development of primary sexual characteri...,220,10,15.89,0.96063,1,1,0.63,BP
GO:0045165,cell fate commitment,289,14,20.88,0.96084,1,1,0.67,BP
GO:0014031,mesenchymal cell development,90,3,6.5,0.96241,1,1,0.46,BP
GO:0031016,pancreas development,90,3,6.5,0.96241,1,1,0.46,BP
GO:0071774,response to fibroblast growth factor,90,3,6.5,0.96241,1,1,0.46,BP
GO:0072091,regulation of stem cell proliferation,90,3,6.5,0.96241,1,1,0.46,BP
GO:0043010,camera-type eye development,341,17,24.63,0.96279,1,1,0.69,BP
GO:0003156,regulation of animal organ formation,44,1,3.18,0.96321,1,1,0.31,BP
GO:0001843,neural tube closure,111,4,8.02,0.96357,1,1,0.5,BP
GO:0007156,homophilic cell adhesion via plasma memb...,111,4,8.02,0.96357,1,1,0.5,BP
GO:0051480,regulation of cytosolic calcium ion conc...,375,19,27.09,0.96368,1,1,0.7,BP
GO:0032637,interleukin-8 production,69,2,4.98,0.96411,1,1,0.4,BP
GO:0045576,mast cell activation,69,2,4.98,0.96411,1,1,0.4,BP
GO:0045995,regulation of embryonic development,131,5,9.46,0.96427,1,1,0.53,BP
GO:0048864,stem cell development,91,3,6.57,0.96446,1,1,0.46,BP
GO:0007281,germ cell development,326,16,23.55,0.96478,1,1,0.68,BP
GO:0042100,B cell proliferation,112,4,8.09,0.96540,1,1,0.49,BP
GO:0060606,tube closure,112,4,8.09,0.96540,1,1,0.49,BP
GO:0022612,gland morphogenesis,151,6,10.91,0.96580,1,1,0.55,BP
GO:0035136,forelimb morphogenesis,45,1,3.25,0.96587,1,1,0.31,BP
GO:0050919,negative chemotaxis,45,1,3.25,0.96587,1,1,0.31,BP
GO:0046649,lymphocyte activation,714,40,51.58,0.96595,1,1,0.78,BP
GO:0001508,action potential,132,5,9.54,0.96595,1,1,0.52,BP
GO:0002562,somatic diversification of immune recept...,70,2,5.06,0.96630,1,1,0.4,BP
GO:0016444,somatic cell DNA recombination,70,2,5.06,0.96630,1,1,0.4,BP
GO:0002286,T cell activation involved in immune res...,113,4,8.16,0.96715,1,1,0.49,BP
GO:0006805,xenobiotic metabolic process,113,4,8.16,0.96715,1,1,0.49,BP
GO:0090101,negative regulation of transmembrane rec...,113,4,8.16,0.96715,1,1,0.49,BP
GO:0060395,SMAD protein signal transduction,93,3,6.72,0.96825,1,1,0.45,BP
GO:0070664,negative regulation of leukocyte prolife...,93,3,6.72,0.96825,1,1,0.45,BP
GO:0043029,T cell homeostasis,46,1,3.32,0.96835,1,1,0.3,BP
GO:0050706,regulation of interleukin-1 beta secreti...,46,1,3.32,0.96835,1,1,0.3,BP
GO:0061045,negative regulation of wound healing,71,2,5.13,0.96837,1,1,0.39,BP
GO:0050829,defense response to Gram-negative bacter...,94,3,6.79,0.96999,1,1,0.44,BP
GO:0003197,endocardial cushion development,47,1,3.4,0.97064,1,1,0.29,BP
GO:0071695,anatomical structure maturation,192,8,13.87,0.97111,1,1,0.58,BP
GO:0045582,positive regulation of T cell differenti...,95,3,6.86,0.97165,1,1,0.44,BP
GO:0060021,roof of mouth development,95,3,6.86,0.97165,1,1,0.44,BP
GO:0042733,embryonic digit morphogenesis,73,2,5.27,0.97213,1,1,0.38,BP
GO:0003382,epithelial cell morphogenesis,48,1,3.47,0.97276,1,1,0.29,BP
GO:0022602,ovulation cycle process,48,1,3.47,0.97276,1,1,0.29,BP
GO:0045581,negative regulation of T cell differenti...,48,1,3.47,0.97276,1,1,0.29,BP
GO:0045910,negative regulation of DNA recombination,48,1,3.47,0.97276,1,1,0.29,BP
GO:0048599,oocyte development,48,1,3.47,0.97276,1,1,0.29,BP
GO:0061053,somite development,96,3,6.93,0.97322,1,1,0.43,BP
GO:0048593,camera-type eye morphogenesis,137,5,9.9,0.97330,1,1,0.51,BP
GO:0090305,nucleic acid phosphodiester bond hydroly...,117,4,8.45,0.97333,1,1,0.47,BP
GO:0007411,axon guidance,248,11,17.91,0.97338,1,1,0.61,BP
GO:0008543,fibroblast growth factor receptor signal...,74,2,5.35,0.97385,1,1,0.37,BP
GO:0042130,negative regulation of T cell proliferat...,74,2,5.35,0.97385,1,1,0.37,BP
GO:0042129,regulation of T cell proliferation,176,7,12.71,0.97409,1,1,0.55,BP
GO:0048729,tissue morphogenesis,679,37,49.05,0.97445,1,1,0.75,BP
GO:0001503,ossification,387,19,27.96,0.97483,1,1,0.68,BP
GO:0097485,neuron projection guidance,250,11,18.06,0.97532,1,1,0.61,BP
GO:0042446,hormone biosynthetic process,75,2,5.42,0.97547,1,1,0.37,BP
GO:0060350,endochondral bone morphogenesis,75,2,5.42,0.97547,1,1,0.37,BP
GO:1903707,negative regulation of hemopoiesis,159,6,11.49,0.97635,1,1,0.52,BP
GO:0001654,eye development,389,19,28.1,0.97636,1,1,0.68,BP
GO:0033003,regulation of mast cell activation,50,1,3.61,0.97656,1,1,0.28,BP
GO:0043370,"regulation of CD4-positive, alpha-beta T...",50,1,3.61,0.97656,1,1,0.28,BP
GO:0022412,cellular process involved in reproductio...,423,21,30.56,0.97674,1,1,0.69,BP
GO:0098609,cell-cell adhesion,731,40,52.81,0.97701,1,1,0.76,BP
GO:0030279,negative regulation of ossification,99,3,7.15,0.97745,1,1,0.42,BP
GO:0007140,male meiotic nuclear division,51,1,3.68,0.97826,1,1,0.27,BP
GO:0060412,ventricular septum morphogenesis,51,1,3.68,0.97826,1,1,0.27,BP
GO:0072132,mesenchyme morphogenesis,51,1,3.68,0.97826,1,1,0.27,BP
GO:0072527,pyrimidine-containing compound metabolic...,51,1,3.68,0.97826,1,1,0.27,BP
GO:0001756,somitogenesis,77,2,5.56,0.97841,1,1,0.36,BP
GO:0002200,somatic diversification of immune recept...,77,2,5.56,0.97841,1,1,0.36,BP
GO:0071466,cellular response to xenobiotic stimulus,161,6,11.63,0.97847,1,1,0.52,BP
GO:0150063,visual system development,392,19,28.32,0.97849,1,1,0.67,BP
GO:0022610,biological adhesion,1323,78,95.57,0.97863,1,1,0.82,BP
GO:0007548,sex differentiation,290,13,20.95,0.97928,1,1,0.62,BP
GO:0023052,signaling,6490,434,468.82,0.97951,1,1,0.93,BP
GO:0001960,negative regulation of cytokine-mediated...,52,1,3.76,0.97984,1,1,0.27,BP
GO:0006956,complement activation,52,1,3.76,0.97984,1,1,0.27,BP
GO:0009994,oocyte differentiation,52,1,3.76,0.97984,1,1,0.27,BP
GO:0044058,regulation of digestive system process,52,1,3.76,0.97984,1,1,0.27,BP
GO:0007155,cell adhesion,1311,77,94.7,0.97987,1,1,0.81,BP
GO:0001578,microtubule bundle formation,101,3,7.3,0.97991,1,1,0.41,BP
GO:0030593,neutrophil chemotaxis,101,3,7.3,0.97991,1,1,0.41,BP
GO:0009617,response to bacterium,769,42,55.55,0.98020,1,1,0.76,BP
GO:0048880,sensory system development,395,19,28.53,0.98045,1,1,0.67,BP
GO:0051249,regulation of lymphocyte activation,430,21,31.06,0.98123,1,1,0.68,BP
GO:0045933,positive regulation of muscle contractio...,53,1,3.83,0.98130,1,1,0.26,BP
GO:0046834,lipid phosphorylation,53,1,3.83,0.98130,1,1,0.26,BP
GO:0050702,interleukin-1 beta secretion,53,1,3.83,0.98130,1,1,0.26,BP
GO:0045619,regulation of lymphocyte differentiation,184,7,13.29,0.98189,1,1,0.53,BP
GO:0030326,embryonic limb morphogenesis,145,5,10.47,0.98206,1,1,0.48,BP
GO:0035113,embryonic appendage morphogenesis,145,5,10.47,0.98206,1,1,0.48,BP
GO:0009948,anterior/posterior axis specification,54,1,3.9,0.98265,1,1,0.26,BP
GO:0048546,digestive tract morphogenesis,54,1,3.9,0.98265,1,1,0.26,BP
GO:0006959,humoral immune response,204,8,14.74,0.98271,1,1,0.54,BP
GO:0072006,nephron development,146,5,10.55,0.98295,1,1,0.47,BP
GO:0060429,epithelium development,1182,68,85.38,0.98306,1,1,0.8,BP
GO:0030317,flagellated sperm motility,104,3,7.51,0.98312,1,1,0.4,BP
GO:0046634,regulation of alpha-beta T cell activati...,104,3,7.51,0.98312,1,1,0.4,BP
GO:0048704,embryonic skeletal system morphogenesis,104,3,7.51,0.98312,1,1,0.4,BP
GO:0007218,neuropeptide signaling pathway,81,2,5.85,0.98331,1,1,0.34,BP
GO:0046660,female sex differentiation,147,5,10.62,0.98379,1,1,0.47,BP
GO:0000018,regulation of DNA recombination,105,3,7.58,0.98408,1,1,0.4,BP
GO:0097722,sperm motility,105,3,7.58,0.98408,1,1,0.4,BP
GO:1902105,regulation of leukocyte differentiation,298,13,21.53,0.98458,1,1,0.6,BP
GO:0002521,leukocyte differentiation,570,29,41.18,0.98485,1,1,0.7,BP
GO:0050865,regulation of cell activation,570,29,41.18,0.98485,1,1,0.7,BP
GO:0002204,somatic recombination of immunoglobulin ...,56,1,4.05,0.98507,1,1,0.25,BP
GO:0002208,somatic diversification of immunoglobuli...,56,1,4.05,0.98507,1,1,0.25,BP
GO:0035019,somatic stem cell population maintenance,56,1,4.05,0.98507,1,1,0.25,BP
GO:0045190,isotype switching,56,1,4.05,0.98507,1,1,0.25,BP
GO:2000648,positive regulation of stem cell prolife...,56,1,4.05,0.98507,1,1,0.25,BP
GO:0070663,regulation of leukocyte proliferation,245,10,17.7,0.98529,1,1,0.56,BP
GO:0002312,B cell activation involved in immune res...,83,2,6,0.98534,1,1,0.33,BP
GO:0090630,activation of GTPase activity,83,2,6,0.98534,1,1,0.33,BP
GO:0030509,BMP signaling pathway,170,6,12.28,0.98599,1,1,0.49,BP
GO:0032653,regulation of interleukin-10 production,57,1,4.12,0.98615,1,1,0.24,BP
GO:0072009,nephron epithelium development,108,3,7.8,0.98665,1,1,0.38,BP
GO:0045580,regulation of T cell differentiation,151,5,10.91,0.98678,1,1,0.46,BP
GO:0061333,renal tubule morphogenesis,85,2,6.14,0.98712,1,1,0.33,BP
GO:1903510,mucopolysaccharide metabolic process,58,1,4.19,0.98716,1,1,0.24,BP
GO:0048598,embryonic morphogenesis,642,33,46.38,0.98734,1,1,0.71,BP
GO:0050670,regulation of lymphocyte proliferation,230,9,16.61,0.98735,1,1,0.54,BP
GO:0002694,regulation of leukocyte activation,528,26,38.14,0.98786,1,1,0.68,BP
GO:0060411,cardiac septum morphogenesis,86,2,6.21,0.98793,1,1,0.32,BP
GO:0001755,neural crest cell migration,59,1,4.26,0.98809,1,1,0.23,BP
GO:0009952,anterior/posterior pattern specification,232,9,16.76,0.98839,1,1,0.54,BP
GO:0032944,regulation of mononuclear cell prolifera...,232,9,16.76,0.98839,1,1,0.54,BP
GO:0035107,appendage morphogenesis,174,6,12.57,0.98847,1,1,0.48,BP
GO:0035108,limb morphogenesis,174,6,12.57,0.98847,1,1,0.48,BP
GO:0009593,detection of chemical stimulus,87,2,6.28,0.98869,1,1,0.32,BP
GO:0050906,detection of stimulus involved in sensor...,133,4,9.61,0.98872,1,1,0.42,BP
GO:0070098,chemokine-mediated signaling pathway,60,1,4.33,0.98895,1,1,0.23,BP
GO:0002285,lymphocyte activation involved in immune...,195,7,14.09,0.98911,1,1,0.5,BP
GO:0030098,lymphocyte differentiation,396,18,28.61,0.98931,1,1,0.63,BP
GO:0032945,negative regulation of mononuclear cell ...,88,2,6.36,0.98941,1,1,0.31,BP
GO:0050672,negative regulation of lymphocyte prolif...,88,2,6.36,0.98941,1,1,0.31,BP
GO:0048592,eye morphogenesis,176,6,12.71,0.98955,1,1,0.47,BP
GO:0030198,extracellular matrix organization,272,11,19.65,0.98965,1,1,0.56,BP
GO:0032613,interleukin-10 production,61,1,4.41,0.98975,1,1,0.23,BP
GO:0050830,defense response to Gram-positive bacter...,113,3,8.16,0.99007,1,1,0.37,BP
GO:0001656,metanephros development,89,2,6.43,0.99008,1,1,0.31,BP
GO:0060562,epithelial tube morphogenesis,381,17,27.52,0.99019,1,1,0.62,BP
GO:0007204,positive regulation of cytosolic calcium...,328,14,23.69,0.99024,1,1,0.59,BP
GO:1990823,response to leukemia inhibitory factor,328,14,23.69,0.99024,1,1,0.59,BP
GO:1990830,cellular response to leukemia inhibitory...,328,14,23.69,0.99024,1,1,0.59,BP
GO:0050864,regulation of B cell activation,136,4,9.82,0.99044,1,1,0.41,BP
GO:0048286,lung alveolus development,62,1,4.48,0.99049,1,1,0.22,BP
GO:0043588,skin development,293,12,21.17,0.99070,1,1,0.57,BP
GO:0003006,developmental process involved in reprod...,784,41,56.63,0.99081,1,1,0.72,BP
GO:0042471,ear morphogenesis,137,4,9.9,0.99096,1,1,0.4,BP
GO:0002009,morphogenesis of an epithelium,555,27,40.09,0.99108,1,1,0.67,BP
GO:0007165,signal transduction,5929,389,428.3,0.99111,1,1,0.91,BP
GO:1905330,regulation of morphogenesis of an epithe...,115,3,8.31,0.99118,1,1,0.36,BP
GO:0050777,negative regulation of immune response,159,5,11.49,0.99126,1,1,0.44,BP
GO:0019226,transmission of nerve impulse,91,2,6.57,0.99130,1,1,0.3,BP
GO:0048469,cell maturation,201,7,14.52,0.99180,1,1,0.48,BP
GO:0001658,branching involved in ureteric bud morph...,64,1,4.62,0.99182,1,1,0.22,BP
GO:0009880,embryonic pattern specification,64,1,4.62,0.99182,1,1,0.22,BP
GO:0072376,protein activation cascade,64,1,4.62,0.99182,1,1,0.22,BP
GO:0071772,response to BMP,181,6,13.07,0.99184,1,1,0.46,BP
GO:0071773,cellular response to BMP stimulus,181,6,13.07,0.99184,1,1,0.46,BP
GO:0009798,axis specification,92,2,6.65,0.99185,1,1,0.3,BP
GO:0042113,B cell activation,278,11,20.08,0.99192,1,1,0.55,BP
GO:0002250,adaptive immune response,439,20,31.71,0.99195,1,1,0.63,BP
GO:0060349,bone morphogenesis,117,3,8.45,0.99218,1,1,0.36,BP
GO:1904321,response to forskolin,65,1,4.7,0.99241,1,1,0.21,BP
GO:1904322,cellular response to forskolin,65,1,4.7,0.99241,1,1,0.21,BP
GO:0001822,kidney development,280,11,20.23,0.99257,1,1,0.54,BP
GO:0050954,sensory perception of mechanical stimulu...,299,12,21.6,0.99270,1,1,0.56,BP
GO:0030216,keratinocyte differentiation,142,4,10.26,0.99316,1,1,0.39,BP
GO:0002381,immunoglobulin production involved in im...,67,1,4.84,0.99347,1,1,0.21,BP
GO:0035637,multicellular organismal signaling,143,4,10.33,0.99354,1,1,0.39,BP
GO:0061448,connective tissue development,284,11,20.52,0.99372,1,1,0.54,BP
GO:0035082,axoneme assembly,68,1,4.91,0.99395,1,1,0.2,BP
GO:0045638,negative regulation of myeloid cell diff...,97,2,7.01,0.99414,1,1,0.29,BP
GO:0072080,nephron tubule development,97,2,7.01,0.99414,1,1,0.29,BP
GO:0050866,negative regulation of cell activation,208,7,15.03,0.99415,1,1,0.47,BP
GO:0007368,determination of left/right symmetry,123,3,8.89,0.99456,1,1,0.34,BP
GO:0050868,negative regulation of T cell activation,123,3,8.89,0.99456,1,1,0.34,BP
GO:0003341,cilium movement,70,1,5.06,0.99479,1,1,0.2,BP
GO:0050909,sensory perception of taste,70,1,5.06,0.99479,1,1,0.2,BP
GO:0001655,urogenital system development,345,14,24.92,0.99495,1,1,0.56,BP
GO:0060675,ureteric bud morphogenesis,71,1,5.13,0.99517,1,1,0.19,BP
GO:0016064,immunoglobulin mediated immune response,126,3,9.1,0.99546,1,1,0.33,BP
GO:0072171,mesonephric tubule morphogenesis,72,1,5.2,0.99552,1,1,0.19,BP
GO:0030183,B cell differentiation,150,4,10.84,0.99565,1,1,0.37,BP
GO:0061326,renal tubule development,103,2,7.44,0.99607,1,1,0.27,BP
GO:0009953,dorsal/ventral pattern formation,104,2,7.51,0.99632,1,1,0.27,BP
GO:0019724,B cell mediated immunity,130,3,9.39,0.99645,1,1,0.32,BP
GO:0048736,appendage development,199,6,14.38,0.99675,1,1,0.42,BP
GO:0060173,limb development,199,6,14.38,0.99675,1,1,0.42,BP
GO:0035282,segmentation,106,2,7.66,0.99678,1,1,0.26,BP
GO:0009855,determination of bilateral symmetry,132,3,9.54,0.99686,1,1,0.31,BP
GO:0042742,defense response to bacterium,281,10,20.3,0.99690,1,1,0.49,BP
GO:0072001,renal system development,301,11,21.74,0.99698,1,1,0.51,BP
GO:0001763,morphogenesis of a branching structure,242,8,17.48,0.99700,1,1,0.46,BP
GO:0009799,specification of symmetry,133,3,9.61,0.99705,1,1,0.31,BP
GO:0051250,negative regulation of lymphocyte activa...,157,4,11.34,0.99709,1,1,0.35,BP
GO:0090596,sensory organ morphogenesis,302,11,21.82,0.99711,1,1,0.5,BP
GO:0072078,nephron tubule morphogenesis,79,1,5.71,0.99735,1,1,0.18,BP
GO:0072088,nephron epithelium morphogenesis,81,1,5.85,0.99772,1,1,0.17,BP
GO:0007605,sensory perception of sound,268,9,19.36,0.99773,1,1,0.46,BP
GO:0001501,skeletal system development,528,23,38.14,0.99773,1,1,0.6,BP
GO:0007601,visual perception,162,4,11.7,0.99783,1,1,0.34,BP
GO:0072028,nephron morphogenesis,82,1,5.92,0.99789,1,1,0.17,BP
GO:0048706,embryonic skeletal system development,139,3,10.04,0.99797,1,1,0.3,BP
GO:0048754,branching morphogenesis of an epithelial...,186,5,13.44,0.99797,1,1,0.37,BP
GO:0030203,glycosaminoglycan metabolic process,83,1,6,0.99804,1,1,0.17,BP
GO:0002695,negative regulation of leukocyte activat...,187,5,13.51,0.99808,1,1,0.37,BP
GO:0003151,outflow tract morphogenesis,84,1,6.07,0.99818,1,1,0.16,BP
GO:0009887,animal organ morphogenesis,1090,56,78.74,0.99821,1,1,0.71,BP
GO:0042472,inner ear morphogenesis,115,2,8.31,0.99824,1,1,0.24,BP
GO:0050953,sensory perception of light stimulus,166,4,11.99,0.99828,1,1,0.33,BP
GO:0072073,kidney epithelium development,142,3,10.26,0.99831,1,1,0.29,BP
GO:0048562,embryonic organ morphogenesis,318,11,22.97,0.99859,1,1,0.48,BP
GO:0048568,embryonic organ development,495,20,35.76,0.99895,1,1,0.56,BP
GO:0007200,phospholipase C-activating G protein-cou...,97,1,7.01,0.99932,1,1,0.14,BP
GO:0030510,regulation of BMP signaling pathway,97,1,7.01,0.99932,1,1,0.14,BP
GO:0060993,kidney morphogenesis,98,1,7.08,0.99937,1,1,0.14,BP
GO:0051216,cartilage development,210,5,15.17,0.99948,1,1,0.33,BP
GO:0006022,aminoglycan metabolic process,101,1,7.3,0.99950,1,1,0.14,BP
GO:0048705,skeletal system morphogenesis,259,7,18.71,0.99957,1,1,0.37,BP
GO:0001657,ureteric bud development,104,1,7.51,0.99960,1,1,0.13,BP
GO:0072163,mesonephric epithelium development,104,1,7.51,0.99960,1,1,0.13,BP
GO:0072164,mesonephric tubule development,104,1,7.51,0.99960,1,1,0.13,BP
GO:0032501,multicellular organismal process,8233,533,594.73,0.99967,1,1,0.9,BP
GO:0001823,mesonephros development,107,1,7.73,0.99968,1,1,0.13,BP
GO:0061138,morphogenesis of a branching epithelium,223,5,16.11,0.99976,1,1,0.31,BP
GO:0003002,regionalization,376,12,27.16,0.99976,1,1,0.44,BP
GO:0002062,chondrocyte differentiation,119,1,8.6,0.99987,1,1,0.12,BP
GO:0048565,digestive tract development,122,1,8.81,0.99990,1,1,0.11,BP
GO:0055123,digestive system development,135,1,9.75,0.99996,1,1,0.1,BP
GO:0007389,pattern specification process,470,12,33.95,1.00000,1,1,0.35,BP
GO:0003008,system process,2937,129,212.16,1.00000,1,1,0.61,BP
GO:0007186,G protein-coupled receptor signaling pat...,1902,41,137.4,1.00000,1,1,0.3,BP
GO:0007600,sensory perception,1781,25,128.65,1.00000,1,1,0.19,BP
GO:0007606,sensory perception of chemical stimulus,1218,1,87.99,1.00000,1,1,0.01,BP
GO:0008150,biological_process,21194,1531,1531,1.00000,1,1,1,BP
GO:0050877,nervous system process,2290,77,165.42,1.00000,1,1,0.47,BP
GO:0000154,rRNA modification,25,0,1.81,1.00000,1,1,0,BP
GO:0000731,DNA synthesis involved in DNA repair,28,0,2.02,1.00000,1,1,0,BP
GO:0000737,"DNA catabolic process, endonucleolytic",26,0,1.88,1.00000,1,1,0,BP
GO:0001539,cilium or flagellum-dependent cell motil...,35,0,2.53,1.00000,1,1,0,BP
GO:0001569,branching involved in blood vessel morph...,44,0,3.18,1.00000,1,1,0,BP
GO:0001580,detection of chemical stimulus involved ...,48,0,3.47,1.00000,1,1,0,BP
GO:0001696,gastric acid secretion,20,0,1.44,1.00000,1,1,0,BP
GO:0001759,organ induction,28,0,2.02,1.00000,1,1,0,BP
GO:0001829,trophectodermal cell differentiation,25,0,1.81,1.00000,1,1,0,BP
GO:0001911,negative regulation of leukocyte mediate...,23,0,1.66,1.00000,1,1,0,BP
GO:0001945,lymph vessel development,29,0,2.09,1.00000,1,1,0,BP
GO:0001946,lymphangiogenesis,21,0,1.52,1.00000,1,1,0,BP
GO:0002052,positive regulation of neuroblast prolif...,27,0,1.95,1.00000,1,1,0,BP
GO:0002063,chondrocyte development,45,0,3.25,1.00000,1,1,0,BP
GO:0002076,osteoblast development,20,0,1.44,1.00000,1,1,0,BP
GO:0002320,lymphoid progenitor cell differentiation,23,0,1.66,1.00000,1,1,0,BP
GO:0002577,regulation of antigen processing and pre...,21,0,1.52,1.00000,1,1,0,BP
GO:0002691,regulation of cellular extravasation,32,0,2.31,1.00000,1,1,0,BP
GO:0002693,positive regulation of cellular extravas...,23,0,1.66,1.00000,1,1,0,BP
GO:0002704,negative regulation of leukocyte mediate...,56,0,4.05,1.00000,1,1,0,BP
GO:0002707,negative regulation of lymphocyte mediat...,46,0,3.32,1.00000,1,1,0,BP
GO:0002712,regulation of B cell mediated immunity,61,0,4.41,1.00000,1,1,0,BP
GO:0002714,positive regulation of B cell mediated i...,46,0,3.32,1.00000,1,1,0,BP
GO:0002716,negative regulation of natural killer ce...,20,0,1.44,1.00000,1,1,0,BP
GO:0002719,negative regulation of cytokine producti...,23,0,1.66,1.00000,1,1,0,BP
GO:0002762,negative regulation of myeloid leukocyte...,48,0,3.47,1.00000,1,1,0,BP
GO:0002820,negative regulation of adaptive immune r...,47,0,3.4,1.00000,1,1,0,BP
GO:0002823,negative regulation of adaptive immune r...,42,0,3.03,1.00000,1,1,0,BP
GO:0002889,regulation of immunoglobulin mediated im...,61,0,4.41,1.00000,1,1,0,BP
GO:0002891,positive regulation of immunoglobulin me...,46,0,3.32,1.00000,1,1,0,BP
GO:0003148,outflow tract septum morphogenesis,29,0,2.09,1.00000,1,1,0,BP
GO:0003176,aortic valve development,23,0,1.66,1.00000,1,1,0,BP
GO:0003177,pulmonary valve development,21,0,1.52,1.00000,1,1,0,BP
GO:0003209,cardiac atrium morphogenesis,34,0,2.46,1.00000,1,1,0,BP
GO:0003272,endocardial cushion formation,24,0,1.73,1.00000,1,1,0,BP
GO:0003338,metanephros morphogenesis,27,0,1.95,1.00000,1,1,0,BP
GO:0003351,epithelial cilium movement,25,0,1.81,1.00000,1,1,0,BP
GO:0003413,chondrocyte differentiation involved in ...,29,0,2.09,1.00000,1,1,0,BP
GO:0003416,endochondral bone growth,43,0,3.11,1.00000,1,1,0,BP
GO:0003417,growth plate cartilage development,36,0,2.6,1.00000,1,1,0,BP
GO:0003418,growth plate cartilage chondrocyte diffe...,22,0,1.59,1.00000,1,1,0,BP
GO:0003433,chondrocyte development involved in endo...,22,0,1.59,1.00000,1,1,0,BP
GO:0006023,aminoglycan biosynthetic process,53,0,3.83,1.00000,1,1,0,BP
GO:0006024,glycosaminoglycan biosynthetic process,43,0,3.11,1.00000,1,1,0,BP
GO:0006026,aminoglycan catabolic process,26,0,1.88,1.00000,1,1,0,BP
GO:0006029,proteoglycan metabolic process,79,0,5.71,1.00000,1,1,0,BP
GO:0006270,DNA replication initiation,29,0,2.09,1.00000,1,1,0,BP
GO:0006335,DNA replication-dependent nucleosome ass...,31,0,2.24,1.00000,1,1,0,BP
GO:0006379,mRNA cleavage,20,0,1.44,1.00000,1,1,0,BP
GO:0006699,bile acid biosynthetic process,20,0,1.44,1.00000,1,1,0,BP
GO:0006760,folic acid-containing compound metabolic...,25,0,1.81,1.00000,1,1,0,BP
GO:0006829,zinc ion transport,32,0,2.31,1.00000,1,1,0,BP
GO:0007190,activation of adenylate cyclase activity,21,0,1.52,1.00000,1,1,0,BP
GO:0007271,"synaptic transmission, cholinergic",34,0,2.46,1.00000,1,1,0,BP
GO:0007431,salivary gland development,42,0,3.03,1.00000,1,1,0,BP
GO:0007435,salivary gland morphogenesis,38,0,2.75,1.00000,1,1,0,BP
GO:0007530,sex determination,29,0,2.09,1.00000,1,1,0,BP
GO:0007608,sensory perception of smell,1120,0,80.91,1.00000,1,1,0,BP
GO:0008206,bile acid metabolic process,29,0,2.09,1.00000,1,1,0,BP
GO:0008340,determination of adult lifespan,28,0,2.02,1.00000,1,1,0,BP
GO:0009187,cyclic nucleotide metabolic process,35,0,2.53,1.00000,1,1,0,BP
GO:0009190,cyclic nucleotide biosynthetic process,24,0,1.73,1.00000,1,1,0,BP
GO:0009595,detection of biotic stimulus,26,0,1.88,1.00000,1,1,0,BP
GO:0009620,response to fungus,39,0,2.82,1.00000,1,1,0,BP
GO:0010623,programmed cell death involved in cell d...,20,0,1.44,1.00000,1,1,0,BP
GO:0014821,phasic smooth muscle contraction,25,0,1.81,1.00000,1,1,0,BP
GO:0014850,response to muscle activity,21,0,1.52,1.00000,1,1,0,BP
GO:0015012,heparan sulfate proteoglycan biosyntheti...,30,0,2.17,1.00000,1,1,0,BP
GO:0015721,bile acid and bile salt transport,23,0,1.66,1.00000,1,1,0,BP
GO:0016073,snRNA metabolic process,42,0,3.03,1.00000,1,1,0,BP
GO:0016075,rRNA catabolic process,24,0,1.73,1.00000,1,1,0,BP
GO:0016180,snRNA processing,25,0,1.81,1.00000,1,1,0,BP
GO:0018149,peptide cross-linking,62,0,4.48,1.00000,1,1,0,BP
GO:0019228,neuronal action potential,45,0,3.25,1.00000,1,1,0,BP
GO:0019236,response to pheromone,105,0,7.58,1.00000,1,1,0,BP
GO:0019373,epoxygenase P450 pathway,31,0,2.24,1.00000,1,1,0,BP
GO:0021511,spinal cord patterning,28,0,2.02,1.00000,1,1,0,BP
GO:0021513,spinal cord dorsal/ventral patterning,26,0,1.88,1.00000,1,1,0,BP
GO:0021602,cranial nerve morphogenesis,31,0,2.24,1.00000,1,1,0,BP
GO:0021846,cell proliferation in forebrain,36,0,2.6,1.00000,1,1,0,BP
GO:0021983,pituitary gland development,39,0,2.82,1.00000,1,1,0,BP
GO:0023019,signal transduction involved in regulati...,23,0,1.66,1.00000,1,1,0,BP
GO:0030166,proteoglycan biosynthetic process,55,0,3.97,1.00000,1,1,0,BP
GO:0030199,collagen fibril organization,54,0,3.9,1.00000,1,1,0,BP
GO:0030201,heparan sulfate proteoglycan metabolic p...,35,0,2.53,1.00000,1,1,0,BP
GO:0030204,chondroitin sulfate metabolic process,22,0,1.59,1.00000,1,1,0,BP
GO:0030212,hyaluronan metabolic process,27,0,1.95,1.00000,1,1,0,BP
GO:0030514,negative regulation of BMP signaling pat...,53,0,3.83,1.00000,1,1,0,BP
GO:0030539,male genitalia development,23,0,1.66,1.00000,1,1,0,BP
GO:0030728,ovulation,23,0,1.66,1.00000,1,1,0,BP
GO:0030851,granulocyte differentiation,38,0,2.75,1.00000,1,1,0,BP
GO:0030889,negative regulation of B cell proliferat...,20,0,1.44,1.00000,1,1,0,BP
GO:0031290,retinal ganglion cell axon guidance,21,0,1.52,1.00000,1,1,0,BP
GO:0031424,keratinization,35,0,2.53,1.00000,1,1,0,BP
GO:0031649,heat generation,22,0,1.59,1.00000,1,1,0,BP
GO:0031954,positive regulation of protein autophosp...,24,0,1.73,1.00000,1,1,0,BP
GO:0032196,transposition,22,0,1.59,1.00000,1,1,0,BP
GO:0032288,myelin assembly,20,0,1.44,1.00000,1,1,0,BP
GO:0032330,regulation of chondrocyte differentiatio...,50,0,3.61,1.00000,1,1,0,BP
GO:0032331,negative regulation of chondrocyte diffe...,22,0,1.59,1.00000,1,1,0,BP
GO:0032332,positive regulation of chondrocyte diffe...,21,0,1.52,1.00000,1,1,0,BP
GO:0032633,interleukin-4 production,38,0,2.75,1.00000,1,1,0,BP
GO:0032673,regulation of interleukin-4 production,31,0,2.24,1.00000,1,1,0,BP
GO:0032693,negative regulation of interleukin-10 pr...,21,0,1.52,1.00000,1,1,0,BP
GO:0032753,positive regulation of interleukin-4 pro...,25,0,1.81,1.00000,1,1,0,BP
GO:0033081,regulation of T cell differentiation in ...,31,0,2.24,1.00000,1,1,0,BP
GO:0033141,positive regulation of peptidyl-serine p...,29,0,2.09,1.00000,1,1,0,BP
GO:0033630,positive regulation of cell adhesion med...,20,0,1.44,1.00000,1,1,0,BP
GO:0033962,cytoplasmic mRNA processing body assembl...,20,0,1.44,1.00000,1,1,0,BP
GO:0034104,negative regulation of tissue remodeling,24,0,1.73,1.00000,1,1,0,BP
GO:0034505,tooth mineralization,24,0,1.73,1.00000,1,1,0,BP
GO:0034723,DNA replication-dependent nucleosome org...,31,0,2.24,1.00000,1,1,0,BP
GO:0035115,embryonic forelimb morphogenesis,36,0,2.6,1.00000,1,1,0,BP
GO:0035268,protein mannosylation,22,0,1.59,1.00000,1,1,0,BP
GO:0035272,exocrine system development,55,0,3.97,1.00000,1,1,0,BP
GO:0035634,response to stilbenoid,22,0,1.59,1.00000,1,1,0,BP
GO:0036037,"CD8-positive, alpha-beta T cell activati...",27,0,1.95,1.00000,1,1,0,BP
GO:0036303,lymph vessel morphogenesis,22,0,1.59,1.00000,1,1,0,BP
GO:0042036,negative regulation of cytokine biosynth...,32,0,2.31,1.00000,1,1,0,BP
GO:0042094,interleukin-2 biosynthetic process,22,0,1.59,1.00000,1,1,0,BP
GO:0042430,indole-containing compound metabolic pro...,25,0,1.81,1.00000,1,1,0,BP
GO:0042462,eye photoreceptor cell development,44,0,3.18,1.00000,1,1,0,BP
GO:0042573,retinoic acid metabolic process,25,0,1.81,1.00000,1,1,0,BP
GO:0042634,regulation of hair cycle,31,0,2.24,1.00000,1,1,0,BP
GO:0042730,fibrinolysis,20,0,1.44,1.00000,1,1,0,BP
GO:0042738,exogenous drug catabolic process,53,0,3.83,1.00000,1,1,0,BP
GO:0043011,myeloid dendritic cell differentiation,20,0,1.44,1.00000,1,1,0,BP
GO:0043371,"negative regulation of CD4-positive, alp...",23,0,1.66,1.00000,1,1,0,BP
GO:0043567,regulation of insulin-like growth factor...,25,0,1.81,1.00000,1,1,0,BP
GO:0043576,regulation of respiratory gaseous exchan...,23,0,1.66,1.00000,1,1,0,BP
GO:0043687,post-translational protein modification,23,0,1.66,1.00000,1,1,0,BP
GO:0044273,sulfur compound catabolic process,21,0,1.52,1.00000,1,1,0,BP
GO:0045063,T-helper 1 cell differentiation,22,0,1.59,1.00000,1,1,0,BP
GO:0045076,regulation of interleukin-2 biosynthetic...,20,0,1.44,1.00000,1,1,0,BP
GO:0045109,intermediate filament organization,26,0,1.88,1.00000,1,1,0,BP
GO:0045191,regulation of isotype switching,40,0,2.89,1.00000,1,1,0,BP
GO:0045494,photoreceptor cell maintenance,41,0,2.96,1.00000,1,1,0,BP
GO:0045589,regulation of regulatory T cell differen...,30,0,2.17,1.00000,1,1,0,BP
GO:0045623,negative regulation of T-helper cell dif...,20,0,1.44,1.00000,1,1,0,BP
GO:0045671,negative regulation of osteoclast differ...,28,0,2.02,1.00000,1,1,0,BP
GO:0045683,negative regulation of epidermis develop...,22,0,1.59,1.00000,1,1,0,BP
GO:0045742,positive regulation of epidermal growth ...,26,0,1.88,1.00000,1,1,0,BP
GO:0045745,positive regulation of G protein-coupled...,36,0,2.6,1.00000,1,1,0,BP
GO:0045746,negative regulation of Notch signaling p...,38,0,2.75,1.00000,1,1,0,BP
GO:0045830,positive regulation of isotype switching,30,0,2.17,1.00000,1,1,0,BP
GO:0045880,positive regulation of smoothened signal...,38,0,2.75,1.00000,1,1,0,BP
GO:0045992,negative regulation of embryonic develop...,29,0,2.09,1.00000,1,1,0,BP
GO:0046636,negative regulation of alpha-beta T cell...,42,0,3.03,1.00000,1,1,0,BP
GO:0046639,negative regulation of alpha-beta T cell...,27,0,1.95,1.00000,1,1,0,BP
GO:0046653,tetrahydrofolate metabolic process,20,0,1.44,1.00000,1,1,0,BP
GO:0046685,response to arsenic-containing substance,24,0,1.73,1.00000,1,1,0,BP
GO:0046854,phosphatidylinositol phosphorylation,41,0,2.96,1.00000,1,1,0,BP
GO:0046885,regulation of hormone biosynthetic proce...,39,0,2.82,1.00000,1,1,0,BP
GO:0048245,eosinophil chemotaxis,20,0,1.44,1.00000,1,1,0,BP
GO:0048333,mesodermal cell differentiation,23,0,1.66,1.00000,1,1,0,BP
GO:0048339,paraxial mesoderm development,22,0,1.59,1.00000,1,1,0,BP
GO:0048483,autonomic nervous system development,49,0,3.54,1.00000,1,1,0,BP
GO:0048485,sympathetic nervous system development,23,0,1.66,1.00000,1,1,0,BP
GO:0048486,parasympathetic nervous system developme...,22,0,1.59,1.00000,1,1,0,BP
GO:0048536,spleen development,45,0,3.25,1.00000,1,1,0,BP
GO:0048841,regulation of axon extension involved in...,33,0,2.38,1.00000,1,1,0,BP
GO:0048843,negative regulation of axon extension in...,27,0,1.95,1.00000,1,1,0,BP
GO:0048846,axon extension involved in axon guidance,37,0,2.67,1.00000,1,1,0,BP
GO:0048857,neural nucleus development,22,0,1.59,1.00000,1,1,0,BP
GO:0050654,chondroitin sulfate proteoglycan metabol...,30,0,2.17,1.00000,1,1,0,BP
GO:0050832,defense response to fungus,25,0,1.81,1.00000,1,1,0,BP
GO:0050907,detection of chemical stimulus involved ...,59,0,4.26,1.00000,1,1,0,BP
GO:0050908,detection of light stimulus involved in ...,21,0,1.52,1.00000,1,1,0,BP
GO:0050910,detection of mechanical stimulus involve...,20,0,1.44,1.00000,1,1,0,BP
GO:0050912,detection of chemical stimulus involved ...,52,0,3.76,1.00000,1,1,0,BP
GO:0050913,sensory perception of bitter taste,51,0,3.68,1.00000,1,1,0,BP
GO:0050962,detection of light stimulus involved in ...,21,0,1.52,1.00000,1,1,0,BP
GO:0050996,positive regulation of lipid catabolic p...,27,0,1.95,1.00000,1,1,0,BP
GO:0051180,vitamin transport,32,0,2.31,1.00000,1,1,0,BP
GO:0051447,negative regulation of meiotic cell cycl...,20,0,1.44,1.00000,1,1,0,BP
GO:0051482,positive regulation of cytosolic calcium...,37,0,2.67,1.00000,1,1,0,BP
GO:0051673,membrane disruption in other organism,28,0,2.02,1.00000,1,1,0,BP
GO:0051797,regulation of hair follicle development,22,0,1.59,1.00000,1,1,0,BP
GO:0051818,disruption of cells of other organism in...,21,0,1.52,1.00000,1,1,0,BP
GO:0051883,killing of cells in other organism invol...,21,0,1.52,1.00000,1,1,0,BP
GO:0051969,regulation of transmission of nerve impu...,23,0,1.66,1.00000,1,1,0,BP
GO:0052652,cyclic purine nucleotide metabolic proce...,24,0,1.73,1.00000,1,1,0,BP
GO:0055003,cardiac myofibril assembly,26,0,1.88,1.00000,1,1,0,BP
GO:0060037,pharyngeal system development,28,0,2.02,1.00000,1,1,0,BP
GO:0060065,uterus development,26,0,1.88,1.00000,1,1,0,BP
GO:0060080,inhibitory postsynaptic potential,23,0,1.66,1.00000,1,1,0,BP
GO:0060252,positive regulation of glial cell prolif...,20,0,1.44,1.00000,1,1,0,BP
GO:0060285,cilium-dependent cell motility,35,0,2.53,1.00000,1,1,0,BP
GO:0060294,cilium movement involved in cell motilit...,20,0,1.44,1.00000,1,1,0,BP
GO:0060351,cartilage development involved in endoch...,52,0,3.76,1.00000,1,1,0,BP
GO:0060445,branching involved in salivary gland mor...,28,0,2.02,1.00000,1,1,0,BP
GO:0060456,positive regulation of digestive system ...,20,0,1.44,1.00000,1,1,0,BP
GO:0060512,prostate gland morphogenesis,34,0,2.46,1.00000,1,1,0,BP
GO:0060575,intestinal epithelial cell differentiati...,22,0,1.59,1.00000,1,1,0,BP
GO:0060713,labyrinthine layer morphogenesis,27,0,1.95,1.00000,1,1,0,BP
GO:0060740,prostate gland epithelium morphogenesis,33,0,2.38,1.00000,1,1,0,BP
GO:0060795,cell fate commitment involved in formati...,31,0,2.24,1.00000,1,1,0,BP
GO:0060972,left/right pattern formation,23,0,1.66,1.00000,1,1,0,BP
GO:0060977,coronary vasculature morphogenesis,32,0,2.31,1.00000,1,1,0,BP
GO:0061035,regulation of cartilage development,69,0,4.98,1.00000,1,1,0,BP
GO:0061036,positive regulation of cartilage develop...,31,0,2.24,1.00000,1,1,0,BP
GO:0061037,negative regulation of cartilage develop...,30,0,2.17,1.00000,1,1,0,BP
GO:0061298,retina vasculature development in camera...,27,0,1.95,1.00000,1,1,0,BP
GO:0061311,cell surface receptor signaling pathway ...,28,0,2.02,1.00000,1,1,0,BP
GO:0062009,secondary palate development,24,0,1.73,1.00000,1,1,0,BP
GO:0070269,pyroptosis,23,0,1.66,1.00000,1,1,0,BP
GO:0070286,axonemal dynein complex assembly,32,0,2.31,1.00000,1,1,0,BP
GO:0071234,cellular response to phenylalanine,25,0,1.81,1.00000,1,1,0,BP
GO:0071361,cellular response to ethanol,27,0,1.95,1.00000,1,1,0,BP
GO:0071425,hematopoietic stem cell proliferation,26,0,1.88,1.00000,1,1,0,BP
GO:0071577,zinc ion transmembrane transport,23,0,1.66,1.00000,1,1,0,BP
GO:0072079,nephron tubule formation,20,0,1.44,1.00000,1,1,0,BP
GO:0072087,renal vesicle development,20,0,1.44,1.00000,1,1,0,BP
GO:0072170,metanephric tubule development,21,0,1.52,1.00000,1,1,0,BP
GO:0072202,cell differentiation involved in metanep...,23,0,1.66,1.00000,1,1,0,BP
GO:0072207,metanephric epithelium development,24,0,1.73,1.00000,1,1,0,BP
GO:0072210,metanephric nephron development,38,0,2.75,1.00000,1,1,0,BP
GO:0072215,regulation of metanephros development,22,0,1.59,1.00000,1,1,0,BP
GO:0072243,metanephric nephron epithelium developme...,20,0,1.44,1.00000,1,1,0,BP
GO:0072273,metanephric nephron morphogenesis,22,0,1.59,1.00000,1,1,0,BP
GO:0072337,modified amino acid transport,23,0,1.66,1.00000,1,1,0,BP
GO:0072606,interleukin-8 secretion,25,0,1.81,1.00000,1,1,0,BP
GO:0072643,interferon-gamma secretion,24,0,1.73,1.00000,1,1,0,BP
GO:0072677,eosinophil migration,24,0,1.73,1.00000,1,1,0,BP
GO:0080053,response to phenylalanine,25,0,1.81,1.00000,1,1,0,BP
GO:0086005,ventricular cardiac muscle cell action p...,28,0,2.02,1.00000,1,1,0,BP
GO:0090050,positive regulation of cell migration in...,21,0,1.52,1.00000,1,1,0,BP
GO:0090280,positive regulation of calcium ion impor...,25,0,1.81,1.00000,1,1,0,BP
GO:0097150,neuronal stem cell population maintenanc...,24,0,1.73,1.00000,1,1,0,BP
GO:0097186,amelogenesis,24,0,1.73,1.00000,1,1,0,BP
GO:0097502,mannosylation,23,0,1.66,1.00000,1,1,0,BP
GO:0098581,detection of external biotic stimulus,23,0,1.66,1.00000,1,1,0,BP
GO:0098868,bone growth,46,0,3.32,1.00000,1,1,0,BP
GO:1902284,neuron projection extension involved in ...,37,0,2.67,1.00000,1,1,0,BP
GO:1902667,regulation of axon guidance,46,0,3.32,1.00000,1,1,0,BP
GO:1902668,negative regulation of axon guidance,28,0,2.02,1.00000,1,1,0,BP
GO:1902914,regulation of protein polyubiquitination,23,0,1.66,1.00000,1,1,0,BP
GO:1903487,regulation of lactation,29,0,2.09,1.00000,1,1,0,BP
GO:1903489,positive regulation of lactation,27,0,1.95,1.00000,1,1,0,BP
GO:1905314,semi-lunar valve development,31,0,2.24,1.00000,1,1,0,BP
GO:1905939,regulation of gonad development,25,0,1.81,1.00000,1,1,0,BP
GO:1990403,embryonic brain development,20,0,1.44,1.00000,1,1,0,BP
GO:2000316,regulation of T-helper 17 type immune re...,23,0,1.66,1.00000,1,1,0,BP
GO:2000482,regulation of interleukin-8 secretion,21,0,1.52,1.00000,1,1,0,BP
GO:2000515,"negative regulation of CD4-positive, alp...",31,0,2.24,1.00000,1,1,0,BP
GO:2000780,negative regulation of double-strand bre...,26,0,1.88,1.00000,1,1,0,BP
GO:2001026,regulation of endothelial cell chemotaxi...,22,0,1.59,1.00000,1,1,0,BP
GO:0005515,protein binding,8941,920,644.07, 1e-30,8.29e-28,1.6580000000000003e-28,1.43,MF
GO:0003735,structural constituent of ribosome,151,75,10.88, 1e-30,8.29e-28,1.6580000000000003e-28,6.89,MF
GO:0005488,binding,13259,1183,955.12, 1e-30,8.29e-28,1.6580000000000003e-28,1.24,MF
GO:0003723,RNA binding,1068,201,76.93, 1e-30,8.29e-28,1.6580000000000003e-28,2.61,MF
GO:0019899,enzyme binding,2351,333,169.36, 1e-30,8.29e-28,1.6580000000000003e-28,1.97,MF
GO:0044877,protein-containing complex binding,1256,202,90.48,1.5e-28,1.2435e-25,2.0725e-26,2.23,MF
GO:1901363,heterocyclic compound binding,5061,526,364.57,1.8e-22,1.4921999999999998e-19,2.0725000000000002e-20,1.44,MF
GO:0097159,organic cyclic compound binding,5162,534,371.85,2.0e-22,1.6580000000000002e-19,2.0725000000000002e-20,1.44,MF
GO:0003954,NADH dehydrogenase activity,29,22,2.09,6.1e-20,5.0569e-17,5.618777777777778e-18,10.53,MF
GO:0005198,structural molecule activity,610,109,43.94,4.9e-19,4.0621e-16,3.918909090909091e-17,2.48,MF
GO:0003729,mRNA binding,270,66,19.45,5.2e-19,4.3108000000000005e-16,3.918909090909091e-17,3.39,MF
GO:0003824,catalytic activity,5780,566,416.36,2.0e-18,1.6580000000000001e-15,1.3816666666666666e-16,1.36,MF
GO:0031625,ubiquitin protein ligase binding,307,70,22.11,2.6e-18,2.1554e-15,1.658e-16,3.17,MF
GO:0051082,unfolded protein binding,97,37,6.99,4.2e-18,3.4818e-15,2.4870000000000003e-16,5.29,MF
GO:0044389,ubiquitin-like protein ligase binding,326,72,23.48,5.5e-18,4.5595e-15,3.0396666666666666e-16,3.07,MF
GO:0019829,cation-transporting ATPase activity,61,29,4.39,1.3e-17,1.0777e-14,5.987222222222222e-16,6.61,MF
GO:0022853,active ion transmembrane transporter act...,61,29,4.39,1.3e-17,1.0777e-14,5.987222222222222e-16,6.61,MF
GO:0042625,ATPase coupled ion transmembrane transpo...,61,29,4.39,1.3e-17,1.0777e-14,5.987222222222222e-16,6.61,MF
GO:0009055,electron transfer activity,72,31,5.19,3.5e-17,2.9015e-14,1.5271052631578948e-15,5.97,MF
GO:0015078,proton transmembrane transporter activit...,121,40,8.72,6.7e-17,5.5543000000000005e-14,2.6754090909090904e-15,4.59,MF
GO:0008137,NADH dehydrogenase (ubiquinone) activity,26,19,1.87,7.1e-17,5.885899999999999e-14,2.6754090909090904e-15,10.16,MF
GO:0050136,NADH dehydrogenase (quinone) activity,26,19,1.87,7.1e-17,5.885899999999999e-14,2.6754090909090904e-15,10.16,MF
GO:0043021,ribonucleoprotein complex binding,152,44,10.95,5.2e-16,4.3107999999999997e-13,1.8742608695652172e-14,4.02,MF
GO:0044769,"ATPase activity, coupled to transmembran...",34,20,2.45,6.6e-15,5.4714e-12,2.27975e-13,8.16,MF
GO:0008135,"translation factor activity, RNA binding",78,29,5.62,3.8e-14,3.1502e-11,1.26008e-12,5.16,MF
GO:0016655,"oxidoreductase activity, acting on NAD(P...",37,20,2.67,6.1e-14,5.0569000000000004e-11,1.9449615384615384e-12,7.49,MF
GO:0019843,rRNA binding,71,27,5.11,1.5e-13,1.2435e-10,4.605555555555555e-12,5.28,MF
GO:0003676,nucleic acid binding,3105,324,223.67,3.9e-13,3.2331e-10,1.1546785714285715e-11,1.45,MF
GO:0019904,protein domain specific binding,813,115,58.56,1.7e-12,1.4093e-9,4.859655172413793e-11,1.96,MF
GO:0003743,translation initiation factor activity,47,21,3.39,1.8e-12,1.4922e-9,4.974e-11,6.19,MF
GO:0000166,nucleotide binding,2075,232,149.47,2.6e-12,2.1554e-9,6.531515151515152e-11,1.55,MF
GO:1901265,nucleoside phosphate binding,2075,232,149.47,2.6e-12,2.1554e-9,6.531515151515152e-11,1.55,MF
GO:0042802,identical protein binding,1906,217,137.3,2.6e-12,2.1554e-9,6.531515151515152e-11,1.58,MF
GO:0016491,oxidoreductase activity,796,112,57.34,4.6e-12,3.8134e-9,1.1215882352941176e-10,1.95,MF
GO:0051117,ATPase binding,94,29,6.77,8.6e-12,7.1294e-9,2.0369714285714285e-10,4.28,MF
GO:0036094,small molecule binding,2460,261,177.21,2.6e-11,2.1554e-8,5.987222222222223e-10,1.47,MF
GO:0097367,carbohydrate derivative binding,2158,234,155.45,4.4e-11,3.6476e-8,9.85837837837838e-10,1.51,MF
GO:0042626,"ATPase activity, coupled to transmembran...",113,31,8.14,4.9e-11,4.0621e-8,1.0689736842105263e-9,3.81,MF
GO:0036442,proton-exporting ATPase activity,31,16,2.23,5.2e-11,4.3108e-8,1.1053333333333332e-9,7.17,MF
GO:0017076,purine nucleotide binding,1843,206,132.76,5.6e-11,4.6424e-8,1.1606000000000001e-9,1.55,MF
GO:0043492,"ATPase activity, coupled to movement of ...",114,31,8.21,6.3e-11,5.2227e-8,1.2738292682926829e-9,3.78,MF
GO:0016651,"oxidoreductase activity, acting on NAD(P...",84,26,6.05,9.4e-11,7.792599999999999e-8,1.8553809523809523e-9,4.3,MF
GO:0032553,ribonucleotide binding,1848,205,133.12,1.2e-10,9.948e-8,2.3134883720930234e-9,1.54,MF
GO:0017111,nucleoside-triphosphatase activity,830,111,59.79,1.4e-10,1.1606000000000001e-7,2.6377272727272726e-9,1.86,MF
GO:0004298,threonine-type endopeptidase activity,21,13,1.51,1.6e-10,1.3264e-7,2.763333333333333e-9,8.61,MF
GO:0070003,threonine-type peptidase activity,21,13,1.51,1.6e-10,1.3264e-7,2.763333333333333e-9,8.61,MF
GO:0032555,purine ribonucleotide binding,1831,203,131.9,1.6e-10,1.3264e-7,2.763333333333333e-9,1.54,MF
GO:0015405,P-P-bond-hydrolysis-driven transmembrane...,118,31,8.5,1.6e-10,1.3264e-7,2.763333333333333e-9,3.65,MF
GO:0016817,"hydrolase activity, acting on acid anhyd...",886,116,63.82,1.9e-10,1.5750999999999999e-7,3.1501999999999993e-9,1.82,MF
GO:0016818,"hydrolase activity, acting on acid anhyd...",886,116,63.82,1.9e-10,1.5750999999999999e-7,3.1501999999999993e-9,1.82,MF
GO:0015399,primary active transmembrane transporter...,119,31,8.57,2.1e-10,1.7409e-7,3.413529411764706e-9,3.62,MF
GO:0016462,pyrophosphatase activity,883,115,63.61,3.2e-10,2.6528e-7,5.101538461538461e-9,1.81,MF
GO:0043168,anion binding,2733,278,196.87,4.8e-10,3.9792e-7,7.507924528301886e-9,1.41,MF
GO:0035639,purine ribonucleoside triphosphate bindi...,1756,193,126.49,1.0e-09,8.29e-7,1.5351851851851853e-8,1.53,MF
GO:0004129,cytochrome-c oxidase activity,24,13,1.73,1.6e-09,1.3264000000000001e-6,2.327017543859649e-8,7.51,MF
GO:0015002,heme-copper terminal oxidase activity,24,13,1.73,1.6e-09,1.3264000000000001e-6,2.327017543859649e-8,7.51,MF
GO:0016676,"oxidoreductase activity, acting on a hem...",24,13,1.73,1.6e-09,1.3264000000000001e-6,2.327017543859649e-8,7.51,MF
GO:0016675,"oxidoreductase activity, acting on a hem...",25,13,1.8,3.1e-09,2.5699e-6,4.430862068965517e-8,7.22,MF
GO:0031072,heat shock protein binding,140,32,10.08,3.7e-09,3.0673e-6,5.198813559322034e-8,3.17,MF
GO:0030234,enzyme regulator activity,973,118,70.09,1.3e-08,1.0777e-5,1.7961666666666667e-7,1.68,MF
GO:0019900,kinase binding,821,103,59.14,2.0e-08,1.658e-5,2.7180327868852457e-7,1.74,MF
GO:0019901,protein kinase binding,740,95,53.31,2.4e-08,1.9896e-5,3.209032258064516e-7,1.78,MF
GO:0046961,"proton-transporting ATPase activity, rot...",21,11,1.51,4.7e-08,3.8963e-5,6.184603174603174e-7,7.28,MF
GO:0031369,translation initiation factor binding,40,15,2.88,4.9e-08,4.0621e-5,6.34703125e-7,5.21,MF
GO:0043022,ribosome binding,66,19,4.75,1.2e-07,9.947999999999999e-5,1.507272727272727e-6,4,MF
GO:0051087,chaperone binding,100,24,7.2,1.2e-07,9.947999999999999e-5,1.507272727272727e-6,3.33,MF
GO:0043167,ion binding,5533,483,398.57,2.8e-07,2.3212000000000002e-4,3.4644776119402987e-6,1.21,MF
GO:0008092,cytoskeletal protein binding,976,113,70.31,3.1e-07,2.5699e-4,3.779264705882353e-6,1.61,MF
GO:0047485,protein N-terminus binding,130,27,9.36,4.8e-07,3.9791999999999996e-4,5.76695652173913e-6,2.88,MF
GO:0042623,"ATPase activity, coupled",286,45,20.6,5.8e-07,4.8081999999999997e-4,6.8688571428571425e-6,2.18,MF
GO:0030554,adenyl nucleotide binding,1505,158,108.41,7.2e-07,5.968799999999999e-4,8.406760563380283e-6,1.46,MF
GO:0016887,ATPase activity,386,55,27.81,9.2e-07,7.6268e-4,1.0592777777777778e-5,1.98,MF
GO:0032550,purine ribonucleoside binding,367,53,26.44,9.5e-07,7.8755e-4,1.0788356164383562e-5,2,MF
GO:0008134,transcription factor binding,726,88,52.3,9.8e-07,8.124199999999999e-4,1.0978648648648649e-5,1.68,MF
GO:0005525,GTP binding,360,52,25.93,1.2e-06,9.948e-4,1.3263999999999999e-5,2.01,MF
GO:0001883,purine nucleoside binding,372,53,26.8,1.5e-06,0.0012435,1.6149350649350648e-5,1.98,MF
GO:0032549,ribonucleoside binding,372,53,26.8,1.5e-06,0.0012435,1.6149350649350648e-5,1.98,MF
GO:0019003,GDP binding,77,19,5.55,1.6e-06,0.0013264,1.7005128205128202e-5,3.42,MF
GO:0015662,"ATPase activity, coupled to transmembran...",39,13,2.81,1.8e-06,0.0014922,1.888860759493671e-5,4.63,MF
GO:0032559,adenyl ribonucleotide binding,1494,155,107.62,1.9e-06,0.0015751,1.968875e-5,1.44,MF
GO:0060590,ATPase regulator activity,40,13,2.88,2.5e-06,0.0020725,2.558641975308642e-5,4.51,MF
GO:0046983,protein dimerization activity,1422,148,102.43,2.7e-06,0.0022383,2.7296341463414633e-5,1.44,MF
GO:0016787,hydrolase activity,2534,240,182.54,3.3e-06,0.0027357,3.2960240963855426e-5,1.31,MF
GO:0001882,nucleoside binding,383,53,27.59,3.5e-06,0.0029015,3.454166666666666e-5,1.92,MF
GO:0019001,guanyl nucleotide binding,384,53,27.66,3.8e-06,0.0031502,3.6630232558139534e-5,1.92,MF
GO:0032561,guanyl ribonucleotide binding,384,53,27.66,3.8e-06,0.0031502,3.6630232558139534e-5,1.92,MF
GO:0001671,ATPase activator activity,26,10,1.87,6.7e-06,0.0055543,6.311704545454545e-5,5.35,MF
GO:0003924,GTPase activity,303,44,21.83,6.7e-06,0.0055543,6.311704545454545e-5,2.02,MF
GO:0048156,tau protein binding,21,9,1.51,6.8e-06,0.0056372,6.333932584269663e-5,5.96,MF
GO:0051287,NAD binding,63,16,4.54,6.9e-06,0.0057201,6.355666666666667e-5,3.52,MF
GO:0015077,monovalent inorganic cation transmembran...,363,50,26.15,7.5e-06,0.0062175,6.832417582417582e-5,1.91,MF
GO:0005524,ATP binding,1429,146,102.94,8.6e-06,0.0071294,7.749347826086957e-5,1.42,MF
GO:0042803,protein homodimerization activity,950,104,68.43,1.1e-05,0.009119,9.805376344086022e-5,1.52,MF
GO:0002020,protease binding,148,26,10.66,1.9e-05,0.015751,1.6756382978723406e-4,2.44,MF
GO:0003712,transcription coregulator activity,460,58,33.14,2.2e-05,0.018238,1.9197894736842105e-4,1.75,MF
GO:0051787,misfolded protein binding,24,9,1.73,2.5e-05,0.020725,2.1588541666666666e-4,5.2,MF
GO:0042287,MHC protein binding,30,10,2.16,2.9e-05,0.024041,2.478453608247423e-4,4.63,MF
GO:0048306,calcium-dependent protein binding,71,16,5.11,3.5e-05,0.029015,2.960714285714286e-4,3.13,MF
GO:0042393,histone binding,218,33,15.7,4.0e-05,0.03316,3.316e-4,2.1,MF
GO:0003727,single-stranded RNA binding,95,19,6.84,4.0e-05,0.03316,3.316e-4,2.78,MF
GO:0008553,"proton-exporting ATPase activity, phosph...",20,8,1.44,4.1e-05,0.033989,3.365247524752475e-4,5.56,MF
GO:0008144,drug binding,1685,163,121.38,5.1e-05,0.042279,4.145e-4,1.34,MF
GO:0015631,tubulin binding,339,45,24.42,5.2e-05,0.043108,4.1852427184466015e-4,1.84,MF
GO:0003713,transcription coactivator activity,261,37,18.8,6.0e-05,0.04974,4.7826923076923074e-4,1.97,MF
GO:0003755,peptidyl-prolyl cis-trans isomerase acti...,34,10,2.45,9.6e-05,0.079584,7.579428571428572e-4,4.08,MF
GO:0016209,antioxidant activity,85,17,6.12,0.00010,0.0829,7.820754716981132e-4,2.78,MF
GO:0005200,structural constituent of cytoskeleton,63,14,4.54,0.00013,0.10776999999999999,9.797272727272725e-4,3.08,MF
GO:0051536,iron-sulfur cluster binding,63,14,4.54,0.00013,0.10776999999999999,9.797272727272725e-4,3.08,MF
GO:0051540,metal cluster binding,63,14,4.54,0.00013,0.10776999999999999,9.797272727272725e-4,3.08,MF
GO:0003730,mRNA 3'-UTR binding,95,18,6.84,0.00013,0.10776999999999999,9.797272727272725e-4,2.63,MF
GO:0098772,molecular function regulator,1760,166,126.78,0.00016,0.13264,0.0011842857142857143,1.31,MF
GO:0045182,translation regulator activity,57,13,4.11,0.00016,0.13264,0.0011842857142857143,3.16,MF
GO:0008022,protein C-terminus binding,238,33,17.14,0.00022,0.18238000000000001,0.0016139823008849558,1.93,MF
GO:0140096,"catalytic activity, acting on a protein",2187,199,157.54,0.00025,0.20725000000000002,0.0018179824561403509,1.26,MF
GO:0016859,cis-trans isomerase activity,38,10,2.74,0.00027,0.22383,0.0019295689655172412,3.65,MF
GO:0033218,amide binding,364,45,26.22,0.00027,0.22383,0.0019295689655172412,1.72,MF
GO:0019208,phosphatase regulator activity,86,16,6.2,0.00038,0.31502,0.0026924786324786327,2.58,MF
GO:0044325,ion channel binding,139,22,10.01,0.00039,0.32331,0.0027399152542372882,2.2,MF
GO:0008047,enzyme activator activity,457,53,32.92,0.00041,0.33988999999999997,0.002856218487394958,1.61,MF
GO:0042277,peptide binding,298,38,21.47,0.00043,0.35647,0.0029705833333333333,1.77,MF
GO:0016684,"oxidoreductase activity, acting on perox...",56,12,4.03,0.00053,0.43937,0.003631157024793388,2.98,MF
GO:0015036,disulfide oxidoreductase activity,42,10,3.03,0.00064,0.53056,0.004348852459016394,3.3,MF
GO:0044183,protein binding involved in protein fold...,22,7,1.58,0.00065,0.5388499999999999,0.00438089430894309,4.43,MF
GO:0004842,ubiquitin-protein transferase activity,383,45,27.59,0.00082,0.6797799999999999,0.005482096774193548,1.63,MF
GO:0019787,ubiquitin-like protein transferase activ...,405,47,29.17,0.00083,0.68807,0.0055045599999999995,1.61,MF
GO:0017025,TBP-class protein binding,23,7,1.66,0.00087,0.72123,0.0056789763779527555,4.22,MF
GO:0090079,"translation regulator activity, nucleic ...",23,7,1.66,0.00087,0.72123,0.0056789763779527555,4.22,MF
GO:0097110,scaffold protein binding,76,14,5.47,0.00096,0.79584,0.0062175,2.56,MF
GO:0048037,cofactor binding,542,59,39.04,0.00099,0.82071,0.006362093023255814,1.51,MF
GO:0004601,peroxidase activity,52,11,3.75,0.00101,0.8372900000000001,0.006440692307692309,2.93,MF
GO:0046982,protein heterodimerization activity,579,62,41.71,0.00112,0.92848,0.007087633587786258,1.49,MF
GO:0005504,fatty acid binding,45,10,3.24,0.00114,0.94506,0.007159545454545454,3.09,MF
GO:0060090,molecular adaptor activity,200,27,14.41,0.00119,0.9865100000000001,0.007417368421052633,1.87,MF
GO:0016853,isomerase activity,152,22,10.95,0.00133,1,0.008167185185185185,2.01,MF
GO:0035254,glutamate receptor binding,70,13,5.04,0.00133,1,0.008167185185185185,2.58,MF
GO:0000287,magnesium ion binding,202,27,14.55,0.00138,1,0.008411911764705881,1.86,MF
GO:0051539,"4 iron, 4 sulfur cluster binding",39,9,2.81,0.00150,1,0.008946043165467626,3.2,MF
GO:0061631,ubiquitin conjugating enzyme activity,39,9,2.81,0.00150,1,0.008946043165467626,3.2,MF
GO:0051537,"2 iron, 2 sulfur cluster binding",25,7,1.8,0.00150,1,0.008946043165467626,3.89,MF
GO:0043531,ADP binding,41,9,2.95,0.00217,1,0.012758368794326241,3.05,MF
GO:0061650,ubiquitin-like protein conjugating enzym...,41,9,2.95,0.00217,1,0.012758368794326241,3.05,MF
GO:0032794,GTPase activating protein binding,20,6,1.44,0.00222,1,0.01296042253521127,4.17,MF
GO:0030544,Hsp70 protein binding,49,10,3.53,0.00225,1,0.013010694444444445,2.83,MF
GO:0051020,GTPase binding,527,56,37.96,0.00226,1,0.013010694444444445,1.48,MF
GO:0008143,poly(A) binding,27,7,1.94,0.00245,1,0.014007241379310344,3.61,MF
GO:0008017,microtubule binding,242,30,17.43,0.00255,1,0.014479109589041098,1.72,MF
GO:0019903,protein phosphatase binding,170,23,12.25,0.00257,1,0.014493401360544217,1.88,MF
GO:0036002,pre-mRNA binding,35,8,2.52,0.00290,1,0.01613489932885906,3.17,MF
GO:0097718,disordered domain specific binding,35,8,2.52,0.00290,1,0.01613489932885906,3.17,MF
GO:0051428,peptide hormone receptor binding,21,6,1.51,0.00293,1,0.01619313333333333,3.97,MF
GO:0048487,beta-tubulin binding,43,9,3.1,0.00307,1,0.01685450331125828,2.9,MF
GO:0051427,hormone receptor binding,183,24,13.18,0.00318,1,0.017343552631578947,1.82,MF
GO:0022804,active transmembrane transporter activit...,355,40,25.57,0.00331,1,0.017934575163398695,1.56,MF
GO:0001540,amyloid-beta binding,61,11,4.39,0.00386,1,0.02077883116883117,2.51,MF
GO:0030276,clathrin binding,53,10,3.82,0.00411,1,0.021840961538461538,2.62,MF
GO:1990841,promoter-specific chromatin binding,53,10,3.82,0.00411,1,0.021840961538461538,2.62,MF
GO:0005080,protein kinase C binding,62,11,4.47,0.00439,1,0.02318031847133758,2.46,MF
GO:0035258,steroid hormone receptor binding,89,14,6.41,0.00444,1,0.023295949367088613,2.18,MF
GO:0031492,nucleosomal DNA binding,23,6,1.66,0.00481,1,0.0250785534591195,3.61,MF
GO:0016790,thiolester hydrolase activity,46,9,3.31,0.00495,1,0.02559086956521739,2.72,MF
GO:0051721,protein phosphatase 2A binding,38,8,2.74,0.00497,1,0.02559086956521739,2.92,MF
GO:0002039,p53 binding,72,12,5.19,0.00507,1,0.02594462962962963,2.31,MF
GO:0019888,protein phosphatase regulator activity,73,12,5.26,0.00568,1,0.028863353658536584,2.28,MF
GO:0005102,signaling receptor binding,1644,145,118.43,0.00571,1,0.028863353658536584,1.22,MF
GO:0048027,mRNA 5'-UTR binding,24,6,1.73,0.00603,1,0.030113674698795178,3.47,MF
GO:0050780,dopamine receptor binding,24,6,1.73,0.00603,1,0.030113674698795178,3.47,MF
GO:0016504,peptidase activator activity,32,7,2.31,0.00677,1,0.03360676646706587,3.03,MF
GO:0016667,"oxidoreductase activity, acting on a sul...",57,10,4.11,0.00701,1,0.0345910119047619,2.43,MF
GO:0019887,protein kinase regulator activity,164,21,11.81,0.00728,1,0.03571076923076923,1.78,MF
GO:0019902,phosphatase binding,217,26,15.63,0.00738,1,0.03598835294117648,1.66,MF
GO:0004812,aminoacyl-tRNA ligase activity,41,8,2.95,0.00801,1,0.03860633720930232,2.71,MF
GO:0016875,"ligase activity, forming carbon-oxygen b...",41,8,2.95,0.00801,1,0.03860633720930232,2.71,MF
GO:0001664,G protein-coupled receptor binding,296,33,21.32,0.00834,1,0.03996450867052023,1.55,MF
GO:0031490,chromatin DNA binding,96,14,6.92,0.00872,1,0.04154528735632184,2.02,MF
GO:0050750,low-density lipoprotein particle recepto...,26,6,1.87,0.00911,1,0.04315537142857143,3.21,MF
GO:0003682,chromatin binding,589,58,42.43,0.00953,1,0.04488846590909091,1.37,MF
GO:0033293,monocarboxylic acid binding,69,11,4.97,0.00996,1,0.04657303370786517,2.21,MF
GO:0003714,transcription corepressor activity,190,23,13.69,0.01000,1,0.04657303370786517,1.68,MF
GO:0019212,phosphatase inhibitor activity,43,8,3.1,0.01071,1,0.04960106145251397,2.58,MF
GO:0017075,syntaxin-1 binding,27,6,1.94,0.01102,1,0.05075322222222222,3.09,MF
GO:0070717,poly-purine tract binding,35,7,2.52,0.01120,1,0.05129723756906077,2.78,MF
GO:0003779,actin binding,429,44,30.9,0.01142,1,0.052017472527472526,1.42,MF
GO:0022890,inorganic cation transmembrane transport...,575,56,41.42,0.01317,1,0.059660819672131146,1.35,MF
GO:0000049,tRNA binding,63,10,4.54,0.01406,1,0.06334641304347825,2.2,MF
GO:0019207,kinase regulator activity,196,23,14.12,0.01419,1,0.06358654054054054,1.63,MF
GO:0008289,lipid binding,748,70,53.88,0.01458,1,0.06498290322580645,1.3,MF
GO:0031690,adrenergic receptor binding,21,5,1.51,0.01483,1,0.0657436898395722,3.31,MF
GO:0003697,single-stranded DNA binding,113,15,8.14,0.01560,1,0.06878936170212767,1.84,MF
GO:0016860,intramolecular oxidoreductase activity,46,8,3.31,0.01593,1,0.0695051052631579,2.42,MF
GO:0051879,Hsp90 protein binding,46,8,3.31,0.01593,1,0.0695051052631579,2.42,MF
GO:0060589,nucleoside-triphosphatase regulator acti...,299,32,21.54,0.01614,1,0.07005267015706806,1.49,MF
GO:0043130,ubiquitin binding,74,11,5.33,0.01646,1,0.07106947916666666,2.06,MF
GO:0051015,actin filament binding,200,23,14.41,0.01768,1,0.07594155440414509,1.6,MF
GO:0001091,RNA polymerase II basal transcription fa...,22,5,1.58,0.01808,1,0.07686317948717948,3.16,MF
GO:0004602,glutathione peroxidase activity,22,5,1.58,0.01808,1,0.07686317948717948,3.16,MF
GO:0070325,lipoprotein particle receptor binding,30,6,2.16,0.01839,1,0.07778219387755103,2.78,MF
GO:0032182,ubiquitin-like protein binding,95,13,6.84,0.01854,1,0.07801857868020305,1.9,MF
GO:0017069,snRNA binding,39,7,2.81,0.01995,1,0.0835280303030303,2.49,MF
GO:0003725,double-stranded RNA binding,86,12,6.2,0.02009,1,0.08369150753768843,1.94,MF
GO:0099106,ion channel regulator activity,117,15,8.43,0.02087,1,0.08650614999999999,1.78,MF
GO:0031681,G-protein beta-subunit binding,23,5,1.66,0.02176,1,0.08974646766169156,3.01,MF
GO:0001098,basal transcription machinery binding,58,9,4.18,0.02212,1,0.09033241379310346,2.15,MF
GO:0001099,basal RNA polymerase II transcription ma...,58,9,4.18,0.02212,1,0.09033241379310346,2.15,MF
GO:0001046,core promoter sequence-specific DNA bind...,49,8,3.53,0.02278,1,0.09257166666666666,2.27,MF
GO:0008234,cysteine-type peptidase activity,172,20,12.39,0.02309,1,0.09320213592233009,1.61,MF
GO:0048365,Rac GTPase binding,68,10,4.9,0.02316,1,0.09320213592233009,2.04,MF
GO:0043169,cation binding,3631,290,261.56,0.02526,1,0.10116202898550725,1.11,MF
GO:0031683,G-protein beta/gamma-subunit complex bin...,24,5,1.73,0.02590,1,0.10273253588516747,2.89,MF
GO:0070840,dynein complex binding,24,5,1.73,0.02590,1,0.10273253588516747,2.89,MF
GO:0005507,copper ion binding,60,9,4.32,0.02704,1,0.10674361904761906,2.08,MF
GO:0030674,"protein binding, bridging",132,16,9.51,0.02800,1,0.11000947867298579,1.68,MF
GO:0001047,core promoter binding,62,9,4.47,0.03268,1,0.12779113207547171,2.01,MF
GO:0016247,channel regulator activity,146,17,10.52,0.03382,1,0.1316280751173709,1.62,MF
GO:0031491,nucleosome binding,53,8,3.82,0.03482,1,0.13488682242990654,2.09,MF
GO:0001786,phosphatidylserine binding,63,9,4.54,0.03578,1,0.13796102325581394,1.98,MF
GO:1901567,fatty acid derivative binding,35,6,2.52,0.03708,1,0.14231166666666667,2.38,MF
GO:0030374,nuclear receptor transcription coactivat...,64,9,4.61,0.03908,1,0.14922,1.95,MF
GO:0140030,modification-dependent protein binding,171,19,12.32,0.03940,1,0.14922,1.54,MF
GO:0004857,enzyme inhibitor activity,381,37,27.45,0.03942,1,0.14922,1.35,MF
GO:0051219,phosphoprotein binding,106,13,7.64,0.04110,1,0.15454660633484163,1.7,MF
GO:0031435,mitogen-activated protein kinase kinase ...,27,5,1.94,0.04120,1,0.15454660633484163,2.58,MF
GO:0030971,receptor tyrosine kinase binding,75,10,5.4,0.04216,1,0.15743531531531532,1.85,MF
GO:1901681,sulfur compound binding,253,26,18.22,0.04281,1,0.15914569506726456,1.43,MF
GO:0000149,SNARE binding,118,14,8.5,0.04443,1,0.1637367111111111,1.65,MF
GO:0046872,metal ion binding,3533,279,254.5,0.04444,1,0.1637367111111111,1.1,MF
GO:0005543,phospholipid binding,422,40,30.4,0.04585,1,0.16818429203539823,1.32,MF
GO:0043394,proteoglycan binding,37,6,2.67,0.04706,1,0.17186229074889867,2.25,MF
GO:0019783,ubiquitin-like protein-specific protease...,109,13,7.85,0.04966,1,0.18013554585152838,1.66,MF
GO:0015485,cholesterol binding,47,7,3.39,0.04976,1,0.18013554585152838,2.06,MF
GO:0016835,carbon-oxygen lyase activity,67,9,4.83,0.05019,1,0.18090221739130433,1.86,MF
GO:0047555,"3',5'-cyclic-GMP phosphodiesterase activ...",20,4,1.44,0.05139,1,0.1844255844155844,2.78,MF
GO:0035257,nuclear hormone receptor binding,154,17,11.09,0.05187,1,0.18534581896551722,1.53,MF
GO:0000979,RNA polymerase II core promoter sequence...,38,6,2.74,0.05262,1,0.18721879828326182,2.19,MF
GO:0061630,ubiquitin protein ligase activity,235,24,16.93,0.05307,1,0.1880129487179487,1.42,MF
GO:0030291,protein serine/threonine kinase inhibito...,29,5,2.09,0.05388,1,0.19007029787234042,2.39,MF
GO:0004620,phospholipase activity,89,11,6.41,0.05456,1,0.1916494092827004,1.72,MF
GO:0015459,potassium channel regulator activity,48,7,3.46,0.05479,1,0.1916494092827004,2.02,MF
GO:0008324,cation transmembrane transporter activit...,627,56,45.17,0.05586,1,0.19457117647058825,1.24,MF
GO:0016740,transferase activity,2276,183,163.95,0.05712,1,0.19812753138075312,1.12,MF
GO:0046914,transition metal ion binding,971,83,69.95,0.05788,1,0.19977876543209877,1.19,MF
GO:0004712,protein serine/threonine/tyrosine kinase...,39,6,2.81,0.05856,1,0.19977876543209877,2.14,MF
GO:0004864,protein phosphatase inhibitor activity,39,6,2.81,0.05856,1,0.19977876543209877,2.14,MF
GO:0043028,cysteine-type endopeptidase regulator ac...,39,6,2.81,0.05856,1,0.19977876543209877,2.14,MF
GO:0016779,nucleotidyltransferase activity,123,14,8.86,0.05924,1,0.20127032786885246,1.58,MF
GO:0030145,manganese ion binding,59,8,4.25,0.05991,1,0.20137651821862346,1.88,MF
GO:0050840,extracellular matrix binding,59,8,4.25,0.05991,1,0.20137651821862346,1.88,MF
GO:0035259,glucocorticoid receptor binding,21,4,1.51,0.06000,1,0.20137651821862346,2.65,MF
GO:0016874,ligase activity,147,16,10.59,0.06421,1,0.21463745967741937,1.51,MF
GO:0098631,cell adhesion mediator activity,40,6,2.88,0.06488,1,0.21600610441767068,2.08,MF
GO:0140104,molecular carrier activity,50,7,3.6,0.06577,1,0.21809331999999998,1.94,MF
GO:1990782,protein tyrosine kinase binding,103,12,7.42,0.06665,1,0.2201308764940239,1.62,MF
GO:0070491,repressing transcription factor binding,71,9,5.11,0.06798,1,0.22363261904761902,1.76,MF
GO:0043236,laminin binding,31,5,2.23,0.06858,1,0.22471470355731227,2.24,MF
GO:0050998,nitric-oxide synthase binding,22,4,1.58,0.06931,1,0.22621255905511808,2.53,MF
GO:0072341,modified amino acid binding,104,12,7.49,0.07065,1,0.22968176470588236,1.6,MF
GO:0001085,RNA polymerase II transcription factor b...,173,18,12.46,0.07384,1,0.2391146875,1.44,MF
GO:0061659,ubiquitin-like protein ligase activity,244,24,17.58,0.07467,1,0.2408615953307393,1.37,MF
GO:0008233,peptidase activity,640,56,46.1,0.07514,1,0.24143821705426355,1.21,MF
GO:0008198,ferrous iron binding,32,5,2.31,0.07668,1,0.24355448275862068,2.16,MF
GO:0030507,spectrin binding,32,5,2.31,0.07668,1,0.24355448275862068,2.16,MF
GO:0051059,NF-kappaB binding,32,5,2.31,0.07668,1,0.24355448275862068,2.16,MF
GO:0005548,phospholipid transporter activity,52,7,3.75,0.07798,1,0.24673824427480914,1.87,MF
GO:0015318,inorganic molecular entity transmembrane...,796,68,57.34,0.08024,1,0.25256238636363637,1.19,MF
GO:0004721,phosphoprotein phosphatase activity,175,18,12.61,0.08043,1,0.25256238636363637,1.43,MF
GO:0031406,carboxylic acid binding,211,21,15.2,0.08256,1,0.2582726037735849,1.38,MF
GO:0048029,monosaccharide binding,85,10,6.12,0.08435,1,0.26153712686567165,1.63,MF
GO:0004860,protein kinase inhibitor activity,53,7,3.82,0.08455,1,0.26153712686567165,1.83,MF
GO:0032934,sterol binding,53,7,3.82,0.08455,1,0.26153712686567165,1.83,MF
GO:0045505,dynein intermediate chain binding,33,5,2.38,0.08527,1,0.2627837546468402,2.1,MF
GO:0043177,organic acid binding,224,22,16.14,0.08595,1,0.2635057564575646,1.36,MF
GO:0043548,phosphatidylinositol 3-kinase binding,43,6,3.1,0.08614,1,0.2635057564575646,1.94,MF
GO:0016765,"transferase activity, transferring alkyl...",64,8,4.61,0.08777,1,0.2675048897058824,1.74,MF
GO:0017022,myosin binding,75,9,5.4,0.08928,1,0.27111032967032966,1.67,MF
GO:0016614,"oxidoreductase activity, acting on CH-OH...",143,15,10.3,0.09128,1,0.27617197080291966,1.46,MF
GO:0008187,poly-pyrimidine tract binding,34,5,2.45,0.09434,1,0.28439221818181815,2.04,MF
GO:0008201,heparin binding,156,16,11.24,0.09685,1,0.29090090579710143,1.42,MF
GO:0016836,hydro-lyase activity,55,7,3.96,0.09860,1,0.29402661870503594,1.77,MF
GO:0031593,polyubiquitin modification-dependent pro...,55,7,3.96,0.09860,1,0.29402661870503594,1.77,MF
GO:0042826,histone deacetylase binding,122,13,8.79,0.10059,1,0.2988856989247312,1.48,MF
GO:0031210,phosphatidylcholine binding,25,4,1.8,0.10134,1,0.29897103202846975,2.22,MF
GO:0050997,quaternary ammonium group binding,25,4,1.8,0.10134,1,0.29897103202846975,2.22,MF
GO:0035255,ionotropic glutamate receptor binding,45,6,3.24,0.10220,1,0.30043900709219856,1.85,MF
GO:0016616,"oxidoreductase activity, acting on the C...",134,14,9.65,0.10267,1,0.3007541696113074,1.45,MF
GO:0008200,ion channel inhibitor activity,35,5,2.52,0.10388,1,0.3032271830985916,1.98,MF
GO:0004843,thiol-dependent ubiquitin-specific prote...,90,10,6.48,0.11261,1,0.32500242214532876,1.54,MF
GO:0000062,fatty-acyl-CoA binding,26,4,1.87,0.11330,1,0.32500242214532876,2.14,MF
GO:0005158,insulin receptor binding,26,4,1.87,0.11330,1,0.32500242214532876,2.14,MF
GO:0017134,fibroblast growth factor binding,26,4,1.87,0.11330,1,0.32500242214532876,2.14,MF
GO:0046966,thyroid hormone receptor binding,26,4,1.87,0.11330,1,0.32500242214532876,2.14,MF
GO:0019905,syntaxin binding,79,9,5.69,0.11408,1,0.326111448275862,1.58,MF
GO:0050662,coenzyme binding,295,27,21.25,0.11893,1,0.3388074570446735,1.27,MF
GO:0019210,kinase inhibitor activity,58,7,4.18,0.12191,1,0.34492624573378844,1.67,MF
GO:0070063,RNA polymerase binding,58,7,4.18,0.12191,1,0.34492624573378844,1.67,MF
GO:0003899,DNA-directed 5'-3' RNA polymerase activi...,37,5,2.67,0.12432,1,0.34818000000000005,1.87,MF
GO:0016248,channel inhibitor activity,37,5,2.67,0.12432,1,0.34818000000000005,1.87,MF
GO:0016877,"ligase activity, forming carbon-sulfur b...",37,5,2.67,0.12432,1,0.34818000000000005,1.87,MF
GO:0005246,calcium channel regulator activity,48,6,3.46,0.12898,1,0.36001488215488214,1.73,MF
GO:0004722,protein serine/threonine phosphatase act...,70,8,5.04,0.12959,1,0.36050372483221477,1.59,MF
GO:0004674,protein serine/threonine kinase activity,463,40,33.35,0.13290,1,0.36847525083612037,1.2,MF
GO:0017112,Rab guanyl-nucleotide exchange factor ac...,38,5,2.74,0.13519,1,0.37110102649006627,1.82,MF
GO:0019205,nucleobase-containing compound kinase ac...,38,5,2.74,0.13519,1,0.37110102649006627,1.82,MF
GO:0043014,alpha-tubulin binding,38,5,2.74,0.13519,1,0.37110102649006627,1.82,MF
GO:0043027,cysteine-type endopeptidase inhibitor ac...,28,4,2.02,0.13893,1,0.3801088118811881,1.98,MF
GO:0015075,ion transmembrane transporter activity,855,70,61.59,0.14309,1,0.3898474426229508,1.14,MF
GO:0017048,Rho GTPase binding,166,16,11.96,0.14343,1,0.3898474426229508,1.34,MF
GO:0034062,5'-3' RNA polymerase activity,39,5,2.81,0.14646,1,0.39548970684039086,1.78,MF
GO:0097747,RNA polymerase activity,39,5,2.81,0.14646,1,0.39548970684039086,1.78,MF
GO:0005496,steroid binding,107,11,7.71,0.14768,1,0.39748935064935065,1.43,MF
GO:0030331,estrogen receptor binding,50,6,3.6,0.14851,1,0.39842974110032364,1.67,MF
GO:0008266,poly(U) RNA binding,29,4,2.09,0.15254,1,0.4066098392282958,1.91,MF
GO:0120013,intermembrane lipid transfer activity,29,4,2.09,0.15254,1,0.4066098392282958,1.91,MF
GO:0070011,"peptidase activity, acting on L-amino ac...",613,51,44.16,0.15717,1,0.41760875,1.15,MF
GO:0004114,"3',5'-cyclic-nucleotide phosphodiesteras...",30,4,2.16,0.16662,1,0.4385015238095238,1.85,MF
GO:0050681,androgen receptor binding,30,4,2.16,0.16662,1,0.4385015238095238,1.85,MF
GO:0070566,adenylyltransferase activity,30,4,2.16,0.16662,1,0.4385015238095238,1.85,MF
GO:0001222,transcription corepressor binding,20,3,1.44,0.17096,1,0.4401423602484472,2.08,MF
GO:0017127,cholesterol transporter activity,20,3,1.44,0.17096,1,0.4401423602484472,2.08,MF
GO:0043274,phospholipase binding,20,3,1.44,0.17096,1,0.4401423602484472,2.08,MF
GO:0050321,tau-protein kinase activity,20,3,1.44,0.17096,1,0.4401423602484472,2.08,MF
GO:0070064,proline-rich region binding,20,3,1.44,0.17096,1,0.4401423602484472,2.08,MF
GO:0070300,phosphatidic acid binding,20,3,1.44,0.17096,1,0.4401423602484472,2.08,MF
GO:0120020,intermembrane cholesterol transfer activ...,20,3,1.44,0.17096,1,0.4401423602484472,2.08,MF
GO:0036459,thiol-dependent ubiquitinyl hydrolase ac...,99,10,7.13,0.17511,1,0.44943092879256963,1.4,MF
GO:0004112,cyclic-nucleotide phosphodiesterase acti...,31,4,2.23,0.18115,1,0.45924571865443425,1.79,MF
GO:0004623,phospholipase A2 activity,31,4,2.23,0.18115,1,0.45924571865443425,1.79,MF
GO:0046875,ephrin receptor binding,31,4,2.23,0.18115,1,0.45924571865443425,1.79,MF
GO:0098632,cell-cell adhesion mediator activity,31,4,2.23,0.18115,1,0.45924571865443425,1.79,MF
GO:0000980,RNA polymerase II distal enhancer sequen...,100,10,7.2,0.18290,1,0.4617202431610942,1.39,MF
GO:0005085,guanyl-nucleotide exchange factor activi...,198,18,14.26,0.18324,1,0.4617202431610942,1.26,MF
GO:0016747,"transferase activity, transferring acyl ...",236,21,17,0.18545,1,0.4658728787878788,1.24,MF
GO:0005215,transporter activity,1099,87,79.17,0.18869,1,0.4688428059701492,1.1,MF
GO:0031489,myosin V binding,21,3,1.51,0.18946,1,0.4688428059701492,1.99,MF
GO:0042975,peroxisome proliferator activated recept...,21,3,1.51,0.18946,1,0.4688428059701492,1.99,MF
GO:0051861,glycolipid binding,21,3,1.51,0.18946,1,0.4688428059701492,1.99,MF
GO:0120015,intermembrane sterol transfer activity,21,3,1.51,0.18946,1,0.4688428059701492,1.99,MF
GO:0101005,ubiquitinyl hydrolase activity,101,10,7.28,0.19085,1,0.47031605341246285,1.37,MF
GO:0051018,protein kinase A binding,54,6,3.89,0.19119,1,0.47031605341246285,1.54,MF
GO:0008374,O-acyltransferase activity,43,5,3.1,0.19516,1,0.47866165680473377,1.61,MF
GO:0035091,phosphatidylinositol binding,251,22,18.08,0.19749,1,0.48294752212389386,1.22,MF
GO:0008081,phosphoric diester hydrolase activity,90,9,6.48,0.19915,1,0.48557455882352946,1.39,MF
GO:0030295,protein kinase activator activity,79,8,5.69,0.20781,1,0.5008361449275363,1.41,MF
GO:0016408,C-acyltransferase activity,22,3,1.58,0.20843,1,0.5008361449275363,1.9,MF
GO:0019789,SUMO transferase activity,22,3,1.58,0.20843,1,0.5008361449275363,1.9,MF
GO:0022829,wide pore channel activity,22,3,1.58,0.20843,1,0.5008361449275363,1.9,MF
GO:0030552,cAMP binding,22,3,1.58,0.20843,1,0.5008361449275363,1.9,MF
GO:0016772,"transferase activity, transferring phosp...",921,73,66.34,0.20937,1,0.501640838150289,1.1,MF
GO:0016417,S-acyltransferase activity,33,4,2.38,0.21136,1,0.5049493948126801,1.68,MF
GO:0016627,"oxidoreductase activity, acting on the C...",56,6,4.03,0.21410,1,0.5100255747126438,1.49,MF
GO:0005516,calmodulin binding,191,17,13.76,0.21554,1,0.5119724501424501,1.24,MF
GO:0004869,cysteine-type endopeptidase inhibitor ac...,68,7,4.9,0.21677,1,0.5119724501424501,1.43,MF
GO:0005518,collagen binding,68,7,4.9,0.21677,1,0.5119724501424501,1.43,MF
GO:0042578,phosphoric ester hydrolase activity,359,30,25.86,0.22301,1,0.5252138920454545,1.16,MF
GO:0045309,protein phosphorylated amino acid bindin...,57,6,4.11,0.22590,1,0.5299995492957746,1.46,MF
GO:0016788,"hydrolase activity, acting on ester bond...",741,59,53.38,0.22670,1,0.5299995492957746,1.11,MF
GO:0004364,glutathione transferase activity,34,4,2.45,0.22696,1,0.5299995492957746,1.63,MF
GO:0017124,SH3 domain binding,131,12,9.44,0.23441,1,0.5458592415730337,1.27,MF
GO:0008270,zinc ion binding,691,55,49.78,0.23673,1,0.5497175630252101,1.1,MF
GO:0001103,RNA polymerase II repressing transcripti...,35,4,2.52,0.24284,1,0.5623306145251397,1.59,MF
GO:0015026,coreceptor activity,24,3,1.73,0.24747,1,0.5714557938718663,1.73,MF
GO:0004197,cysteine-type endopeptidase activity,96,9,6.92,0.25422,1,0.5854121666666666,1.3,MF
GO:0005539,glycosaminoglycan binding,210,18,15.13,0.25499,1,0.5855587534626039,1.19,MF
GO:0005310,dicarboxylic acid transmembrane transpor...,36,4,2.59,0.25896,1,0.5913990082644628,1.54,MF
GO:0042162,telomeric DNA binding,36,4,2.59,0.25896,1,0.5913990082644628,1.54,MF
GO:0016597,amino acid binding,72,7,5.19,0.26057,1,0.5934410164835165,1.35,MF
GO:0016298,lipase activity,122,11,8.79,0.26340,1,0.5982427397260275,1.25,MF
GO:0016769,"transferase activity, transferring nitro...",25,3,1.8,0.26740,1,0.5990474663072776,1.67,MF
GO:0030371,translation repressor activity,25,3,1.8,0.26740,1,0.5990474663072776,1.67,MF
GO:0030515,snoRNA binding,25,3,1.8,0.26740,1,0.5990474663072776,1.67,MF
GO:0030742,GTP-dependent protein binding,25,3,1.8,0.26740,1,0.5990474663072776,1.67,MF
GO:0047617,acyl-CoA hydrolase activity,25,3,1.8,0.26740,1,0.5990474663072776,1.67,MF
GO:0019209,kinase activator activity,85,8,6.12,0.26809,1,0.5990474663072776,1.31,MF
GO:0019894,kinesin binding,49,5,3.53,0.27656,1,0.6163124731182795,1.42,MF
GO:1902936,phosphatidylinositol bisphosphate bindin...,111,10,8,0.27770,1,0.6171938337801608,1.25,MF
GO:0022857,transmembrane transporter activity,1013,78,72.97,0.28263,1,0.6264713101604279,1.07,MF
GO:0016878,acid-thiol ligase activity,26,3,1.87,0.28750,1,0.6338763297872341,1.6,MF
GO:0046625,sphingolipid binding,26,3,1.87,0.28750,1,0.6338763297872341,1.6,MF
GO:0140110,transcription regulator activity,1354,103,97.54,0.29146,1,0.6398651851851852,1.06,MF
GO:0000993,RNA polymerase II complex binding,38,4,2.74,0.29176,1,0.6398651851851852,1.46,MF
GO:0140101,"catalytic activity, acting on a tRNA",113,10,8.14,0.29637,1,0.6482605013192613,1.23,MF
GO:0016746,"transferase activity, transferring acyl ...",270,22,19.45,0.30474,1,0.657168971722365,1.13,MF
GO:0001158,enhancer sequence-specific DNA binding,127,11,9.15,0.30744,1,0.657168971722365,1.2,MF
GO:0003785,actin monomer binding,27,3,1.94,0.30771,1,0.657168971722365,1.55,MF
GO:0015605,organophosphate ester transmembrane tran...,27,3,1.94,0.30771,1,0.657168971722365,1.55,MF
GO:0016289,CoA hydrolase activity,27,3,1.94,0.30771,1,0.657168971722365,1.55,MF
GO:0016866,intramolecular transferase activity,27,3,1.94,0.30771,1,0.657168971722365,1.55,MF
GO:0080025,"phosphatidylinositol-3,5-bisphosphate bi...",27,3,1.94,0.30771,1,0.657168971722365,1.55,MF
GO:0016409,palmitoyltransferase activity,39,4,2.81,0.30837,1,0.657168971722365,1.42,MF
GO:0042169,SH2 domain binding,39,4,2.81,0.30837,1,0.657168971722365,1.42,MF
GO:0044390,ubiquitin-like protein conjugating enzym...,39,4,2.81,0.30837,1,0.657168971722365,1.42,MF
GO:0017016,Ras GTPase binding,417,33,30.04,0.31165,1,0.6624560256410256,1.1,MF
GO:0003724,RNA helicase activity,65,6,4.68,0.32619,1,0.6900478172588832,1.28,MF
GO:0001530,lipopolysaccharide binding,28,3,2.02,0.32796,1,0.6900478172588832,1.49,MF
GO:0004407,histone deacetylase activity,28,3,2.02,0.32796,1,0.6900478172588832,1.49,MF
GO:0008574,ATP-dependent microtubule motor activity...,28,3,2.02,0.32796,1,0.6900478172588832,1.49,MF
GO:0052689,carboxylic ester hydrolase activity,143,12,10.3,0.33444,1,0.7019006582278482,1.17,MF
GO:0005547,"phosphatidylinositol-3,4,5-trisphosphate...",41,4,2.95,0.34181,1,0.7137543828715365,1.36,MF
GO:0032266,phosphatidylinositol-3-phosphate binding,41,4,2.95,0.34181,1,0.7137543828715365,1.36,MF
GO:0015301,anion:anion antiporter activity,29,3,2.09,0.34820,1,0.7155460148514852,1.44,MF
GO:0019706,protein-cysteine S-palmitoyltransferase ...,29,3,2.09,0.34820,1,0.7155460148514852,1.44,MF
GO:0019707,protein-cysteine S-acyltransferase activ...,29,3,2.09,0.34820,1,0.7155460148514852,1.44,MF
GO:0033558,protein deacetylase activity,29,3,2.09,0.34820,1,0.7155460148514852,1.44,MF
GO:0071813,lipoprotein particle binding,29,3,2.09,0.34820,1,0.7155460148514852,1.44,MF
GO:0071814,protein-lipid complex binding,29,3,2.09,0.34820,1,0.7155460148514852,1.44,MF
GO:0099516,ion antiporter activity,54,5,3.89,0.34871,1,0.7155460148514852,1.29,MF
GO:0005253,anion channel activity,80,7,5.76,0.35404,1,0.7246892839506174,1.22,MF
GO:0016301,kinase activity,778,59,56.04,0.35811,1,0.7285853431372549,1.05,MF
GO:0004180,carboxypeptidase activity,42,4,3.03,0.35858,1,0.7285853431372549,1.32,MF
GO:0016620,"oxidoreductase activity, acting on the a...",42,4,3.03,0.35858,1,0.7285853431372549,1.32,MF
GO:0016791,phosphatase activity,266,21,19.16,0.36349,1,0.7367560146699267,1.1,MF
GO:0042562,hormone binding,107,9,7.71,0.36499,1,0.737991975609756,1.17,MF
GO:0004693,cyclin-dependent protein serine/threonin...,30,3,2.16,0.36838,1,0.7430341119221411,1.39,MF
GO:0043175,RNA polymerase core enzyme binding,43,4,3.1,0.37534,1,0.7535268765133172,1.29,MF
GO:0140098,"catalytic activity, acting on RNA",362,28,26.08,0.37540,1,0.7535268765133172,1.07,MF
GO:0031267,small GTPase binding,432,33,31.12,0.38839,1,0.7740787499999999,1.06,MF
GO:0015248,sterol transporter activity,31,3,2.23,0.38844,1,0.7740787499999999,1.35,MF
GO:0097472,cyclin-dependent protein kinase activity,31,3,2.23,0.38844,1,0.7740787499999999,1.35,MF
GO:0004177,aminopeptidase activity,44,4,3.17,0.39206,1,0.7775544019138756,1.26,MF
GO:0018024,histone-lysine N-methyltransferase activ...,44,4,3.17,0.39206,1,0.7775544019138756,1.26,MF
GO:0030332,cyclin binding,32,3,2.31,0.40834,1,0.8057052969121139,1.3,MF
GO:0071855,neuropeptide receptor binding,32,3,2.31,0.40834,1,0.8057052969121139,1.3,MF
GO:0035326,enhancer binding,138,11,9.94,0.40917,1,0.8057052969121139,1.11,MF
GO:0004725,protein tyrosine phosphatase activity,98,8,7.06,0.41041,1,0.8062319668246445,1.13,MF
GO:0043178,alcohol binding,85,7,6.12,0.41414,1,0.8116360756501182,1.14,MF
GO:1901981,phosphatidylinositol phosphate binding,166,13,11.96,0.41892,1,0.819067641509434,1.09,MF
GO:0004672,protein kinase activity,616,46,44.37,0.42126,1,0.8217048000000001,1.04,MF
GO:0048020,CCR chemokine receptor binding,46,4,3.31,0.42527,1,0.8275794131455398,1.21,MF
GO:0005484,SNAP receptor activity,33,3,2.38,0.42804,1,0.8310191100702575,1.26,MF
GO:0004175,endopeptidase activity,440,33,31.7,0.43062,1,0.8340747196261682,1.04,MF
GO:0016538,cyclin-dependent protein serine/threonin...,47,4,3.39,0.44171,1,0.8495906712962963,1.18,MF
GO:0070888,E-box binding,47,4,3.39,0.44171,1,0.8495906712962963,1.18,MF
GO:0016773,"phosphotransferase activity, alcohol gro...",717,53,51.65,0.44265,1,0.8495906712962963,1.03,MF
GO:0005178,integrin binding,128,10,9.22,0.44273,1,0.8495906712962963,1.08,MF
GO:0008238,exopeptidase activity,101,8,7.28,0.44384,1,0.8497537182448037,1.1,MF
GO:0016776,"phosphotransferase activity, phosphate g...",34,3,2.45,0.44750,1,0.8528218390804597,1.22,MF
GO:0051019,mitogen-activated protein kinase binding,34,3,2.45,0.44750,1,0.8528218390804597,1.22,MF
GO:0035064,methylated histone binding,88,7,6.34,0.45007,1,0.8537941189931351,1.1,MF
GO:0140034,methylation-dependent protein binding,88,7,6.34,0.45007,1,0.8537941189931351,1.1,MF
GO:0034593,phosphatidylinositol bisphosphate phosph...,21,2,1.51,0.45288,1,0.8539642045454545,1.32,MF
GO:0099095,ligand-gated anion channel activity,21,2,1.51,0.45288,1,0.8539642045454545,1.32,MF
GO:0017137,Rab GTPase binding,170,13,12.25,0.45325,1,0.8539642045454545,1.06,MF
GO:0004527,exonuclease activity,75,6,5.4,0.45701,1,0.8583338461538461,1.11,MF
GO:0061134,peptidase regulator activity,239,18,17.22,0.45764,1,0.8583338461538461,1.05,MF
GO:0016829,lyase activity,185,14,13.33,0.46425,1,0.8687658013544017,1.05,MF
GO:0016407,acetyltransferase activity,117,9,8.43,0.46932,1,0.8762754054054054,1.07,MF
GO:0008483,transaminase activity,22,2,1.58,0.47732,1,0.8832550892857144,1.27,MF
GO:0031420,alkali metal ion binding,22,2,1.58,0.47732,1,0.8832550892857144,1.27,MF
GO:0034237,protein kinase A regulatory subunit bind...,22,2,1.58,0.47732,1,0.8832550892857144,1.27,MF
GO:0070530,K63-linked polyubiquitin modification-de...,22,2,1.58,0.47732,1,0.8832550892857144,1.27,MF
GO:0005154,epidermal growth factor receptor binding,36,3,2.59,0.48557,1,0.8945278444444444,1.16,MF
GO:0030551,cyclic nucleotide binding,36,3,2.59,0.48557,1,0.8945278444444444,1.16,MF
GO:0008408,3'-5' exonuclease activity,50,4,3.6,0.49007,1,0.9008160310421286,1.11,MF
GO:0015297,antiporter activity,78,6,5.62,0.49541,1,0.9073847494553375,1.07,MF
GO:0033613,activating transcription factor binding,92,7,6.63,0.49726,1,0.9073847494553375,1.06,MF
GO:0050839,cell adhesion molecule binding,245,18,17.65,0.50082,1,0.9073847494553375,1.02,MF
GO:0016405,CoA-ligase activity,23,2,1.66,0.50109,1,0.9073847494553375,1.2,MF
GO:0017056,structural constituent of nuclear pore,23,2,1.66,0.50109,1,0.9073847494553375,1.2,MF
GO:0019825,oxygen binding,23,2,1.66,0.50109,1,0.9073847494553375,1.2,MF
GO:0030695,GTPase regulator activity,259,19,18.66,0.50165,1,0.9073847494553375,1.02,MF
GO:0008757,S-adenosylmethionine-dependent methyltra...,148,11,10.66,0.50240,1,0.9073847494553375,1.03,MF
GO:0001221,transcription cofactor binding,51,4,3.67,0.50581,1,0.9077370562770563,1.09,MF
GO:0016830,carbon-carbon lyase activity,51,4,3.67,0.50581,1,0.9077370562770563,1.09,MF
GO:0061135,endopeptidase regulator activity,204,15,14.7,0.50588,1,0.9077370562770563,1.02,MF
GO:0008080,N-acetyltransferase activity,94,7,6.77,0.52038,1,0.9274304077253218,1.03,MF
GO:0005546,"phosphatidylinositol-4,5-bisphosphate bi...",80,6,5.76,0.52050,1,0.9274304077253218,1.04,MF
GO:0042379,chemokine receptor binding,66,5,4.75,0.52078,1,0.9274304077253218,1.05,MF
GO:0016903,"oxidoreductase activity, acting on the a...",52,4,3.75,0.52133,1,0.9274304077253218,1.07,MF
GO:0008235,metalloexopeptidase activity,53,4,3.82,0.53661,1,0.9525689293361885,1.05,MF
GO:0005048,signal sequence binding,39,3,2.81,0.54015,1,0.9568041666666667,1.07,MF
GO:0005184,neuropeptide hormone activity,25,2,1.8,0.54647,1,0.9597958262711865,1.11,MF
GO:0005343,organic acid:sodium symporter activity,25,2,1.8,0.54647,1,0.9597958262711865,1.11,MF
GO:0008171,O-methyltransferase activity,25,2,1.8,0.54647,1,0.9597958262711865,1.11,MF
GO:0052866,phosphatidylinositol phosphate phosphata...,25,2,1.8,0.54647,1,0.9597958262711865,1.11,MF
GO:0020037,heme binding,155,11,11.17,0.56536,1,0.9810696875000001,0.98,MF
GO:0035591,signaling adaptor activity,55,4,3.96,0.56641,1,0.9810696875000001,1.01,MF
GO:0000030,mannosyltransferase activity,26,2,1.87,0.56805,1,0.9810696875000001,1.07,MF
GO:0004709,MAP kinase kinase kinase activity,26,2,1.87,0.56805,1,0.9810696875000001,1.07,MF
GO:0005328,neurotransmitter:sodium symporter activi...,26,2,1.87,0.56805,1,0.9810696875000001,1.07,MF
GO:0005537,mannose binding,26,2,1.87,0.56805,1,0.9810696875000001,1.07,MF
GO:0016922,nuclear receptor binding,26,2,1.87,0.56805,1,0.9810696875000001,1.07,MF
GO:0030547,receptor inhibitor activity,26,2,1.87,0.56805,1,0.9810696875000001,1.07,MF
GO:0004386,helicase activity,156,11,11.24,0.57410,1,0.9886426970954357,0.98,MF
GO:0016741,"transferase activity, transferring one-c...",213,15,15.34,0.57482,1,0.9886426970954357,0.98,MF
GO:0005088,Ras guanyl-nucleotide exchange factor ac...,128,9,9.22,0.57939,1,0.9929368865979382,0.98,MF
GO:0016278,lysine N-methyltransferase activity,56,4,4.03,0.58091,1,0.9929368865979382,0.99,MF
GO:0016279,protein-lysine N-methyltransferase activ...,56,4,4.03,0.58091,1,0.9929368865979382,0.99,MF
GO:0019213,deacetylase activity,42,3,3.03,0.59125,1,1,0.99,MF
GO:0008168,methyltransferase activity,201,14,14.48,0.59173,1,1,0.97,MF
GO:0008013,beta-catenin binding,86,6,6.2,0.59245,1,1,0.97,MF
GO:0008276,protein methyltransferase activity,86,6,6.2,0.59245,1,1,0.97,MF
GO:0016410,N-acyltransferase activity,115,8,8.28,0.59288,1,1,0.97,MF
GO:0003823,antigen binding,57,4,4.11,0.59513,1,1,0.97,MF
GO:0042054,histone methyltransferase activity,57,4,4.11,0.59513,1,1,0.97,MF
GO:0005070,SH3/SH2 adaptor activity,28,2,2.02,0.60895,1,1,0.99,MF
GO:0016645,"oxidoreductase activity, acting on the C...",28,2,2.02,0.60895,1,1,0.99,MF
GO:0033612,receptor serine/threonine kinase binding,28,2,2.02,0.60895,1,1,0.99,MF
GO:0043325,"phosphatidylinositol-3,4-bisphosphate bi...",28,2,2.02,0.60895,1,1,0.99,MF
GO:0015932,nucleobase-containing compound transmemb...,44,3,3.17,0.62320,1,1,0.95,MF
GO:0003774,motor activity,133,9,9.58,0.62589,1,1,0.94,MF
GO:0000175,3'-5'-exoribonuclease activity,29,2,2.09,0.62827,1,1,0.96,MF
GO:0035198,miRNA binding,29,2,2.09,0.62827,1,1,0.96,MF
GO:0035925,mRNA 3'-UTR AU-rich region binding,29,2,2.09,0.62827,1,1,0.96,MF
GO:0043539,protein serine/threonine kinase activato...,29,2,2.09,0.62827,1,1,0.96,MF
GO:0071889,14-3-3 protein binding,29,2,2.09,0.62827,1,1,0.96,MF
GO:0070851,growth factor receptor binding,148,10,10.66,0.62948,1,1,0.94,MF
GO:0001784,phosphotyrosine residue binding,45,3,3.24,0.63852,1,1,0.93,MF
GO:0004715,non-membrane spanning protein tyrosine k...,45,3,3.24,0.63852,1,1,0.93,MF
GO:0046906,tetrapyrrole binding,164,11,11.81,0.64109,1,1,0.93,MF
GO:0034212,peptide N-acetyltransferase activity,76,5,5.47,0.64762,1,1,0.91,MF
GO:0005319,lipid transporter activity,136,9,9.8,0.65243,1,1,0.92,MF
GO:1901505,carbohydrate derivative transmembrane tr...,46,3,3.31,0.65340,1,1,0.91,MF
GO:0001968,fibronectin binding,31,2,2.23,0.66465,1,1,0.9,MF
GO:0016896,"exoribonuclease activity, producing 5'-p...",31,2,2.23,0.66465,1,1,0.9,MF
GO:0017091,AU-rich element binding,31,2,2.23,0.66465,1,1,0.9,MF
GO:0050699,WW domain binding,31,2,2.23,0.66465,1,1,0.9,MF
GO:0004532,exoribonuclease activity,32,2,2.31,0.68174,1,1,0.87,MF
GO:0043425,bHLH transcription factor binding,32,2,2.31,0.68174,1,1,0.87,MF
GO:0050661,NADP binding,48,3,3.46,0.68182,1,1,0.87,MF
GO:0070405,ammonium ion binding,80,5,5.76,0.69196,1,1,0.87,MF
GO:1990939,ATP-dependent microtubule motor activity,49,3,3.53,0.69537,1,1,0.85,MF
GO:0004402,histone acetyltransferase activity,65,4,4.68,0.69789,1,1,0.85,MF
GO:0004521,endoribonuclease activity,65,4,4.68,0.69789,1,1,0.85,MF
GO:0043621,protein self-association,65,4,4.68,0.69789,1,1,0.85,MF
GO:0017080,sodium channel regulator activity,33,2,2.38,0.69810,1,1,0.84,MF
GO:0035035,histone acetyltransferase binding,33,2,2.38,0.69810,1,1,0.84,MF
GO:0042974,retinoic acid receptor binding,33,2,2.38,0.69810,1,1,0.84,MF
GO:0051959,dynein light intermediate chain binding,33,2,2.38,0.69810,1,1,0.84,MF
GO:0005326,neurotransmitter transporter activity,50,3,3.6,0.70847,1,1,0.83,MF
GO:0016831,carboxy-lyase activity,34,2,2.45,0.71377,1,1,0.82,MF
GO:0061733,peptide-lysine-N-acetyltransferase activ...,67,4,4.83,0.72043,1,1,0.83,MF
GO:0001965,G-protein alpha-subunit binding,35,2,2.52,0.72874,1,1,0.79,MF
GO:0003777,microtubule motor activity,84,5,6.05,0.73233,1,1,0.83,MF
GO:0038024,cargo receptor activity,84,5,6.05,0.73233,1,1,0.83,MF
GO:0016796,"exonuclease activity, active with either...",52,3,3.75,0.73337,1,1,0.8,MF
GO:0017046,peptide hormone binding,52,3,3.75,0.73337,1,1,0.8,MF
GO:0008237,metallopeptidase activity,177,11,12.75,0.73668,1,1,0.86,MF
GO:0005254,chloride channel activity,69,4,4.97,0.74169,1,1,0.8,MF
GO:0005231,excitatory extracellular ligand-gated io...,36,2,2.59,0.74305,1,1,0.77,MF
GO:0061980,regulatory RNA binding,36,2,2.59,0.74305,1,1,0.77,MF
GO:0030246,carbohydrate binding,269,17,19.38,0.74703,1,1,0.88,MF
GO:0030165,PDZ domain binding,118,7,8.5,0.75454,1,1,0.82,MF
GO:0046915,transition metal ion transmembrane trans...,37,2,2.67,0.75670,1,1,0.75,MF
GO:0003677,DNA binding,2059,141,148.32,0.75710,1,1,0.95,MF
GO:0004866,endopeptidase inhibitor activity,197,12,14.19,0.76661,1,1,0.85,MF
GO:0001102,RNA polymerase II activating transcripti...,55,3,3.96,0.76753,1,1,0.76,MF
GO:0008170,N-methyltransferase activity,88,5,6.34,0.76871,1,1,0.79,MF
GO:0019840,isoprenoid binding,38,2,2.74,0.76972,1,1,0.73,MF
GO:0005506,iron ion binding,167,10,12.03,0.77108,1,1,0.83,MF
GO:0001618,virus receptor activity,20,1,1.44,0.77596,1,1,0.69,MF
GO:0005242,inward rectifier potassium channel activ...,20,1,1.44,0.77596,1,1,0.69,MF
GO:0017049,GTP-Rho binding,20,1,1.44,0.77596,1,1,0.69,MF
GO:0052745,inositol phosphate phosphatase activity,20,1,1.44,0.77596,1,1,0.69,MF
GO:0104005,hijacked molecular function,20,1,1.44,0.77596,1,1,0.69,MF
GO:0015238,drug transmembrane transporter activity,89,5,6.41,0.77719,1,1,0.78,MF
GO:0004518,nuclease activity,200,12,14.41,0.78384,1,1,0.83,MF
GO:0015179,L-amino acid transmembrane transporter a...,57,3,4.11,0.78826,1,1,0.73,MF
GO:0016782,"transferase activity, transferring sulfu...",74,4,5.33,0.78943,1,1,0.75,MF
GO:0001067,regulatory region nucleic acid binding,999,66,71.96,0.78963,1,1,0.92,MF
GO:0001871,pattern binding,21,1,1.51,0.79212,1,1,0.66,MF
GO:0005540,hyaluronic acid binding,21,1,1.51,0.79212,1,1,0.66,MF
GO:0008327,methyl-CpG binding,21,1,1.51,0.79212,1,1,0.66,MF
GO:0008373,sialyltransferase activity,21,1,1.51,0.79212,1,1,0.66,MF
GO:0019200,carbohydrate kinase activity,21,1,1.51,0.79212,1,1,0.66,MF
GO:0030247,polysaccharide binding,21,1,1.51,0.79212,1,1,0.66,MF
GO:0004520,endodeoxyribonuclease activity,40,2,2.88,0.79395,1,1,0.69,MF
GO:0004879,nuclear receptor activity,40,2,2.88,0.79395,1,1,0.69,MF
GO:0016893,"endonuclease activity, active with eithe...",40,2,2.88,0.79395,1,1,0.69,MF
GO:0042056,chemoattractant activity,40,2,2.88,0.79395,1,1,0.69,MF
GO:0098531,"transcription factor activity, direct li...",40,2,2.88,0.79395,1,1,0.69,MF
GO:0015171,amino acid transmembrane transporter act...,75,4,5.4,0.79808,1,1,0.74,MF
GO:0001223,transcription coactivator binding,22,1,1.58,0.80711,1,1,0.63,MF
GO:0001848,complement binding,22,1,1.58,0.80711,1,1,0.63,MF
GO:0008157,protein phosphatase 1 binding,22,1,1.58,0.80711,1,1,0.63,MF
GO:0016799,"hydrolase activity, hydrolyzing N-glycos...",22,1,1.58,0.80711,1,1,0.63,MF
GO:0016917,GABA receptor activity,22,1,1.58,0.80711,1,1,0.63,MF
GO:0015081,sodium ion transmembrane transporter act...,143,8,10.3,0.81667,1,1,0.78,MF
GO:0003950,NAD+ ADP-ribosyltransferase activity,23,1,1.66,0.82102,1,1,0.6,MF
GO:0010485,H4 histone acetyltransferase activity,23,1,1.66,0.82102,1,1,0.6,MF
GO:0016895,"exodeoxyribonuclease activity, producing...",23,1,1.66,0.82102,1,1,0.6,MF
GO:0030506,ankyrin binding,23,1,1.66,0.82102,1,1,0.6,MF
GO:0046965,retinoid X receptor binding,23,1,1.66,0.82102,1,1,0.6,MF
GO:0030414,peptidase inhibitor activity,208,12,14.98,0.82532,1,1,0.8,MF
GO:0008009,chemokine activity,43,2,3.1,0.82606,1,1,0.65,MF
GO:0004519,endonuclease activity,129,7,9.29,0.82947,1,1,0.75,MF
GO:0005096,GTPase activator activity,241,14,17.36,0.83315,1,1,0.81,MF
GO:0019838,growth factor binding,146,8,10.52,0.83370,1,1,0.76,MF
GO:0015491,cation:cation antiporter activity,24,1,1.73,0.83392,1,1,0.58,MF
GO:0016628,"oxidoreductase activity, acting on the C...",24,1,1.73,0.83392,1,1,0.58,MF
GO:0016638,"oxidoreductase activity, acting on the C...",24,1,1.73,0.83392,1,1,0.58,MF
GO:0005509,calcium ion binding,621,39,44.73,0.83699,1,1,0.87,MF
GO:0016706,"oxidoreductase activity, acting on paire...",45,2,3.24,0.84489,1,1,0.62,MF
GO:0000217,DNA secondary structure binding,25,1,1.8,0.84590,1,1,0.56,MF
GO:0004181,metallocarboxypeptidase activity,25,1,1.8,0.84590,1,1,0.56,MF
GO:0004529,exodeoxyribonuclease activity,25,1,1.8,0.84590,1,1,0.56,MF
GO:0005212,structural constituent of eye lens,25,1,1.8,0.84590,1,1,0.56,MF
GO:0008106,alcohol dehydrogenase (NADP+) activity,25,1,1.8,0.84590,1,1,0.56,MF
GO:0008307,structural constituent of muscle,25,1,1.8,0.84590,1,1,0.56,MF
GO:0016722,"oxidoreductase activity, oxidizing metal...",25,1,1.8,0.84590,1,1,0.56,MF
GO:0070412,R-SMAD binding,25,1,1.8,0.84590,1,1,0.56,MF
GO:0071837,HMG box domain binding,25,1,1.8,0.84590,1,1,0.56,MF
GO:0015103,inorganic anion transmembrane transporte...,132,7,9.51,0.84643,1,1,0.74,MF
GO:0044212,transcription regulatory region DNA bind...,995,64,71.68,0.84816,1,1,0.89,MF
GO:0004540,ribonuclease activity,116,6,8.36,0.84987,1,1,0.72,MF
GO:0016811,"hydrolase activity, acting on carbon-nit...",82,4,5.91,0.85083,1,1,0.68,MF
GO:0032813,tumor necrosis factor receptor superfami...,46,2,3.31,0.85359,1,1,0.6,MF
GO:0005342,organic acid transmembrane transporter a...,150,8,10.81,0.85446,1,1,0.74,MF
GO:0046943,carboxylic acid transmembrane transporte...,150,8,10.81,0.85446,1,1,0.74,MF
GO:0004553,"hydrolase activity, hydrolyzing O-glycos...",100,5,7.2,0.85527,1,1,0.69,MF
GO:0005104,fibroblast growth factor receptor bindin...,26,1,1.87,0.85701,1,1,0.53,MF
GO:0016879,"ligase activity, forming carbon-nitrogen...",47,2,3.39,0.86185,1,1,0.59,MF
GO:0003887,DNA-directed DNA polymerase activity,27,1,1.94,0.86733,1,1,0.52,MF
GO:0004683,calmodulin-dependent protein kinase acti...,27,1,1.94,0.86733,1,1,0.52,MF
GO:0019239,deaminase activity,27,1,1.94,0.86733,1,1,0.52,MF
GO:0032452,histone demethylase activity,27,1,1.94,0.86733,1,1,0.52,MF
GO:1904680,peptide transmembrane transporter activi...,27,1,1.94,0.86733,1,1,0.52,MF
GO:0050660,flavin adenine dinucleotide binding,85,4,6.12,0.86959,1,1,0.65,MF
GO:0042805,actinin binding,48,2,3.46,0.86968,1,1,0.58,MF
GO:0046332,SMAD binding,86,4,6.2,0.87537,1,1,0.65,MF
GO:0004033,aldo-keto reductase (NADP) activity,28,1,2.02,0.87690,1,1,0.5,MF
GO:0016891,"endoribonuclease activity, producing 5'-...",28,1,2.02,0.87690,1,1,0.5,MF
GO:0016763,"transferase activity, transferring pento...",50,2,3.6,0.88412,1,1,0.56,MF
GO:0015085,calcium ion transmembrane transporter ac...,140,7,10.08,0.88509,1,1,0.69,MF
GO:0004190,aspartic-type endopeptidase activity,29,1,2.09,0.88578,1,1,0.48,MF
GO:0015298,solute:cation antiporter activity,29,1,2.09,0.88578,1,1,0.48,MF
GO:0140142,nucleocytoplasmic carrier activity,29,1,2.09,0.88578,1,1,0.48,MF
GO:0005089,Rho guanyl-nucleotide exchange factor ac...,70,3,5.04,0.88842,1,1,0.6,MF
GO:0015370,solute:sodium symporter activity,70,3,5.04,0.88842,1,1,0.6,MF
GO:0016702,"oxidoreductase activity, acting on singl...",30,1,2.16,0.89402,1,1,0.46,MF
GO:0045503,dynein light chain binding,30,1,2.16,0.89402,1,1,0.46,MF
GO:0070001,aspartic-type peptidase activity,30,1,2.16,0.89402,1,1,0.46,MF
GO:0098918,structural constituent of synapse,30,1,2.16,0.89402,1,1,0.46,MF
GO:0016798,"hydrolase activity, acting on glycosyl b...",125,6,9,0.89418,1,1,0.67,MF
GO:0008028,monocarboxylic acid transmembrane transp...,52,2,3.75,0.89707,1,1,0.53,MF
GO:0008514,organic anion transmembrane transporter ...,210,11,15.13,0.89754,1,1,0.73,MF
GO:0008094,DNA-dependent ATPase activity,72,3,5.19,0.89935,1,1,0.58,MF
GO:0016701,"oxidoreductase activity, acting on singl...",31,1,2.23,0.90166,1,1,0.45,MF
GO:0030170,pyridoxal phosphate binding,53,2,3.82,0.90303,1,1,0.52,MF
GO:0043565,sequence-specific DNA binding,1145,72,82.48,0.90356,1,1,0.87,MF
GO:0005160,transforming growth factor beta receptor...,54,2,3.89,0.90866,1,1,0.51,MF
GO:0070279,vitamin B6 binding,54,2,3.89,0.90866,1,1,0.51,MF
GO:0005501,retinoid binding,32,1,2.31,0.90876,1,1,0.43,MF
GO:0015175,neutral amino acid transmembrane transpo...,32,1,2.31,0.90876,1,1,0.43,MF
GO:0004713,protein tyrosine kinase activity,129,6,9.29,0.90997,1,1,0.65,MF
GO:0008083,growth factor activity,147,7,10.59,0.91189,1,1,0.66,MF
GO:0008509,anion transmembrane transporter activity,313,17,22.55,0.91322,1,1,0.75,MF
GO:0099529,neurotransmitter receptor activity invol...,55,2,3.96,0.91398,1,1,0.51,MF
GO:0051213,dioxygenase activity,94,4,6.77,0.91414,1,1,0.59,MF
GO:0019956,chemokine binding,33,1,2.38,0.91534,1,1,0.42,MF
GO:0034061,DNA polymerase activity,33,1,2.38,0.91534,1,1,0.42,MF
GO:0008146,sulfotransferase activity,56,2,4.03,0.91902,1,1,0.5,MF
GO:0015108,chloride transmembrane transporter activ...,96,4,6.92,0.92197,1,1,0.58,MF
GO:0098960,postsynaptic neurotransmitter receptor a...,57,2,4.11,0.92377,1,1,0.49,MF
GO:0042605,peptide antigen binding,35,1,2.52,0.92712,1,1,0.4,MF
GO:0003690,double-stranded DNA binding,1014,62,73.04,0.92738,1,1,0.85,MF
GO:1990837,sequence-specific double-stranded DNA bi...,925,56,66.63,0.92908,1,1,0.84,MF
GO:0070273,phosphatidylinositol-4-phosphate binding,36,1,2.59,0.93237,1,1,0.39,MF
GO:0004536,deoxyribonuclease activity,59,2,4.25,0.93250,1,1,0.47,MF
GO:0033764,"steroid dehydrogenase activity, acting o...",37,1,2.67,0.93725,1,1,0.37,MF
GO:0051393,alpha-actinin binding,37,1,2.67,0.93725,1,1,0.37,MF
GO:0071949,FAD binding,37,1,2.67,0.93725,1,1,0.37,MF
GO:0004222,metalloendopeptidase activity,101,4,7.28,0.93882,1,1,0.55,MF
GO:0008536,Ran GTPase binding,38,1,2.74,0.94178,1,1,0.36,MF
GO:0001012,RNA polymerase II regulatory region DNA ...,845,50,60.87,0.94204,1,1,0.82,MF
GO:0015079,potassium ion transmembrane transporter ...,159,7,11.45,0.94541,1,1,0.61,MF
GO:0008173,RNA methyltransferase activity,63,2,4.54,0.94720,1,1,0.44,MF
GO:0000976,transcription regulatory region sequence...,882,52,63.54,0.94867,1,1,0.82,MF
GO:0000977,RNA polymerase II regulatory region sequ...,837,49,60.29,0.94964,1,1,0.81,MF
GO:0005272,sodium channel activity,40,1,2.88,0.94988,1,1,0.35,MF
GO:0008138,protein tyrosine/serine/threonine phosph...,40,1,2.88,0.94988,1,1,0.35,MF
GO:0032451,demethylase activity,42,1,3.03,0.95686,1,1,0.33,MF
GO:0005109,frizzled binding,43,1,3.1,0.95997,1,1,0.32,MF
GO:0042887,amide transmembrane transporter activity,43,1,3.1,0.95997,1,1,0.32,MF
GO:0005179,hormone activity,129,5,9.29,0.96000,1,1,0.54,MF
GO:0008376,acetylgalactosaminyltransferase activity,44,1,3.17,0.96286,1,1,0.32,MF
GO:0019955,cytokine binding,131,5,9.44,0.96363,1,1,0.53,MF
GO:0005044,scavenger receptor activity,45,1,3.24,0.96554,1,1,0.31,MF
GO:0016229,steroid dehydrogenase activity,45,1,3.24,0.96554,1,1,0.31,MF
GO:0099528,G protein-coupled neurotransmitter recep...,45,1,3.24,0.96554,1,1,0.31,MF
GO:0045296,cadherin binding,70,2,5.04,0.96588,1,1,0.4,MF
GO:0005230,extracellular ligand-gated ion channel a...,71,2,5.11,0.96796,1,1,0.39,MF
GO:0005126,cytokine receptor binding,330,16,23.77,0.96811,1,1,0.67,MF
GO:0140097,"catalytic activity, acting on DNA",191,8,13.76,0.96920,1,1,0.58,MF
GO:0022834,ligand-gated channel activity,136,5,9.8,0.97143,1,1,0.51,MF
GO:0004896,cytokine receptor activity,98,3,7.06,0.97573,1,1,0.42,MF
GO:0008528,G protein-coupled peptide receptor activ...,140,5,10.08,0.97652,1,1,0.5,MF
GO:0015294,solute:cation symporter activity,99,3,7.13,0.97708,1,1,0.42,MF
GO:0015291,secondary active transmembrane transport...,235,10,16.93,0.97738,1,1,0.59,MF
GO:0005245,voltage-gated calcium channel activity,52,1,3.75,0.97961,1,1,0.27,MF
GO:1904315,transmitter-gated ion channel activity i...,52,1,3.75,0.97961,1,1,0.27,MF
GO:0005544,calcium-dependent phospholipid binding,54,1,3.89,0.98245,1,1,0.26,MF
GO:0000987,proximal promoter sequence-specific DNA ...,585,30,42.14,0.98354,1,1,0.71,MF
GO:0003707,steroid hormone receptor activity,55,1,3.96,0.98371,1,1,0.25,MF
GO:0003684,damaged DNA binding,56,1,4.03,0.98489,1,1,0.25,MF
GO:0008375,acetylglucosaminyltransferase activity,56,1,4.03,0.98489,1,1,0.25,MF
GO:0001653,peptide receptor activity,149,5,10.73,0.98504,1,1,0.47,MF
GO:0000978,RNA polymerase II proximal promoter sequ...,573,29,41.28,0.98544,1,1,0.7,MF
GO:0016758,"transferase activity, transferring hexos...",209,8,15.06,0.98576,1,1,0.53,MF
GO:0022824,transmitter-gated ion channel activity,58,1,4.18,0.98699,1,1,0.24,MF
GO:0022835,transmitter-gated channel activity,58,1,4.18,0.98699,1,1,0.24,MF
GO:0005249,voltage-gated potassium channel activity,86,2,6.2,0.98774,1,1,0.32,MF
GO:0004714,transmembrane receptor protein tyrosine ...,59,1,4.25,0.98793,1,1,0.24,MF
GO:0016810,"hydrolase activity, acting on carbon-nit...",133,4,9.58,0.98849,1,1,0.42,MF
GO:0005244,voltage-gated ion channel activity,195,7,14.05,0.98882,1,1,0.5,MF
GO:0022832,voltage-gated channel activity,195,7,14.05,0.98882,1,1,0.5,MF
GO:0003678,DNA helicase activity,61,1,4.39,0.98961,1,1,0.23,MF
GO:0042165,neurotransmitter binding,61,1,4.39,0.98961,1,1,0.23,MF
GO:0019842,vitamin binding,135,4,9.72,0.98968,1,1,0.41,MF
GO:0016757,"transferase activity, transferring glyco...",278,11,20.03,0.99166,1,1,0.55,MF
GO:0001227,DNA-binding transcription repressor acti...,241,9,17.36,0.99194,1,1,0.52,MF
GO:0030545,receptor regulator activity,527,25,37.96,0.99219,1,1,0.66,MF
GO:0016705,"oxidoreductase activity, acting on paire...",203,7,14.62,0.99234,1,1,0.48,MF
GO:0004867,serine-type endopeptidase inhibitor acti...,118,3,8.5,0.99249,1,1,0.35,MF
GO:0015293,symporter activity,145,4,10.45,0.99409,1,1,0.38,MF
GO:0046873,metal ion transmembrane transporter acti...,433,19,31.19,0.99437,1,1,0.61,MF
GO:0005262,calcium channel activity,123,3,8.86,0.99444,1,1,0.34,MF
GO:0005267,potassium channel activity,123,3,8.86,0.99444,1,1,0.34,MF
GO:0001228,DNA-binding transcription activator acti...,443,19,31.91,0.99607,1,1,0.6,MF
GO:0005125,cytokine activity,217,7,15.63,0.99612,1,1,0.45,MF
GO:0019199,transmembrane receptor protein kinase ac...,76,1,5.47,0.99663,1,1,0.18,MF
GO:0015276,ligand-gated ion channel activity,133,3,9.58,0.99698,1,1,0.31,MF
GO:0003700,DNA-binding transcription factor activit...,999,51,71.96,0.99752,1,1,0.71,MF
GO:0048018,receptor ligand activity,492,21,35.44,0.99757,1,1,0.59,MF
GO:0022836,gated channel activity,335,12,24.13,0.99835,1,1,0.5,MF
GO:0030594,neurotransmitter receptor activity,117,2,8.43,0.99843,1,1,0.24,MF
GO:0022843,voltage-gated cation channel activity,146,3,10.52,0.99865,1,1,0.29,MF
GO:0008194,UDP-glycosyltransferase activity,151,3,10.88,0.99902,1,1,0.28,MF
GO:0099094,ligand-gated cation channel activity,99,1,7.13,0.99940,1,1,0.14,MF
GO:0000981,DNA-binding transcription factor activit...,767,34,55.25,0.99951,1,1,0.62,MF
GO:0022839,ion gated channel activity,323,10,23.27,0.99955,1,1,0.43,MF
GO:0005201,extracellular matrix structural constitu...,141,2,10.16,0.99969,1,1,0.2,MF
GO:0008236,serine-type peptidase activity,203,4,14.62,0.99981,1,1,0.27,MF
GO:0015267,channel activity,444,15,31.98,0.99982,1,1,0.47,MF
GO:0022803,passive transmembrane transporter activi...,444,15,31.98,0.99982,1,1,0.47,MF
GO:0005216,ion channel activity,407,13,29.32,0.99985,1,1,0.44,MF
GO:0017171,serine hydrolase activity,208,4,14.98,0.99986,1,1,0.27,MF
GO:0022838,substrate-specific channel activity,420,13,30.25,0.99992,1,1,0.43,MF
GO:0004497,monooxygenase activity,141,1,10.16,0.99997,1,1,0.1,MF
GO:0005261,cation channel activity,317,6,22.84,1.00000,1,1,0.26,MF
GO:0004252,serine-type endopeptidase activity,181,1,13.04,1.00000,1,1,0.08,MF
GO:0003674,molecular_function,20837,1501,1501,1.00000,1,1,1,MF
GO:0004888,transmembrane signaling receptor activit...,2107,14,151.78,1.00000,1,1,0.09,MF
GO:0004930,G protein-coupled receptor activity,750,7,54.03,1.00000,1,1,0.13,MF
GO:0038023,signaling receptor activity,2295,21,165.32,1.00000,1,1,0.13,MF
GO:0060089,molecular transducer activity,2344,25,168.85,1.00000,1,1,0.15,MF
GO:0001614,purinergic nucleotide receptor activity,20,0,1.44,1.00000,1,1,0,MF
GO:0001637,G protein-coupled chemoattractant recept...,25,0,1.8,1.00000,1,1,0,MF
GO:0003688,DNA replication origin binding,23,0,1.66,1.00000,1,1,0,MF
GO:0004003,ATP-dependent DNA helicase activity,22,0,1.58,1.00000,1,1,0,MF
GO:0004745,retinol dehydrogenase activity,21,0,1.51,1.00000,1,1,0,MF
GO:0004806,triglyceride lipase activity,27,0,1.94,1.00000,1,1,0,MF
GO:0004950,chemokine receptor activity,25,0,1.8,1.00000,1,1,0,MF
GO:0004984,olfactory receptor activity,1110,0,79.96,1.00000,1,1,0,MF
GO:0004993,G protein-coupled serotonin receptor act...,39,0,2.81,1.00000,1,1,0,MF
GO:0005112,Notch binding,25,0,1.8,1.00000,1,1,0,MF
GO:0005132,type I interferon receptor binding,24,0,1.73,1.00000,1,1,0,MF
GO:0005148,prolactin receptor binding,27,0,1.94,1.00000,1,1,0,MF
GO:0005164,tumor necrosis factor receptor binding,34,0,2.45,1.00000,1,1,0,MF
GO:0005217,intracellular ligand-gated ion channel a...,32,0,2.31,1.00000,1,1,0,MF
GO:0005227,calcium activated cation channel activit...,29,0,2.09,1.00000,1,1,0,MF
GO:0005248,voltage-gated sodium channel activity,21,0,1.51,1.00000,1,1,0,MF
GO:0005251,delayed rectifier potassium channel acti...,30,0,2.16,1.00000,1,1,0,MF
GO:0005355,glucose transmembrane transporter activi...,23,0,1.66,1.00000,1,1,0,MF
GO:0005385,zinc ion transmembrane transporter activ...,22,0,1.58,1.00000,1,1,0,MF
GO:0005402,carbohydrate:cation symporter activity,20,0,1.44,1.00000,1,1,0,MF
GO:0005520,insulin-like growth factor binding,28,0,2.02,1.00000,1,1,0,MF
GO:0005549,odorant binding,578,0,41.64,1.00000,1,1,0,MF
GO:0005550,pheromone binding,216,0,15.56,1.00000,1,1,0,MF
GO:0008026,ATP-dependent helicase activity,22,0,1.58,1.00000,1,1,0,MF
GO:0008066,glutamate receptor activity,27,0,1.94,1.00000,1,1,0,MF
GO:0008175,tRNA methyltransferase activity,32,0,2.31,1.00000,1,1,0,MF
GO:0008188,neuropeptide receptor activity,45,0,3.24,1.00000,1,1,0,MF
GO:0008227,G protein-coupled amine receptor activit...,72,0,5.19,1.00000,1,1,0,MF
GO:0008378,galactosyltransferase activity,36,0,2.59,1.00000,1,1,0,MF
GO:0008391,arachidonic acid monooxygenase activity,38,0,2.74,1.00000,1,1,0,MF
GO:0008392,arachidonic acid epoxygenase activity,34,0,2.45,1.00000,1,1,0,MF
GO:0008395,steroid hydroxylase activity,73,0,5.26,1.00000,1,1,0,MF
GO:0008519,ammonium transmembrane transporter activ...,32,0,2.31,1.00000,1,1,0,MF
GO:0008527,taste receptor activity,36,0,2.59,1.00000,1,1,0,MF
GO:0008569,ATP-dependent microtubule motor activity...,21,0,1.51,1.00000,1,1,0,MF
GO:0009975,cyclase activity,25,0,1.8,1.00000,1,1,0,MF
GO:0015020,glucuronosyltransferase activity,33,0,2.38,1.00000,1,1,0,MF
GO:0015101,organic cation transmembrane transporter...,23,0,1.66,1.00000,1,1,0,MF
GO:0015106,bicarbonate transmembrane transporter ac...,20,0,1.44,1.00000,1,1,0,MF
GO:0015125,bile acid transmembrane transporter acti...,20,0,1.44,1.00000,1,1,0,MF
GO:0015144,carbohydrate transmembrane transporter a...,38,0,2.74,1.00000,1,1,0,MF
GO:0015145,monosaccharide transmembrane transporter...,25,0,1.8,1.00000,1,1,0,MF
GO:0015149,hexose transmembrane transporter activit...,23,0,1.66,1.00000,1,1,0,MF
GO:0015278,calcium-release channel activity,20,0,1.44,1.00000,1,1,0,MF
GO:0015295,solute:proton symporter activity,22,0,1.58,1.00000,1,1,0,MF
GO:0015464,acetylcholine receptor activity,22,0,1.58,1.00000,1,1,0,MF
GO:0016493,C-C chemokine receptor activity,24,0,1.73,1.00000,1,1,0,MF
GO:0016502,nucleotide receptor activity,20,0,1.44,1.00000,1,1,0,MF
GO:0016503,pheromone receptor activity,99,0,7.13,1.00000,1,1,0,MF
GO:0016641,"oxidoreductase activity, acting on the C...",21,0,1.51,1.00000,1,1,0,MF
GO:0016709,"oxidoreductase activity, acting on paire...",45,0,3.24,1.00000,1,1,0,MF
GO:0016712,"oxidoreductase activity, acting on paire...",61,0,4.39,1.00000,1,1,0,MF
GO:0016725,"oxidoreductase activity, acting on CH or...",23,0,1.66,1.00000,1,1,0,MF
GO:0016814,"hydrolase activity, acting on carbon-nit...",29,0,2.09,1.00000,1,1,0,MF
GO:0016849,phosphorus-oxygen lyase activity,25,0,1.8,1.00000,1,1,0,MF
GO:0017116,single-stranded DNA-dependent ATP-depend...,20,0,1.44,1.00000,1,1,0,MF
GO:0017147,Wnt-protein binding,38,0,2.74,1.00000,1,1,0,MF
GO:0019865,immunoglobulin binding,22,0,1.58,1.00000,1,1,0,MF
GO:0019957,C-C chemokine binding,25,0,1.8,1.00000,1,1,0,MF
GO:0030020,extracellular matrix structural constitu...,39,0,2.81,1.00000,1,1,0,MF
GO:0030215,semaphorin receptor binding,22,0,1.58,1.00000,1,1,0,MF
GO:0031624,ubiquitin conjugating enzyme binding,34,0,2.45,1.00000,1,1,0,MF
GO:0032947,protein-containing complex scaffold acti...,22,0,1.58,1.00000,1,1,0,MF
GO:0033038,bitter taste receptor activity,29,0,2.09,1.00000,1,1,0,MF
GO:0035014,phosphatidylinositol 3-kinase regulator ...,20,0,1.44,1.00000,1,1,0,MF
GO:0035250,UDP-galactosyltransferase activity,25,0,1.8,1.00000,1,1,0,MF
GO:0035586,purinergic receptor activity,25,0,1.8,1.00000,1,1,0,MF
GO:0042923,neuropeptide binding,25,0,1.8,1.00000,1,1,0,MF
GO:0043015,gamma-tubulin binding,29,0,2.09,1.00000,1,1,0,MF
GO:0043138,3'-5' DNA helicase activity,21,0,1.51,1.00000,1,1,0,MF
GO:0043142,single-stranded DNA-dependent ATPase act...,20,0,1.44,1.00000,1,1,0,MF
GO:0045499,chemorepellent activity,28,0,2.02,1.00000,1,1,0,MF
GO:0050431,transforming growth factor beta binding,21,0,1.51,1.00000,1,1,0,MF
GO:0051119,sugar transmembrane transporter activity,26,0,1.87,1.00000,1,1,0,MF
GO:0051371,muscle alpha-actinin binding,21,0,1.51,1.00000,1,1,0,MF
GO:0070035,purine NTP-dependent helicase activity,22,0,1.58,1.00000,1,1,0,MF
GO:0070330,aromatase activity,35,0,2.52,1.00000,1,1,0,MF
GO:0070696,transmembrane receptor protein serine/th...,20,0,1.44,1.00000,1,1,0,MF
GO:0072509,divalent inorganic cation transmembrane ...,27,0,1.94,1.00000,1,1,0,MF
GO:0090482,vitamin transmembrane transporter activi...,22,0,1.58,1.00000,1,1,0,MF
GO:0099589,serotonin receptor activity,39,0,2.81,1.00000,1,1,0,MF
GO:0099604,ligand-gated calcium channel activity,26,0,1.87,1.00000,1,1,0,MF
GO:0140103,"catalytic activity, acting on a glycopro...",22,0,1.58,1.00000,1,1,0,MF
GO:1901338,catecholamine binding,21,0,1.51,1.00000,1,1,0,MF
GO:1901618,organic hydroxy compound transmembrane t...,43,0,3.1,1.00000,1,1,0,MF
GO:1901682,sulfur compound transmembrane transporte...,31,0,2.23,1.00000,1,1,0,MF
GO:0005622,intracellular,13747,1454,999.3, 1e-30,6.300000000000001e-28,1.3404255319148938e-29,1.46,CC
GO:0044424,intracellular part,13717,1451,997.12, 1e-30,6.300000000000001e-28,1.3404255319148938e-29,1.46,CC
GO:0005737,cytoplasm,10993,1296,799.11, 1e-30,6.300000000000001e-28,1.3404255319148938e-29,1.62,CC
GO:0044444,cytoplasmic part,8386,1114,609.6, 1e-30,6.300000000000001e-28,1.3404255319148938e-29,1.83,CC
GO:0043229,intracellular organelle,11997,1321,872.09, 1e-30,6.300000000000001e-28,1.3404255319148938e-29,1.51,CC
GO:0043231,intracellular membrane-bounded organelle,10334,1211,751.2, 1e-30,6.300000000000001e-28,1.3404255319148938e-29,1.61,CC
GO:0043226,organelle,12314,1332,895.14, 1e-30,6.300000000000001e-28,1.3404255319148938e-29,1.49,CC
GO:0043227,membrane-bounded organelle,11062,1253,804.12, 1e-30,6.300000000000001e-28,1.3404255319148938e-29,1.56,CC
GO:0044464,cell part,16127,1491,1172.31, 1e-30,6.300000000000001e-28,1.3404255319148938e-29,1.27,CC
GO:0005623,cell,16132,1491,1172.67, 1e-30,6.300000000000001e-28,1.3404255319148938e-29,1.27,CC
GO:0044446,intracellular organelle part,7228,940,525.42, 1e-30,6.300000000000001e-28,1.3404255319148938e-29,1.79,CC
GO:0032991,protein-containing complex,5422,779,394.14, 1e-30,6.300000000000001e-28,1.3404255319148938e-29,1.98,CC
GO:0044422,organelle part,7595,951,552.1, 1e-30,6.300000000000001e-28,1.3404255319148938e-29,1.72,CC
GO:0005739,mitochondrion,1809,372,131.5, 1e-30,6.300000000000001e-28,1.3404255319148938e-29,2.83,CC
GO:0005743,mitochondrial inner membrane,446,156,32.42, 1e-30,6.300000000000001e-28,1.3404255319148938e-29,4.81,CC
GO:0044429,mitochondrial part,851,220,61.86, 1e-30,6.300000000000001e-28,1.3404255319148938e-29,3.56,CC
GO:0005740,mitochondrial envelope,663,189,48.2, 1e-30,6.300000000000001e-28,1.3404255319148938e-29,3.92,CC
GO:0031090,organelle membrane,1753,329,127.43, 1e-30,6.300000000000001e-28,1.3404255319148938e-29,2.58,CC
GO:0019866,organelle inner membrane,489,158,35.55, 1e-30,6.300000000000001e-28,1.3404255319148938e-29,4.44,CC
GO:0031966,mitochondrial membrane,619,179,45, 1e-30,6.300000000000001e-28,1.3404255319148938e-29,3.98,CC
GO:0098798,mitochondrial protein complex,266,116,19.34, 1e-30,6.300000000000001e-28,1.3404255319148938e-29,6,CC
GO:0098800,inner mitochondrial membrane protein com...,130,82,9.45, 1e-30,6.300000000000001e-28,1.3404255319148938e-29,8.68,CC
GO:0044455,mitochondrial membrane part,219,103,15.92, 1e-30,6.300000000000001e-28,1.3404255319148938e-29,6.47,CC
GO:0005829,cytosol,3292,478,239.3, 1e-30,6.300000000000001e-28,1.3404255319148938e-29,2,CC
GO:0031967,organelle envelope,1063,234,77.27, 1e-30,6.300000000000001e-28,1.3404255319148938e-29,3.03,CC
GO:0031975,envelope,1064,234,77.34, 1e-30,6.300000000000001e-28,1.3404255319148938e-29,3.03,CC
GO:0070469,respiratory chain,91,65,6.62, 1e-30,6.300000000000001e-28,1.3404255319148938e-29,9.82,CC
GO:0005746,mitochondrial respiratory chain,79,60,5.74, 1e-30,6.300000000000001e-28,1.3404255319148938e-29,10.45,CC
GO:0043209,myelin sheath,219,97,15.92, 1e-30,6.300000000000001e-28,1.3404255319148938e-29,6.09,CC
GO:0098803,respiratory chain complex,83,60,6.03, 1e-30,6.300000000000001e-28,1.3404255319148938e-29,9.95,CC
GO:0005840,ribosome,227,94,16.5, 1e-30,6.300000000000001e-28,1.3404255319148938e-29,5.7,CC
GO:1990904,ribonucleoprotein complex,967,204,70.29, 1e-30,6.300000000000001e-28,1.3404255319148938e-29,2.9,CC
GO:0005634,nucleus,6846,752,497.65, 1e-30,6.300000000000001e-28,1.3404255319148938e-29,1.51,CC
GO:1902494,catalytic complex,1365,246,99.23, 1e-30,6.300000000000001e-28,1.3404255319148938e-29,2.48,CC
GO:0098796,membrane protein complex,1134,218,82.43, 1e-30,6.300000000000001e-28,1.3404255319148938e-29,2.64,CC
GO:0044391,ribosomal subunit,192,81,13.96, 1e-30,6.300000000000001e-28,1.3404255319148938e-29,5.8,CC
GO:0045202,synapse,1417,247,103.01, 1e-30,6.300000000000001e-28,1.3404255319148938e-29,2.4,CC
GO:0044445,cytosolic part,265,93,19.26, 1e-30,6.300000000000001e-28,1.3404255319148938e-29,4.83,CC
GO:1990204,oxidoreductase complex,109,60,7.92, 1e-30,6.300000000000001e-28,1.3404255319148938e-29,7.58,CC
GO:0022626,cytosolic ribosome,109,58,7.92, 1e-30,6.300000000000001e-28,1.3404255319148938e-29,7.32,CC
GO:0005747,mitochondrial respiratory chain complex ...,50,39,3.63, 1e-30,6.300000000000001e-28,1.3404255319148938e-29,10.74,CC
GO:0030964,NADH dehydrogenase complex,50,39,3.63, 1e-30,6.300000000000001e-28,1.3404255319148938e-29,10.74,CC
GO:0045271,respiratory chain complex I,50,39,3.63, 1e-30,6.300000000000001e-28,1.3404255319148938e-29,10.74,CC
GO:0070013,intracellular organelle lumen,3883,473,282.26, 1e-30,6.300000000000001e-28,1.3404255319148938e-29,1.68,CC
GO:0031974,membrane-enclosed lumen,3884,473,282.34, 1e-30,6.300000000000001e-28,1.3404255319148938e-29,1.68,CC
GO:0043233,organelle lumen,3884,473,282.34, 1e-30,6.300000000000001e-28,1.3404255319148938e-29,1.68,CC
GO:0097458,neuron part,1982,287,144.08, 1e-30,6.300000000000001e-28,1.3404255319148938e-29,1.99,CC
GO:0012505,endomembrane system,3805,450,276.59,1.7e-29,1.0709999999999999e-26,2.23125e-28,1.63,CC
GO:0043232,intracellular non-membrane-bounded organ...,4141,477,301.02,8.3e-29,5.229e-26,1.0671428571428572e-27,1.58,CC
GO:0043228,non-membrane-bounded organelle,4161,477,302.47,2.6e-28,1.638e-25,3.276e-27,1.58,CC
GO:0044456,synapse part,1098,184,79.82,1.2e-27,7.56e-25,1.4823529411764708e-26,2.31,CC
GO:0015934,large ribosomal subunit,122,51,8.87,1.8e-26,1.1340000000000001e-23,2.180769230769231e-25,5.75,CC
GO:0044428,nuclear part,3985,452,289.68,1.6e-25,1.0080000000000001e-22,1.9018867924528303e-24,1.56,CC
GO:0098805,whole membrane,1114,178,80.98,2.7e-24,1.701e-21,3.15e-23,2.2,CC
GO:0022625,cytosolic large ribosomal subunit,61,33,4.43,5.0e-22,3.1499999999999996e-19,5.727272727272727e-21,7.45,CC
GO:0022627,cytosolic small ribosomal subunit,44,28,3.2,1.4e-21,8.82e-19,1.575e-20,8.75,CC
GO:0098588,bounding membrane of organelle,1060,164,77.05,6.2e-21,3.906e-18,6.852631578947368e-20,2.13,CC
GO:0031981,nuclear lumen,3506,393,254.86,9.2e-21,5.796e-18,9.993103448275862e-20,1.54,CC
GO:0015935,small ribosomal subunit,76,35,5.52,2.9e-20,1.827e-17,3.0966101694915254e-19,6.34,CC
GO:0016469,proton-transporting two-sector ATPase co...,49,28,3.56,9.2e-20,5.796e-17,9.66e-19,7.87,CC
GO:0043005,neuron projection,1523,201,110.71,2.1e-17,1.323e-14,2.1688524590163932e-16,1.82,CC
GO:0000502,proteasome complex,66,30,4.8,2.3e-17,1.449e-14,2.3370967741935486e-16,6.25,CC
GO:0005654,nucleoplasm,2607,301,189.51,2.5e-17,1.575e-14,2.5e-16,1.59,CC
GO:0005783,endoplasmic reticulum,1715,219,124.67,2.8e-17,1.7639999999999998e-14,2.7562499999999997e-16,1.76,CC
GO:1905369,endopeptidase complex,67,30,4.87,3.8e-17,2.394e-14,3.683076923076923e-16,6.16,CC
GO:1905368,peptidase complex,93,35,6.76,7.4e-17,4.6619999999999995e-14,7.063636363636362e-16,5.18,CC
GO:0005844,polysome,75,31,5.45,1.9e-16,1.197e-13,1.7865671641791045e-15,5.69,CC
GO:0005759,mitochondrial matrix,266,60,19.34,1.8e-15,1.134e-12,1.6676470588235297e-14,3.1,CC
GO:0098794,postsynapse,740,116,53.79,1.9e-15,1.197e-12,1.7347826086956523e-14,2.16,CC
GO:0042788,polysomal ribosome,31,19,2.25,1.3e-14,8.19e-12,1.17e-13,8.44,CC
GO:0031982,vesicle,1969,233,143.13,1.6e-14,1.008e-11,1.419718309859155e-13,1.63,CC
GO:0031410,cytoplasmic vesicle,1830,220,133.03,1.9e-14,1.197e-11,1.6625e-13,1.65,CC
GO:0097708,intracellular vesicle,1835,220,133.39,2.5e-14,1.575e-11,2.1575342465753425e-13,1.65,CC
GO:0005753,mitochondrial proton-transporting ATP sy...,20,15,1.45,8.6e-14,5.418e-11,7.321621621621622e-13,10.34,CC
GO:0120025,plasma membrane bounded cell projection,2273,256,165.23,2.0e-13,1.26e-10,1.6800000000000001e-12,1.55,CC
GO:0045259,proton-transporting ATP synthase complex,21,15,1.53,2.8e-13,1.764e-10,2.3210526315789475e-12,9.8,CC
GO:0042995,cell projection,2473,272,179.77,4.7e-13,2.961e-10,3.845454545454545e-12,1.51,CC
GO:0022624,proteasome accessory complex,25,16,1.82,6.2e-13,3.906e-10,5.007692307692308e-12,8.79,CC
GO:0008021,synaptic vesicle,227,50,16.5,1.1e-12,6.93e-10,8.772151898734177e-12,3.03,CC
GO:0044432,endoplasmic reticulum part,641,98,46.6,1.4e-12,8.820000000000001e-10,1.1025e-11,2.1,CC
GO:0005768,endosome,840,118,61.06,2.5e-12,1.5749999999999998e-9,1.9444444444444443e-11,1.93,CC
GO:0044433,cytoplasmic vesicle part,527,85,38.31,2.6e-12,1.638e-9,1.9975609756097558e-11,2.22,CC
GO:0098793,presynapse,564,89,41,2.7e-12,1.7009999999999998e-9,2.0493975903614456e-11,2.17,CC
GO:0031984,organelle subcompartment,913,125,66.37,3.3e-12,2.079e-9,2.4750000000000002e-11,1.88,CC
GO:0036477,somatodendritic compartment,1056,139,76.76,3.6e-12,2.268e-9,2.6682352941176472e-11,1.81,CC
GO:0070069,cytochrome complex,32,17,2.33,8.0e-12,5.04e-9,5.86046511627907e-11,7.3,CC
GO:0070382,exocytic vesicle,247,51,17.96,8.4e-12,5.2919999999999995e-9,6.082758620689655e-11,2.84,CC
GO:0014069,postsynaptic density,397,69,28.86,9.9e-12,6.237e-9,7.0875e-11,2.39,CC
GO:0098984,neuron to neuron synapse,425,72,30.89,1.2e-11,7.56e-9,8.494382022471911e-11,2.33,CC
GO:0044297,cell body,811,113,58.95,1.3e-11,8.190000000000001e-9,9.1e-11,1.92,CC
GO:0032279,asymmetric synapse,400,69,29.08,1.4e-11,8.82e-9,9.692307692307693e-11,2.37,CC
GO:0031300,intrinsic component of organelle membran...,256,51,18.61,3.4e-11,2.142e-8,2.3282608695652172e-10,2.74,CC
GO:0005773,vacuole,536,83,38.96,4.0e-11,2.5199999999999997e-8,2.7096774193548384e-10,2.13,CC
GO:0030425,dendrite,728,103,52.92,4.4e-11,2.7720000000000003e-8,2.948936170212766e-10,1.95,CC
GO:0030133,transport vesicle,324,59,23.55,4.7e-11,2.961e-8,3.116842105263158e-10,2.51,CC
GO:0005838,proteasome regulatory particle,23,14,1.67,4.8e-11,3.024e-8,3.15e-10,8.38,CC
GO:0097447,dendritic tree,731,103,53.14,5.5e-11,3.4649999999999996e-8,3.572164948453608e-10,1.94,CC
GO:0098827,endoplasmic reticulum subcompartment,543,83,39.47,7.8e-11,4.914e-8,5.014285714285715e-10,2.1,CC
GO:0044463,cell projection part,1567,182,113.91,8.8e-11,5.5440000000000005e-8,5.544000000000001e-10,1.6,CC
GO:0120038,plasma membrane bounded cell projection ...,1567,182,113.91,8.8e-11,5.5440000000000005e-8,5.544000000000001e-10,1.6,CC
GO:0042175,nuclear outer membrane-endoplasmic retic...,554,84,40.27,9.1e-11,5.733e-8,5.676237623762377e-10,2.09,CC
GO:0005789,endoplasmic reticulum membrane,529,81,38.45,1.2e-10,7.56e-8,7.411764705882353e-10,2.11,CC
GO:0048471,perinuclear region of cytoplasm,656,94,47.69,1.6e-10,1.0079999999999999e-7,9.78640776699029e-10,1.97,CC
GO:0098978,glutamatergic synapse,514,79,37.36,1.7e-10,1.071e-7,1.0298076923076923e-9,2.11,CC
GO:0101031,chaperone complex,21,13,1.53,1.8e-10,1.134e-7,1.08e-9,8.5,CC
GO:0099572,postsynaptic specialization,436,70,31.69,2.8e-10,1.7640000000000002e-7,1.6641509433962265e-9,2.21,CC
GO:0030424,axon,717,99,52.12,4.1e-10,2.583e-7,2.4140186915887853e-9,1.9,CC
GO:0031301,integral component of organelle membrane,228,45,16.57,6.5e-10,4.095e-7,3.791666666666667e-9,2.72,CC
GO:0030672,synaptic vesicle membrane,112,29,8.14,1.1e-09,6.93e-7,6.3e-9,3.56,CC
GO:0099501,exocytic vesicle membrane,112,29,8.14,1.1e-09,6.93e-7,6.3e-9,3.56,CC
GO:0005794,Golgi apparatus,1398,161,101.62,2.2e-09,1.386e-6,1.2486486486486486e-8,1.58,CC
GO:0016607,nuclear speck,323,55,23.48,2.7e-09,1.701e-6,1.51875e-8,2.34,CC
GO:0033177,proton-transporting two-sector ATPase co...,22,12,1.6,6.8e-09,4.284e-6,3.791150442477876e-8,7.5,CC
GO:0030176,integral component of endoplasmic reticu...,143,32,10.4,8.1e-09,5.103e-6,4.476315789473684e-8,3.08,CC
GO:0035770,ribonucleoprotein granule,214,41,15.56,9.2e-09,5.796e-6,5.04e-8,2.63,CC
GO:0030658,transport vesicle membrane,144,32,10.47,9.8e-09,6.174e-6,5.322413793103448e-8,3.06,CC
GO:0044309,neuron spine,202,39,14.68,1.7e-08,1.071e-5,9.076271186440678e-8,2.66,CC
GO:0005681,spliceosomal complex,194,38,14.1,1.7e-08,1.071e-5,9.076271186440678e-8,2.7,CC
GO:0043197,dendritic spine,197,38,14.32,2.6e-08,1.6380000000000002e-5,1.376470588235294e-7,2.65,CC
GO:0030659,cytoplasmic vesicle membrane,309,51,22.46,2.9e-08,1.827e-5,1.5225e-7,2.27,CC
GO:0031227,intrinsic component of endoplasmic retic...,151,32,10.98,3.3e-08,2.079e-5,1.718181818181818e-7,2.91,CC
GO:0034399,nuclear periphery,115,27,8.36,4.0e-08,2.52e-5,2.0655737704918033e-7,3.23,CC
GO:0044451,nucleoplasm part,1017,121,73.93,4.3e-08,2.709e-5,2.202439024390244e-7,1.64,CC
GO:0033267,axon part,454,66,33,5.0e-08,3.15e-5,2.5403225806451616e-7,2,CC
GO:0010008,endosome membrane,210,39,15.27,5.1e-08,3.213e-5,2.5704e-7,2.55,CC
GO:0005770,late endosome,203,38,14.76,6.0e-08,3.78e-5,2.9763779527559054e-7,2.57,CC
GO:0036464,cytoplasmic ribonucleoprotein granule,203,38,14.76,6.0e-08,3.78e-5,2.9763779527559054e-7,2.57,CC
GO:0033176,proton-transporting V-type ATPase comple...,26,12,1.89,7.7e-08,4.851e-5,3.78984375e-7,6.35,CC
GO:0150034,distal axon,374,57,27.19,8.1e-08,5.103e-5,3.9558139534883716e-7,2.1,CC
GO:0008180,COP9 signalosome,36,14,2.62,9.0e-08,5.6699999999999996e-5,4.361538461538461e-7,5.34,CC
GO:0098563,intrinsic component of synaptic vesicle ...,65,19,4.73,1.0e-07,6.3e-5,4.809160305343511e-7,4.02,CC
GO:0032592,integral component of mitochondrial memb...,72,20,5.23,1.2e-07,7.56e-5,5.727272727272726e-7,3.82,CC
GO:0000313,organellar ribosome,93,23,6.76,1.5e-07,9.449999999999999e-5,7.052238805970149e-7,3.4,CC
GO:0005761,mitochondrial ribosome,93,23,6.76,1.5e-07,9.449999999999999e-5,7.052238805970149e-7,3.4,CC
GO:0031305,integral component of mitochondrial inne...,43,15,3.13,1.7e-07,1.0709999999999999e-4,7.933333333333333e-7,4.79,CC
GO:0012506,vesicle membrane,336,52,24.42,1.8e-07,1.1339999999999999e-4,8.338235294117648e-7,2.13,CC
GO:0098573,intrinsic component of mitochondrial mem...,74,20,5.38,2.0e-07,1.26e-4,9.197080291970803e-7,3.72,CC
GO:0005730,nucleolus,821,100,59.68,2.2e-07,1.386e-4,1.0043478260869565e-6,1.68,CC
GO:0031304,intrinsic component of mitochondrial inn...,44,15,3.2,2.4e-07,1.512e-4,1.0877697841726618e-6,4.69,CC
GO:0045121,membrane raft,370,55,26.9,3.1e-07,1.953e-4,1.395e-6,2.04,CC
GO:0016604,nuclear body,670,85,48.7,3.3e-07,2.079e-4,1.4744680851063829e-6,1.75,CC
GO:0030285,integral component of synaptic vesicle m...,45,15,3.27,3.4e-07,2.1419999999999998e-4,1.4875e-6,4.59,CC
GO:0031970,organelle envelope lumen,90,22,6.54,3.4e-07,2.1419999999999998e-4,1.4875e-6,3.36,CC
GO:0098857,membrane microdomain,371,55,26.97,3.4e-07,2.1419999999999998e-4,1.4875e-6,2.04,CC
GO:0044440,endosomal part,234,40,17.01,3.5e-07,2.205e-4,1.5206896551724137e-6,2.35,CC
GO:0005764,lysosome,440,62,31.98,3.9e-07,2.457e-4,1.6828767123287672e-6,1.94,CC
GO:0000323,lytic vacuole,441,62,32.06,4.2e-07,2.646e-4,1.787837837837838e-6,1.93,CC
GO:0098589,membrane region,383,56,27.84,4.2e-07,2.646e-4,1.787837837837838e-6,2.01,CC
GO:0016020,membrane,9366,774,680.84,4.8e-07,3.024e-4,2.0295302013422818e-6,1.14,CC
GO:0005774,vacuolar membrane,169,32,12.29,5.0e-07,3.1499999999999996e-4,2.1e-6,2.6,CC
GO:0000315,organellar large ribosomal subunit,60,17,4.36,7.8e-07,4.914e-4,3.2328947368421053e-6,3.9,CC
GO:0005762,mitochondrial large ribosomal subunit,60,17,4.36,7.8e-07,4.914e-4,3.2328947368421053e-6,3.9,CC
GO:0099503,secretory vesicle,585,75,42.53,1.1e-06,6.93e-4,4.5e-6,1.76,CC
GO:0043025,neuronal cell body,722,88,52.48,1.1e-06,6.93e-4,4.5e-6,1.68,CC
GO:0071013,catalytic step 2 spliceosome,83,20,6.03,1.5e-06,9.45e-4,6.0967741935483874e-6,3.32,CC
GO:0005758,mitochondrial intermembrane space,77,19,5.6,1.8e-06,0.001134,7.269230769230769e-6,3.39,CC
GO:0044437,vacuolar part,180,32,13.08,2.1e-06,0.001323,8.426751592356687e-6,2.45,CC
GO:0030135,coated vesicle,181,32,13.16,2.4e-06,0.0015119999999999999,9.569620253164557e-6,2.43,CC
GO:0030427,site of polarized growth,211,35,15.34,3.7e-06,0.002331,1.4660377358490567e-5,2.28,CC
GO:0045277,respiratory chain complex IV,20,9,1.45,4.5e-06,0.0028350000000000003,1.771875e-5,6.21,CC
GO:0005790,smooth endoplasmic reticulum,36,12,2.62,5.0e-06,0.0031500000000000005,1.956521739130435e-5,4.58,CC
GO:0016363,nuclear matrix,90,20,6.54,5.6e-06,0.003528,2.1777777777777776e-5,3.06,CC
GO:0030426,growth cone,206,34,14.97,5.7e-06,0.0035909999999999996,2.2030674846625766e-5,2.27,CC
GO:0031252,cell leading edge,387,53,28.13,6.2e-06,0.0039059999999999997,2.3817073170731707e-5,1.88,CC
GO:0005798,Golgi-associated vesicle,135,25,9.81,1.3e-05,0.00819,4.963636363636363e-5,2.55,CC
GO:0097525,spliceosomal snRNP complex,59,15,4.29,1.5e-05,0.00945,5.658682634730539e-5,3.5,CC
GO:0099568,cytoplasmic region,481,61,34.97,1.5e-05,0.00945,5.658682634730539e-5,1.74,CC
GO:0030137,COPI-coated vesicle,28,10,2.04,1.6e-05,0.010079999999999999,5.929411764705882e-5,4.9,CC
GO:0097386,glial cell projection,28,10,2.04,1.6e-05,0.010079999999999999,5.929411764705882e-5,4.9,CC
GO:0005741,mitochondrial outer membrane,171,29,12.43,1.6e-05,0.010079999999999999,5.929411764705882e-5,2.33,CC
GO:0120114,Sm-like protein family complex,75,17,5.45,2.1e-05,0.013229999999999999,7.691860465116278e-5,3.12,CC
GO:0044431,Golgi apparatus part,497,62,36.13,2.1e-05,0.013229999999999999,7.691860465116278e-5,1.72,CC
GO:0031902,late endosome membrane,54,14,3.93,2.2e-05,0.013859999999999999,8.011560693641618e-5,3.56,CC
GO:0005856,cytoskeleton,2118,202,153.96,2.6e-05,0.01638,9.413793103448276e-5,1.31,CC
GO:0098685,Schaffer collateral - CA1 synapse,116,22,8.43,2.8e-05,0.01764,1.008e-4,2.61,CC
GO:0005791,rough endoplasmic reticulum,92,19,6.69,2.9e-05,0.01827,1.0380681818181818e-4,2.84,CC
GO:0120111,neuron projection cytoplasm,42,12,3.05,3.0e-05,0.0189,1.0677966101694915e-4,3.93,CC
GO:0015629,actin cytoskeleton,494,61,35.91,3.4e-05,0.02142,1.203370786516854e-4,1.7,CC
GO:0030532,small nuclear ribonucleoprotein complex,64,15,4.65,4.2e-05,0.026459999999999997,1.4782122905027933e-4,3.23,CC
GO:0030904,retromer complex,20,8,1.45,4.4e-05,0.027719999999999998,1.54e-4,5.52,CC
GO:0005874,microtubule,429,54,31.19,5.6e-05,0.03528,1.9384615384615385e-4,1.73,CC
GO:0005776,autophagosome,73,16,5.31,5.6e-05,0.03528,1.9384615384615385e-4,3.01,CC
GO:0015630,microtubule cytoskeleton,1156,119,84.03,6.6e-05,0.041580000000000006,2.2721311475409838e-4,1.42,CC
GO:1990234,transferase complex,770,85,55.97,7.3e-05,0.045989999999999996,2.49945652173913e-4,1.52,CC
GO:0002102,podosome,27,9,1.96,7.8e-05,0.049139999999999996,2.656216216216216e-4,4.59,CC
GO:0016234,inclusion body,76,16,5.52,9.4e-05,0.059219999999999995,3.1838709677419353e-4,2.9,CC
GO:0031256,leading edge membrane,152,25,11.05,9.9e-05,0.062369999999999995,3.298429319371728e-4,2.26,CC
GO:0009295,nucleoid,47,12,3.42,1.0e-04,0.063,3.298429319371728e-4,3.51,CC
GO:0042645,mitochondrial nucleoid,47,12,3.42,1.0e-04,0.063,3.298429319371728e-4,3.51,CC
GO:0019867,outer membrane,189,29,13.74,0.00010,0.063,3.298429319371728e-4,2.11,CC
GO:0031968,organelle outer membrane,189,29,13.74,0.00010,0.063,3.298429319371728e-4,2.11,CC
GO:0005938,cell cortex,316,42,22.97,0.00011,0.0693,3.5721649484536086e-4,1.83,CC
GO:0030496,midbody,144,24,10.47,0.00011,0.0693,3.5721649484536086e-4,2.29,CC
GO:0045335,phagocytic vesicle,93,18,6.76,0.00011,0.0693,3.5721649484536086e-4,2.66,CC
GO:0000421,autophagosome membrane,23,8,1.67,0.00014,0.08819999999999999,4.523076923076923e-4,4.79,CC
GO:0005635,nuclear envelope,414,51,30.09,0.00015,0.09449999999999999,4.796954314720812e-4,1.69,CC
GO:0044430,cytoskeletal part,1561,151,113.47,0.00015,0.09449999999999999,4.796954314720812e-4,1.33,CC
GO:0000775,"chromosome, centromeric region",195,29,14.18,0.00018,0.1134,5.727272727272727e-4,2.05,CC
GO:0019897,extrinsic component of plasma membrane,187,28,13.59,0.00021,0.1323,6.615e-4,2.06,CC
GO:0031253,cell projection membrane,305,40,22.17,0.00021,0.1323,6.615e-4,1.8,CC
GO:0030120,vesicle coat,58,13,4.22,0.00022,0.1386,6.895522388059702e-4,3.08,CC
GO:0005769,early endosome,266,36,19.34,0.00023,0.1449,7.173267326732673e-4,1.86,CC
GO:0000785,chromatin,588,66,42.74,0.00028,0.17639999999999997,8.689655172413793e-4,1.54,CC
GO:0044295,axonal growth cone,45,11,3.27,0.00029,0.1827,8.955882352941176e-4,3.36,CC
GO:0098562,cytoplasmic side of membrane,182,27,13.23,0.00031,0.1953,9.526829268292683e-4,2.04,CC
GO:0099512,supramolecular fiber,899,93,65.35,0.00035,0.2205,0.0010600961538461539,1.42,CC
GO:0005777,peroxisome,146,23,10.61,0.00035,0.2205,0.0010600961538461539,2.17,CC
GO:0042579,microbody,146,23,10.61,0.00035,0.2205,0.0010600961538461539,2.17,CC
GO:0005689,U12-type spliceosomal complex,26,8,1.89,0.00037,0.2331,0.001115311004784689,4.23,CC
GO:0005793,endoplasmic reticulum-Golgi intermediate...,69,14,5.02,0.00038,0.2394,0.00114,2.79,CC
GO:0001726,ruffle,147,23,10.69,0.00039,0.2457,0.0011644549763033176,2.15,CC
GO:0099081,supramolecular polymer,905,93,65.79,0.00043,0.2709,0.0012658878504672897,1.41,CC
GO:0005834,heterotrimeric G-protein complex,33,9,2.4,0.00043,0.2709,0.0012658878504672897,3.75,CC
GO:1905360,GTPase complex,33,9,2.4,0.00043,0.2709,0.0012658878504672897,3.75,CC
GO:0099080,supramolecular complex,906,93,65.86,0.00045,0.2835,0.0013186046511627907,1.41,CC
GO:0098590,plasma membrane region,1226,120,89.12,0.00047,0.2961,0.0013708333333333333,1.35,CC
GO:0032839,dendrite cytoplasm,27,8,1.96,0.00049,0.3087,0.0014225806451612904,4.08,CC
GO:0044427,chromosomal part,991,100,72.04,0.00050,0.315,0.0014383561643835617,1.39,CC
GO:0030662,coated vesicle membrane,79,15,5.74,0.00050,0.315,0.0014383561643835617,2.61,CC
GO:0044306,neuron projection terminus,207,29,15.05,0.00051,0.32130000000000003,0.0014472972972972974,1.93,CC
GO:0032587,ruffle membrane,71,14,5.16,0.00051,0.32130000000000003,0.0014472972972972974,2.71,CC
GO:1904949,ATPase complex,96,17,6.98,0.00051,0.32130000000000003,0.0014472972972972974,2.44,CC
GO:0030660,Golgi-associated vesicle membrane,64,13,4.65,0.00060,0.37799999999999995,0.001695067264573991,2.8,CC
GO:0005684,U2-type spliceosomal complex,89,16,6.47,0.00063,0.39690000000000003,0.001771875,2.47,CC
GO:0031234,extrinsic component of cytoplasmic side ...,98,17,7.12,0.00066,0.4158,0.0018479999999999998,2.39,CC
GO:0010494,cytoplasmic stress granule,65,13,4.73,0.00070,0.441,0.0019513274336283187,2.75,CC
GO:0009898,cytoplasmic side of plasma membrane,165,24,11.99,0.00087,0.5481,0.0024145374449339205,2,CC
GO:0019898,extrinsic component of membrane,320,39,23.26,0.00106,0.6678,0.0029289473684210522,1.68,CC
GO:0036452,ESCRT complex,24,7,1.74,0.00122,0.7686,0.0033563318777292575,4.02,CC
GO:0030139,endocytic vesicle,179,25,13.01,0.00124,0.7812,0.003396521739130435,1.92,CC
GO:0005875,microtubule associated complex,150,22,10.9,0.00125,0.7875,0.003409090909090909,2.02,CC
GO:0030134,COPII-coated ER to Golgi transport vesic...,53,11,3.85,0.00128,0.8064000000000001,0.003475862068965518,2.86,CC
GO:0001772,immunological synapse,38,9,2.76,0.00131,0.8253,0.0035420600858369097,3.26,CC
GO:0044448,cell cortex part,212,28,15.41,0.00157,0.9891,0.004226923076923077,1.82,CC
GO:0005694,chromosome,1111,107,80.76,0.00162,1,0.004342978723404255,1.32,CC
GO:0030863,cortical cytoskeleton,134,20,9.74,0.00164,1,0.004377966101694915,2.05,CC
GO:0099513,polymeric cytoskeletal fiber,679,70,49.36,0.00194,1,0.005156962025316456,1.42,CC
GO:0000776,kinetochore,137,20,9.96,0.00215,1,0.005691176470588235,2.01,CC
GO:0098791,Golgi subcompartment,444,49,32.28,0.00231,1,0.006089121338912134,1.52,CC
GO:0005686,U2 snRNP,20,6,1.45,0.00233,1,0.00611625,4.14,CC
GO:0005765,lysosomal membrane,110,17,8,0.00244,1,0.006378423236514523,2.12,CC
GO:0030027,lamellipodium,168,23,12.21,0.00248,1,0.006456198347107438,1.88,CC
GO:0098852,lytic vacuole membrane,111,17,8.07,0.00269,1,0.006974074074074074,2.11,CC
GO:0071011,precatalytic spliceosome,50,10,3.63,0.00281,1,0.0072553278688524585,2.75,CC
GO:0000139,Golgi membrane,242,30,17.59,0.00292,1,0.007508571428571429,1.71,CC
GO:0000790,nuclear chromatin,406,45,29.51,0.00314,1,0.008041463414634147,1.52,CC
GO:0098687,chromosomal region,308,36,22.39,0.00328,1,0.008365991902834007,1.61,CC
GO:0000792,heterochromatin,95,15,6.91,0.00346,1,0.008789516129032258,2.17,CC
GO:0043679,axon terminus,185,24,13.45,0.00410,1,0.010373493975903616,1.78,CC
GO:0005813,centrosome,517,54,37.58,0.00461,1,0.011617200000000001,1.44,CC
GO:0030117,membrane coat,100,15,7.27,0.00566,1,0.01415,2.06,CC
GO:0048475,coated membrane,100,15,7.27,0.00566,1,0.01415,2.06,CC
GO:0000407,phagophore assembly site,31,7,2.25,0.00592,1,0.014741501976284583,3.11,CC
GO:0000932,P-body,73,12,5.31,0.00610,1,0.01512992125984252,2.26,CC
GO:0030175,filopodium,93,14,6.76,0.00714,1,0.01764,2.07,CC
GO:0031672,A band,40,8,2.91,0.00725,1,0.017841796875,2.75,CC
GO:0048786,presynaptic active zone,94,14,6.83,0.00784,1,0.019218677042801557,2.05,CC
GO:0031201,SNARE complex,49,9,3.56,0.00805,1,0.01958108108108108,2.53,CC
GO:0071005,U2-type precatalytic spliceosome,49,9,3.56,0.00805,1,0.01958108108108108,2.53,CC
GO:0000803,sex chromosome,41,8,2.98,0.00845,1,0.020265399239543725,2.68,CC
GO:0099522,region of cytosol,41,8,2.98,0.00845,1,0.020265399239543725,2.68,CC
GO:0046540,U4/U6 x U5 tri-snRNP complex,33,7,2.4,0.00846,1,0.020265399239543725,2.92,CC
GO:0097526,spliceosomal tri-snRNP complex,33,7,2.4,0.00846,1,0.020265399239543725,2.92,CC
GO:0005868,cytoplasmic dynein complex,26,6,1.89,0.00951,1,0.02263245283018868,3.17,CC
GO:0000118,histone deacetylase complex,59,10,4.29,0.00952,1,0.02263245283018868,2.33,CC
GO:0032154,cleavage furrow,42,8,3.05,0.00979,1,0.023186842105263155,2.62,CC
GO:0070603,SWI/SNF superfamily-type complex,78,12,5.67,0.01033,1,0.024374157303370787,2.12,CC
GO:0005788,endoplasmic reticulum lumen,60,10,4.36,0.01070,1,0.025152985074626863,2.29,CC
GO:0005720,nuclear heterochromatin,43,8,3.13,0.01128,1,0.026417843866171006,2.56,CC
GO:0070971,endoplasmic reticulum exit site,27,6,1.96,0.01150,1,0.02673431734317343,3.06,CC
GO:0099524,postsynaptic cytosol,27,6,1.96,0.01150,1,0.02673431734317343,3.06,CC
GO:0043204,perikaryon,139,18,10.1,0.01205,1,0.027909926470588237,1.78,CC
GO:0000159,protein phosphatase type 2A complex,20,5,1.45,0.01245,1,0.028521818181818183,3.45,CC
GO:0031082,BLOC complex,20,5,1.45,0.01245,1,0.028521818181818183,3.45,CC
GO:0044292,dendrite terminus,20,5,1.45,0.01245,1,0.028521818181818183,3.45,CC
GO:0030864,cortical actin cytoskeleton,101,14,7.34,0.01443,1,0.03293804347826087,1.91,CC
GO:0055038,recycling endosome membrane,45,8,3.27,0.01475,1,0.03354693140794224,2.45,CC
GO:0005905,clathrin-coated pit,64,10,4.65,0.01655,1,0.037505395683453235,2.15,CC
GO:0008287,protein serine/threonine phosphatase com...,46,8,3.34,0.01675,1,0.0376875,2.4,CC
GO:1903293,phosphatase complex,46,8,3.34,0.01675,1,0.0376875,2.4,CC
GO:0055037,recycling endosome,145,18,10.54,0.01803,1,0.04042313167259787,1.71,CC
GO:0001741,XY body,22,5,1.6,0.01874,1,0.04142526315789474,3.12,CC
GO:0001891,phagocytic cup,22,5,1.6,0.01874,1,0.04142526315789474,3.12,CC
GO:0031307,integral component of mitochondrial oute...,22,5,1.6,0.01874,1,0.04142526315789474,3.12,CC
GO:0031430,M band,22,5,1.6,0.01874,1,0.04142526315789474,3.12,CC
GO:0044305,calyx of Held,30,6,2.18,0.01915,1,0.04218356643356644,2.75,CC
GO:0000314,organellar small ribosomal subunit,31,6,2.25,0.02233,1,0.048846875,2.67,CC
GO:0005763,mitochondrial small ribosomal subunit,31,6,2.25,0.02233,1,0.048846875,2.67,CC
GO:0031306,intrinsic component of mitochondrial out...,23,5,1.67,0.02255,1,0.04915743944636679,2.99,CC
GO:0000151,ubiquitin ligase complex,282,30,20.5,0.02326,1,0.050530344827586206,1.46,CC
GO:0043198,dendritic shaft,68,10,4.94,0.02449,1,0.05301958762886598,2.02,CC
GO:0005881,cytoplasmic microtubule,78,11,5.67,0.02507,1,0.05408938356164383,1.94,CC
GO:0032589,neuron projection membrane,69,10,5.02,0.02685,1,0.0577320819112628,1.99,CC
GO:0032838,plasma membrane bounded cell projection ...,174,20,12.65,0.02804,1,0.060085714285714284,1.58,CC
GO:0072686,mitotic spindle,110,14,8,0.02833,1,0.0605013559322034,1.75,CC
GO:0031901,early endosome membrane,51,8,3.71,0.02974,1,0.06329797297297297,2.16,CC
GO:0044425,membrane part,7301,565,530.73,0.03081,1,0.06535454545454546,1.06,CC
GO:0044438,microbody part,61,9,4.43,0.03132,1,0.06599197324414716,2.03,CC
GO:0044439,peroxisomal part,61,9,4.43,0.03132,1,0.06599197324414716,2.03,CC
GO:0042588,zymogen granule,25,5,1.82,0.03158,1,0.06609767441860465,2.75,CC
GO:0099523,presynaptic cytosol,25,5,1.82,0.03158,1,0.06609767441860465,2.75,CC
GO:0070062,extracellular exosome,91,12,6.62,0.03179,1,0.06631688741721854,1.81,CC
GO:0044853,plasma membrane raft,123,15,8.94,0.03337,1,0.06927927631578946,1.68,CC
GO:1902911,protein kinase complex,102,13,7.41,0.03343,1,0.06927927631578946,1.75,CC
GO:0000307,cyclin-dependent protein kinase holoenzy...,43,7,3.13,0.03405,1,0.0703327868852459,2.24,CC
GO:0032155,cell division site part,53,8,3.85,0.03647,1,0.07508529411764706,2.08,CC
GO:0099059,integral component of presynaptic active...,26,5,1.89,0.03683,1,0.07557947882736157,2.65,CC
GO:0017053,transcriptional repressor complex,83,11,6.03,0.03754,1,0.07678636363636362,1.82,CC
GO:0005802,trans-Golgi network,225,24,16.36,0.03805,1,0.07757766990291262,1.47,CC
GO:0051233,spindle midzone,35,6,2.54,0.03852,1,0.07828258064516129,2.36,CC
GO:0061695,"transferase complex, transferring phosph...",249,26,18.1,0.03988,1,0.08078585209003215,1.44,CC
GO:0016528,sarcoplasm,85,11,6.18,0.04356,1,0.0879576923076923,1.78,CC
GO:0031228,intrinsic component of Golgi membrane,55,8,4,0.04416,1,0.08888434504792332,2,CC
GO:0048787,presynaptic active zone membrane,46,7,3.34,0.04692,1,0.09413885350318472,2.1,CC
GO:0016529,sarcoplasmic reticulum,76,10,5.52,0.04794,1,0.09588,1.81,CC
GO:0030141,secretory granule,385,37,27.99,0.05014,1,0.0999626582278481,1.32,CC
GO:0031519,PcG protein complex,47,7,3.42,0.05182,1,0.10298611987381703,2.05,CC
GO:0005876,spindle microtubule,57,8,4.14,0.05284,1,0.10372429906542056,1.93,CC
GO:0005680,anaphase-promoting complex,20,4,1.45,0.05285,1,0.10372429906542056,2.76,CC
GO:0090723,growth cone part,20,4,1.45,0.05285,1,0.10372429906542056,2.76,CC
GO:0098993,anchored component of synaptic vesicle m...,20,4,1.45,0.05285,1,0.10372429906542056,2.76,CC
GO:0005819,spindle,280,28,20.35,0.05380,1,0.1052608695652174,1.38,CC
GO:1903561,extracellular vesicle,99,12,7.2,0.05517,1,0.10760712074303405,1.67,CC
GO:0032153,cell division site,58,8,4.22,0.05756,1,0.11192222222222221,1.9,CC
GO:0030673,axolemma,21,4,1.53,0.06166,1,0.11879449541284404,2.61,CC
GO:0032806,carboxy-terminal domain protein kinase c...,21,4,1.53,0.06166,1,0.11879449541284404,2.61,CC
GO:0035145,exon-exon junction complex,21,4,1.53,0.06166,1,0.11879449541284404,2.61,CC
GO:0005801,cis-Golgi network,49,7,3.56,0.06255,1,0.12014176829268292,1.97,CC
GO:0030017,sarcomere,192,20,13.96,0.06631,1,0.12697659574468084,1.43,CC
GO:0005815,microtubule organizing center,680,60,49.43,0.06830,1,0.13039090909090909,1.21,CC
GO:0098945,intrinsic component of presynaptic activ...,31,5,2.25,0.07075,1,0.13466012084592144,2.22,CC
GO:0030132,clathrin coat of coated pit,22,4,1.6,0.07120,1,0.13510843373493978,2.5,CC
GO:0043292,contractile fiber,229,23,16.65,0.07193,1,0.13590269461077845,1.38,CC
GO:0098797,plasma membrane protein complex,545,49,39.62,0.07205,1,0.13590269461077845,1.24,CC
GO:0098982,GABA-ergic synapse,104,12,7.56,0.07453,1,0.14016089552238806,1.59,CC
GO:0005643,nuclear pore,72,9,5.23,0.07631,1,0.14308125,1.72,CC
GO:0030666,endocytic vesicle membrane,32,5,2.33,0.07907,1,0.14781632047477744,2.15,CC
GO:0005771,multivesicular body,42,6,3.05,0.08143,1,0.15177781065088758,1.97,CC
GO:0016605,PML body,73,9,5.31,0.08172,1,0.15186902654867257,1.69,CC
GO:0030173,integral component of Golgi membrane,53,7,3.85,0.08777,1,0.16241436950146626,1.82,CC
GO:0097060,synaptic membrane,516,46,37.51,0.08791,1,0.16241436950146626,1.23,CC
GO:0032432,actin filament bundle,96,11,6.98,0.08849,1,0.16290000000000002,1.58,CC
GO:0098858,actin-based cell projection,211,21,15.34,0.08869,1,0.16290000000000002,1.37,CC
GO:0005721,pericentric heterochromatin,24,4,1.74,0.09237,1,0.169165988372093,2.3,CC
GO:0044304,main axon,86,10,6.25,0.09383,1,0.17134173913043477,1.6,CC
GO:0034358,plasma lipoprotein particle,34,5,2.47,0.09718,1,0.1764363112391931,2.02,CC
GO:1990777,lipoprotein particle,34,5,2.47,0.09718,1,0.1764363112391931,2.02,CC
GO:0042641,actomyosin,98,11,7.12,0.09890,1,0.17904310344827587,1.54,CC
GO:0042383,sarcolemma,167,17,12.14,0.09991,1,0.18035329512893983,1.4,CC
GO:0099738,cell cortex region,55,7,4,0.10225,1,0.18405,1.75,CC
GO:0030136,clathrin-coated vesicle,99,11,7.2,0.10437,1,0.18733076923076925,1.53,CC
GO:0000791,euchromatin,45,6,3.27,0.10561,1,0.18901789772727273,1.83,CC
GO:0005719,nuclear euchromatin,35,5,2.54,0.10696,1,0.19089178470254958,1.97,CC
GO:0030684,preribosome,78,9,5.67,0.11212,1,0.19953559322033898,1.59,CC
GO:0044449,contractile fiber part,206,20,14.97,0.11385,1,0.20204366197183102,1.34,CC
GO:0030054,cell junction,1144,94,83.16,0.11429,1,0.20225477528089889,1.13,CC
GO:0005732,small nucleolar ribonucleoprotein comple...,26,4,1.89,0.11615,1,0.20439804469273745,2.12,CC
GO:0097038,perinuclear endoplasmic reticulum,26,4,1.89,0.11615,1,0.20439804469273745,2.12,CC
GO:0016592,mediator complex,36,5,2.62,0.11720,1,0.2051,1.91,CC
GO:0032994,protein-lipid complex,36,5,2.62,0.11720,1,0.2051,1.91,CC
GO:0005884,actin filament,125,13,9.09,0.12167,1,0.21233268698060942,1.43,CC
GO:0043230,extracellular organelle,114,12,8.29,0.12490,1,0.21736740331491713,1.45,CC
GO:0030286,dynein complex,58,7,4.22,0.12622,1,0.2190595041322314,1.66,CC
GO:0030665,clathrin-coated vesicle membrane,37,5,2.69,0.12788,1,0.22072438356164384,1.86,CC
GO:0031463,Cul3-RING ubiquitin ligase complex,37,5,2.69,0.12788,1,0.22072438356164384,1.86,CC
GO:0097440,apical dendrite,27,4,1.96,0.12895,1,0.22196311475409836,2.04,CC
GO:0032590,dendrite membrane,48,6,3.49,0.13308,1,0.22844795640326976,1.72,CC
GO:0042734,presynaptic membrane,200,19,14.54,0.14002,1,0.23970815217391306,1.31,CC
GO:0071007,U2-type catalytic step 2 spliceosome,28,4,2.04,0.14229,1,0.2429341463414634,1.96,CC
GO:0005901,caveola,94,10,6.83,0.14451,1,0.24605756756756755,1.46,CC
GO:0005811,lipid droplet,83,9,6.03,0.14795,1,0.25056048387096774,1.49,CC
GO:1902554,serine/threonine protein kinase complex,83,9,6.03,0.14795,1,0.25056048387096774,1.49,CC
GO:0090575,RNA polymerase II transcription factor c...,166,16,12.07,0.15137,1,0.2556651474530831,1.33,CC
GO:0098686,hippocampal mossy fiber to CA3 synapse,50,6,3.63,0.15308,1,0.2574936,1.65,CC
GO:0030016,myofibril,215,20,15.63,0.15327,1,0.2574936,1.28,CC
GO:0030667,secretory granule membrane,84,9,6.11,0.15573,1,0.260930585106383,1.47,CC
GO:0030125,clathrin vesicle coat,29,4,2.11,0.15616,1,0.26095702917771885,1.9,CC
GO:0001650,fibrillar center,131,13,9.52,0.15677,1,0.2612833333333333,1.37,CC
GO:0014704,intercalated disc,63,7,4.58,0.17178,1,0.2855445910290237,1.53,CC
GO:0097223,sperm part,244,22,17.74,0.17388,1,0.2872832898172324,1.24,CC
GO:0005849,mRNA cleavage factor complex,20,3,1.45,0.17425,1,0.2872832898172324,2.07,CC
GO:0031091,platelet alpha granule,20,3,1.45,0.17425,1,0.2872832898172324,2.07,CC
GO:0000152,nuclear ubiquitin ligase complex,41,5,2.98,0.17465,1,0.2872832898172324,1.68,CC
GO:0045177,apical part of cell,422,36,30.68,0.17920,1,0.29339767441860465,1.17,CC
GO:0001725,stress fiber,87,9,6.32,0.18023,1,0.29339767441860465,1.42,CC
GO:0043195,terminal bouton,87,9,6.32,0.18023,1,0.29339767441860465,1.42,CC
GO:0097517,contractile actin filament bundle,87,9,6.32,0.18023,1,0.29339767441860465,1.42,CC
GO:0044452,nucleolar part,184,17,13.38,0.18388,1,0.2985680412371134,1.27,CC
GO:0008023,transcription elongation factor complex,53,6,3.85,0.18538,1,0.30022982005141385,1.56,CC
GO:0055029,nuclear DNA-directed RNA polymerase comp...,100,10,7.27,0.19010,1,0.3070846153846154,1.38,CC
GO:0000242,pericentriolar material,21,3,1.53,0.19301,1,0.3086200507614213,1.96,CC
GO:0012507,ER to Golgi transport vesicle membrane,21,3,1.53,0.19301,1,0.3086200507614213,1.96,CC
GO:0035267,NuA4 histone acetyltransferase complex,21,3,1.53,0.19301,1,0.3086200507614213,1.96,CC
GO:0043189,H4/H2A histone acetyltransferase complex,21,3,1.53,0.19301,1,0.3086200507614213,1.96,CC
GO:0016591,"RNA polymerase II, holoenzyme",77,8,5.6,0.19547,1,0.3117622784810127,1.43,CC
GO:0000428,DNA-directed RNA polymerase complex,101,10,7.34,0.19826,1,0.31541363636363634,1.36,CC
GO:0008076,voltage-gated potassium channel complex,78,8,5.67,0.20500,1,0.32531486146095717,1.41,CC
GO:0098889,intrinsic component of presynaptic membr...,128,12,9.3,0.22020,1,0.34855778894472367,1.29,CC
GO:0099056,integral component of presynaptic membra...,116,11,8.43,0.22211,1,0.350595,1.3,CC
GO:0005925,focal adhesion,153,14,11.12,0.22260,1,0.350595,1.26,CC
GO:0030880,RNA polymerase complex,104,10,7.56,0.22362,1,0.35132319201995016,1.32,CC
GO:0030055,cell-substrate junction,166,15,12.07,0.22652,1,0.3537356435643565,1.24,CC
GO:0005778,peroxisomal membrane,45,5,3.27,0.22684,1,0.3537356435643565,1.53,CC
GO:0031903,microbody membrane,45,5,3.27,0.22684,1,0.3537356435643565,1.53,CC
GO:0032588,trans-Golgi network membrane,34,4,2.47,0.23182,1,0.3562726829268293,1.62,CC
GO:0034364,high-density lipoprotein particle,23,3,1.67,0.23186,1,0.3562726829268293,1.8,CC
GO:0035371,microtubule plus-end,23,3,1.67,0.23186,1,0.3562726829268293,1.8,CC
GO:0046930,pore complex,23,3,1.67,0.23186,1,0.3562726829268293,1.8,CC
GO:0071782,endoplasmic reticulum tubular network,23,3,1.67,0.23186,1,0.3562726829268293,1.8,CC
GO:0099243,extrinsic component of synaptic membrane,23,3,1.67,0.23186,1,0.3562726829268293,1.8,CC
GO:0031248,protein acetyltransferase complex,93,9,6.76,0.23385,1,0.3575861650485437,1.33,CC
GO:1902493,acetyltransferase complex,93,9,6.76,0.23385,1,0.3575861650485437,1.33,CC
GO:0016324,apical plasma membrane,320,27,23.26,0.23642,1,0.36064067796610166,1.16,CC
GO:0044454,nuclear chromosome part,621,50,45.14,0.24359,1,0.3706804347826087,1.11,CC
GO:0044798,nuclear transcription factor complex,207,18,15.05,0.24788,1,0.37629975903614454,1.2,CC
GO:0030018,Z disc,133,12,9.67,0.26003,1,0.39379543269230766,1.24,CC
GO:0044291,cell-cell contact zone,84,8,6.11,0.26561,1,0.40128129496402876,1.31,CC
GO:0005924,cell-substrate adherens junction,159,14,11.56,0.26658,1,0.40178325358851674,1.21,CC
GO:0000228,nuclear chromosome,655,52,47.61,0.27185,1,0.40792500000000004,1.09,CC
GO:0030687,"preribosome, large subunit precursor",25,3,1.82,0.27195,1,0.40792500000000004,1.65,CC
GO:0031965,nuclear membrane,237,20,17.23,0.27588,1,0.412837054631829,1.16,CC
GO:0031594,neuromuscular junction,98,9,7.12,0.28237,1,0.4215476303317536,1.26,CC
GO:0030315,T-tubule,74,7,5.38,0.29113,1,0.4335978723404255,1.3,CC
GO:0005903,brush border,137,12,9.96,0.29355,1,0.4361709905660377,1.2,CC
GO:0005669,transcription factor TFIID complex,38,4,2.76,0.29748,1,0.44097035294117654,1.45,CC
GO:0060076,excitatory synapse,76,7,5.52,0.31472,1,0.465430985915493,1.27,CC
GO:0034705,potassium channel complex,89,8,6.47,0.31957,1,0.47149672131147546,1.24,CC
GO:0031526,brush border membrane,77,7,5.6,0.32664,1,0.4808018691588785,1.25,CC
GO:0016235,aggresome,40,4,2.91,0.33116,1,0.48631888111888116,1.37,CC
GO:0031045,dense core granule,28,3,2.04,0.33314,1,0.4880888372093023,1.47,CC
GO:1990351,transporter complex,325,26,23.63,0.33418,1,0.48847656612528995,1.1,CC
GO:0098862,cluster of actin-based cell projections,194,16,14.1,0.33686,1,0.49125416666666666,1.13,CC
GO:0005902,microvillus,92,8,6.69,0.35289,1,0.5120524137931034,1.2,CC
GO:0030140,trans-Golgi network transport vesicle,29,3,2.11,0.35356,1,0.5120524137931034,1.42,CC
GO:0090568,nuclear transcriptional repressor comple...,29,3,2.11,0.35356,1,0.5120524137931034,1.42,CC
GO:0034708,methyltransferase complex,118,10,8.58,0.35477,1,0.512626376146789,1.17,CC
GO:0031674,I band,145,12,10.54,0.36368,1,0.5242983981693364,1.14,CC
GO:0097431,mitotic spindle pole,30,3,2.18,0.37390,1,0.5378013698630137,1.38,CC
GO:0035097,histone methyltransferase complex,94,8,6.83,0.37532,1,0.5386141230068336,1.17,CC
GO:0005667,transcription factor complex,426,33,30.97,0.37734,1,0.5402822727272728,1.07,CC
GO:0031461,cullin-RING ubiquitin ligase complex,160,13,11.63,0.38002,1,0.5428857142857143,1.12,CC
GO:0031312,extrinsic component of organelle membran...,56,5,4.07,0.38543,1,0.549368552036199,1.23,CC
GO:1990752,microtubule end,31,3,2.25,0.39411,1,0.560472460496614,1.33,CC
GO:0005871,kinesin complex,57,5,4.14,0.40017,1,0.5678087837837837,1.21,CC
GO:0032281,AMPA glutamate receptor complex,32,3,2.33,0.41414,1,0.5847302013422819,1.29,CC
GO:0080008,Cul4-RING E3 ubiquitin ligase complex,32,3,2.33,0.41414,1,0.5847302013422819,1.29,CC
GO:0045171,intercellular bridge,58,5,4.22,0.41488,1,0.5847302013422819,1.18,CC
GO:0099240,intrinsic component of synaptic membrane,246,19,17.88,0.42617,1,0.5993015625,1.06,CC
GO:0031616,spindle pole centrosome,20,2,1.45,0.43247,1,0.6041155210643017,1.38,CC
GO:0043083,synaptic cleft,20,2,1.45,0.43247,1,0.6041155210643017,1.38,CC
GO:0044232,organelle membrane contact site,20,2,1.45,0.43247,1,0.6041155210643017,1.38,CC
GO:0000781,"chromosome, telomeric region",114,9,8.29,0.44899,1,0.6258046460176991,1.09,CC
GO:0016323,basolateral plasma membrane,236,18,17.16,0.45151,1,0.6279278145695365,1.05,CC
GO:0042611,MHC protein complex,21,2,1.53,0.45767,1,0.6350927312775331,1.31,CC
GO:0001669,acrosomal vesicle,129,10,9.38,0.46414,1,0.6426553846153846,1.07,CC
GO:0015030,Cajal body,35,3,2.54,0.47279,1,0.6531967105263158,1.18,CC
GO:0030118,clathrin coat,49,4,3.56,0.48132,1,0.6633157205240174,1.12,CC
GO:0043194,axon initial segment,22,2,1.6,0.48222,1,0.6633157205240174,1.25,CC
GO:0099699,integral component of synaptic membrane,228,17,16.57,0.49318,1,0.6769137254901961,1.03,CC
GO:0035861,site of double-strand break,50,4,3.63,0.49732,1,0.6811121739130435,1.1,CC
GO:0001673,male germ cell nucleus,23,2,1.67,0.50606,1,0.6871073275862069,1.2,CC
GO:0005797,Golgi medial cisterna,23,2,1.67,0.50606,1,0.6871073275862069,1.2,CC
GO:0045120,pronucleus,23,2,1.67,0.50606,1,0.6871073275862069,1.2,CC
GO:0097470,ribbon synapse,23,2,1.67,0.50606,1,0.6871073275862069,1.2,CC
GO:0090734,site of DNA damage,65,5,4.73,0.51524,1,0.6975327623126337,1.06,CC
GO:1902495,transmembrane transporter complex,314,23,22.83,0.51631,1,0.6975327623126337,1.01,CC
GO:0000784,"nuclear chromosome, telomeric region",79,6,5.74,0.51706,1,0.6975327623126337,1.05,CC
GO:0036126,sperm flagellum,121,9,8.8,0.52149,1,0.7020057692307693,1.02,CC
GO:0033017,sarcoplasmic reticulum membrane,24,2,1.74,0.52917,1,0.7078070063694267,1.15,CC
GO:0043601,nuclear replisome,24,2,1.74,0.52917,1,0.7078070063694267,1.15,CC
GO:0097346,INO80-type complex,24,2,1.74,0.52917,1,0.7078070063694267,1.15,CC
GO:0044450,microtubule organizing center part,165,12,11.99,0.54249,1,0.7240862288135593,1,CC
GO:0030894,replisome,25,2,1.82,0.55154,1,0.7315162105263158,1.1,CC
GO:0035327,transcriptionally active chromatin,25,2,1.82,0.55154,1,0.7315162105263158,1.1,CC
GO:0060077,inhibitory synapse,25,2,1.82,0.55154,1,0.7315162105263158,1.1,CC
GO:0019005,SCF ubiquitin ligase complex,68,5,4.94,0.55606,1,0.7359617647058824,1.01,CC
GO:0000123,histone acetyltransferase complex,83,6,6.03,0.56625,1,0.747877358490566,1,CC
GO:0070461,SAGA-type complex,26,2,1.89,0.57315,1,0.7554069037656904,1.06,CC
GO:0097729,9+2 motile cilium,128,9,9.3,0.59052,1,0.7766755741127349,0.97,CC
GO:0005795,Golgi stack,86,6,6.25,0.60149,1,0.789455625,0.96,CC
GO:0005913,cell-cell adherens junction,115,8,8.36,0.60333,1,0.7902243243243243,0.96,CC
GO:0005657,replication fork,72,5,5.23,0.60767,1,0.793904347826087,0.96,CC
GO:0005911,cell-cell junction,484,34,35.18,0.60866,1,0.793904347826087,0.97,CC
GO:0005912,adherens junction,301,21,21.88,0.61031,1,0.7944117768595041,0.96,CC
GO:1902562,H4 histone acetyltransferase complex,43,3,3.13,0.61375,1,0.7959907407407407,0.96,CC
GO:0097225,sperm midpiece,28,2,2.04,0.61405,1,0.7959907407407407,0.98,CC
GO:0098552,side of membrane,615,43,44.71,0.62885,1,0.8135020533880903,0.96,CC
GO:0005929,cilium,632,44,45.94,0.64120,1,0.8277786885245901,0.96,CC
GO:0030131,clathrin adaptor complex,30,2,2.18,0.65187,1,0.8330184584178498,0.92,CC
GO:0030686,90S preribosome,30,2,2.18,0.65187,1,0.8330184584178498,0.92,CC
GO:0043073,germ cell nucleus,30,2,2.18,0.65187,1,0.8330184584178498,0.92,CC
GO:0044665,MLL1/2 complex,30,2,2.18,0.65187,1,0.8330184584178498,0.92,CC
GO:0071339,MLL1 complex,30,2,2.18,0.65187,1,0.8330184584178498,0.92,CC
GO:0032391,photoreceptor connecting cilium,46,3,3.34,0.65960,1,0.8394909090909091,0.9,CC
GO:0034707,chloride channel complex,46,3,3.34,0.65960,1,0.8394909090909091,0.9,CC
GO:0034703,cation channel complex,224,15,16.28,0.66718,1,0.8437589999999999,0.92,CC
GO:0042470,melanosome,31,2,2.25,0.66965,1,0.8437589999999999,0.89,CC
GO:0045334,clathrin-coated endocytic vesicle,31,2,2.25,0.66965,1,0.8437589999999999,0.89,CC
GO:0048770,pigment granule,31,2,2.25,0.66965,1,0.8437589999999999,0.89,CC
GO:1902555,endoribonuclease complex,31,2,2.25,0.66965,1,0.8437589999999999,0.89,CC
GO:0005604,basement membrane,108,7,7.85,0.67753,1,0.8519838323353293,0.89,CC
GO:0098802,plasma membrane receptor complex,182,12,13.23,0.67896,1,0.8520812749003984,0.91,CC
GO:0099023,tethering complex,63,4,4.58,0.68113,1,0.8531051689860836,0.87,CC
GO:0034451,centriolar satellite,32,2,2.33,0.68669,1,0.8549697628458498,0.86,CC
GO:0099092,"postsynaptic density, intracellular comp...",32,2,2.33,0.68669,1,0.8549697628458498,0.86,CC
GO:1905348,endonuclease complex,32,2,2.33,0.68669,1,0.8549697628458498,0.86,CC
GO:0032421,stereocilium bundle,64,4,4.65,0.69312,1,0.861273372781065,0.86,CC
GO:0070161,anchoring junction,316,21,22.97,0.69760,1,0.8651338582677165,0.91,CC
GO:0031514,motile cilium,204,13,14.83,0.72834,1,0.9014817288801571,0.88,CC
GO:0097546,ciliary base,35,2,2.54,0.73348,1,0.9060635294117648,0.79,CC
GO:0005930,axoneme,130,8,9.45,0.73662,1,0.9081616438356165,0.85,CC
GO:0005814,centriole,115,7,8.36,0.73914,1,0.909488671875,0.84,CC
GO:0097014,ciliary plasm,131,8,9.52,0.74430,1,0.9140526315789473,0.84,CC
GO:0032809,neuronal cell body membrane,36,2,2.62,0.74770,1,0.9164416342412453,0.76,CC
GO:0060170,ciliary membrane,53,3,3.85,0.75082,1,0.9184788349514563,0.78,CC
GO:0032040,small-subunit processome,37,2,2.69,0.76126,1,0.9286833655705996,0.74,CC
GO:0032420,stereocilium,54,3,3.93,0.76211,1,0.9286833655705996,0.76,CC
GO:0000922,spindle pole,134,8,9.74,0.76638,1,0.9320837837837838,0.82,CC
GO:0044298,cell body membrane,38,2,2.76,0.77419,1,0.9361606525911709,0.72,CC
GO:0099091,"postsynaptic specialization, intracellul...",38,2,2.76,0.77419,1,0.9361606525911709,0.72,CC
GO:1990391,DNA repair complex,38,2,2.76,0.77419,1,0.9361606525911709,0.72,CC
GO:0016010,dystrophin-associated glycoprotein compl...,20,1,1.45,0.77911,1,0.9367162213740459,0.69,CC
GO:0031231,intrinsic component of peroxisomal membr...,20,1,1.45,0.77911,1,0.9367162213740459,0.69,CC
GO:0090665,glycoprotein complex,20,1,1.45,0.77911,1,0.9367162213740459,0.69,CC
GO:0071944,cell periphery,5388,379,391.67,0.78729,1,0.944748,0.97,CC
GO:0008328,ionotropic glutamate receptor complex,57,3,4.14,0.79348,1,0.9487943181818181,0.72,CC
GO:0030992,intraciliary transport particle B,21,1,1.53,0.79518,1,0.9487943181818181,0.65,CC
GO:1902710,GABA receptor complex,21,1,1.53,0.79518,1,0.9487943181818181,0.65,CC
GO:0001917,photoreceptor inner segment,58,3,4.22,0.80314,1,0.9546758490566037,0.71,CC
GO:0016328,lateral plasma membrane,58,3,4.22,0.80314,1,0.9546758490566037,0.71,CC
GO:0043596,nuclear replication fork,41,2,2.98,0.80935,1,0.9577891181988744,0.67,CC
GO:0016327,apicolateral plasma membrane,22,1,1.6,0.81009,1,0.9577891181988744,0.62,CC
GO:0009986,cell surface,955,63,69.42,0.81032,1,0.9577891181988744,0.91,CC
GO:0098878,neurotransmitter receptor complex,59,3,4.29,0.81242,1,0.9584730337078652,0.7,CC
GO:0005637,nuclear inner membrane,42,2,3.05,0.81994,1,0.9648016728624537,0.66,CC
GO:0016459,myosin complex,60,3,4.36,0.82132,1,0.9648016728624537,0.69,CC
GO:0002080,acrosomal membrane,23,1,1.67,0.82391,1,0.9648016728624537,0.6,CC
GO:0098831,presynaptic active zone cytoplasmic comp...,23,1,1.67,0.82391,1,0.9648016728624537,0.6,CC
GO:0032993,protein-DNA complex,191,11,13.88,0.82767,1,0.9665133333333333,0.79,CC
GO:0034702,ion channel complex,299,18,21.74,0.82844,1,0.9665133333333333,0.83,CC
GO:0045211,postsynaptic membrane,376,23,27.33,0.83339,1,0.9704911275415897,0.84,CC
GO:0031985,Golgi cisterna,62,3,4.51,0.83805,1,0.9741171586715867,0.67,CC
GO:0099146,intrinsic component of postsynaptic dens...,80,4,5.82,0.84230,1,0.9772541436464088,0.69,CC
GO:0098839,postsynaptic density membrane,98,5,7.12,0.84868,1,0.9828463235294118,0.7,CC
GO:0098936,intrinsic component of postsynaptic memb...,180,10,13.08,0.85062,1,0.983285504587156,0.76,CC
GO:0030119,AP-type membrane coat adaptor complex,48,2,3.49,0.87305,1,1,0.57,CC
GO:0099055,integral component of postsynaptic membr...,171,9,12.43,0.88147,1,1,0.72,CC
GO:0005923,bicellular tight junction,122,6,8.87,0.88600,1,1,0.68,CC
GO:0000780,"condensed nuclear chromosome, centromeri...",29,1,2.11,0.88810,1,1,0.47,CC
GO:0016342,catenin complex,29,1,2.11,0.88810,1,1,0.47,CC
GO:0030990,intraciliary transport particle,29,1,2.11,0.88810,1,1,0.47,CC
GO:0000786,nucleosome,88,4,6.4,0.89048,1,1,0.62,CC
GO:0000779,"condensed chromosome, centromeric region",51,2,3.71,0.89382,1,1,0.54,CC
GO:0005865,striated muscle thin filament,30,1,2.18,0.89624,1,1,0.46,CC
GO:0005942,phosphatidylinositol 3-kinase complex,30,1,2.18,0.89624,1,1,0.46,CC
GO:0043296,apical junction complex,142,7,10.32,0.89851,1,1,0.68,CC
GO:0035869,ciliary transition zone,73,3,5.31,0.90777,1,1,0.56,CC
GO:0005886,plasma membrane,5243,360,381.13,0.90779,1,1,0.94,CC
GO:0044441,ciliary part,464,27,33.73,0.90781,1,1,0.8,CC
GO:0008305,integrin complex,32,1,2.33,0.91080,1,1,0.43,CC
GO:0036379,myofilament,32,1,2.33,0.91080,1,1,0.43,CC
GO:0099061,integral component of postsynaptic densi...,74,3,5.38,0.91252,1,1,0.56,CC
GO:0070160,tight junction,129,6,9.38,0.91426,1,1,0.64,CC
GO:0044459,plasma membrane part,2879,192,209.28,0.91612,1,1,0.92,CC
GO:0005921,gap junction,33,1,2.4,0.91729,1,1,0.42,CC
GO:0098688,parallel fiber to Purkinje cell synapse,33,1,2.4,0.91729,1,1,0.42,CC
GO:0062023,collagen-containing extracellular matrix,360,20,26.17,0.91843,1,1,0.76,CC
GO:0036064,ciliary basal body,148,7,10.76,0.91964,1,1,0.65,CC
GO:0044815,DNA packaging complex,96,4,6.98,0.92525,1,1,0.57,CC
GO:0000777,condensed chromosome kinetochore,35,1,2.54,0.92890,1,1,0.39,CC
GO:0097731,9+0 non-motile cilium,116,5,8.43,0.93055,1,1,0.59,CC
GO:0097730,non-motile cilium,152,7,11.05,0.93151,1,1,0.63,CC
GO:0031941,filamentous actin,37,1,2.69,0.93887,1,1,0.37,CC
GO:0098636,protein complex involved in cell adhesio...,37,1,2.69,0.93887,1,1,0.37,CC
GO:0099634,postsynaptic specialization membrane,137,6,9.96,0.93892,1,1,0.6,CC
GO:0000788,nuclear nucleosome,38,1,2.76,0.94333,1,1,0.36,CC
GO:0031225,anchored component of membrane,192,9,13.96,0.94414,1,1,0.64,CC
GO:0045095,keratin filament,40,1,2.91,0.95128,1,1,0.34,CC
GO:0034704,calcium channel complex,64,2,4.65,0.95218,1,1,0.43,CC
GO:0005882,intermediate filament,125,5,9.09,0.95426,1,1,0.55,CC
GO:0045178,basal part of cell,66,2,4.8,0.95782,1,1,0.42,CC
GO:0009925,basal plasma membrane,43,1,3.13,0.96117,1,1,0.32,CC
GO:0045111,intermediate filament cytoskeleton,166,7,12.07,0.96179,1,1,0.58,CC
GO:0098948,intrinsic component of postsynaptic spec...,113,4,8.21,0.96836,1,1,0.49,CC
GO:0097733,photoreceptor cell cilium,114,4,8.29,0.96998,1,1,0.48,CC
GO:0043235,receptor complex,396,20,28.79,0.97051,1,1,0.69,CC
GO:0046658,anchored component of plasma membrane,73,2,5.31,0.97296,1,1,0.38,CC
GO:0044420,extracellular matrix component,52,1,3.78,0.98034,1,1,0.26,CC
GO:0001750,photoreceptor outer segment,80,2,5.82,0.98278,1,1,0.34,CC
GO:0099060,integral component of postsynaptic speci...,107,3,7.78,0.98640,1,1,0.39,CC
GO:0000793,condensed chromosome,197,7,14.32,0.99066,1,1,0.49,CC
GO:0005615,extracellular space,1621,93,117.83,0.99524,1,1,0.79,CC
GO:0031012,extracellular matrix,477,21,34.67,0.99645,1,1,0.61,CC
GO:0044421,extracellular region part,1855,104,134.84,0.99877,1,1,0.77,CC
GO:0016442,RISC complex,123,2,8.94,0.99903,1,1,0.22,CC
GO:0031332,RNAi effector complex,123,2,8.94,0.99903,1,1,0.22,CC
GO:0009897,external side of plasma membrane,434,16,31.55,0.99946,1,1,0.51,CC
GO:0000794,condensed nuclear chromosome,144,2,10.47,0.99977,1,1,0.19,CC
GO:0005576,extracellular region,2399,118,174.39,1.00000,1,1,0.68,CC
GO:0016021,integral component of membrane,5896,341,428.59,1.00000,1,1,0.8,CC
GO:0031224,intrinsic component of membrane,6068,352,441.1,1.00000,1,1,0.8,CC
GO:0005887,integral component of plasma membrane,1526,56,110.93,1.00000,1,1,0.5,CC
GO:0031226,intrinsic component of plasma membrane,1604,59,116.6,1.00000,1,1,0.51,CC
GO:0005575,cellular_component,21419,1557,1557,1.00000,1,1,1,CC
GO:0000178,exosome (RNase complex),23,0,1.67,1.00000,1,1,0,CC
GO:0000795,synaptonemal complex,81,0,5.89,1.00000,1,1,0,CC
GO:0000930,gamma-tubulin complex,20,0,1.45,1.00000,1,1,0,CC
GO:0001533,cornified envelope,56,0,4.07,1.00000,1,1,0,CC
GO:0005581,collagen trimer,83,0,6.03,1.00000,1,1,0,CC
GO:0005858,axonemal dynein complex,24,0,1.74,1.00000,1,1,0,CC
GO:0005891,voltage-gated calcium channel complex,45,0,3.27,1.00000,1,1,0,CC
GO:0005922,connexin complex,20,0,1.45,1.00000,1,1,0,CC
GO:0018995,host,24,0,1.74,1.00000,1,1,0,CC
GO:0030057,desmosome,25,0,1.82,1.00000,1,1,0,CC
GO:0031233,intrinsic component of external side of ...,25,0,1.82,1.00000,1,1,0,CC
GO:0031362,anchored component of external side of p...,22,0,1.6,1.00000,1,1,0,CC
GO:0032426,stereocilium tip,20,0,1.45,1.00000,1,1,0,CC
GO:0033643,host cell part,22,0,1.6,1.00000,1,1,0,CC
GO:0033646,host intracellular part,20,0,1.45,1.00000,1,1,0,CC
GO:0034706,sodium channel complex,24,0,1.74,1.00000,1,1,0,CC
GO:0043656,intracellular region of host,20,0,1.45,1.00000,1,1,0,CC
GO:0043657,host cell,24,0,1.74,1.00000,1,1,0,CC
GO:0044215,other organism,30,0,2.18,1.00000,1,1,0,CC
GO:0044216,other organism cell,30,0,2.18,1.00000,1,1,0,CC
GO:0044217,other organism part,30,0,2.18,1.00000,1,1,0,CC
GO:0044447,axoneme part,40,0,2.91,1.00000,1,1,0,CC
GO:0061702,inflammasome complex,21,0,1.53,1.00000,1,1,0,CC
GO:0097228,sperm principal piece,32,0,2.33,1.00000,1,1,0,CC
GO:0099086,synaptonemal structure,81,0,5.89,1.00000,1,1,0,CC
GO:1905354,exoribonuclease complex,23,0,1.67,1.00000,1,1,0,CC
